BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 001566
(1052 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 199 bits (506), Expect = 7e-51, Method: Composition-based stats.
Identities = 104/270 (38%), Positives = 162/270 (60%), Gaps = 3/270 (1%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHK 831
A+ NFS +N++G GGFG YK L G LVAVK+L R QG + QF E+ + H+
Sbjct: 36 ASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHR 95
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAYL 889
NL+ L G+ + E LVY +++ G++ + + ++ S + W +IA+ A+ LAYL
Sbjct: 96 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYL 155
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
H C P+I+HRD+K +NILLDEE A + DFGLA+L++ + H V GT G++APEY
Sbjct: 156 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYL 215
Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
+T + S+K DV+ +GV+LLELI+G+R+ D + + ++ W K L+KE + L
Sbjct: 216 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDV 275
Query: 1010 ELWEAGPQENLLGMMRLASTCTVETLSTRP 1039
+L E + ++++A CT + RP
Sbjct: 276 DLQGNYKDEEVEQLIQVALLCTQSSPMERP 305
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant
Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 195 bits (495), Expect = 1e-49, Method: Composition-based stats.
Identities = 102/270 (37%), Positives = 160/270 (59%), Gaps = 3/270 (1%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHK 831
A+ NF +N++G GGFG YK L G LVAVK+L R QG + QF E+ + H+
Sbjct: 28 ASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 87
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAYL 889
NL+ L G+ + E LVY +++ G++ + + ++ S + W +IA+ A+ LAYL
Sbjct: 88 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYL 147
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
H C P+I+HRD+K +NILLDEE A + DFGLA+L++ + H V G G++APEY
Sbjct: 148 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYL 207
Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
+T + S+K DV+ +GV+LLELI+G+R+ D + + ++ W K L+KE + L
Sbjct: 208 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDV 267
Query: 1010 ELWEAGPQENLLGMMRLASTCTVETLSTRP 1039
+L E + ++++A CT + RP
Sbjct: 268 DLQGNYKDEEVEQLIQVALLCTQSSPMERP 297
>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1
pdb|3RGZ|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1
Length = 768
Score = 150 bits (379), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 181/645 (28%), Positives = 265/645 (41%), Gaps = 134/645 (20%)
Query: 53 LLSFKASISRDPSNLLATWNSSTDHCTWHGVTCDHFTGRVTALRITGKATPWPSKS---- 108
L+SFK + NLL W+S+ + CT+ GVTC +VT++ ++ K +
Sbjct: 17 LISFKDVLPD--KNLLPDWSSNKNPCTFDGVTCRD--DKVTSIDLSSKPLNVGFSAVSSS 72
Query: 109 --------------SVISGTLSASIAKLTELRTLSVPHNSFSGEIPAXXXXXXXXXXXXX 154
S I+G++S L +L + NS SG +
Sbjct: 73 LLSLTGLESLFLSNSHINGSVSGFKCS-ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFL 131
Query: 155 QGNNFSGKIPYQMS---NLERLRVLNLSFNSFSGEVPRGLI---GNGELSVIDMSSNRLS 208
++ + P ++S L L VL+LS NS SG G + G GEL + +S N++S
Sbjct: 132 NVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKIS 191
Query: 209 GGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTIS 268
G + + S C L +L +S N + IP +G C L++L + GN L G + I T +
Sbjct: 192 GDVDV---SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCT 247
Query: 269 ELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLL 328
ELK+L++S N IP P L
Sbjct: 248 ELKLLNISSNQFVGPIP-------------------------------------PLPL-- 268
Query: 329 SRSLEVLWAPRANLGGRLPDNWSESC-SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSL 387
+SL+ L G +PD S +C +L L+L N GAVP G C L L LS
Sbjct: 269 -KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 327
Query: 388 NNLEGYLPMQ--LPVPCMVYFNVSQNNITGVLPR-FENVSCDNHFGFQDLQYANVPVMGS 444
NN G LPM L + + ++S N +G LP N+S
Sbjct: 328 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS------------------ 369
Query: 445 ISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKC 504
++ D S N F G I L L NN F G +P
Sbjct: 370 ------LLTLDLSSNNFSG-----PILPNLCQNPKNTLQELYLQNNGFTGKIP------- 411
Query: 505 NDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLR 564
L +C +LV + N +SG+I + +G L KL+ L L
Sbjct: 412 ---------------------PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 565 GNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASL 624
N + G +P EL +K L+ ++L N+LTGEIPS + +L + LS+N LTG IP +
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 510
Query: 625 TKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP 669
+ L L L++N SG IP +L LDL+ N +G IP
Sbjct: 511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555
Score = 146 bits (368), Expect = 6e-35, Method: Compositional matrix adjust.
Identities = 177/603 (29%), Positives = 269/603 (44%), Gaps = 87/603 (14%)
Query: 124 ELRTLSVPHNSFSGEIPAXXXXXXXXXXXXXQGNNFSGKIPYQMSNLERLRVLNLSFNSF 183
EL+ L++ N SG++ NNFS IP+ + + L+ L++S N
Sbjct: 179 ELKHLAISGNKISGDVDVSRCVNLEFLDV--SSNNFSTGIPF-LGDCSALQHLDISGNKL 235
Query: 184 SGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEI-GK 242
SG+ R + EL ++++SSN+ G + + L YL L++N T IP + G
Sbjct: 236 SGDFSRAISTCTELKLLNISSNQFVGPIP---PLPLKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 243 CRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVE-LADCSKLSVL---- 297
C L L L GN G++P G+ S L+ L +S N+ + +P++ L L VL
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 352
Query: 298 ---------VLTNIDASL-DLDNSRGEFSAFDGGVPYELLLS--RSLEVLWAPRANLGGR 345
LTN+ ASL LD S FS G + L + +L+ L+ G+
Sbjct: 353 NEFSGELPESLTNLSASLLTLDLSSNNFS---GPILPNLCQNPKNTLQELYLQNNGFTGK 409
Query: 346 LPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLP-VPCMV 404
+P S L L+L N L G +P SLG L L L LN LEG +P +L V +
Sbjct: 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE 469
Query: 405 YFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISD-----ENFVIIHDFSGN 459
+ N++TG +P N + +N + G I EN I+ S N
Sbjct: 470 TLILDFNDLTGEIPS----GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK-LSNN 524
Query: 460 KFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLL 519
F G++P +GD + L LN N+FNG++P + S ++AN +
Sbjct: 525 SFSGNIPA-ELGD------CRSLIWLDLNTNLFNGTIPAAMFKQ-------SGKIAANFI 570
Query: 520 SGMSYEAFLLDCVQ--------LVEFEAANNQISGSIAAGVGKLMKLQRLDLRG-----N 566
+G Y D ++ L+EF+ ++ +L RL R +
Sbjct: 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSE-------------QLNRLSTRNPCNITS 617
Query: 567 RVSGSLP----DELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPA 622
RV G D G + FL + N L+G IP + G + L +L+L HN ++GSIP
Sbjct: 618 RVYGGHTSPTFDNNGSMMFLD---MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674
Query: 623 SLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGN 682
+ L L L+ N+L G IP + S L L+ +DLS NNLSG IP + + F
Sbjct: 675 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE--TFPPA 732
Query: 683 KYL 685
K+L
Sbjct: 733 KFL 735
Score = 64.3 bits (155), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 71/293 (24%), Positives = 113/293 (38%), Gaps = 51/293 (17%)
Query: 109 SVISGTLSASIAKLTELRTLSVPHNSFSGEIPAXXXXXXXXXXXXXQGNNFSGKIPYQMS 168
+++ G + + + L TL + N +GEIP+ N +G+IP +
Sbjct: 452 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG 511
Query: 169 NLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLS 228
LE L +L LS NSFSG +P L L +D+++N +G + F K++
Sbjct: 512 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP-----AAMFKQSGKIA 566
Query: 229 DNFLT---------ESIPKEIGKCRNLKNLL--------------------LDGNILEGS 259
NF+ + + KE C NLL + + G
Sbjct: 567 ANFIAGKRYVYIKNDGMKKE---CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGH 623
Query: 260 IPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFD 319
+ LD+S N L+ IP E+ L +L L + D S
Sbjct: 624 TSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS-------------- 669
Query: 320 GGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPK 372
G +P E+ R L +L L GR+P S L ++L N+L G +P+
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 722
>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1
Ectodomain
pdb|3RJ0|A Chain A, Plant Steroid Receptor Bri1 Ectodomain In Complex With
Brassinolide
Length = 772
Score = 150 bits (379), Expect = 4e-36, Method: Compositional matrix adjust.
Identities = 181/645 (28%), Positives = 265/645 (41%), Gaps = 134/645 (20%)
Query: 53 LLSFKASISRDPSNLLATWNSSTDHCTWHGVTCDHFTGRVTALRITGKATPWPSKS---- 108
L+SFK + NLL W+S+ + CT+ GVTC +VT++ ++ K +
Sbjct: 14 LISFKDVLPD--KNLLPDWSSNKNPCTFDGVTCRD--DKVTSIDLSSKPLNVGFSAVSSS 69
Query: 109 --------------SVISGTLSASIAKLTELRTLSVPHNSFSGEIPAXXXXXXXXXXXXX 154
S I+G++S L +L + NS SG +
Sbjct: 70 LLSLTGLESLFLSNSHINGSVSGFKCS-ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFL 128
Query: 155 QGNNFSGKIPYQMS---NLERLRVLNLSFNSFSGEVPRGLI---GNGELSVIDMSSNRLS 208
++ + P ++S L L VL+LS NS SG G + G GEL + +S N++S
Sbjct: 129 NVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKIS 188
Query: 209 GGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTIS 268
G + + S C L +L +S N + IP +G C L++L + GN L G + I T +
Sbjct: 189 GDVDV---SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCT 244
Query: 269 ELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLL 328
ELK+L++S N IP P L
Sbjct: 245 ELKLLNISSNQFVGPIP-------------------------------------PLPL-- 265
Query: 329 SRSLEVLWAPRANLGGRLPDNWSESC-SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSL 387
+SL+ L G +PD S +C +L L+L N GAVP G C L L LS
Sbjct: 266 -KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 324
Query: 388 NNLEGYLPMQ--LPVPCMVYFNVSQNNITGVLPR-FENVSCDNHFGFQDLQYANVPVMGS 444
NN G LPM L + + ++S N +G LP N+S
Sbjct: 325 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS------------------ 366
Query: 445 ISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKC 504
++ D S N F G I L L NN F G +P
Sbjct: 367 ------LLTLDLSSNNFSG-----PILPNLCQNPKNTLQELYLQNNGFTGKIP------- 408
Query: 505 NDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLR 564
L +C +LV + N +SG+I + +G L KL+ L L
Sbjct: 409 ---------------------PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 447
Query: 565 GNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASL 624
N + G +P EL +K L+ ++L N+LTGEIPS + +L + LS+N LTG IP +
Sbjct: 448 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 507
Query: 625 TKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP 669
+ L L L++N SG IP +L LDL+ N +G IP
Sbjct: 508 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 552
Score = 146 bits (368), Expect = 7e-35, Method: Compositional matrix adjust.
Identities = 177/603 (29%), Positives = 269/603 (44%), Gaps = 87/603 (14%)
Query: 124 ELRTLSVPHNSFSGEIPAXXXXXXXXXXXXXQGNNFSGKIPYQMSNLERLRVLNLSFNSF 183
EL+ L++ N SG++ NNFS IP+ + + L+ L++S N
Sbjct: 176 ELKHLAISGNKISGDVDVSRCVNLEFLDV--SSNNFSTGIPF-LGDCSALQHLDISGNKL 232
Query: 184 SGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEI-GK 242
SG+ R + EL ++++SSN+ G + + L YL L++N T IP + G
Sbjct: 233 SGDFSRAISTCTELKLLNISSNQFVGPIP---PLPLKSLQYLSLAENKFTGEIPDFLSGA 289
Query: 243 CRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVE-LADCSKLSVL---- 297
C L L L GN G++P G+ S L+ L +S N+ + +P++ L L VL
Sbjct: 290 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 349
Query: 298 ---------VLTNIDASL-DLDNSRGEFSAFDGGVPYELLLS--RSLEVLWAPRANLGGR 345
LTN+ ASL LD S FS G + L + +L+ L+ G+
Sbjct: 350 NEFSGELPESLTNLSASLLTLDLSSNNFS---GPILPNLCQNPKNTLQELYLQNNGFTGK 406
Query: 346 LPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLP-VPCMV 404
+P S L L+L N L G +P SLG L L L LN LEG +P +L V +
Sbjct: 407 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE 466
Query: 405 YFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISD-----ENFVIIHDFSGN 459
+ N++TG +P N + +N + G I EN I+ S N
Sbjct: 467 TLILDFNDLTGEIPS----GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK-LSNN 521
Query: 460 KFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLL 519
F G++P +GD + L LN N+FNG++P + S ++AN +
Sbjct: 522 SFSGNIPA-ELGD------CRSLIWLDLNTNLFNGTIPAAMFKQ-------SGKIAANFI 567
Query: 520 SGMSYEAFLLDCVQ--------LVEFEAANNQISGSIAAGVGKLMKLQRLDLRG-----N 566
+G Y D ++ L+EF+ ++ +L RL R +
Sbjct: 568 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSE-------------QLNRLSTRNPCNITS 614
Query: 567 RVSGSLP----DELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPA 622
RV G D G + FL + N L+G IP + G + L +L+L HN ++GSIP
Sbjct: 615 RVYGGHTSPTFDNNGSMMFLD---MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 671
Query: 623 SLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGN 682
+ L L L+ N+L G IP + S L L+ +DLS NNLSG IP + + F
Sbjct: 672 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE--TFPPA 729
Query: 683 KYL 685
K+L
Sbjct: 730 KFL 732
Score = 64.3 bits (155), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 71/293 (24%), Positives = 113/293 (38%), Gaps = 51/293 (17%)
Query: 109 SVISGTLSASIAKLTELRTLSVPHNSFSGEIPAXXXXXXXXXXXXXQGNNFSGKIPYQMS 168
+++ G + + + L TL + N +GEIP+ N +G+IP +
Sbjct: 449 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG 508
Query: 169 NLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLS 228
LE L +L LS NSFSG +P L L +D+++N +G + F K++
Sbjct: 509 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP-----AAMFKQSGKIA 563
Query: 229 DNFLT---------ESIPKEIGKCRNLKNLL--------------------LDGNILEGS 259
NF+ + + KE C NLL + + G
Sbjct: 564 ANFIAGKRYVYIKNDGMKKE---CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGH 620
Query: 260 IPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFD 319
+ LD+S N L+ IP E+ L +L L + D S
Sbjct: 621 TSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS-------------- 666
Query: 320 GGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPK 372
G +P E+ R L +L L GR+P S L ++L N+L G +P+
Sbjct: 667 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 719
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 144 bits (364), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 98/271 (36%), Positives = 143/271 (52%), Gaps = 8/271 (2%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN 832
AT NF + LIG G FG YK L G VA+K+ + QGI++F+ EI TL RH +
Sbjct: 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS--GKKIQWSVIHKIAIDIAQALAYLH 890
LV+LIG+ EM L+Y ++ GNL+ ++ + W +I I A+ L YLH
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL-LEVSETHATTDVAGTFGYVAPEYA 949
I+HRD+K NILLDE ++DFG+++ E+ +TH V GT GY+ PEY
Sbjct: 157 TRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYF 213
Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
R+++K+DVYSFGVVL E++ + ++ S N+ WA G+ ++ P
Sbjct: 214 IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNNGQLEQIVDP 271
Query: 1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
L + E+L A C + RPS
Sbjct: 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 144 bits (364), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 98/271 (36%), Positives = 143/271 (52%), Gaps = 8/271 (2%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN 832
AT NF + LIG G FG YK L G VA+K+ + QGI++F+ EI TL RH +
Sbjct: 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS--GKKIQWSVIHKIAIDIAQALAYLH 890
LV+LIG+ EM L+Y ++ GNL+ ++ + W +I I A+ L YLH
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL-LEVSETHATTDVAGTFGYVAPEYA 949
I+HRD+K NILLDE ++DFG+++ E+ +TH V GT GY+ PEY
Sbjct: 157 TRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYF 213
Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
R+++K+DVYSFGVVL E++ + ++ S N+ WA G+ ++ P
Sbjct: 214 IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNNGQLEQIVDP 271
Query: 1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
L + E+L A C + RPS
Sbjct: 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 129 bits (324), Expect = 9e-30, Method: Compositional matrix adjust.
Identities = 87/217 (40%), Positives = 123/217 (56%), Gaps = 17/217 (7%)
Query: 774 TGNFSIR------NLIGTGGFGSTYKAELVPGYLVAVKKLS----IGRFQGIQQFDAEIG 823
T NF R N +G GGFG YK V VAVKKL+ I + QQFD EI
Sbjct: 24 TNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIK 82
Query: 824 TLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK-IQWSVIHKIAIDI 882
+ + +H+NLV L+G+ ++ LVY ++ G+L + G + W + KIA
Sbjct: 83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA 142
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE-VSETHATTDVAGTF 941
A + +LH + +HRDIK +NILLDE A +SDFGLAR E ++T + + GT
Sbjct: 143 ANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTT 199
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD 978
Y+APE A ++ K+D+YSFGVVLLE+I+G ++D
Sbjct: 200 AYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 235
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 128 bits (322), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 87/217 (40%), Positives = 122/217 (56%), Gaps = 17/217 (7%)
Query: 774 TGNFSIR------NLIGTGGFGSTYKAELVPGYLVAVKKLS----IGRFQGIQQFDAEIG 823
T NF R N +G GGFG YK V VAVKKL+ I + QQFD EI
Sbjct: 24 TNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIK 82
Query: 824 TLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK-IQWSVIHKIAIDI 882
+ + +H+NLV L+G+ ++ LVY ++ G+L + G + W + KIA
Sbjct: 83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA 142
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE-VSETHATTDVAGTF 941
A + +LH + +HRDIK +NILLDE A +SDFGLAR E ++T + GT
Sbjct: 143 ANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTT 199
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD 978
Y+APE A ++ K+D+YSFGVVLLE+I+G ++D
Sbjct: 200 AYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 235
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 126 bits (316), Expect = 7e-29, Method: Compositional matrix adjust.
Identities = 86/217 (39%), Positives = 121/217 (55%), Gaps = 17/217 (7%)
Query: 774 TGNFSIR------NLIGTGGFGSTYKAELVPGYLVAVKKLS----IGRFQGIQQFDAEIG 823
T NF R N +G GGFG YK V VAVKKL+ I + QQFD EI
Sbjct: 18 TNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIK 76
Query: 824 TLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK-IQWSVIHKIAIDI 882
+ + +H+NLV L+G+ ++ LVY ++ G+L + G + W + KIA
Sbjct: 77 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA 136
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE-VSETHATTDVAGTF 941
A + +LH + +HRDIK +NILLDE A +SDFGLAR E ++ + GT
Sbjct: 137 ANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTT 193
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD 978
Y+APE A ++ K+D+YSFGVVLLE+I+G ++D
Sbjct: 194 AYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 229
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 121 bits (303), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 86/217 (39%), Positives = 117/217 (53%), Gaps = 17/217 (7%)
Query: 774 TGNFSIR------NLIGTGGFGSTYKAELVPGYLVAVKKLS----IGRFQGIQQFDAEIG 823
T NF R N G GGFG YK V VAVKKL+ I + QQFD EI
Sbjct: 15 TNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIK 73
Query: 824 TLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK-IQWSVIHKIAIDI 882
+ +H+NLV L+G+ ++ LVY + G+L + G + W KIA
Sbjct: 74 VXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGA 133
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE-VSETHATTDVAGTF 941
A + +LH + +HRDIK +NILLDE A +SDFGLAR E ++ + + GT
Sbjct: 134 ANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTT 190
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD 978
Y APE A ++ K+D+YSFGVVLLE+I+G ++D
Sbjct: 191 AYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 226
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 115 bits (289), Expect = 9e-26, Method: Compositional matrix adjust.
Identities = 73/201 (36%), Positives = 113/201 (56%), Gaps = 8/201 (3%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKNL 833
+ +I+ IG G FG+ ++AE G VAVK L F + +F E+ + R+RH N+
Sbjct: 38 DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI--AIDIAQALAYLHY 891
V +G + +V +LS G+L +HK SG + Q ++ A D+A+ + YLH
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
P IVHRD+K N+L+D++ + DFGL+R L+ S + AGT ++APE
Sbjct: 156 RNPP-IVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLRD 213
Query: 952 CRVSDKADVYSFGVVLLELIS 972
++K+DVYSFGV+L EL +
Sbjct: 214 EPSNEKSDVYSFGVILWELAT 234
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 115 bits (287), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 72/201 (35%), Positives = 114/201 (56%), Gaps = 8/201 (3%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKNL 833
+ +I+ IG G FG+ ++AE G VAVK L F + +F E+ + R+RH N+
Sbjct: 38 DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI--AIDIAQALAYLHY 891
V +G + +V +LS G+L +H KSG + Q ++ A D+A+ + YLH
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
P IVHR++K N+L+D++ + DFGL+R L+ S ++ AGT ++APE
Sbjct: 156 RNPP-IVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 952 CRVSDKADVYSFGVVLLELIS 972
++K+DVYSFGV+L EL +
Sbjct: 214 EPSNEKSDVYSFGVILWELAT 234
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 109 bits (273), Expect = 6e-24, Method: Compositional matrix adjust.
Identities = 76/232 (32%), Positives = 116/232 (50%), Gaps = 26/232 (11%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQ----FDAEIGTLGRIRH 830
++ +IG GGFG Y+A + G VAVK + I Q E ++H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
N++ L G + E + LV F GG L + SGK+I ++ A+ IA+ + YLH
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLH 122
Query: 891 YSCVPRIVHRDIKPSNILLDEELN--------AYLSDFGLARLLEVSETHATTDV--AGT 940
+ I+HRD+K SNIL+ +++ ++DFGLAR E H TT + AG
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGA 177
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGK---RSLDPSFSEYGNGFN 989
+ ++APE S +DV+S+GV+L EL++G+ R +D YG N
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 102 bits (255), Expect = 9e-22, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
G ++ IG+G FG+ YK + V + ++ Q +Q F E+G L + RH N++
Sbjct: 35 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 94
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
+GY + ++ +V + G +L +H K +I IA AQ + YLH
Sbjct: 95 LFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 151
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATTCR 953
I+HRD+K +NI L E+L + DFGLA + S +H ++G+ ++APE R
Sbjct: 152 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 206
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
+ DK +DVY+FG+VL EL++G+
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTGQ 233
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 102 bits (255), Expect = 9e-22, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
G ++ IG+G FG+ YK + V + ++ Q +Q F E+G L + RH N++
Sbjct: 13 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
+GY + ++ +V + G +L +H K +I IA AQ + YLH
Sbjct: 73 LFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 129
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATTCR 953
I+HRD+K +NI L E+L + DFGLA + S +H ++G+ ++APE R
Sbjct: 130 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 184
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
+ DK +DVY+FG+VL EL++G+
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQ 211
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 102 bits (255), Expect = 9e-22, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
G ++ IG+G FG+ YK + V + ++ Q +Q F E+G L + RH N++
Sbjct: 36 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
+GY + ++ +V + G +L +H K +I IA AQ + YLH
Sbjct: 96 LFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 152
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATTCR 953
I+HRD+K +NI L E+L + DFGLA + S +H ++G+ ++APE R
Sbjct: 153 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 207
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
+ DK +DVY+FG+VL EL++G+
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQ 234
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 102 bits (254), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
G ++ IG+G FG+ YK + V + ++ Q +Q F E+G L + RH N++
Sbjct: 10 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 69
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
+GY + ++ +V + G +L +H K +I IA AQ + YLH
Sbjct: 70 LFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 126
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATTCR 953
I+HRD+K +NI L E+L + DFGLA + S +H ++G+ ++APE R
Sbjct: 127 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 181
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
+ DK +DVY+FG+VL EL++G+
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTGQ 208
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 102 bits (254), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
G ++ IG+G FG+ YK + V + ++ Q +Q F E+G L + RH N++
Sbjct: 13 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
+GY + ++ +V + G +L +H K +I IA AQ + YLH
Sbjct: 73 LFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 129
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATTCR 953
I+HRD+K +NI L E+L + DFGLA + S +H ++G+ ++APE R
Sbjct: 130 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 184
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
+ DK +DVY+FG+VL EL++G+
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQ 211
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 102 bits (254), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
G ++ IG+G FG+ YK + V + ++ Q +Q F E+G L + RH N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
+GY + ++ +V + G +L +H K +I IA AQ + YLH
Sbjct: 68 LFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 124
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATTCR 953
I+HRD+K +NI L E+L + DFGLA + S +H ++G+ ++APE R
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 179
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
+ DK +DVY+FG+VL EL++G+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQ 206
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 102 bits (253), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
G ++ IG+G FG+ YK + V + ++ Q +Q F E+G L + RH N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
+GY ++ +V + G +L +H K +I IA AQ + YLH
Sbjct: 68 LFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 124
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATTCR 953
I+HRD+K +NI L E+L + DFGLA + S +H ++G+ ++APE R
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 179
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
+ DK +DVY+FG+VL EL++G+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQ 206
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 101 bits (252), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
G ++ IG+G FG+ YK + V + ++ Q +Q F E+G L + RH N++
Sbjct: 28 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 87
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
+GY + ++ +V + G +L +H K +I IA AQ + YLH
Sbjct: 88 LFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 144
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLA-RLLEVSETHATTDVAGTFGYVAPEYATTCR 953
I+HRD+K +NI L E+L + DFGLA S +H ++G+ ++APE R
Sbjct: 145 --IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIR 199
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
+ DK +DVY+FG+VL EL++G+
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTGQ 226
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 101 bits (252), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
G ++ IG+G FG+ YK + V + ++ Q +Q F E+G L + RH N++
Sbjct: 36 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
+GY + ++ +V + G +L +H K +I IA AQ + YLH
Sbjct: 96 LFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 152
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLA-RLLEVSETHATTDVAGTFGYVAPEYATTCR 953
I+HRD+K +NI L E+L + DFGLA S +H ++G+ ++APE R
Sbjct: 153 --IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIR 207
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
+ DK +DVY+FG+VL EL++G+
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQ 234
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 101 bits (251), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 67/207 (32%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
G ++ IG+G FG+ YK + V + ++ Q +Q F E+G L + RH N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
+GY + ++ +V + G +L +H K +I IA AQ + YLH
Sbjct: 68 LFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 124
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLA-RLLEVSETHATTDVAGTFGYVAPEYATTCR 953
I+HRD+K +NI L E+L + DFGLA S +H ++G+ ++APE R
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIR 179
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
+ DK +DVY+FG+VL EL++G+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQ 206
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 100 bits (250), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 64/193 (33%), Positives = 102/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + ++RH+ LV L V
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAV-VS 332
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V ++S G+L F+ ++GK ++ + +A IA +AY+ VHRD+
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 389
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ E L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 963 FGVVLLELISGKR 975
FG++L EL + R
Sbjct: 450 FGILLTELTTKGR 462
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 100 bits (250), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 5/197 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + ++RH+ LV L V
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAV-VS 249
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V ++S G+L F+ ++GK ++ + +A IA +AY+ VHRD+
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 306
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ E L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 963 FGVVLLELISGKRSLDP 979
FG++L EL + R P
Sbjct: 367 FGILLTELTTKGRVPYP 383
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 100 bits (249), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 5/197 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + ++RH+ LV L V
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAV-VS 249
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V ++S G+L F+ ++GK ++ + +A IA +AY+ VHRD+
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 306
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ E L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 963 FGVVLLELISGKRSLDP 979
FG++L EL + R P
Sbjct: 367 FGILLTELTTKGRVPYP 383
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 100 bits (249), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
G ++ IG+G FG+ YK + V + ++ Q +Q F E+G L + RH N++
Sbjct: 12 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 71
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
+GY + ++ +V + G +L +H S K + + IA A+ + YLH
Sbjct: 72 LFMGYST-KPQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLHAKS- 128
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATTCR 953
I+HRD+K +NI L E+ + DFGLA + S +H ++G+ ++APE R
Sbjct: 129 --IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 183
Query: 954 VSD------KADVYSFGVVLLELISGK 974
+ D ++DVY+FG+VL EL++G+
Sbjct: 184 MQDSNPYSFQSDVYAFGIVLYELMTGQ 210
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 100 bits (248), Expect = 5e-21, Method: Composition-based stats.
Identities = 64/193 (33%), Positives = 102/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + ++RH+ LV L V
Sbjct: 19 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 76
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V ++S G+L F+ ++GK ++ + +A IA +AY+ VHRD+
Sbjct: 77 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 133
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ E L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 134 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 193
Query: 963 FGVVLLELISGKR 975
FG++L EL + R
Sbjct: 194 FGILLTELTTKGR 206
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 100 bits (248), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 5/197 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + ++RH+ LV L V
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAV-VS 249
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V ++S G+L F+ ++GK ++ + +A IA +AY+ VHRD+
Sbjct: 250 EEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 306
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ E L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 963 FGVVLLELISGKRSLDP 979
FG++L EL + R P
Sbjct: 367 FGILLTELTTKGRVPYP 383
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 100 bits (248), Expect = 6e-21, Method: Composition-based stats.
Identities = 65/193 (33%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + +IRH+ LV L V
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKIRHEKLVQLYAV-VS 83
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V ++S G+L F+ + GK ++ + +A IA +AY+ VHRD+
Sbjct: 84 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ E L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 963 FGVVLLELISGKR 975
FG++L EL + R
Sbjct: 201 FGILLTELTTKGR 213
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 99.8 bits (247), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 64/207 (30%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
G ++ IG+G FG+ YK + V + ++ Q +Q F E+G L + RH N++
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
+GY + ++ +V + G +L +H S K + + IA A+ + YLH
Sbjct: 84 LFMGYST-KPQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLHAKS- 140
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLA-RLLEVSETHATTDVAGTFGYVAPEYATTCR 953
I+HRD+K +NI L E+ + DFGLA S +H ++G+ ++APE R
Sbjct: 141 --IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIR 195
Query: 954 VSD------KADVYSFGVVLLELISGK 974
+ D ++DVY+FG+VL EL++G+
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQ 222
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 99.4 bits (246), Expect = 8e-21, Method: Composition-based stats.
Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + ++RH+ LV L V
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V ++S G+L F+ + GK ++ + +A IA +AY+ VHRD+
Sbjct: 84 EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ E L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 963 FGVVLLELISGKR 975
FG++L EL + R
Sbjct: 201 FGILLTELTTKGR 213
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 99.4 bits (246), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
G ++ IG+G FG+ YK + V + ++ Q +Q F E+G L + RH N++
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
+GY ++ +V + G +L +H S K + + IA A+ + YLH
Sbjct: 84 LFMGYSTA-PQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLHAKS- 140
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLA-RLLEVSETHATTDVAGTFGYVAPEYATTCR 953
I+HRD+K +NI L E+ + DFGLA S +H ++G+ ++APE R
Sbjct: 141 --IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIR 195
Query: 954 VSD------KADVYSFGVVLLELISGK 974
+ D ++DVY+FG+VL EL++G+
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQ 222
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 99.0 bits (245), Expect = 1e-20, Method: Composition-based stats.
Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + ++RH+ LV L V
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V ++S G+L F+ + GK ++ + +A IA +AY+ VHRD+
Sbjct: 84 EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ E L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 963 FGVVLLELISGKR 975
FG++L EL + R
Sbjct: 201 FGILLTELTTKGR 213
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 99.0 bits (245), Expect = 1e-20, Method: Composition-based stats.
Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + ++RH+ LV L V
Sbjct: 15 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 72
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V ++S G+L F+ + GK ++ + +A IA +AY+ VHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 129
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ E L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 130 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 189
Query: 963 FGVVLLELISGKR 975
FG++L EL + R
Sbjct: 190 FGILLTELTTKGR 202
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 99.0 bits (245), Expect = 1e-20, Method: Composition-based stats.
Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + ++RH+ LV L V
Sbjct: 17 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 74
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V ++S G+L F+ + GK ++ + +A IA +AY+ VHRD+
Sbjct: 75 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 131
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ E L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 132 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 191
Query: 963 FGVVLLELISGKR 975
FG++L EL + R
Sbjct: 192 FGILLTELTTKGR 204
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 99.0 bits (245), Expect = 1e-20, Method: Composition-based stats.
Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + ++RH+ LV L V
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V ++S G+L F+ + GK ++ + +A IA +AY+ VHRD+
Sbjct: 84 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ E L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 963 FGVVLLELISGKR 975
FG++L EL + R
Sbjct: 201 FGILLTELTTKGR 213
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 98.6 bits (244), Expect = 1e-20, Method: Composition-based stats.
Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + ++RH+ LV L V
Sbjct: 16 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 73
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E + +V ++S G+L F+ ++GK ++ + +A IA +AY+ VHRD+
Sbjct: 74 EEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 130
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ E L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 131 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 190
Query: 963 FGVVLLELISGKR 975
FG++L EL + R
Sbjct: 191 FGILLTELTTKGR 203
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 98.6 bits (244), Expect = 2e-20, Method: Composition-based stats.
Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + ++RH+ LV L V
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V ++S G+L F+ + GK ++ + +A IA +AY+ VHRD+
Sbjct: 84 EEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ E L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 963 FGVVLLELISGKR 975
FG++L EL + R
Sbjct: 201 FGILLTELTTKGR 213
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 98.2 bits (243), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 5/197 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + ++RH+ LV L V
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNM-SPEAFLQEAQVMKKLRHEKLVQLYAV-VS 250
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V ++S G+L F+ + GK ++ + +A IA +AY+ VHRD+
Sbjct: 251 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 307
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ E L ++DFGL RL+E +E A + APE A R + K+DV+S
Sbjct: 308 RAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 367
Query: 963 FGVVLLELISGKRSLDP 979
FG++L EL + R P
Sbjct: 368 FGILLTELTTKGRVPYP 384
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 97.8 bits (242), Expect = 3e-20, Method: Composition-based stats.
Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + ++RH+ LV L V
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V ++S G L F+ + GK ++ + +A IA +AY+ VHRD+
Sbjct: 84 EEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ E L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 963 FGVVLLELISGKR 975
FG++L EL + R
Sbjct: 201 FGILLTELTTKGR 213
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 97.8 bits (242), Expect = 3e-20, Method: Composition-based stats.
Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + ++RH+ LV L V
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V ++S G+L F+ + GK ++ + +A IA +AY+ VHRD+
Sbjct: 84 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+NIL+ E L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 141 AAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 963 FGVVLLELISGKR 975
FG++L EL + R
Sbjct: 201 FGILLTELTTKGR 213
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 97.4 bits (241), Expect = 3e-20, Method: Composition-based stats.
Identities = 62/193 (32%), Positives = 102/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + ++RH+ LV L V
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 80
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V +++ G+L F+ ++GK ++ + ++ IA +AY+ VHRD+
Sbjct: 81 EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM---NYVHRDL 137
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ E L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 197
Query: 963 FGVVLLELISGKR 975
FG++L EL + R
Sbjct: 198 FGILLTELTTKGR 210
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 97.4 bits (241), Expect = 3e-20, Method: Composition-based stats.
Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + ++RH+ LV L V
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V ++S G L F+ + GK ++ + +A IA +AY+ VHRD+
Sbjct: 84 EEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ E L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 963 FGVVLLELISGKR 975
FG++L EL + R
Sbjct: 201 FGILLTELTTKGR 213
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 97.4 bits (241), Expect = 4e-20, Method: Composition-based stats.
Identities = 62/193 (32%), Positives = 102/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + ++RH+ LV L V
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 80
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V +++ G+L F+ ++GK ++ + ++ IA +AY+ VHRD+
Sbjct: 81 EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM---NYVHRDL 137
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ E L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 197
Query: 963 FGVVLLELISGKR 975
FG++L EL + R
Sbjct: 198 FGILLTELTTKGR 210
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 96.7 bits (239), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 28/264 (10%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
IG+G FG+ YK + V + K+ + Q F E+ L + RH N++ +GY
Sbjct: 44 IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ + +V + G +L +H + K + +I IA AQ + YLH I+HRD+
Sbjct: 104 D-NLAIVTQWCEGSSLYKHLHVQETKFQMFQLI-DIARQTAQGMDYLH---AKNIIHRDM 158
Query: 903 KPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATTCRVSD----- 956
K +NI L E L + DFGLA + S + G+ ++APE R+ D
Sbjct: 159 KSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPE---VIRMQDNNPFS 215
Query: 957 -KADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015
++DVYS+G+VL EL++G + +S N I+ ++ G +S L +L++
Sbjct: 216 FQSDVYSYGIVLYELMTG----ELPYSHINNRDQII----FMVGRGYASP-DLSKLYKNC 266
Query: 1016 PQENLLGMMRLASTCTVETLSTRP 1039
P+ M RL + C + RP
Sbjct: 267 PK----AMKRLVADCVKKVKEERP 286
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 96.3 bits (238), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 8 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 68 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V T +V T Y APE C
Sbjct: 127 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 182
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 220
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 96.3 bits (238), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 11 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 71 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V T +V T Y APE C
Sbjct: 130 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 185
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 186 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 223
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 96.3 bits (238), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V T +V T Y APE C
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 96.3 bits (238), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V T +V T Y APE C
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 177
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 215
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 96.3 bits (238), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 7 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+TF+ + I +I + Q LA+ H
Sbjct: 67 IVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 181
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 219
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 96.3 bits (238), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V T +V T Y APE C
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 177
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 215
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 95.9 bits (237), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 5 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 65 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V T +V T Y APE C
Sbjct: 124 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 179
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 217
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 95.9 bits (237), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V T +V T Y APE C
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 95.9 bits (237), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 7 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FLS +L+ F+ + I +I + Q LA+ H
Sbjct: 67 IVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 126 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 181
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 219
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 95.5 bits (236), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 5 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FLS +L+ F+ + I +I + Q LA+ H
Sbjct: 65 IVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 124 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 179
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 217
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 95.5 bits (236), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 7 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FLS +L+ F+ + I +I + Q LA+ H
Sbjct: 67 IVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 181
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 219
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 95.5 bits (236), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 6 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FLS +L+ F+ + I +I + Q LA+ H
Sbjct: 66 IVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 125 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 180
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 218
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 94.7 bits (234), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q L++ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V T +V T Y APE C
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 94.4 bits (233), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 73/230 (31%), Positives = 113/230 (49%), Gaps = 27/230 (11%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKAELVPGY-LVAVKKLSIGRFQG-------IQQFDAEIGT 824
A IG GGFG +K LV +VA+K L +G +G Q+F E+
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 825 LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
+ + H N+V L G M V F+ G+L + K+ I+WSV ++ +DIA
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIAL 133
Query: 885 ALAYLHYSCVPRIVHRDIKPSNILL---DEE--LNAYLSDFGLARLLEVSETHATTDVAG 939
+ Y+ P IVHRD++ NI L DE + A ++DFGL++ H+ + + G
Sbjct: 134 GIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLG 188
Query: 940 TFGYVAPEY--ATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
F ++APE A ++KAD YSF ++L +++G+ D EY G
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD----EYSYG 234
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 94.4 bits (233), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 8 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 68 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 127 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 182
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 220
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 94.4 bits (233), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 7 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 67 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 181
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 219
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 94.4 bits (233), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 6 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 66 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 125 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 180
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 218
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 94.4 bits (233), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 6 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 66 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 125 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 180
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 218
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 94.0 bits (232), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ + +L+TF+ + I +I + Q LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V T +V T Y APE C
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 177
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 215
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 94.0 bits (232), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 5 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 65 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 124 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 179
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 217
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 94.0 bits (232), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 7 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 67 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 181
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 219
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 94.0 bits (232), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 6 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 66 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 125 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 180
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 218
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 94.0 bits (232), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 177
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 215
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 94.0 bits (232), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 94.0 bits (232), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 94.0 bits (232), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 94.0 bits (232), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 177
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 215
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 94.0 bits (232), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 94.0 bits (232), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 5 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 65 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 124 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 179
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 217
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 94.0 bits (232), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+ K+ + +G+ EI L + H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V T +V T Y APE C
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 94.0 bits (232), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+ K+ + +G+ EI L + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V T +V T Y APE C
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 177
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 215
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 94.0 bits (232), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VA+K L G + F E + +++H LV L V
Sbjct: 17 LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP-ESFLEEAQIMKKLKHDKLVQLYAV-VS 74
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V +++ G+L F+ G+ ++ + +A +A +AY+ +HRD+
Sbjct: 75 EEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDL 131
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ L ++DFGLARL+E +E A + APE A R + K+DV+S
Sbjct: 132 RSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 191
Query: 963 FGVVLLELISGKRSLDPSFS 982
FG++L EL++ R P +
Sbjct: 192 FGILLTELVTKGRVPYPGMN 211
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 94.0 bits (232), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 123 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 93.6 bits (231), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 5 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 65 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 124 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 179
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 217
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 92.4 bits (228), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 72/230 (31%), Positives = 112/230 (48%), Gaps = 27/230 (11%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKAELVPGY-LVAVKKLSIGRFQG-------IQQFDAEIGT 824
A IG GGFG +K LV +VA+K L +G +G Q+F E+
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 825 LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
+ + H N+V L G M V F+ G+L + K+ I+WSV ++ +DIA
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIAL 133
Query: 885 ALAYLHYSCVPRIVHRDIKPSNILL---DEE--LNAYLSDFGLARLLEVSETHATTDVAG 939
+ Y+ P IVHRD++ NI L DE + A ++DFG ++ H+ + + G
Sbjct: 134 GIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGLLG 188
Query: 940 TFGYVAPEY--ATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
F ++APE A ++KAD YSF ++L +++G+ D EY G
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD----EYSYG 234
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 92.4 bits (228), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 72/230 (31%), Positives = 112/230 (48%), Gaps = 27/230 (11%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKAELVPGY-LVAVKKLSIGRFQG-------IQQFDAEIGT 824
A IG GGFG +K LV +VA+K L +G +G Q+F E+
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 825 LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
+ + H N+V L G M V F+ G+L + K+ I+WSV ++ +DIA
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIAL 133
Query: 885 ALAYLHYSCVPRIVHRDIKPSNILL---DEE--LNAYLSDFGLARLLEVSETHATTDVAG 939
+ Y+ P IVHRD++ NI L DE + A ++DF L++ H+ + + G
Sbjct: 134 GIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGLLG 188
Query: 940 TFGYVAPEY--ATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
F ++APE A ++KAD YSF ++L +++G+ D EY G
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD----EYSYG 234
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 92.0 bits (227), Expect = 1e-18, Method: Composition-based stats.
Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VAVK L G F AE + +++H+ LV L V
Sbjct: 29 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 86
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ ++++ ++ G+L F+ SG K+ + + +A IA+ +A++ +HRD+
Sbjct: 87 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 143
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ + L+ ++DFGLARL+E +E A + APE + K+DV+S
Sbjct: 144 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 203
Query: 963 FGVVLLELISGKRSLDPSFS 982
FG++L E+++ R P +
Sbjct: 204 FGILLTEIVTHGRIPYPGMT 223
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 92.0 bits (227), Expect = 1e-18, Method: Composition-based stats.
Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VAVK L G F AE + +++H+ LV L V
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 84
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ ++++ ++ G+L F+ SG K+ + + +A IA+ +A++ +HRD+
Sbjct: 85 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 141
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ + L+ ++DFGLARL+E +E A + APE + K+DV+S
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 201
Query: 963 FGVVLLELISGKRSLDPSFS 982
FG++L E+++ R P +
Sbjct: 202 FGILLTEIVTHGRIPYPGMT 221
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 92.0 bits (227), Expect = 1e-18, Method: Composition-based stats.
Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VAVK L G F AE + +++H+ LV L V
Sbjct: 23 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 80
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ ++++ ++ G+L F+ SG K+ + + +A IA+ +A++ +HRD+
Sbjct: 81 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 137
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ + L+ ++DFGLARL+E +E A + APE + K+DV+S
Sbjct: 138 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 197
Query: 963 FGVVLLELISGKRSLDPSFS 982
FG++L E+++ R P +
Sbjct: 198 FGILLTEIVTHGRIPYPGMT 217
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 92.0 bits (227), Expect = 1e-18, Method: Composition-based stats.
Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VAVK L G F AE + +++H+ LV L V
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 78
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ ++++ ++ G+L F+ SG K+ + + +A IA+ +A++ +HRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ + L+ ++DFGLARL+E +E A + APE + K+DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 963 FGVVLLELISGKRSLDPSFS 982
FG++L E+++ R P +
Sbjct: 196 FGILLTEIVTHGRIPYPGMT 215
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 92.0 bits (227), Expect = 1e-18, Method: Composition-based stats.
Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VAVK L G F AE + +++H+ LV L V
Sbjct: 30 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 87
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ ++++ ++ G+L F+ SG K+ + + +A IA+ +A++ +HRD+
Sbjct: 88 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 144
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ + L+ ++DFGLARL+E +E A + APE + K+DV+S
Sbjct: 145 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 204
Query: 963 FGVVLLELISGKRSLDPSFS 982
FG++L E+++ R P +
Sbjct: 205 FGILLTEIVTHGRIPYPGMT 224
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 92.0 bits (227), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VAVK L G F AE + +++H+ LV L V
Sbjct: 22 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 79
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ ++++ ++ G+L F+ SG K+ + + +A IA+ +A++ +HRD+
Sbjct: 80 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 136
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ + L+ ++DFGLARL+E +E A + APE + K+DV+S
Sbjct: 137 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 196
Query: 963 FGVVLLELISGKRSLDPSFS 982
FG++L E+++ R P +
Sbjct: 197 FGILLTEIVTHGRIPYPGMT 216
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 91.7 bits (226), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 11 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 71 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V T +V T Y APE
Sbjct: 130 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGX 185
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 186 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 223
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 91.7 bits (226), Expect = 2e-18, Method: Composition-based stats.
Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VAVK L G F AE + +++H+ LV L V
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 84
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ ++++ ++ G+L F+ SG K+ + + +A IA+ +A++ +HRD+
Sbjct: 85 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 141
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ + L+ ++DFGLARL+E +E A + APE + K+DV+S
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 201
Query: 963 FGVVLLELISGKRSLDPSFS 982
FG++L E+++ R P +
Sbjct: 202 FGILLTEIVTHGRIPYPGMT 221
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 91.7 bits (226), Expect = 2e-18, Method: Composition-based stats.
Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VAVK L G F AE + +++H+ LV L V
Sbjct: 31 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 88
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ ++++ ++ G+L F+ SG K+ + + +A IA+ +A++ +HRD+
Sbjct: 89 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 145
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ + L+ ++DFGLARL+E +E A + APE + K+DV+S
Sbjct: 146 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 205
Query: 963 FGVVLLELISGKRSLDPSFS 982
FG++L E+++ R P +
Sbjct: 206 FGILLTEIVTHGRIPYPGMT 225
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 91.7 bits (226), Expect = 2e-18, Method: Composition-based stats.
Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VAVK L G F AE + +++H+ LV L V
Sbjct: 26 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 83
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ ++++ ++ G+L F+ SG K+ + + +A IA+ +A++ +HRD+
Sbjct: 84 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 140
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ + L+ ++DFGLARL+E +E A + APE + K+DV+S
Sbjct: 141 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 200
Query: 963 FGVVLLELISGKRSLDPSFS 982
FG++L E+++ R P +
Sbjct: 201 FGILLTEIVTHGRIPYPGMT 220
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 91.7 bits (226), Expect = 2e-18, Method: Composition-based stats.
Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 4/190 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VAVK L G +Q F E + ++H LV L
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E ++++ +++ G+L F+ G K+ + + IA+ +AY+ +HRD+
Sbjct: 80 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDL 136
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +N+L+ E L ++DFGLAR++E +E A + APE + K+DV+S
Sbjct: 137 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWS 196
Query: 963 FGVVLLELIS 972
FG++L E+++
Sbjct: 197 FGILLYEIVT 206
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 91.7 bits (226), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VAVK L G F AE + +++H+ LV L V
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 78
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ ++++ ++ G+L F+ SG K+ + + +A IA+ +A++ +HRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ + L+ ++DFGLARL+E +E A + APE + K+DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 963 FGVVLLELISGKRSLDPSFS 982
FG++L E+++ R P +
Sbjct: 196 FGILLTEIVTHGRIPYPGMT 215
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 91.7 bits (226), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ FL +L+ F+ + I +I + Q LA+ H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V T +V T Y APE
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGX 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 91.3 bits (225), Expect = 2e-18, Method: Composition-based stats.
Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 4/190 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VAVK L G +Q F E + ++H LV L
Sbjct: 20 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E ++++ F++ G+L F+ G K+ + + IA+ +AY+ +HRD+
Sbjct: 79 EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDL 135
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +N+L+ E L ++DFGLAR++E +E A + APE + K++V+S
Sbjct: 136 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWS 195
Query: 963 FGVVLLELIS 972
FG++L E+++
Sbjct: 196 FGILLYEIVT 205
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 91.3 bits (225), Expect = 2e-18, Method: Composition-based stats.
Identities = 76/280 (27%), Positives = 129/280 (46%), Gaps = 22/280 (7%)
Query: 762 PAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDA 820
P+ YD + ++++ +G G +G Y+ L VAVK L + +++F
Sbjct: 5 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 63
Query: 821 EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI 880
E + I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A
Sbjct: 64 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
I+ A+ YL +HRD+ N L+ E ++DFGL+RL+ A
Sbjct: 124 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP 180
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
+ APE + S K+DV++FGV+L E+ + S P G ++ +LL K+
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKD 233
Query: 1001 GRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
R PE G E + +MR C S RPS
Sbjct: 234 YRMER---PE----GCPEKVYELMR---ACWQWNPSDRPS 263
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 91.3 bits (225), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VAVK L G F AE + +++H+ LV L V
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 78
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ ++++ ++ G+L F+ SG K+ + + +A IA+ +A++ +HRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ + L+ ++DFGLARL+E +E A + APE + K+DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 963 FGVVLLELISGKRSLDPSFS 982
FG++L E+++ R P +
Sbjct: 196 FGILLTEIVTHGRIPYPGMT 215
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 91.3 bits (225), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VAVK L G F AE + +++H+ LV L V
Sbjct: 16 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 73
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ ++++ ++ G+L F+ SG K+ + + +A IA+ +A++ +HRD+
Sbjct: 74 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 130
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ + L+ ++DFGLARL+E +E A + APE + K+DV+S
Sbjct: 131 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 190
Query: 963 FGVVLLELISGKRSLDPSFS 982
FG++L E+++ R P +
Sbjct: 191 FGILLTEIVTHGRIPYPGMT 210
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 91.3 bits (225), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 71/223 (31%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
R F R+L +G G FGS P G +VAVKKL + ++ F+ E
Sbjct: 5 RDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
I L ++H N+V G Y G + L+ FL G+L ++ K HK
Sbjct: 65 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQK-----------HKER 113
Query: 880 IDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
ID + L Y + Y R +HRD+ NIL++ E + DFGL ++L +
Sbjct: 114 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 173
Query: 933 ATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
G F Y APE T + S +DV+SFGVVL EL +
Sbjct: 174 XKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 215
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 90.9 bits (224), Expect = 3e-18, Method: Composition-based stats.
Identities = 76/280 (27%), Positives = 129/280 (46%), Gaps = 22/280 (7%)
Query: 762 PAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDA 820
P+ YD + ++++ +G G +G Y+ L VAVK L + +++F
Sbjct: 5 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 63
Query: 821 EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI 880
E + I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A
Sbjct: 64 EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
I+ A+ YL +HRD+ N L+ E ++DFGL+RL+ A
Sbjct: 124 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
+ APE + S K+DV++FGV+L E+ + S P G ++ +LL K+
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKD 233
Query: 1001 GRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
R PE G E + +MR C S RPS
Sbjct: 234 YRMER---PE----GCPEKVYELMR---ACWQWNPSDRPS 263
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex
With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In Complex
With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex
With Dp- 987
Length = 277
Score = 90.9 bits (224), Expect = 3e-18, Method: Composition-based stats.
Identities = 76/280 (27%), Positives = 129/280 (46%), Gaps = 22/280 (7%)
Query: 762 PAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDA 820
P+ YD + ++++ +G G +G Y+ L VAVK L + +++F
Sbjct: 5 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 63
Query: 821 EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI 880
E + I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A
Sbjct: 64 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
I+ A+ YL +HRD+ N L+ E ++DFGL+RL+ A
Sbjct: 124 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
+ APE + S K+DV++FGV+L E+ + S P G ++ +LL K+
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKD 233
Query: 1001 GRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
R PE G E + +MR C S RPS
Sbjct: 234 YRMER---PE----GCPEKVYELMR---ACWQWNPSDRPS 263
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With
Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex With
Inno-406
Length = 293
Score = 90.9 bits (224), Expect = 3e-18, Method: Composition-based stats.
Identities = 76/280 (27%), Positives = 129/280 (46%), Gaps = 22/280 (7%)
Query: 762 PAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDA 820
P+ YD + ++++ +G G +G Y+ L VAVK L + +++F
Sbjct: 5 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 63
Query: 821 EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI 880
E + I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A
Sbjct: 64 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
I+ A+ YL +HRD+ N L+ E ++DFGL+RL+ A
Sbjct: 124 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
+ APE + S K+DV++FGV+L E+ + S P G ++ +LL K+
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKD 233
Query: 1001 GRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
R PE G E + +MR C S RPS
Sbjct: 234 YRMER---PE----GCPEKVYELMR---ACWQWNPSDRPS 263
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With
Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex With
Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With
Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex With
Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1) I
Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1) I
Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2) In
The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2) In
The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2) In
The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2) In
The Myristate Site
Length = 293
Score = 90.9 bits (224), Expect = 3e-18, Method: Composition-based stats.
Identities = 76/280 (27%), Positives = 129/280 (46%), Gaps = 22/280 (7%)
Query: 762 PAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDA 820
P+ YD + ++++ +G G +G Y+ L VAVK L + +++F
Sbjct: 5 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 63
Query: 821 EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI 880
E + I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A
Sbjct: 64 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 123
Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
I+ A+ YL +HRD+ N L+ E ++DFGL+RL+ A
Sbjct: 124 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
+ APE + S K+DV++FGV+L E+ + S P G ++ +LL K+
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKD 233
Query: 1001 GRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
R PE G E + +MR C S RPS
Sbjct: 234 YRMER---PE----GCPEKVYELMR---ACWQWNPSDRPS 263
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 90.9 bits (224), Expect = 4e-18, Method: Composition-based stats.
Identities = 67/227 (29%), Positives = 110/227 (48%), Gaps = 27/227 (11%)
Query: 777 FSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSI---GRFQGIQQFDAEIGTLGRIRHKN 832
+ I + +G GG + Y AE + VA+K + I + + +++F+ E+ ++ H+N
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIA-----QALA 887
+V++I + +LV ++ G L +I +++D A Q L
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG----------PLSVDTAINFTNQILD 122
Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
+ ++ RIVHRDIKP NIL+D + DFG+A+ L + T V GT Y +PE
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 948 YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWA 994
A + D+YS G+VL E++ G +P F NG VS A
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVG----EPPF----NGETAVSIA 221
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 90.5 bits (223), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 69/231 (29%), Positives = 108/231 (46%), Gaps = 24/231 (10%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSI-------GRFQGIQQFDAEIGTLG 826
NF I IG G F Y+A L+ G VA+KK+ I R I+ EI L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK----EIDLLK 87
Query: 827 RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH--KKSGKKIQWSVIHKIAIDIAQ 884
++ H N++ ++ + E+ +V G+L I KK + I + K + +
Sbjct: 88 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
AL ++H R++HRDIKP+N+ + L D GL R S+T A + GT Y+
Sbjct: 148 ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYM 203
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAK 995
+PE + K+D++S G +L E+ +L F YG+ N+ S K
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMA----ALQSPF--YGDKMNLYSLCK 248
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 90.5 bits (223), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 69/219 (31%), Positives = 109/219 (49%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
NF IG G +G YKA + G +VA+KK+ + +G+ EI L + H N
Sbjct: 7 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+V L+ E +++LV+ + +L+ F+ + I +I + Q LA+ H
Sbjct: 67 IVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
R++HRD+KP N+L++ E L+DFGLAR V +V T Y APE C
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 181
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
+ S D++S G + E+++ +R+L P SE F I
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 219
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 90.1 bits (222), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 70/224 (31%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 771 VRATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDA 820
+R F R+L +G G FGS P G +VAVKKL + ++ F+
Sbjct: 1 MRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 821 EIGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI 878
EI L ++H N+V G Y G + L+ +L G+L ++ K HK
Sbjct: 61 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKE 109
Query: 879 AIDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
ID + L Y + Y R +HRD+ NIL++ E + DFGL ++L +
Sbjct: 110 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169
Query: 932 HATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
G F Y APE T + S +DV+SFGVVL EL +
Sbjct: 170 XXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 212
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 90.1 bits (222), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 70/223 (31%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
R F R+L +G G FGS P G +VAVKKL + ++ F+ E
Sbjct: 6 RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 65
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
I L ++H N+V G Y G + L+ +L G+L ++ K HK
Sbjct: 66 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKER 114
Query: 880 IDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
ID + L Y + Y R +HRD+ NIL++ E + DFGL ++L +
Sbjct: 115 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 174
Query: 933 ATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
G F Y APE T + S +DV+SFGVVL EL +
Sbjct: 175 XKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 216
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 90.1 bits (222), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 70/223 (31%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
R F R+L +G G FGS P G +VAVKKL + ++ F+ E
Sbjct: 5 RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
I L ++H N+V G Y G + L+ +L G+L ++ K HK
Sbjct: 65 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKER 113
Query: 880 IDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
ID + L Y + Y R +HRD+ NIL++ E + DFGL ++L +
Sbjct: 114 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 173
Query: 933 ATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
G F Y APE T + S +DV+SFGVVL EL +
Sbjct: 174 XKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 215
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 89.7 bits (221), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 70/223 (31%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
R F R+L +G G FGS P G +VAVKKL + ++ F+ E
Sbjct: 1 RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 60
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
I L ++H N+V G Y G + L+ +L G+L ++ K HK
Sbjct: 61 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKER 109
Query: 880 IDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
ID + L Y + Y R +HRD+ NIL++ E + DFGL ++L +
Sbjct: 110 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 169
Query: 933 ATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
G F Y APE T + S +DV+SFGVVL EL +
Sbjct: 170 XKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 211
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 89.7 bits (221), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 70/223 (31%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
R F R+L +G G FGS P G +VAVKKL + ++ F+ E
Sbjct: 9 RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 68
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
I L ++H N+V G Y G + L+ +L G+L ++ K HK
Sbjct: 69 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKER 117
Query: 880 IDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
ID + L Y + Y R +HRD+ NIL++ E + DFGL ++L +
Sbjct: 118 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 177
Query: 933 ATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
G F Y APE T + S +DV+SFGVVL EL +
Sbjct: 178 XKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 219
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 89.7 bits (221), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 70/223 (31%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
R F R+L +G G FGS P G +VAVKKL + ++ F+ E
Sbjct: 8 RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 67
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
I L ++H N+V G Y G + L+ +L G+L ++ K HK
Sbjct: 68 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKER 116
Query: 880 IDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
ID + L Y + Y R +HRD+ NIL++ E + DFGL ++L +
Sbjct: 117 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 176
Query: 933 ATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
G F Y APE T + S +DV+SFGVVL EL +
Sbjct: 177 XKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 218
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 89.7 bits (221), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 69/229 (30%), Positives = 114/229 (49%), Gaps = 25/229 (10%)
Query: 766 TYDNVVRATGNF---------SIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRF 812
TY++ +A F +I +IG G FG L +PG VA+K L +G
Sbjct: 4 TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 813 QGIQQ-FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ ++ F E +G+ H N++ L G + +V ++ G+L+TF+ K G Q
Sbjct: 64 EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDG---Q 120
Query: 872 WSVIHKIAI--DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS 929
++VI + + I+ + YL VHRD+ NIL++ L +SDFGL+R+LE
Sbjct: 121 FTVIQLVGMLRGISAGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDD 177
Query: 930 ETHATTDVAGTFG--YVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
A T G + APE + + +DV+S+G+V+ E++S G+R
Sbjct: 178 PEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGER 226
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 89.7 bits (221), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 70/223 (31%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
R F R+L +G G FGS P G +VAVKKL + ++ F+ E
Sbjct: 33 RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 92
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
I L ++H N+V G Y G + L+ +L G+L ++ K HK
Sbjct: 93 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKER 141
Query: 880 IDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
ID + L Y + Y R +HRD+ NIL++ E + DFGL ++L +
Sbjct: 142 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 201
Query: 933 ATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
G F Y APE T + S +DV+SFGVVL EL +
Sbjct: 202 XKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 243
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 89.7 bits (221), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 70/223 (31%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
R F R+L +G G FGS P G +VAVKKL + ++ F+ E
Sbjct: 7 RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 66
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
I L ++H N+V G Y G + L+ +L G+L ++ K HK
Sbjct: 67 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKER 115
Query: 880 IDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
ID + L Y + Y R +HRD+ NIL++ E + DFGL ++L +
Sbjct: 116 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 175
Query: 933 ATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
G F Y APE T + S +DV+SFGVVL EL +
Sbjct: 176 XKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 217
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 89.7 bits (221), Expect = 8e-18, Method: Composition-based stats.
Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + A VAVK + G ++ F AE + ++H LV L
Sbjct: 23 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E ++++ F++ G+L F+ G K + + IA+ +A++ +HRD+
Sbjct: 82 EP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDL 137
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ L ++DFGLAR++E +E A + APE + K+DV+S
Sbjct: 138 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 197
Query: 963 FGVVLLELISGKRSLDPSFS 982
FG++L+E+++ R P S
Sbjct: 198 FGILLMEIVTYGRIPYPGMS 217
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 89.4 bits (220), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G FG + VAVK L G F AE + +++H+ LV L V
Sbjct: 17 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 74
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ ++++ ++ G+L F+ SG K+ + + +A IA+ +A++ +HR++
Sbjct: 75 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRNL 131
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ + L+ ++DFGLARL+E +E A + APE + K+DV+S
Sbjct: 132 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 191
Query: 963 FGVVLLELISGKRSLDPSFS 982
FG++L E+++ R P +
Sbjct: 192 FGILLTEIVTHGRIPYPGMT 211
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 89.4 bits (220), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 67/212 (31%), Positives = 109/212 (51%), Gaps = 27/212 (12%)
Query: 780 RNLIGTGGFGSTYKAEL--------VPGYLVAVKKLSIGRFQGIQQFD--AEIGTLGRIR 829
+ +IG G FG YK L VP VA+K L G + Q+ D E G +G+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVP---VAIKTLKAG-YTEKQRVDFLGEAGIMGQFS 104
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALA 887
H N++ L G M ++ ++ G L+ F+ +K G ++SV+ + + IA +
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMK 161
Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYV 944
YL VHRD+ NIL++ L +SDFGL+R+LE + AT +G +
Sbjct: 162 YLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWT 217
Query: 945 APEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
APE + + + +DV+SFG+V+ E+++ G+R
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 89.4 bits (220), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 74/275 (26%), Positives = 128/275 (46%), Gaps = 22/275 (8%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
YD + ++++ +G G +G Y+ L VAVK L + +++F E +
Sbjct: 251 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 309
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A
Sbjct: 310 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 369
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YL +HR++ N L+ E ++DFGL+RL+ A + A
Sbjct: 370 MEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 426
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
PE + S K+DV++FGV+L E+ + S P G ++ +LL K+ R
Sbjct: 427 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYR--- 476
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
+ PE G E + +MR C S RPS
Sbjct: 477 MERPE----GCPEKVYELMR---ACWQWNPSDRPS 504
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 89.4 bits (220), Expect = 1e-17, Method: Composition-based stats.
Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 9/210 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
+ ++++ +G G FG Y+ L VAVK L + +++F E + I+H NLV
Sbjct: 12 DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A+ YL
Sbjct: 71 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-- 128
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
+HRD+ N L+ E ++DFGL+RL+ A + APE +
Sbjct: 129 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKF 187
Query: 955 SDKADVYSFGVVLLEL----ISGKRSLDPS 980
S K+DV++FGV+L E+ +S +DPS
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSPYPGIDPS 217
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 89.4 bits (220), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 66/207 (31%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
+G G FGS P G +VAVKKL + ++ F+ EI L ++H N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 838 G--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------- 888
G Y G + L+ +L G+L ++ K HK ID + L Y
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKERIDHIKLLQYTSQICKG 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYVA 945
+ Y R +HRD+ NIL++ E + DFGL ++L + G F Y A
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-A 185
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS 972
PE T + S +DV+SFGVVL EL +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 89.4 bits (220), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 66/207 (31%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
+G G FGS P G +VAVKKL + ++ F+ EI L ++H N+V
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 838 G--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------- 888
G Y G + L+ +L G+L ++ K HK ID + L Y
Sbjct: 96 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKERIDHIKLLQYTSQICKG 144
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYVA 945
+ Y R +HRD+ NIL++ E + DFGL ++L + G F Y A
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-A 203
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS 972
PE T + S +DV+SFGVVL EL +
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYELFT 230
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 89.4 bits (220), Expect = 1e-17, Method: Composition-based stats.
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
YD + ++++ +G G +G Y+ L VAVK L + +++F E +
Sbjct: 6 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 64
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A
Sbjct: 65 KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 124
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YL +HRD+ N L+ E ++DFGL+RL+ A + A
Sbjct: 125 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTA 181
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
PE + S K+DV++FGV+L E+ + S P G ++ +LL K+ R
Sbjct: 182 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 234
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
PE G E + +MR C S RPS
Sbjct: 235 ---PE----GCPEKVYELMR---ACWQWNPSDRPS 259
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 89.0 bits (219), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 66/207 (31%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
+G G FGS P G +VAVKKL + ++ F+ EI L ++H N+V
Sbjct: 16 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 838 G--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------- 888
G Y G + L+ +L G+L ++ K HK ID + L Y
Sbjct: 76 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKERIDHIKLLQYTSQICKG 124
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYVA 945
+ Y R +HRD+ NIL++ E + DFGL ++L + G F Y A
Sbjct: 125 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-A 183
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS 972
PE T + S +DV+SFGVVL EL +
Sbjct: 184 PESLTESKFSVASDVWSFGVVLYELFT 210
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 89.0 bits (219), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 66/207 (31%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
+G G FGS P G +VAVKKL + ++ F+ EI L ++H N+V
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 838 G--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------- 888
G Y G + L+ +L G+L ++ K HK ID + L Y
Sbjct: 96 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKERIDHIKLLQYTSQICKG 144
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYVA 945
+ Y R +HRD+ NIL++ E + DFGL ++L + G F Y A
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-A 203
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS 972
PE T + S +DV+SFGVVL EL +
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYELFT 230
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 89.0 bits (219), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 74/275 (26%), Positives = 128/275 (46%), Gaps = 22/275 (8%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
YD + ++++ +G G +G Y+ L VAVK L + +++F E +
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 270
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YL +HR++ N L+ E ++DFGL+RL+ A + A
Sbjct: 331 MEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 387
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
PE + S K+DV++FGV+L E+ + S P G ++ +LL K+ R
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYR--- 437
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
+ PE G E + +MR C S RPS
Sbjct: 438 MERPE----GCPEKVYELMR---ACWQWNPSDRPS 465
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 89.0 bits (219), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 5/207 (2%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+ + +G G FG + A VAVK + G ++ F AE + ++H LV
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVK 247
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
L E ++++ F++ G+L F+ G K + + IA+ +A++
Sbjct: 248 LHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--- 303
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
+HRD++ +NIL+ L ++DFGLAR++E +E A + APE +
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 956 DKADVYSFGVVLLELISGKRSLDPSFS 982
K+DV+SFG++L+E+++ R P S
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMS 390
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 89.0 bits (219), Expect = 1e-17, Method: Composition-based stats.
Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G G G + VAVK L G F AE + +++H+ LV L V
Sbjct: 21 LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 78
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ ++++ ++ G+L F+ SG K+ + + +A IA+ +A++ +HRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
+ +NIL+ + L+ ++DFGLARL+E +E A + APE + K+DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 963 FGVVLLELISGKRSLDPSFS 982
FG++L E+++ R P +
Sbjct: 196 FGILLTEIVTHGRIPYPGMT 215
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl
Mutant In Complex With The Aurora Kinase Inhibitor Vx-680
Length = 287
Score = 89.0 bits (219), Expect = 1e-17, Method: Composition-based stats.
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
YD + ++++ +G G +G Y+ L VAVK L + +++F E +
Sbjct: 6 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 64
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A
Sbjct: 65 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 124
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YL +HRD+ N L+ E ++DFGL+RL+ A + A
Sbjct: 125 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTA 181
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
PE + S K+DV++FGV+L E+ + S P G ++ +LL K+ R
Sbjct: 182 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 234
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
PE G E + +MR C S RPS
Sbjct: 235 ---PE----GCPEKVYELMR---ACWQWNPSDRPS 259
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase
Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase
Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase
Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase
Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase
Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase
Domain
Length = 287
Score = 89.0 bits (219), Expect = 1e-17, Method: Composition-based stats.
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
YD + ++++ +G G +G Y+ L VAVK L + +++F E +
Sbjct: 7 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 65
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A
Sbjct: 66 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 125
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YL +HRD+ N L+ E ++DFGL+RL+ A + A
Sbjct: 126 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTA 182
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
PE + S K+DV++FGV+L E+ + S P G ++ +LL K+ R
Sbjct: 183 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 235
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
PE G E + +MR C S RPS
Sbjct: 236 ---PE----GCPEKVYELMR---ACWQWNPSDRPS 260
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 88.6 bits (218), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 781 NLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGY 839
++G G FG K G ++ +K+L + + F E+ + + H N++ IG
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ + + ++ GG L I K + WS A DIA +AYLH I+H
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIH 131
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT-------------TDVAGTFGYVAP 946
RD+ N L+ E N ++DFGLARL+ +T V G ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 947 EYATTCRVSDKADVYSFGVVLLELISGKRSLDPSF 981
E +K DV+SFG+VL E+I G+ + DP +
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDY 225
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 88.6 bits (218), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 74/275 (26%), Positives = 128/275 (46%), Gaps = 22/275 (8%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
YD + ++++ +G G +G Y+ L VAVK L + +++F E +
Sbjct: 209 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 267
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A
Sbjct: 268 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 327
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YL +HR++ N L+ E ++DFGL+RL+ A + A
Sbjct: 328 MEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 384
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
PE + S K+DV++FGV+L E+ + S P G ++ +LL K+ R
Sbjct: 385 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYR--- 434
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
+ PE G E + +MR C S RPS
Sbjct: 435 MERPE----GCPEKVYELMR---ACWQWNPSDRPS 462
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
YD + ++++ +G G +G Y+ L VAVK L + +++F E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YL +HRD+ N L+ E ++DFGL+RL+ A + A
Sbjct: 124 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
PE + S K+DV++FGV+L E+ + S P G ++ +LL K+ R
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 233
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
PE G E + +MR C S RPS
Sbjct: 234 ---PE----GCPEKVYELMR---ACWQWNPSDRPS 258
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid Leukemi
Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid Leukemi
Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
YD + ++++ +G G +G Y+ L VAVK L + +++F E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YL +HRD+ N L+ E ++DFGL+RL+ A + A
Sbjct: 124 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
PE + S K+DV++FGV+L E+ + S P G ++ +LL K+ R
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 233
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
PE G E + +MR C S RPS
Sbjct: 234 ---PE----GCPEKVYELMR---ACWQWNPSDRPS 258
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
YD + ++++ +G G +G Y+ L VAVK L + +++F E +
Sbjct: 18 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 76
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A
Sbjct: 77 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 136
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YL +HRD+ N L+ E ++DFGL+RL+ A + A
Sbjct: 137 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 193
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
PE + S K+DV++FGV+L E+ + S P G ++ +LL K+ R
Sbjct: 194 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 246
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
PE G E + +MR C S RPS
Sbjct: 247 ---PE----GCPEKVYELMR---ACWQWNPSDRPS 271
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
YD + ++++ +G G +G Y+ L VAVK L + +++F E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 123
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YL +HRD+ N L+ E ++DFGL+RL+ A + A
Sbjct: 124 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
PE + S K+DV++FGV+L E+ + S P G ++ +LL K+ R
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 233
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
PE G E + +MR C S RPS
Sbjct: 234 ---PE----GCPEKVYELMR---ACWQWNPSDRPS 258
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
YD + ++++ +G G +G Y+ L VAVK L + +++F E +
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 67
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 127
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YL +HRD+ N L+ E ++DFGL+RL+ A + A
Sbjct: 128 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
PE + S K+DV++FGV+L E+ + S P G ++ +LL K+ R
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 237
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
PE G E + +MR C S RPS
Sbjct: 238 ---PE----GCPEKVYELMR---ACWQWNPSDRPS 262
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
YD + ++++ +G G +G Y+ L VAVK L + +++F E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 123
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YL +HRD+ N L+ E ++DFGL+RL+ A + A
Sbjct: 124 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
PE + S K+DV++FGV+L E+ + S P G ++ +LL K+ R
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 233
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
PE G E + +MR C S RPS
Sbjct: 234 ---PE----GCPEKVYELMR---ACWQWNPSDRPS 258
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
YD + ++++ +G G +G Y+ L VAVK L + +++F E +
Sbjct: 7 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 65
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A
Sbjct: 66 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 125
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YL +HRD+ N L+ E ++DFGL+RL+ A + A
Sbjct: 126 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 182
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
PE + S K+DV++FGV+L E+ + S P G ++ +LL K+ R
Sbjct: 183 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 235
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
PE G E + +MR C S RPS
Sbjct: 236 ---PE----GCPEKVYELMR---ACWQWNPSDRPS 260
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase
Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase
Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase
Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase
Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
YD + ++++ +G G +G Y+ L VAVK L + +++F E +
Sbjct: 7 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 65
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A
Sbjct: 66 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 125
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YL +HRD+ N L+ E ++DFGL+RL+ A + A
Sbjct: 126 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 182
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
PE + S K+DV++FGV+L E+ + S P G ++ +LL K+ R
Sbjct: 183 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 235
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
PE G E + +MR C S RPS
Sbjct: 236 ---PE----GCPEKVYELMR---ACWQWNPSDRPS 260
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out
Inhibitor Ap24534
Length = 284
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
YD + ++++ +G G +G Y+ L VAVK L + +++F E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YL +HRD+ N L+ E ++DFGL+RL+ A + A
Sbjct: 124 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
PE + S K+DV++FGV+L E+ + S P G ++ +LL K+ R
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 233
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
PE G E + +MR C S RPS
Sbjct: 234 ---PE----GCPEKVYELMR---ACWQWNPSDRPS 258
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
YD + ++++ +G G +G Y+ L VAVK L + +++F E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
I+H NLV L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YL +HRD+ N L+ E ++DFGL+RL+ A + A
Sbjct: 124 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
PE + S K+DV++FGV+L E+ + S P G ++ +LL K+ R
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 233
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
PE G E + +MR C S RPS
Sbjct: 234 ---PE----GCPEKVYELMR---ACWQWNPSDRPS 258
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 88.6 bits (218), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 106/210 (50%), Gaps = 9/210 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
+ ++++ +G G +G Y+ L VAVK L + +++F E + I+H NLV
Sbjct: 12 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A+ YL
Sbjct: 71 QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-- 128
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
+HRD+ N L+ E ++DFGL+RL+ A + APE +
Sbjct: 129 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKF 187
Query: 955 SDKADVYSFGVVLLEL----ISGKRSLDPS 980
S K+DV++FGV+L E+ +S +DPS
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSPYPGIDPS 217
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 88.2 bits (217), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 66/207 (31%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
+G G FGS P G +VAVKKL + ++ F+ EI L ++H N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 838 G--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------- 888
G Y G + L+ +L G+L ++ K HK ID + L Y
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKERIDHIKLLQYTSQICKG 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYVA 945
+ Y R +HRD+ NIL++ E + DFGL ++L + G F Y A
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-A 185
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS 972
PE T + S +DV+SFGVVL EL +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 88.2 bits (217), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
N SI ++G G FG L +P VA+K L +G + ++ F E +G+ H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
N++ L G + +V ++ G+L++F+ K Q++VI + + IA + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
L VHRD+ NIL++ L +SDFGLAR+LE A T G + +P
Sbjct: 163 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
E + + +DV+S+G+VL E++S G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 88.2 bits (217), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 69/223 (30%), Positives = 101/223 (45%), Gaps = 34/223 (15%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
R F R+L +G G FGS P G +VAVKKL + ++ F+ E
Sbjct: 3 RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 62
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
I L ++H N+V G Y G + L+ +L G+L ++ K HK
Sbjct: 63 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKER 111
Query: 880 IDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
ID + L Y + Y R +HR++ NIL++ E + DFGL ++L + +
Sbjct: 112 IDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEY 171
Query: 933 ATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
G F Y APE T + S +DV+SFGVVL EL +
Sbjct: 172 YKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 213
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 88.2 bits (217), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 69/228 (30%), Positives = 108/228 (47%), Gaps = 23/228 (10%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
G+ + + G FG +KA+L+ + VAVK + Q Q + EI + ++H+NL+
Sbjct: 15 GSLQLLEIKARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS-EREIFSTPGMKHENLL 72
Query: 835 TLIGYYVG----EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
I E E++L+ F G+L ++ G I W+ + +A +++ L+YLH
Sbjct: 73 QFIAAEKRGSNLEVELWLITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGLSYLH 129
Query: 891 YSC--------VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTF 941
P I HRD K N+LL +L A L+DFGLA E + T GT
Sbjct: 130 EDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTR 189
Query: 942 GYVAPEYATTC-----RVSDKADVYSFGVVLLELISGKRSLDPSFSEY 984
Y+APE + D+Y+ G+VL EL+S ++ D EY
Sbjct: 190 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEY 237
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 87.8 bits (216), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 68/203 (33%), Positives = 99/203 (48%), Gaps = 14/203 (6%)
Query: 777 FSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKNLV 834
F + +GTG F AE G L AVK + +G + + EI L +I+H+N+V
Sbjct: 24 FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
L Y ++LV +SGG L + + K + S + + +D A+ YLH
Sbjct: 84 ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD---AVYYLHRMG 140
Query: 894 VPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
IVHRD+KP N+L DEE +SDFGL+++ + +T GT GYVAPE
Sbjct: 141 ---IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTA--CGTPGYVAPEVLA 195
Query: 951 TCRVSDKADVYSFGVVLLELISG 973
S D +S GV+ L+ G
Sbjct: 196 QKPYSKAVDCWSIGVIAYILLCG 218
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated
Protein Kinase Alpha-2 Subunit Mutant (T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 87.8 bits (216), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 69/257 (26%), Positives = 118/257 (45%), Gaps = 24/257 (9%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQ---QFDAEIGTLGRIRH 830
G++ + + +G G FG E + G+ VAVK L+ + + + + EI L RH
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+++ L + F+V ++SGG L +I K +++ ++ I A+ Y H
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCH 128
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
V VHRD+KP N+LLD +NA ++DFGL+ ++ S+ D G+ Y APE +
Sbjct: 129 RHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRDSCGSPNYAAPEVIS 183
Query: 951 -TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
+ D++S GV+L L+ G D L K+ R ++P
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEH------------VPTLFKKIRGGVFYIP 231
Query: 1010 ELWEAGPQENLLGMMRL 1026
E L+ M+++
Sbjct: 232 EYLNRSVATLLMHMLQV 248
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 87.8 bits (216), Expect = 3e-17, Method: Composition-based stats.
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 777 FSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLV 834
+ R+++GTG F AE LVA+K ++ +G + + EI L +I+H N+V
Sbjct: 20 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNL------ETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
L Y ++L+ +SGG L + F ++ ++ + V+ A+ Y
Sbjct: 80 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL--------DAVKY 131
Query: 889 LHYSCVPRIVHRDIKPSNIL---LDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
LH IVHRD+KP N+L LDE+ +SDFGL+++ + +T GT GYVA
Sbjct: 132 LHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVA 186
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISG 973
PE S D +S GV+ L+ G
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCG 214
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 87.4 bits (215), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
N SI ++G G FG L +P VA+K L +G + ++ F E +G+ H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
N++ L G + +V ++ G+L++F+ K Q++VI + + IA + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
L VHRD+ NIL++ L +SDFGL+R+LE A T G + +P
Sbjct: 163 LSDMG---FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
E + + +DV+S+G+VL E++S G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 87.4 bits (215), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 18/212 (8%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGY-LVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNL 833
++ ++ +IG+G A P VA+K++++ + Q + + EI + + H N+
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFI-------HKKSGKKIQWSVIHKIAIDIAQAL 886
V+ +V + E++LV LSGG++ I KSG + S I I ++ + L
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIATILREVLEGL 134
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL----EVSETHATTDVAGTFG 942
YLH + +HRD+K NILL E+ + ++DFG++ L +++ GT
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 943 YVAPEYATTCRVSD-KADVYSFGVVLLELISG 973
++APE R D KAD++SFG+ +EL +G
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATG 223
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 87.4 bits (215), Expect = 4e-17, Method: Composition-based stats.
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 777 FSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLV 834
+ R+++GTG F AE LVA+K ++ +G + + EI L +I+H N+V
Sbjct: 20 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNL------ETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
L Y ++L+ +SGG L + F ++ ++ + V+ A+ Y
Sbjct: 80 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL--------DAVKY 131
Query: 889 LHYSCVPRIVHRDIKPSNIL---LDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
LH IVHRD+KP N+L LDE+ +SDFGL+++ + +T GT GYVA
Sbjct: 132 LHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVA 186
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISG 973
PE S D +S GV+ L+ G
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCG 214
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 87.4 bits (215), Expect = 4e-17, Method: Composition-based stats.
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 777 FSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLV 834
+ R+++GTG F AE LVA+K ++ +G + + EI L +I+H N+V
Sbjct: 20 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNL------ETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
L Y ++L+ +SGG L + F ++ ++ + V+ A+ Y
Sbjct: 80 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL--------DAVKY 131
Query: 889 LHYSCVPRIVHRDIKPSNIL---LDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
LH IVHRD+KP N+L LDE+ +SDFGL+++ + +T GT GYVA
Sbjct: 132 LHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVA 186
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISG 973
PE S D +S GV+ L+ G
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCG 214
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 87.4 bits (215), Expect = 4e-17, Method: Composition-based stats.
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 777 FSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLV 834
+ R+++GTG F AE LVA+K ++ +G + + EI L +I+H N+V
Sbjct: 20 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNL------ETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
L Y ++L+ +SGG L + F ++ ++ + V+ A+ Y
Sbjct: 80 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL--------DAVKY 131
Query: 889 LHYSCVPRIVHRDIKPSNIL---LDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
LH IVHRD+KP N+L LDE+ +SDFGL+++ + +T GT GYVA
Sbjct: 132 LHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVA 186
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISG 973
PE S D +S GV+ L+ G
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCG 214
>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|C Chain C, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|D Chain D, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|E Chain E, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|F Chain F, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
Length = 384
Score = 87.4 bits (215), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 776 NFSIRNLIGTGGFGST---YKAELVPGYLVAV--KKLSIGRFQGIQQFDAEIGTLGRIRH 830
+F I IG G FG K + Y + K+ + R ++ E+ + + H
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER-NEVRNVFKELQIMQGLEH 74
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
LV L + E +MF+V + L GG+L H + + + ++ AL YL
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLR--YHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
RI+HRD+KP NILLDE + +++DF +A +L ET TT +AGT Y+APE +
Sbjct: 133 NQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-RETQITT-MAGTKPYMAPEMFS 187
Query: 951 TCR---VSDKADVYSFGVVLLELISGKR 975
+ + S D +S GV EL+ G+R
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRR 215
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 87.4 bits (215), Expect = 4e-17, Method: Composition-based stats.
Identities = 59/210 (28%), Positives = 106/210 (50%), Gaps = 9/210 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
+ ++++ +G G +G Y+ L VAVK L + +++F E + I+H NLV
Sbjct: 12 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+G E +++ F++ GNL ++ + + +++ V+ +A I+ A+ YL
Sbjct: 71 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-- 128
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
+HRD+ N L+ E ++DFGL+RL+ A + APE +
Sbjct: 129 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKF 187
Query: 955 SDKADVYSFGVVLLEL----ISGKRSLDPS 980
S K+DV++FGV+L E+ +S +DPS
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSPYPGIDPS 217
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 87.4 bits (215), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
N SI ++G G FG L +P VA+K L +G + ++ F E +G+ H
Sbjct: 34 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
N++ L G + +V ++ G+L++F+ K Q++VI + + IA + Y
Sbjct: 94 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 150
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
L VHRD+ NIL++ L +SDFGL+R+LE A T G + +P
Sbjct: 151 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 207
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
E + + +DV+S+G+VL E++S G+R
Sbjct: 208 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 237
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 87.4 bits (215), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
N SI ++G G FG L +P VA+K L +G + ++ F E +G+ H
Sbjct: 17 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
N++ L G + +V ++ G+L++F+ K Q++VI + + IA + Y
Sbjct: 77 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 133
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
L VHRD+ NIL++ L +SDFGL+R+LE A T G + +P
Sbjct: 134 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
E + + +DV+S+G+VL E++S G+R
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 220
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 87.0 bits (214), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 18/212 (8%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGY-LVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNL 833
++ ++ +IG+G A P VA+K++++ + Q + + EI + + H N+
Sbjct: 11 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFI-------HKKSGKKIQWSVIHKIAIDIAQAL 886
V+ +V + E++LV LSGG++ I KSG + S I I ++ + L
Sbjct: 71 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIATILREVLEGL 129
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL----EVSETHATTDVAGTFG 942
YLH + +HRD+K NILL E+ + ++DFG++ L +++ GT
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 943 YVAPEYATTCRVSD-KADVYSFGVVLLELISG 973
++APE R D KAD++SFG+ +EL +G
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATG 218
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 87.0 bits (214), Expect = 4e-17, Method: Composition-based stats.
Identities = 70/229 (30%), Positives = 111/229 (48%), Gaps = 25/229 (10%)
Query: 766 TYDNVVRATGNFS---------IRNLIGTGGFGSTYKAEL-VPG---YLVAVKKLSIGRF 812
TY++ RA F+ I +IG G FG L +PG VA+K L +G
Sbjct: 25 TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 813 QGIQQ-FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ ++ F E +G+ H N+V L G + +V F+ G L+ F+ K G Q
Sbjct: 85 EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDG---Q 141
Query: 872 WSVIHKIAI--DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS 929
++VI + + IA + YL VHRD+ NIL++ L +SDFGL+R++E
Sbjct: 142 FTVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198
Query: 930 ETHATTDVAGTFG--YVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
T G + APE + + +DV+S+G+V+ E++S G+R
Sbjct: 199 PEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 247
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 87.0 bits (214), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
N SI ++G G FG L +P VA+K L +G + ++ F E +G+ H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
N++ L G + +V ++ G+L++F+ K Q++VI + + IA + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
L VHRD+ NIL++ L +SDFGL+R+LE A T G + +P
Sbjct: 163 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
E + + +DV+S+G+VL E++S G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 87.0 bits (214), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 60/236 (25%), Positives = 118/236 (50%), Gaps = 20/236 (8%)
Query: 776 NFSIRNLIGTGGFGSTY--KAELVPGY--LVAVKKLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F I +GTG FG + ++ Y + +KK + R + ++ + E L + H
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
++ + G + ++F++ +++ GG L + + K ++ V A ++ AL YLH
Sbjct: 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
I++RD+KP NILLD+ + ++DFG A+ + T + GT Y+APE +T
Sbjct: 125 K---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYXLCGTPDYIAPEVVST 177
Query: 952 CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007
+ D +SFG+++ E+++G ++ + + + ++ K+L E R F
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAG-------YTPFYDSNTMKTYEKILNAELRFPPFF 226
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 87.0 bits (214), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
N SI ++G G FG L +P VA+K L +G + ++ F E +G+ H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
N++ L G + +V ++ G+L++F+ K Q++VI + + IA + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
L VHRD+ NIL++ L +SDFGL+R+LE A T G + +P
Sbjct: 163 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
E + + +DV+S+G+VL E++S G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 87.0 bits (214), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
N SI ++G G FG L +P VA+K L +G + ++ F E +G+ H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
N++ L G + +V ++ G+L++F+ K Q++VI + + IA + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
L VHRD+ NIL++ L +SDFGL+R+LE A T G + +P
Sbjct: 163 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
E + + +DV+S+G+VL E++S G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 86.7 bits (213), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
N SI ++G G FG L +P VA+K L +G + ++ F E +G+ H
Sbjct: 44 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
N++ L G + +V ++ G+L++F+ K Q++VI + + IA + Y
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 160
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
L VHRD+ NIL++ L +SDFGL+R+LE A T G + +P
Sbjct: 161 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 217
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
E + + +DV+S+G+VL E++S G+R
Sbjct: 218 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 247
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 86.7 bits (213), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
N SI ++G G FG L +P VA+K L +G + ++ F E +G+ H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
N++ L G + +V ++ G+L++F+ K Q++VI + + IA + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
L VHRD+ NIL++ L +SDFGL+R+LE A T G + +P
Sbjct: 163 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
E + + +DV+S+G+VL E++S G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 86.7 bits (213), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
N SI ++G G FG L +P VA+K L +G + ++ F E +G+ H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
N++ L G + +V ++ G+L++F+ K Q++VI + + IA + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
L VHRD+ NIL++ L +SDFGL R+LE A T G + +P
Sbjct: 163 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
E + + +DV+S+G+VL E++S G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 86.7 bits (213), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 70/216 (32%), Positives = 104/216 (48%), Gaps = 22/216 (10%)
Query: 786 GGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG--- 842
G FG +KA+L+ Y VAVK I Q Q + E+ +L ++H+N++ IG
Sbjct: 35 GRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 843 -EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC-------V 894
+ +++L+ F G+L F+ + W+ + IA +A+ LAYLH
Sbjct: 93 VDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHK 149
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTC- 952
P I HRDIK N+LL L A ++DFGLA E ++ T GT Y+APE
Sbjct: 150 PAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAI 209
Query: 953 ----RVSDKADVYSFGVVLLELISGKRSLDPSFSEY 984
+ D+Y+ G+VL EL S + D EY
Sbjct: 210 NFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein
Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain)
Length = 276
Score = 86.7 bits (213), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 69/257 (26%), Positives = 118/257 (45%), Gaps = 24/257 (9%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQ---QFDAEIGTLGRIRH 830
G++ + + +G G FG E + G+ VAVK L+ + + + + EI L RH
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+++ L + F+V ++SGG L +I K +++ ++ I A+ Y H
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCH 128
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
V VHRD+KP N+LLD +NA ++DFGL+ ++ E T+ G+ Y APE +
Sbjct: 129 RHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS 183
Query: 951 -TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
+ D++S GV+L L+ G D L K+ R ++P
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEH------------VPTLFKKIRGGVFYIP 231
Query: 1010 ELWEAGPQENLLGMMRL 1026
E L+ M+++
Sbjct: 232 EYLNRSVATLLMHMLQV 248
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 86.7 bits (213), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 64/209 (30%), Positives = 108/209 (51%), Gaps = 18/209 (8%)
Query: 779 IRNLIGTGGFGSTYKAEL-VPG---YLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKNL 833
I +IG G FG L +PG VA+K L G + ++ F +E +G+ H N+
Sbjct: 37 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 96
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAYLHY 891
+ L G + ++ F+ G+L++F+ + G Q++VI + + IA + YL
Sbjct: 97 IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYL-- 151
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE--VSETHATTDVAGTFG--YVAPE 947
VHRD+ NIL++ L +SDFGL+R LE S+ T+ + G + APE
Sbjct: 152 -ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 210
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKR 975
+ + +DV+S+G+V+ E++S G+R
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVMSYGER 239
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 86.3 bits (212), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA----TTDVAGTFGYV 944
H R++HRDIKP N+LL ++DFG + HA TD+ GT Y+
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYL 173
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
PE +K D++S GV+ E + GK
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 86.3 bits (212), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 128
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA----TTDVAGTFGYV 944
H R++HRDIKP N+LL ++DFG + HA TD+ GT Y+
Sbjct: 129 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYL 178
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
PE +K D++S GV+ E + GK
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 86.3 bits (212), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA----TTDVAGTFGYV 944
H R++HRDIKP N+LL ++DFG + HA TD+ GT Y+
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYL 173
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
PE +K D++S GV+ E + GK
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 86.3 bits (212), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 54/190 (28%), Positives = 97/190 (51%), Gaps = 5/190 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
IG+G FG + + VA+K + G + F E + ++ H LV L G +
Sbjct: 18 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+A + LV+ F+ G L ++ + G +++ + +D+ + +AYL +CV +HRD+
Sbjct: 77 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL-GMCLDVCEGMAYLEEACV---IHRDL 132
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
N L+ E +SDFG+ R + + ++T + +PE + R S K+DV+S
Sbjct: 133 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 963 FGVVLLELIS 972
FGV++ E+ S
Sbjct: 193 FGVLMWEVFS 202
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 86.3 bits (212), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 54/190 (28%), Positives = 97/190 (51%), Gaps = 5/190 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
IG+G FG + + VA+K + G + F E + ++ H LV L G +
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+A + LV+ F+ G L ++ + G +++ + +D+ + +AYL +CV +HRD+
Sbjct: 74 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL-GMCLDVCEGMAYLEEACV---IHRDL 129
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
N L+ E +SDFG+ R + + ++T + +PE + R S K+DV+S
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 963 FGVVLLELIS 972
FGV++ E+ S
Sbjct: 190 FGVLMWEVFS 199
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 86.3 bits (212), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 63/194 (32%), Positives = 100/194 (51%), Gaps = 11/194 (5%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
IG G FG + G VAVK I Q F AE + ++RH NLV L+G V
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 843 E-AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
E +++V +++ G+L ++ + + + K ++D+ +A+ YL + VHRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 127
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
+ N+L+ E+ A +SDFGL + E S T T + + APE + S K+DV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSDVW 183
Query: 962 SFGVVLLELISGKR 975
SFG++L E+ S R
Sbjct: 184 SFGILLWEIYSFGR 197
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 86.3 bits (212), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 124
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA----TTDVAGTFGYV 944
H R++HRDIKP N+LL ++DFG + HA TD+ GT Y+
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYL 174
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
PE +K D++S GV+ E + GK
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 85.9 bits (211), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 54/190 (28%), Positives = 97/190 (51%), Gaps = 5/190 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
IG+G FG + + VA+K + G + F E + ++ H LV L G +
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+A + LV+ F+ G L ++ + G +++ + +D+ + +AYL +CV +HRD+
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL-GMCLDVCEGMAYLEEACV---IHRDL 127
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
N L+ E +SDFG+ R + + ++T + +PE + R S K+DV+S
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 963 FGVVLLELIS 972
FGV++ E+ S
Sbjct: 188 FGVLMWEVFS 197
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 85.9 bits (211), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 20/216 (9%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
R F R+L +G G FGS P G +VAVKKL + ++ F+ E
Sbjct: 5 RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
I L ++H N+V G Y G + L+ +L G+L ++ + ++I + +
Sbjct: 65 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QAHAERIDHIKLLQYT 123
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
I + + YL R +HRD+ NIL++ E + DFGL ++L + G
Sbjct: 124 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180
Query: 940 T---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
F Y APE T + S +DV+SFGVVL EL +
Sbjct: 181 ESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 215
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 85.9 bits (211), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 63/194 (32%), Positives = 100/194 (51%), Gaps = 11/194 (5%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
IG G FG + G VAVK I Q F AE + ++RH NLV L+G V
Sbjct: 29 IGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 843 E-AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
E +++V +++ G+L ++ + + + K ++D+ +A+ YL + VHRD
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 142
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
+ N+L+ E+ A +SDFGL + E S T T + + APE + S K+DV+
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSDVW 198
Query: 962 SFGVVLLELISGKR 975
SFG++L E+ S R
Sbjct: 199 SFGILLWEIYSFGR 212
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 85.9 bits (211), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 32 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 92 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 149
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT----DVAGTFGYV 944
H R++HRDIKP N+LL ++DFG + HA + D+ GT Y+
Sbjct: 150 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTLDYL 199
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
PE +K D++S GV+ E + GK
Sbjct: 200 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 85.9 bits (211), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
N SI ++G G FG L +P VA+K L +G + ++ F E +G+ H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
N++ L G + +V + G+L++F+ K Q++VI + + IA + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
L VHRD+ NIL++ L +SDFGL+R+LE A T G + +P
Sbjct: 163 LSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
E + + +DV+S+G+VL E++S G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 85.9 bits (211), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 63/194 (32%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
IG G FG + G VAVK I Q F AE + ++RH NLV L+G V
Sbjct: 20 IGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 843 E-AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
E +++V +++ G+L ++ + + + K ++D+ +A+ YL + VHRD
Sbjct: 77 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 133
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
+ N+L+ E+ A +SDFGL + E S T T + + APE S K+DV+
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREAAFSTKSDVW 189
Query: 962 SFGVVLLELISGKR 975
SFG++L E+ S R
Sbjct: 190 SFGILLWEIYSFGR 203
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 85.9 bits (211), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 5/190 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
IG+G FG + + VA+K + G F E + ++ H LV L G +
Sbjct: 35 IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+A + LV+ F+ G L ++ + G +++ + +D+ + +AYL +CV +HRD+
Sbjct: 94 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL-GMCLDVCEGMAYLEEACV---IHRDL 149
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
N L+ E +SDFG+ R + + ++T + +PE + R S K+DV+S
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 963 FGVVLLELIS 972
FGV++ E+ S
Sbjct: 210 FGVLMWEVFS 219
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 85.5 bits (210), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
N SI ++G G FG L +P VA+K L +G + ++ F E +G+ H
Sbjct: 17 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
N++ L G + +V + G+L++F+ K Q++VI + + IA + Y
Sbjct: 77 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 133
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
L VHRD+ NIL++ L +SDFGL+R+LE A T G + +P
Sbjct: 134 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
E + + +DV+S+G+VL E++S G+R
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 220
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 85.5 bits (210), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 70/243 (28%), Positives = 117/243 (48%), Gaps = 30/243 (12%)
Query: 753 QVMVTFADTPAELTYDNVVRATGNFS---------IRNLIGTGGFGSTYKAEL-VPG--- 799
Q + TF D T+++ +A F+ I +IG G FG L VPG
Sbjct: 1 QGVRTFVDP---FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKRE 57
Query: 800 YLVAVKKLSIGRFQGIQQFD--AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGN 857
VA+K L G + Q+ D +E +G+ H N++ L G + ++ ++ G+
Sbjct: 58 ICVAIKTLKAG-YTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGS 116
Query: 858 LETFIHKKSGKKIQWSVIHKIAI--DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNA 915
L+ F+ K G+ ++VI + + I + YL VHRD+ NIL++ L
Sbjct: 117 LDAFLRKNDGR---FTVIQLVGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVC 170
Query: 916 YLSDFGLARLLEVSETHATTDVAGT--FGYVAPEYATTCRVSDKADVYSFGVVLLELIS- 972
+SDFG++R+LE A T G + APE + + +DV+S+G+V+ E++S
Sbjct: 171 KVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 230
Query: 973 GKR 975
G+R
Sbjct: 231 GER 233
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 85.1 bits (209), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F + NL+G G F Y+AE + G VA+K K ++ + +Q+ E+ +++H
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
+++ L Y+ ++LV G + ++ K K + I + YLH
Sbjct: 72 SILELYNYFEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYAT 950
I+HRD+ SN+LL +N ++DFGLA L++ E H T + GT Y++PE AT
Sbjct: 131 HG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIAT 185
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLD 978
++DV+S G + L+ G+ D
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFD 213
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 85.1 bits (209), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 61/195 (31%), Positives = 100/195 (51%), Gaps = 9/195 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSI-GRFQGIQQFD-AEIGTLGRIRHKNLVTLIGYY 840
+G G +G YKA+ G +VA+K++ + +GI EI L + H N+V+LI
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
E + LV+ F+ + K+G +Q S I + + +A+ H RI+HR
Sbjct: 89 HSERCLTLVFEFMEKDLKKVLDENKTG--LQDSQIKIYLYQLLRGVAHCHQH---RILHR 143
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKAD 959
D+KP N+L++ + L+DFGLAR + T +V T Y AP+ + + S D
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVD 202
Query: 960 VYSFGVVLLELISGK 974
++S G + E+I+GK
Sbjct: 203 IWSIGCIFAEMITGK 217
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 85.1 bits (209), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 61/195 (31%), Positives = 100/195 (51%), Gaps = 9/195 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSI-GRFQGIQQFD-AEIGTLGRIRHKNLVTLIGYY 840
+G G +G YKA+ G +VA+K++ + +GI EI L + H N+V+LI
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
E + LV+ F+ + K+G +Q S I + + +A+ H RI+HR
Sbjct: 89 HSERCLTLVFEFMEKDLKKVLDENKTG--LQDSQIKIYLYQLLRGVAHCHQH---RILHR 143
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKAD 959
D+KP N+L++ + L+DFGLAR + T +V T Y AP+ + + S D
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVD 202
Query: 960 VYSFGVVLLELISGK 974
++S G + E+I+GK
Sbjct: 203 IWSIGCIFAEMITGK 217
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 85.1 bits (209), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
N SI ++G G FG L +P VA+K L +G + ++ F E +G+ H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
N++ L G + +V + G+L++F+ K Q++VI + + IA + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
L VHRD+ NIL++ L +SDFGL+R+LE A T G + +P
Sbjct: 163 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
E + + +DV+S+G+VL E++S G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 85.1 bits (209), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 54/193 (27%), Positives = 103/193 (53%), Gaps = 8/193 (4%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
IG G G+ Y A ++ G VA++++++ + + EI + ++ N+V + Y+
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
E+++V +L+GG+L + + + Q I + + QAL +LH + +++HRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQ---IAAVCRECLQALEFLHSN---QVIHRD 141
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
IK NILL + + L+DFG + E +++ GT ++APE T K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 962 SFGVVLLELISGK 974
S G++ +E+I G+
Sbjct: 201 SLGIMAIEMIEGE 213
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 85.1 bits (209), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 783 IGTGGFGSTYKAELVP----GYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTL 836
IG G FG KA LV G +K+++I R ++ ++ E+ L ++H N+V
Sbjct: 32 IGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
+ +++V ++ GG+L I+ + G Q I + I AL ++H +
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---K 145
Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
I+HRDIK NI L ++ L DFG+AR+L S GT Y++PE ++
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARACIGTPYYLSPEICENKPYNN 204
Query: 957 KADVYSFGVVLLELISGKRSLD 978
K+D+++ G VL EL + K + +
Sbjct: 205 KSDIWALGCVLYELCTLKHAFE 226
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY--ITELANALSY 128
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H R++HRDIKP N+LL ++DFG + + + TT + GT Y+ PE
Sbjct: 129 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 182
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
+K D++S GV+ E + GK
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGK 208
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
IG G FG + G VAVK I Q F AE + ++RH NLV L+G V
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 843 E-AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
E +++V +++ G+L ++ + + + K ++D+ +A+ YL + VHRD
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 314
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
+ N+L+ E+ A +SDFGL + E S T T + + APE + S K+DV+
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSDVW 370
Query: 962 SFGVVLLELISGKRSLDP 979
SFG++L E+ S R P
Sbjct: 371 SFGILLWEIYSFGRVPYP 388
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 54/193 (27%), Positives = 104/193 (53%), Gaps = 8/193 (4%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
IG G G+ Y A ++ G VA++++++ + + EI + ++ N+V + Y+
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
E+++V +L+GG+L + + + Q I + + QAL +LH + +++HRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQ---IAAVCRECLQALEFLHSN---QVIHRD 141
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
IK NILL + + L+DFG + ++ +T + GT ++APE T K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 962 SFGVVLLELISGK 974
S G++ +E+I G+
Sbjct: 201 SLGIMAIEMIEGE 213
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 32 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 92 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 149
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H R++HRDIKP N+LL ++DFG + + + TT + GT Y+ PE
Sbjct: 150 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 203
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
+K D++S GV+ E + GK
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGK 229
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA----TTDVAGTFGYV 944
H R++HRDIKP N+LL ++DFG + HA T++ GT Y+
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTELCGTLDYL 173
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
PE +K D++S GV+ E + GK
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 84.7 bits (208), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 777 FSIRNLIGTGGFGSTYKAEL-VPG---YLVAVKKLSIGRFQGIQQFD--AEIGTLGRIRH 830
I +IG G FG L VPG VA+K L G + Q+ D +E +G+ H
Sbjct: 10 IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG-YTDKQRRDFLSEASIMGQFDH 68
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
N++ L G + ++ ++ G+L+ F+ K G+ ++VI + + I + Y
Sbjct: 69 PNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR---FTVIQLVGMLRGIGSGMKY 125
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
L VHRD+ NIL++ L +SDFG++R+LE A T G + AP
Sbjct: 126 LSDMSY---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 182
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
E + + +DV+S+G+V+ E++S G+R
Sbjct: 183 EAIAYRKFTSASDVWSYGIVMWEVMSYGER 212
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 84.7 bits (208), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 777 FSIRNLIGTGGFGSTYKAEL-VPG---YLVAVKKLSIGRFQGIQQFD--AEIGTLGRIRH 830
I +IG G FG L VPG VA+K L G + Q+ D +E +G+ H
Sbjct: 16 IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG-YTDKQRRDFLSEASIMGQFDH 74
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
N++ L G + ++ ++ G+L+ F+ K G+ ++VI + + I + Y
Sbjct: 75 PNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR---FTVIQLVGMLRGIGSGMKY 131
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
L VHRD+ NIL++ L +SDFG++R+LE A T G + AP
Sbjct: 132 LSDMSY---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 188
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
E + + +DV+S+G+V+ E++S G+R
Sbjct: 189 EAIAYRKFTSASDVWSYGIVMWEVMSYGER 218
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 84.3 bits (207), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT----DVAGTFGYV 944
H R++HRDIKP N+LL ++DFG + HA + D+ GT Y+
Sbjct: 127 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTLDYL 176
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
PE +K D++S GV+ E + GK
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 84.3 bits (207), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 5/190 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
IG+G FG + + VA+K + G + F E + ++ H LV L G +
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+A + LV F+ G L ++ + G +++ + +D+ + +AYL +CV +HRD+
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLL-GMCLDVCEGMAYLEEACV---IHRDL 130
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
N L+ E +SDFG+ R + + ++T + +PE + R S K+DV+S
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 963 FGVVLLELIS 972
FGV++ E+ S
Sbjct: 191 FGVLMWEVFS 200
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 84.3 bits (207), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 54/185 (29%), Positives = 95/185 (51%), Gaps = 10/185 (5%)
Query: 799 GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL 858
G LVAVKK+ + + Q + E+ + +H+N+V + Y+ E+++V FL GG L
Sbjct: 176 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 235
Query: 859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS 918
+ + ++ I + + + QAL+ LH V +HRDIK +ILL + LS
Sbjct: 236 TDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 289
Query: 919 DFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD 978
DFG + E + GT ++APE + + D++S G++++E++ G+
Sbjct: 290 DFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---P 345
Query: 979 PSFSE 983
P F+E
Sbjct: 346 PYFNE 350
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 84.3 bits (207), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 23 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 83 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 140
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H R++HRDIKP N+LL ++DFG + + + TT + GT Y+ PE
Sbjct: 141 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 194
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
+K D++S GV+ E + GK
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGK 220
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 84.0 bits (206), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 775 GNFSIRNLIGTGGFGSTY--KAELVPGYLVAVKKLSIGRFQGIQ---QFDAEIGTLGRIR 829
G++ + + +G G FG K EL G+ VAVK L+ + + + + EI L R
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
H +++ L +++F+V ++SGG L +I K ++ ++ I + Y
Sbjct: 75 HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYC 132
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
H V VHRD+KP N+LLD +NA ++DFGL+ ++ S+ G+ Y APE
Sbjct: 133 HRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRXSCGSPNYAAPEVI 187
Query: 950 T-TCRVSDKADVYSFGVVLLELISGKRSLD 978
+ + D++S GV+L L+ G D
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 84.0 bits (206), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 8/199 (4%)
Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
F + +G G +GS YKA G +VA+K++ + +Q+ EI + + ++V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
G Y ++++V + G++ I ++ K + I I + L YLH+
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFM--- 144
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
R +HRDIK NILL+ E +A L+DFG+A L V GT ++APE +
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQL-TDXMAKRNXVIGTPFWMAPEVIQEIGYN 203
Query: 956 DKADVYSFGVVLLELISGK 974
AD++S G+ +E+ GK
Sbjct: 204 CVADIWSLGITAIEMAEGK 222
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 84.0 bits (206), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H R++HRDIKP N+LL ++DFG + + + TT + GT Y+ PE
Sbjct: 127 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 180
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
+K D++S GV+ E + GK
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGK 206
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 84.0 bits (206), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 779 IRNLIGTGGFGSTYKAEL-VPGY---LVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNL 833
I +IG G FG + L PG VA+K L G + ++F +E +G+ H N+
Sbjct: 20 IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 79
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAYLHY 891
+ L G + ++ F+ G L++F+ G Q++VI + + IA + YL
Sbjct: 80 IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDG---QFTVIQLVGMLRGIASGMRYLAE 136
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE--VSETHATTDVAGTFG--YVAPE 947
VHRD+ NIL++ L +SDFGL+R LE S+ T+ + G + APE
Sbjct: 137 MSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPE 193
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKR 975
+ + +D +S+G+V+ E++S G+R
Sbjct: 194 AIAFRKFTSASDAWSYGIVMWEVMSFGER 222
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 84.0 bits (206), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H R++HRDIKP N+LL ++DFG + + + TT + GT Y+ PE
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 177
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
+K D++S GV+ E + GK
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGK 203
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 84.0 bits (206), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 128
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H R++HRDIKP N+LL ++DFG + + + TT + GT Y+ PE
Sbjct: 129 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 182
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
+K D++S GV+ E + GK
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGK 208
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 83.6 bits (205), Expect = 5e-16, Method: Composition-based stats.
Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPG------YLVAVKKLSIGRFQGIQQFDAEIGTLGRIRH 830
F + ++G G FG + + + G Y + V K + + + + E L + H
Sbjct: 27 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 86
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKIAIDIAQALA 887
+V L + E +++L+ +FL GG+L T + K+ + + +++ + ++A AL
Sbjct: 87 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELALALD 141
Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
+LH I++RD+KP NILLDEE + L+DFGL++ + GT Y+APE
Sbjct: 142 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPE 197
Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
+ AD +SFGV++ E+++G
Sbjct: 198 VVNRRGHTQSADWWSFGVLMFEMLTG 223
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 83.6 bits (205), Expect = 5e-16, Method: Composition-based stats.
Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPG------YLVAVKKLSIGRFQGIQQFDAEIGTLGRIRH 830
F + ++G G FG + + + G Y + V K + + + + E L + H
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKIAIDIAQALA 887
+V L + E +++L+ +FL GG+L T + K+ + + +++ + ++A AL
Sbjct: 86 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELALALD 140
Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
+LH I++RD+KP NILLDEE + L+DFGL++ + GT Y+APE
Sbjct: 141 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPE 196
Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
+ AD +SFGV++ E+++G
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTG 222
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 83.6 bits (205), Expect = 5e-16, Method: Composition-based stats.
Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPG------YLVAVKKLSIGRFQGIQQFDAEIGTLGRIRH 830
F + ++G G FG + + + G Y + V K + + + + E L + H
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKIAIDIAQALA 887
+V L + E +++L+ +FL GG+L T + K+ + + +++ + ++A AL
Sbjct: 86 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELALALD 140
Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
+LH I++RD+KP NILLDEE + L+DFGL++ + GT Y+APE
Sbjct: 141 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPE 196
Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
+ AD +SFGV++ E+++G
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTG 222
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 83.6 bits (205), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 54/193 (27%), Positives = 102/193 (52%), Gaps = 8/193 (4%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
IG G G+ Y A ++ G VA++++++ + + EI + ++ N+V + Y+
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
E+++V +L+GG+L + + + Q I + + QAL +LH + +++HRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQ---IAAVCRECLQALEFLHSN---QVIHRD 141
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
IK NILL + + L+DFG + E + + GT ++APE T K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 962 SFGVVLLELISGK 974
S G++ +E+I G+
Sbjct: 201 SLGIMAIEMIEGE 213
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 83.6 bits (205), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 54/185 (29%), Positives = 95/185 (51%), Gaps = 10/185 (5%)
Query: 799 GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL 858
G LVAVKK+ + + Q + E+ + +H+N+V + Y+ E+++V FL GG L
Sbjct: 56 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 115
Query: 859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS 918
+ + ++ I + + + QAL+ LH V +HRDIK +ILL + LS
Sbjct: 116 TDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 169
Query: 919 DFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD 978
DFG + E + GT ++APE + + D++S G++++E++ G+
Sbjct: 170 DFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---P 225
Query: 979 PSFSE 983
P F+E
Sbjct: 226 PYFNE 230
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 83.6 bits (205), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 18/209 (8%)
Query: 779 IRNLIGTGGFGSTYKAEL-VPG---YLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKNL 833
I +IG G FG L +PG VA+K L G + ++ F +E +G+ H N+
Sbjct: 11 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAYLHY 891
+ L G + ++ F+ G+L++F+ + G Q++VI + + IA + YL
Sbjct: 71 IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYL-- 125
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE--VSETHATTDVAGT--FGYVAPE 947
VHR + NIL++ L +SDFGL+R LE S+ T+ + G + APE
Sbjct: 126 -ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKR 975
+ + +DV+S+G+V+ E++S G+R
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGER 213
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 83.6 bits (205), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 54/193 (27%), Positives = 102/193 (52%), Gaps = 8/193 (4%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
IG G G+ Y A ++ G VA++++++ + + EI + ++ N+V + Y+
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
E+++V +L+GG+L + + + Q I + + QAL +LH + +++HRD
Sbjct: 89 VGDELWVVMEYLAGGSLTDVVTETCMDEGQ---IAAVCRECLQALEFLHSN---QVIHRD 142
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
IK NILL + + L+DFG + E + + GT ++APE T K D++
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 962 SFGVVLLELISGK 974
S G++ +E+I G+
Sbjct: 202 SLGIMAIEMIEGE 214
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 83.6 bits (205), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 779 IRNLIGTGGFGSTYKAEL-VPGY---LVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNL 833
I +IG G FG + L PG VA+K L G + ++F +E +G+ H N+
Sbjct: 18 IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 77
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAYLHY 891
+ L G + ++ F+ G L++F+ G Q++VI + + IA + YL
Sbjct: 78 IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDG---QFTVIQLVGMLRGIASGMRYLAE 134
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE--VSETHATTDVAGTFG--YVAPE 947
VHRD+ NIL++ L +SDFGL+R LE S+ T+ + G + APE
Sbjct: 135 MSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPE 191
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKR 975
+ + +D +S+G+V+ E++S G+R
Sbjct: 192 AIAFRKFTSASDAWSYGIVMWEVMSFGER 220
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 83.6 bits (205), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 128
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H R++HRDIKP N+LL ++DFG + + + TT + GT Y+ PE
Sbjct: 129 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEX 182
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
+K D++S GV+ E + GK
Sbjct: 183 IEGRXHDEKVDLWSLGVLCYEFLVGK 208
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 83.6 bits (205), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 54/185 (29%), Positives = 95/185 (51%), Gaps = 10/185 (5%)
Query: 799 GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL 858
G LVAVKK+ + + Q + E+ + +H+N+V + Y+ E+++V FL GG L
Sbjct: 54 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 113
Query: 859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS 918
+ + ++ I + + + QAL+ LH V +HRDIK +ILL + LS
Sbjct: 114 TDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 167
Query: 919 DFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD 978
DFG + E + GT ++APE + + D++S G++++E++ G+
Sbjct: 168 DFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---P 223
Query: 979 PSFSE 983
P F+E
Sbjct: 224 PYFNE 228
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 83.2 bits (204), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 54/185 (29%), Positives = 95/185 (51%), Gaps = 10/185 (5%)
Query: 799 GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL 858
G LVAVKK+ + + Q + E+ + +H+N+V + Y+ E+++V FL GG L
Sbjct: 45 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104
Query: 859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS 918
+ + ++ I + + + QAL+ LH V +HRDIK +ILL + LS
Sbjct: 105 TDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 158
Query: 919 DFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD 978
DFG + E + GT ++APE + + D++S G++++E++ G+
Sbjct: 159 DFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---P 214
Query: 979 PSFSE 983
P F+E
Sbjct: 215 PYFNE 219
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 83.2 bits (204), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 124
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA----TTDVAGTFGYV 944
H R++HRDIKP N+LL ++DFG + HA T ++GT Y+
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------CHAPSSRRTTLSGTLDYL 174
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
PE +K D++S GV+ E + GK
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 83.2 bits (204), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 63/232 (27%), Positives = 110/232 (47%), Gaps = 22/232 (9%)
Query: 759 ADTPA----ELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQ 813
+D+PA E+ + G F + L+G G +G YK V G L A+K + + +
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE 63
Query: 814 GIQQFDAEIGTLGRI-RHKNLVTLIGYYVG------EAEMFLVYNFLSGGNLETFIHKKS 866
++ EI L + H+N+ T G ++ + +++LV F G++ I
Sbjct: 64 E-EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 867 GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL 926
G ++ I I +I + L++LH +++HRDIK N+LL E L DFG++ L
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179
Query: 927 EVSETHATTDVAGTFGYVAPEYATTCRVSD-----KADVYSFGVVLLELISG 973
+ + T + GT ++APE D K+D++S G+ +E+ G
Sbjct: 180 DRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 83.2 bits (204), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 5 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 65 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 122
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H R++HRDIKP N+LL ++DFG + + + TT + GT Y+ PE
Sbjct: 123 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 176
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
+K D++S GV+ E + GK
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGK 202
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 83.2 bits (204), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 54/185 (29%), Positives = 95/185 (51%), Gaps = 10/185 (5%)
Query: 799 GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL 858
G LVAVKK+ + + Q + E+ + +H+N+V + Y+ E+++V FL GG L
Sbjct: 49 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 108
Query: 859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS 918
+ + ++ I + + + QAL+ LH V +HRDIK +ILL + LS
Sbjct: 109 TDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 162
Query: 919 DFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD 978
DFG + E + GT ++APE + + D++S G++++E++ G+
Sbjct: 163 DFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---P 218
Query: 979 PSFSE 983
P F+E
Sbjct: 219 PYFNE 223
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 82.8 bits (203), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 10 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 70 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 127
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H R++HRDIKP N+LL ++DFG + + + TT + GT Y+ PE
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 181
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
+K D++S GV+ E + GK
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGK 207
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 82.8 bits (203), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H R++HRDIKP N+LL ++DFG + + + TT + GT Y+ PE
Sbjct: 127 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 180
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
+K D++S GV+ E + GK
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGK 206
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 82.8 bits (203), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY--ITELANALSY 128
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD----VAGTFGYV 944
H R++HRDIKP N+LL ++DFG + HA + + GT Y+
Sbjct: 129 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLXGTLDYL 178
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
PE +K D++S GV+ E + GK
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 82.8 bits (203), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 3 ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 63 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 120
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H R++HRDIKP N+LL ++DFG + + + TT + GT Y+ PE
Sbjct: 121 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 174
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
+K D++S GV+ E + GK
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGK 200
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 82.8 bits (203), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA----TTDVAGTFGYV 944
H R++HRDIKP N+LL ++DFG + HA T + GT Y+
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTXLCGTLDYL 173
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
PE +K D++S GV+ E + GK
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203
>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk-1 Bound To Amp-Pcp
pdb|2Z7R|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Staurosporine
pdb|2Z7S|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Purvalnol A
Length = 321
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 18/207 (8%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP----GYLVAVKKLSIG--RFQGIQQFDAEIGTLGRIR 829
+F + ++G G FG + V G+L A+K L + + + E L +
Sbjct: 29 HFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVN 88
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKIAIDIAQAL 886
H +V L + E +++L+ +FL GG+L T + K+ + + +++ + ++A L
Sbjct: 89 HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELALGL 143
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
+LH I++RD+KP NILLDEE + L+DFGL++ E A + GT Y+AP
Sbjct: 144 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS-FCGTVEYMAP 199
Query: 947 EYATTCRVSDKADVYSFGVVLLELISG 973
E S AD +S+GV++ E+++G
Sbjct: 200 EVVNRQGHSHSADWWSYGVLMFEMLTG 226
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 54/193 (27%), Positives = 104/193 (53%), Gaps = 8/193 (4%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
IG G G+ Y A ++ G VA++++++ + + EI + ++ N+V + Y+
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
E+++V +L+GG+L + + + Q I + + QAL +LH + +++HR+
Sbjct: 89 VGDELWVVMEYLAGGSLTDVVTETCMDEGQ---IAAVCRECLQALEFLHSN---QVIHRN 142
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
IK NILL + + L+DFG + ++ +T V GT ++APE T K D++
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 201
Query: 962 SFGVVLLELISGK 974
S G++ +E+I G+
Sbjct: 202 SLGIMAIEMIEGE 214
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 18/222 (8%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKN 832
++ + IGTG +G K G ++ K+L G Q +E+ L ++H N
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 833 LVTLIGYYVGEAE--MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+V + +++V + GG+L + I K G K + + + + + L
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK--GTKERQYLDEEFVLRVMTQLTLAL 124
Query: 891 YSCVPR------IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
C R ++HRD+KP+N+ LD + N L DFGLAR+L E A + GT Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA-KEFVGTPYYM 183
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGN 986
+PE ++K+D++S G +L EL +L P F+ +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELC----ALMPPFTAFSQ 221
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H R++HRDIKP N+LL ++DFG + S A + GT Y+ PE
Sbjct: 127 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA---LCGTLDYLPPEM 180
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
+K D++S GV+ E + GK
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGK 206
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 18/222 (8%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKN 832
++ + IGTG +G K G ++ K+L G Q +E+ L ++H N
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 833 LVTLIGYYVGEAE--MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+V + +++V + GG+L + I K G K + + + + + L
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK--GTKERQYLDEEFVLRVMTQLTLAL 124
Query: 891 YSCVPR------IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
C R ++HRD+KP+N+ LD + N L DFGLAR+L + A T V GT Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYM 183
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGN 986
+PE ++K+D++S G +L EL +L P F+ +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELC----ALMPPFTAFSQ 221
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 68 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 125
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD----VAGTFGYV 944
H R++HRDIKP N+LL ++DFG + HA + + GT Y+
Sbjct: 126 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDYL 175
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
PE +K D++S GV+ E + GK
Sbjct: 176 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 82.0 bits (201), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 68/227 (29%), Positives = 110/227 (48%), Gaps = 21/227 (9%)
Query: 766 TYDNVVRATGNFS---------IRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRF 812
TY+ RA +F+ I +IG+G G L VPG VA+K L G
Sbjct: 31 TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 813 QGIQQ-FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ ++ F +E +G+ H N++ L G +V ++ G+L+TF+ G Q
Sbjct: 91 ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG---Q 147
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
++++ + + + A + Y VHRD+ N+L+D L +SDFGL+R+LE
Sbjct: 148 FTIMQLVGM-LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206
Query: 932 HATTDVAGT--FGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
A T G + APE S +DV+SFGVV+ E+++ G+R
Sbjct: 207 AAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 81.6 bits (200), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 124
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD----VAGTFGYV 944
H R++HRDIKP N+LL ++DFG + HA + + GT Y+
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDTLCGTLDYL 174
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
PE +K D++S GV+ E + GK
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 81.6 bits (200), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 5/190 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
IG+G FG + + VA+K + G + F E + ++ H LV L G +
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+A + LV+ F+ G L ++ + G +++ + +D+ + +AYL + V +HRD+
Sbjct: 74 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL-GMCLDVCEGMAYLEEASV---IHRDL 129
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
N L+ E +SDFG+ R + + ++T + +PE + R S K+DV+S
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 963 FGVVLLELIS 972
FGV++ E+ S
Sbjct: 190 FGVLMWEVFS 199
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 81.6 bits (200), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H R++HRDIKP N+LL ++DFG + S A + GT Y+ PE
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA---LCGTLDYLPPEM 177
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
+K D++S GV+ E + GK
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGK 203
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 81.6 bits (200), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 68 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 125
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H R++HRDIKP N+LL +++FG + + + TT + GT Y+ PE
Sbjct: 126 CHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT-LCGTLDYLPPEM 179
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
+K D++S GV+ E + GK
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGK 205
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 81.6 bits (200), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 60/224 (26%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 771 VRATGNFSIRNLIGTGGFGSTYK-AELVPGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRI 828
+ G + ++ +GTGGFG + G VA+K+ + +++ EI + ++
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 829 RHKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFIHK-KSGKKIQWSVIHKIAID 881
H N+V+ G ++ L + GG+L ++++ ++ ++ I + D
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVA 938
I+ AL YLH + RI+HRD+KP NI+L + L + D G A+ E+ + T+
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFV 184
Query: 939 GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
GT Y+APE + + D +SFG + E I+G R P++
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 81.6 bits (200), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 13/204 (6%)
Query: 777 FSIRNLIGTGGFGSTY-KAELVPGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLV 834
F + +G+G FG + E G +K ++ R Q ++Q +AEI L + H N++
Sbjct: 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 835 TLIGYYVGEAEMFLVYNFLSGGN-LETFIHKKS-GKKIQWSVIHKIAIDIAQALAYLHYS 892
+ + M++V GG LE + ++ GK + + ++ + ALAY H
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 893 CVPRIVHRDIKPSNILLDE---ELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+VH+D+KP NIL + + DFGLA L + E +T+ AGT Y+APE
Sbjct: 144 ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVF 198
Query: 950 TTCRVSDKADVYSFGVVLLELISG 973
V+ K D++S GVV+ L++G
Sbjct: 199 KR-DVTFKCDIWSAGVVMYFLLTG 221
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 81.6 bits (200), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 60/224 (26%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 771 VRATGNFSIRNLIGTGGFGSTYK-AELVPGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRI 828
+ G + ++ +GTGGFG + G VA+K+ + +++ EI + ++
Sbjct: 11 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 70
Query: 829 RHKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFIHK-KSGKKIQWSVIHKIAID 881
H N+V+ G ++ L + GG+L ++++ ++ ++ I + D
Sbjct: 71 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 130
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVA 938
I+ AL YLH + RI+HRD+KP NI+L + L + D G A+ E+ + T+
Sbjct: 131 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFV 185
Query: 939 GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
GT Y+APE + + D +SFG + E I+G R P++
Sbjct: 186 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 229
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 81.3 bits (199), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 68/227 (29%), Positives = 110/227 (48%), Gaps = 21/227 (9%)
Query: 766 TYDNVVRATGNFS---------IRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRF 812
TY+ RA +F+ I +IG+G G L VPG VA+K L G
Sbjct: 31 TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 813 QGIQQ-FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ ++ F +E +G+ H N++ L G +V ++ G+L+TF+ G Q
Sbjct: 91 ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG---Q 147
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
++++ + + + A + Y VHRD+ N+L+D L +SDFGL+R+LE
Sbjct: 148 FTIMQLVGM-LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206
Query: 932 HATTDVAGT--FGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
A T G + APE S +DV+SFGVV+ E+++ G+R
Sbjct: 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 81.3 bits (199), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H R++HRDIKP N+LL +++FG + + + TT + GT Y+ PE
Sbjct: 127 CHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT-LCGTLDYLPPEM 180
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
+K D++S GV+ E + GK
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGK 206
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 81.3 bits (199), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD----VAGTFGYV 944
H R++HRDIKP N+LL ++DFG + HA + + GT Y+
Sbjct: 127 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDYL 176
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
PE +K D++S GV+ E + GK
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 81.3 bits (199), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD----VAGTFGYV 944
H R++HRDIKP N+LL ++DFG + HA + + GT Y+
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDYL 173
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
PE +K D++S GV+ E + GK
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 81.3 bits (199), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
IG G G A E G VAVKK+ + + Q + E+ + H N+V + Y+
Sbjct: 53 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
E+++V FL GG L + + ++ I + + + +AL+YLH V +HRD
Sbjct: 113 VGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHNQGV---IHRD 166
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
IK +ILL + LSDFG + E + GT ++APE + + D++
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIW 225
Query: 962 SFGVVLLELISGKRSLDPSFSE 983
S G++++E+I G+ P F+E
Sbjct: 226 SLGIMVIEMIDGE---PPYFNE 244
>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1
Reveals A Novel Autoinhibitory Conformation For A Dual
Kinase Protein
Length = 355
Score = 81.3 bits (199), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGY----LVAVKKLS----IGRFQGIQQFDAEIGTLGR 827
NF + ++GTG +G + + G+ L A+K L + + + + E L
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 828 IRHKN-LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
IR LVTL + E ++ L+ ++++GG L F H ++ + +I AL
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
+LH I++RDIK NILLD + L+DFGL++ ET D GT Y+AP
Sbjct: 173 EHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 947 EYATTCRV-SDKA-DVYSFGVVLLELISG 973
+ DKA D +S GV++ EL++G
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 80.9 bits (198), Expect = 3e-15, Method: Composition-based stats.
Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 5/198 (2%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
+ ++++ +G G +G Y L VAVK L + +++F E + I+H NLV
Sbjct: 33 DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 91
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+G E ++V ++ GNL ++ + + +++ V+ +A I+ A+ YL
Sbjct: 92 QLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKK-- 149
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
+HRD+ N L+ E ++DFGL+RL+ A + APE
Sbjct: 150 -NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTF 208
Query: 955 SDKADVYSFGVVLLELIS 972
S K+DV++FGV+L E+ +
Sbjct: 209 SIKSDVWAFGVLLWEIAT 226
>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase
Inhibiting Protein), A Leucine Rich Repeat Protein
Involved In Plant Defense
Length = 313
Score = 80.9 bits (198), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 62/190 (32%), Positives = 88/190 (46%), Gaps = 28/190 (14%)
Query: 527 FLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKL-KFLKWI 585
FL LV + + N +SG++ + L L + GNR+SG++PD G K +
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179
Query: 586 LLGGNNLTGEIPSQFGHLISLVVLDLSHNALTG--------------------SIPASLT 625
+ N LTG+IP F +L +L +DLS N L G S+ L
Sbjct: 180 TISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
Query: 626 K---ATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPH---LQHLDCIAF 679
K + L L L +NR+ G +P + L L +L++SFNNL G IP LQ D A+
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
Query: 680 KGNKYLASCP 689
NK L P
Sbjct: 299 ANNKCLCGSP 308
Score = 75.5 bits (184), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 70/237 (29%), Positives = 105/237 (44%), Gaps = 15/237 (6%)
Query: 49 DSASLLSFKASISRDPSNLLATWNSSTDHC--TWHGVTCDHFTG--RVTALRITGKATPW 104
D +LL K + +P+ L ++W +TD C TW GV CD T RV L ++G P
Sbjct: 7 DKQALLQIKKDLG-NPTTL-SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 105 PSKSSVISGTLSASIAKLTELRTLSVPH-NSFSGEIPAXXXXXXXXXXXXXQGNNFSGKI 163
P + +S+A L L L + N+ G IP N SG I
Sbjct: 65 PYP-------IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117
Query: 164 PYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLT 223
P +S ++ L L+ S+N+ SG +P + L I NR+SG + S + T
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177
Query: 224 YLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSL 280
+ +S N LT IP NL + L N+LEG G+ + + +++NSL
Sbjct: 178 SMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233
Score = 72.0 bits (175), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 46/126 (36%), Positives = 72/126 (57%), Gaps = 2/126 (1%)
Query: 542 NQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFG 601
N + G I + KL +L L + VSG++PD L ++K L + N L+G +P
Sbjct: 87 NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 602 HLISLVVLDLSHNALTGSIPASLTKATKL-ESLFLAHNRLSGEIPVSFSTLVNLSALDLS 660
L +LV + N ++G+IP S +KL S+ ++ NRL+G+IP +F+ L NL+ +DLS
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLS 205
Query: 661 FNNLSG 666
N L G
Sbjct: 206 RNMLEG 211
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 41/124 (33%), Positives = 69/124 (55%), Gaps = 2/124 (1%)
Query: 548 IAAGVGKLMKLQRLDLRG-NRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISL 606
I + + L L L + G N + G +P + KL L ++ + N++G IP + +L
Sbjct: 68 IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 607 VVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNL-SALDLSFNNLS 665
V LD S+NAL+G++P S++ L + NR+SG IP S+ + L +++ +S N L+
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 666 GHIP 669
G IP
Sbjct: 188 GKIP 191
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 78/264 (29%), Positives = 119/264 (45%), Gaps = 40/264 (15%)
Query: 362 GQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLP-VPCMVYFNVSQNNITGVLPRF 420
G N+L G +P ++ L YL ++ N+ G +P L + +V + S N ++G LP
Sbjct: 85 GINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP-- 142
Query: 421 ENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYK 480
P + S+ N V I F GN+ G++P D + + K
Sbjct: 143 -------------------PSISSL--PNLVGI-TFDGNRISGAIP-----DSY-GSFSK 174
Query: 481 PHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAA 540
+ ++ N G +P +L V+LS N+L G + F D + A
Sbjct: 175 LFTSMTISRNRLTGKIPPTFA----NLNLAFVDLSRNMLEGDASVLFGSD-KNTQKIHLA 229
Query: 541 NNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQF 600
N ++ + VG L LDLR NR+ G+LP L +LKFL + + NNL GEIP Q
Sbjct: 230 KNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QG 287
Query: 601 GHLISLVVLDLSHN-ALTGS-IPA 622
G+L V ++N L GS +PA
Sbjct: 288 GNLQRFDVSAYANNKCLCGSPLPA 311
Score = 39.7 bits (91), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 44/233 (18%)
Query: 313 GEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPK 372
G + G +P + L L+ N+ G +PD S+ +L L+ N+L G +P
Sbjct: 84 GGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP 143
Query: 373 SLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVY--FNVSQNNITG-VLPRFENVSCDNHF 429
S+ NL + N + G +P ++ +S+N +TG + P F N+ +
Sbjct: 144 SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL----NL 199
Query: 430 GFQDLQYANVPVMGSI---SDENFVIIH----------------------DFSGNKFLGS 464
F DL + S+ SD+N IH D N+ G+
Sbjct: 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGT 259
Query: 465 LPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSAN 517
LP G K+ + NN G +P + +LQ F V+ AN
Sbjct: 260 LP-----QGLTQLKFLHSLNVSFNN--LCGEIP-----QGGNLQRFDVSAYAN 300
Score = 35.8 bits (81), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 18/50 (36%), Positives = 29/50 (58%), Gaps = 4/50 (8%)
Query: 155 QGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSS 204
+ N G +P ++ L+ L LN+SFN+ GE+P+G G L D+S+
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG----GNLQRFDVSA 297
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 80.9 bits (198), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 75/270 (27%), Positives = 126/270 (46%), Gaps = 33/270 (12%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+ ++G G FG KA+ VA+K++ + + F E+ L R+ H N+V
Sbjct: 10 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVK 66
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA--IDIAQALAYLHYSC 893
L G + + LV + GG+L +H ++ H ++ + +Q +AYLH
Sbjct: 67 LYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQ 123
Query: 894 VPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
++HRD+KP N+LL + DFG A ++ TH T + G+ ++APE
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNN-KGSAAWMAPEVFEGS 179
Query: 953 RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF--LPE 1010
S+K DV+S+G++L E+I+ ++ D E G + WA + G L LP+
Sbjct: 180 NYSEKCDVFSWGIILWEVITRRKPFD----EIGGPAFRIMWA---VHNGTRPPLIKNLPK 232
Query: 1011 LWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
P E+L+ + C + S RPS
Sbjct: 233 -----PIESLM------TRCWSKDPSQRPS 251
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its
Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 80.5 bits (197), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 75/270 (27%), Positives = 126/270 (46%), Gaps = 33/270 (12%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+ ++G G FG KA+ VA+K++ + + F E+ L R+ H N+V
Sbjct: 9 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVK 65
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA--IDIAQALAYLHYSC 893
L G + + LV + GG+L +H ++ H ++ + +Q +AYLH
Sbjct: 66 LYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 894 VPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
++HRD+KP N+LL + DFG A ++ TH T + G+ ++APE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNN-KGSAAWMAPEVFEGS 178
Query: 953 RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF--LPE 1010
S+K DV+S+G++L E+I+ ++ D E G + WA + G L LP+
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFD----EIGGPAFRIMWA---VHNGTRPPLIKNLPK 231
Query: 1011 LWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
P E+L+ + C + S RPS
Sbjct: 232 -----PIESLM------TRCWSKDPSQRPS 250
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 80.5 bits (197), Expect = 4e-15, Method: Composition-based stats.
Identities = 58/230 (25%), Positives = 112/230 (48%), Gaps = 17/230 (7%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+G+G FG + Y VAVK + G +F E T+ ++ H LV G
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
E +++V ++S G L ++ + GK ++ S + ++ D+ + +A+L + +HRD+
Sbjct: 75 EYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDL 130
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
N L+D +L +SDFG+ R + + ++ + APE + S K+DV++
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 963 FGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011
FG+++ E+ S GK D + + +++++K + L+ P L
Sbjct: 191 FGILMWEVFSLGKMPYD-----------LYTNSEVVLKVSQGHRLYRPHL 229
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 80.5 bits (197), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 18/222 (8%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKN 832
++ + IGTG +G K G ++ K+L G Q +E+ L ++H N
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 833 LVTLIGYYVGEAE--MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+V + +++V + GG+L + I K G K + + + + + L
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK--GTKERQYLDEEFVLRVMTQLTLAL 124
Query: 891 YSCVPR------IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
C R ++HRD+KP+N+ LD + N L DFGLAR+L + A V GT Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYM 183
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGN 986
+PE ++K+D++S G +L EL +L P F+ +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELC----ALMPPFTAFSQ 221
>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
pdb|1S9I|B Chain B, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
Length = 354
Score = 80.1 bits (196), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 9/206 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
+F + +G G G K + P L+ +KL + Q E+ L +
Sbjct: 17 DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 76
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G + + E+ + + GG+L+ + K K+I ++ K++I + + LAYL
Sbjct: 77 VGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLREKH 134
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
+I+HRD+KPSNIL++ L DFG++ L S ++ GT Y+APE
Sbjct: 135 --QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMAPERLQGTH 189
Query: 954 VSDKADVYSFGVVLLELISGKRSLDP 979
S ++D++S G+ L+EL G+ + P
Sbjct: 190 YSVQSDIWSMGLSLVELAVGRYPIPP 215
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 80.1 bits (196), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 73/243 (30%), Positives = 110/243 (45%), Gaps = 32/243 (13%)
Query: 745 GRIASLRGQVMVT--FADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVP-GYL 801
GR SL+ + F D P +L FS IG G FG+ Y A V +
Sbjct: 33 GRAGSLKDPDVAELFFKDDPEKL-----------FSDLREIGHGSFGAVYFARDVRNSEV 81
Query: 802 VAVKKLSIGRFQGIQQFD---AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL 858
VA+KK+S Q +++ E+ L ++RH N + G Y+ E +LV + G
Sbjct: 82 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS 141
Query: 859 ETF-IHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYL 917
+ +HKK ++++ + + A+ Q LAYLH ++HRD+K NILL E L
Sbjct: 142 DLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL 195
Query: 918 SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC---RVSDKADVYSFGVVLLELISGK 974
DFG A ++ GT ++APE + K DV+S G+ +EL K
Sbjct: 196 GDFGSASIMA-----PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
Query: 975 RSL 977
L
Sbjct: 251 PPL 253
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 80.1 bits (196), Expect = 6e-15, Method: Composition-based stats.
Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 783 IGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
IG G G A + G LVAVKK+ + + Q + E+ + +H+N+V + Y+
Sbjct: 82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
E+++V FL GG L + + ++ I + + + QAL+ LH V +HRD
Sbjct: 142 VGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGV---IHRD 195
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
IK +ILL + LSDFG + E + GT ++APE + + D++
Sbjct: 196 IKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 254
Query: 962 SFGVVLLELISGKRSLDPSFSE 983
S G++++E++ G+ P F+E
Sbjct: 255 SLGIMVIEMVDGE---PPYFNE 273
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 80.1 bits (196), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
A +F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y
Sbjct: 66 RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H +++HRDIKP N+LL ++DFG + S A + GT Y+ PE
Sbjct: 124 CHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA---LCGTLDYLPPEM 177
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
+K D++S GV+ E + GK
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGK 203
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 80.1 bits (196), Expect = 7e-15, Method: Composition-based stats.
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
+F LIG+GGFG +KA+ + G +K++ ++ + E+ L ++ H N+V
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIV 67
Query: 835 TLIGYYVG---EAE-------------MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI 878
G + G + E +F+ F G LE +I K+ G+K+ + ++
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA 938
I + + Y+H ++++RD+KPSNI L + + DFGL L+ +
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK-- 182
Query: 939 GTFGYVAPEYATTCRVSDKADVYSFGVVLLELI 971
GT Y++PE ++ + D+Y+ G++L EL+
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 79.7 bits (195), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 12/202 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRIRHK 831
+F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +RH
Sbjct: 13 DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y H
Sbjct: 73 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY--ITELANALSYCHS 130
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
R++HRDIKP N+LL ++DFG + + + TT + GT Y+ PE
Sbjct: 131 K---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEG 184
Query: 952 CRVSDKADVYSFGVVLLELISG 973
+K D++S GV+ E + G
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVG 206
>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|B Chain B, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|C Chain C, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|D Chain D, Structure Of Human Phosphorylase Kinase, Gamma 2
Length = 365
Score = 79.3 bits (194), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 50/151 (33%), Positives = 83/151 (54%), Gaps = 15/151 (9%)
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
H +++TLI Y + MFLV++ + G L ++ +K + I + +A+++L
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFL 216
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
H + IVHRD+KP NILLD+ + LSDFG + LE E ++ GT GY+APE
Sbjct: 217 HAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPE-I 270
Query: 950 TTCRVSD-------KADVYSFGVVLLELISG 973
C + + + D+++ GV+L L++G
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 79.3 bits (194), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 18/225 (8%)
Query: 755 MVTFADTPAELTYD-NVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ 813
M TF E Y+ +G F+I G G Y A+ + ++ + + R
Sbjct: 2 MSTFRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSR-- 59
Query: 814 GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS 873
++ + E+ L IRH N++TL + + ++ L+ +SGG L F+ +K S
Sbjct: 60 --EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE------S 111
Query: 874 VIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLARLLEV 928
+ A + Q L +HY RI H D+KP NI LLD+ + L DFG+A +E
Sbjct: 112 LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 171
Query: 929 SETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
+ ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 172 G--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 79.0 bits (193), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRF-QGIQQFDAEIGT 824
YD +++ + + IGTGGF A ++ G +VA+K + + + EI
Sbjct: 5 YDELLKY---YELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEA 61
Query: 825 LGRIRHKNLVTLIGYYVGEA--EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDI 882
L +RH+++ L Y+V E ++F+V + GG L +I S ++ + I
Sbjct: 62 LKNLRHQHICQL--YHVLETANKIFMVLEYCPGGELFDYI--ISQDRLSEEETRVVFRQI 117
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG 942
A+AY+H HRD+KP N+L DE L DFGL + ++ + G+
Sbjct: 118 VSAVAYVHSQ---GYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLA 174
Query: 943 YVAPEYAT-TCRVSDKADVYSFGVVLLELISG 973
Y APE + +ADV+S G++L L+ G
Sbjct: 175 YAAPELIQGKSYLGSEADVWSMGILLYVLMCG 206
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 79.0 bits (193), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 106/209 (50%), Gaps = 12/209 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFD-AEIGTLGRIRH 830
++ F +G G + + YK G VA+K++ + +G EI + ++H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS----GKKIQWSVIHKIAIDIAQAL 886
+N+V L E ++ LV+ F+ +L+ ++ ++ + ++ +++ + Q L
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
A+ H + +I+HRD+KP N+L+++ L DFGLAR + +++V T Y AP
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAP 177
Query: 947 EYATTCRV-SDKADVYSFGVVLLELISGK 974
+ R S D++S G +L E+I+GK
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGK 206
>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid-
Regulated Kinase 1 In Complex With Amp-Pnp
pdb|3HDM|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 1
pdb|3HDN|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 2
Length = 373
Score = 79.0 bits (193), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 14/212 (6%)
Query: 776 NFSIRNLIGTGGFG----STYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGR-IRH 830
+F +IG G FG + +KAE V + ++K +I + + + +E L + ++H
Sbjct: 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
LV L + +++ V ++++GG E F H + + A +IA AL YLH
Sbjct: 99 PFLVGLHFSFQTADKLYFVLDYINGG--ELFYHLQRERCFLEPRARFYAAEIASALGYLH 156
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
IV+RD+KP NILLD + + L+DFGL + + T+ GT Y+APE
Sbjct: 157 SL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAPEVLH 212
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
D + G VL E++ G L P +S
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYG---LPPFYS 241
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 79.0 bits (193), Expect = 1e-14, Method: Composition-based stats.
Identities = 69/216 (31%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
+G G FGS P G LVAVK+L + F EI L + +V
Sbjct: 15 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 838 G--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------- 888
G Y G E+ LV +L G L F+ + H+ +D ++ L Y
Sbjct: 75 GVSYGPGRPELRLVMEYLPSGCLRDFLQR-----------HRARLDASRLLLYSSQICKG 123
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYVA 945
+ Y R VHRD+ NIL++ E + ++DFGLA+LL + + G F Y A
Sbjct: 124 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWY-A 182
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPS 980
PE + S ++DV+SFGVVL EL + +S PS
Sbjct: 183 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 218
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 78.6 bits (192), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 12/223 (5%)
Query: 754 VMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYK-AELVPGYLVAVKKLSIGRF 812
+ + P E+ +D+V+ ++ I +GTG FG ++ E G A K +
Sbjct: 33 IWKQYYPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE 89
Query: 813 QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQW 872
+ EI T+ +RH LV L + + EM ++Y F+SGG L + + K +
Sbjct: 90 SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED 149
Query: 873 SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS--DFGLARLLEVSE 930
+ + + + L ++H + VH D+KP NI+ + + L DFGL L+ +
Sbjct: 150 EAVEYMR-QVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 205
Query: 931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
+ T GT + APE A V D++S GV+ L+SG
Sbjct: 206 SVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 78.6 bits (192), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 69/228 (30%), Positives = 104/228 (45%), Gaps = 30/228 (13%)
Query: 758 FADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQ 816
F D P +L FS IG G FG+ Y A V +VA+KK+S Q +
Sbjct: 9 FKDDPEKL-----------FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE 57
Query: 817 QFD---AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETF-IHKKSGKKIQW 872
++ E+ L ++RH N + G Y+ E +LV + G + +HKK ++++
Sbjct: 58 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI 117
Query: 873 SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
+ + A+ Q LAYLH ++HRD+K NILL E L DFG A ++
Sbjct: 118 AAVTHGAL---QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----- 166
Query: 933 ATTDVAGTFGYVAPEYATTC---RVSDKADVYSFGVVLLELISGKRSL 977
GT ++APE + K DV+S G+ +EL K L
Sbjct: 167 PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 78.6 bits (192), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F +T A EL A+K K I + + E + R+ H
Sbjct: 31 DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 148
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 149 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F GN + I + K++ E E F P+
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 258
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 78.6 bits (192), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 17/214 (7%)
Query: 767 YDNVVRATGNFSIRNLIGT-GGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGT 824
Y++V R +IG G FG YKA+ L A K + + ++ + EI
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDI 60
Query: 825 LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDI 882
L H N+V L+ + E ++++ F +GG ++ + + + + Q V+ K +D
Sbjct: 61 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD- 119
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG 942
AL YLH + +I+HRD+K NIL + + L+DFG++ + GT
Sbjct: 120 --ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTXIQRRDSFIGTPY 174
Query: 943 YVAPEYATTCRVSD------KADVYSFGVVLLEL 970
++APE C S KADV+S G+ L+E+
Sbjct: 175 WMAPE-VVMCETSKDRPYDYKADVWSLGITLIEM 207
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 78.6 bits (192), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN 832
+G F+I G G Y A+ + ++ + + R ++ + E+ L IRH N
Sbjct: 14 GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSR----EEIEREVNILREIRHPN 69
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID-IAQALAYLHY 891
++TL + + ++ L+ +SGG L F+ +K S+ A + Q L +HY
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHY 123
Query: 892 SCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
RI H D+KP NI LLD+ + L DFG+A +E + ++ GT +VAPE
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTPEFVAPE 181
Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
+ +AD++S GV+ L+SG
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSG 207
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 78.6 bits (192), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+ + +G G FG + A VAVK + G ++ F AE + ++H LV
Sbjct: 183 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVK 241
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
L E ++++ F++ G+L F+ G K + + IA+ +A++
Sbjct: 242 LHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--- 297
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTCR 953
+HRD++ +NIL+ L ++DFGLAR V F + APE
Sbjct: 298 NYIHRDLRAANILVSASLVCKIADFGLAR------------VGAKFPIKWTAPEAINFGS 345
Query: 954 VSDKADVYSFGVVLLELISGKRSLDPSFS 982
+ K+DV+SFG++L+E+++ R P S
Sbjct: 346 FTIKSDVWSFGILLMEIVTYGRIPYPGMS 374
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 12/223 (5%)
Query: 754 VMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYK-AELVPGYLVAVKKLSIGRF 812
+ + P E+ +D+V+ ++ I +GTG FG ++ E G A K +
Sbjct: 139 IWKQYYPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE 195
Query: 813 QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQW 872
+ EI T+ +RH LV L + + EM ++Y F+SGG L + + K +
Sbjct: 196 SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED 255
Query: 873 SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS--DFGLARLLEVSE 930
+ + + + L ++H + VH D+KP NI+ + + L DFGL L+ +
Sbjct: 256 EAVEYMR-QVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
Query: 931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
+ T GT + APE A V D++S GV+ L+SG
Sbjct: 312 SVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 783 IGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLVTLIGYY 840
IG G FG + L LVAVK ++ +F E L + H N+V LIG
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
+ +++V + GG+ TF+ + G +++ + ++ D A + YL C +HR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESKCC---IHR 237
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF-----GYVAPEYATTCRVS 955
D+ N L+ E+ +SDFG++R E +G + APE R S
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSR----EEADGVXAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 956 DKADVYSFGVVLLELISGKRSLDPSFS 982
++DV+SFG++L E S S P+ S
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLS 320
>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer
Length = 395
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
+F + +G G G +K P LV +KL + Q E+ L +
Sbjct: 69 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 128
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G + + E+ + + GG+L+ + KK+G+ I ++ K++I + + L YL
Sbjct: 129 VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREKH 186
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
+I+HRD+KPSNIL++ L DFG++ L S ++ GT Y++PE
Sbjct: 187 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 241
Query: 954 VSDKADVYSFGVVLLELISGKRSLDP 979
S ++D++S G+ L+E+ G+ + P
Sbjct: 242 YSVQSDIWSMGLSLVEMAVGRYPIPP 267
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 78.2 bits (191), Expect = 2e-14, Method: Composition-based stats.
Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
+F LIG+GGFG +KA+ + G ++++ ++ + E+ L ++ H N+V
Sbjct: 13 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIV 68
Query: 835 TLIGYYVG------------EAE-----------------MFLVYNFLSGGNLETFIHKK 865
G + G E+ +F+ F G LE +I K+
Sbjct: 69 HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 866 SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL 925
G+K+ + ++ I + + Y+H +++HRD+KPSNI L + + DFGL
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 926 LEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELI 971
L+ T GT Y++PE ++ + D+Y+ G++L EL+
Sbjct: 186 LK--NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 19/218 (8%)
Query: 772 RATGNFSIRNLIGTGGFGSTYKAELVPGYL----VAVKKLS---IGRFQGIQQFDAEIGT 824
R G + IR +G G FG K +L Y VA+K +S + + + + EI
Sbjct: 6 RHIGPYIIRETLGEGSFG---KVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY 62
Query: 825 LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
L +RH +++ L ++ +V + +GG L +I +K K++ + I
Sbjct: 63 LKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEK--KRMTEDEGRRFFQQIIC 119
Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
A+ Y H +IVHRD+KP N+LLD+ LN ++DFGL+ ++ T+ G+ Y
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYA 174
Query: 945 APEYAT-TCRVSDKADVYSFGVVLLELISGKRSLDPSF 981
APE + DV+S G+VL ++ G+ D F
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRIRHK 831
+F I +G G FG+ Y A E +++A+K L + + G++ Q E+ +RH
Sbjct: 13 DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
N++ L GY+ ++L+ + G + + K S Q + + ++A AL+Y H
Sbjct: 73 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY--ITELANALSYCHS 130
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD----VAGTFGYVAPE 947
R++HRDIKP N+LL ++DFG + HA + + GT Y+ PE
Sbjct: 131 K---RVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRDTLCGTLDYLPPE 180
Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
+K D++S GV+ E + G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 77.8 bits (190), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN 832
+G F+I G G Y A+ + + + + R ++ + E+ L IRH N
Sbjct: 35 GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSR----EEIEREVNILREIRHPN 90
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID-IAQALAYLHY 891
++TL + + ++ L+ +SGG L F+ +K S+ A + Q L +HY
Sbjct: 91 IITLHDIFENKTDVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHY 144
Query: 892 SCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
RI H D+KP NI LLD+ + L DFG+A +E + ++ GT +VAPE
Sbjct: 145 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTPEFVAPE 202
Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
+ +AD++S GV+ L+SG
Sbjct: 203 IVNYEPLGLEADMWSIGVITYILLSG 228
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 77.8 bits (190), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPGY------LVAVKKLSIGRF----QGIQQFDAEI---- 822
F +R L G+G +G + G+ ++ + GR+ + I++F EI
Sbjct: 39 FKVRKL-GSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 823 GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAID 881
L + H N++ L + + +LV F GG L E I++ + + I K
Sbjct: 98 SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK---Q 154
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEE---LNAYLSDFGLARLLEVSETHATTDVA 938
I + YLH IVHRDIKP NILL+ + LN + DFGL+ S+ + D
Sbjct: 155 ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLRDRL 209
Query: 939 GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
GT Y+APE + ++K DV+S GV++ L+ G
Sbjct: 210 GTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG 243
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 77.8 bits (190), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 783 IGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLVTLIGYY 840
IG G FG + L LVAVK ++ +F E L + H N+V LIG
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
+ +++V + GG+ TF+ + G +++ + ++ D A + YL C +HR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESKCC---IHR 237
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF-----GYVAPEYATTCRVS 955
D+ N L+ E+ +SDFG++R E +G + APE R S
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 956 DKADVYSFGVVLLELISGKRSLDPSFS 982
++DV+SFG++L E S S P+ S
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLS 320
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 77.4 bits (189), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+IG G FG Y L+ AVK L+ I + QF E + H N+++
Sbjct: 35 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+G + E +V ++ G+L FI ++ +I + +A+ + YL
Sbjct: 95 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 150
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
+ VHRD+ N +LDE+ ++DFGLAR + E H T ++A E T
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 952 CRVSDKADVYSFGVVLLELIS 972
+ + K+DV+SFGV+L EL++
Sbjct: 211 QKFTTKSDVWSFGVLLWELMT 231
>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human
Pdk1 Complex 2
Length = 311
Score = 77.4 bits (189), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 93 FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 150
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 151 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
S +D+++ G ++ +L++G P F GN + I + K++ E E F P+
Sbjct: 208 EKSASKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 260
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 68/216 (31%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
+G G FGS P G LVAVK+L + F EI L + +V
Sbjct: 18 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 838 G--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------- 888
G Y G + LV +L G L F+ + H+ +D ++ L Y
Sbjct: 78 GVSYGPGRQSLRLVMEYLPSGCLRDFLQR-----------HRARLDASRLLLYSSQICKG 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYVA 945
+ Y R VHRD+ NIL++ E + ++DFGLA+LL + + + G F Y A
Sbjct: 127 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-A 185
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPS 980
PE + S ++DV+SFGVVL EL + +S PS
Sbjct: 186 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 221
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 68/216 (31%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
+G G FGS P G LVAVK+L + F EI L + +V
Sbjct: 19 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 838 G--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------- 888
G Y G + LV +L G L F+ + H+ +D ++ L Y
Sbjct: 79 GVSYGPGRQSLRLVMEYLPSGCLRDFLQR-----------HRARLDASRLLLYSSQICKG 127
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYVA 945
+ Y R VHRD+ NIL++ E + ++DFGLA+LL + + + G F Y A
Sbjct: 128 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-A 186
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPS 980
PE + S ++DV+SFGVVL EL + +S PS
Sbjct: 187 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 222
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 68/216 (31%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
+G G FGS P G LVAVK+L + F EI L + +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 838 G--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------- 888
G Y G + LV +L G L F+ + H+ +D ++ L Y
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQR-----------HRARLDASRLLLYSSQICKG 139
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYVA 945
+ Y R VHRD+ NIL++ E + ++DFGLA+LL + + + G F Y A
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-A 198
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPS 980
PE + S ++DV+SFGVVL EL + +S PS
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4858061 And Mgatp
Length = 307
Score = 77.4 bits (189), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
+F + +G G G +K P LV +KL + Q E+ L +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G + + E+ + + GG+L+ + KK+G+ I ++ K++I + + L YL
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREKH 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
+I+HRD+KPSNIL++ L DFG++ L S ++ GT Y++PE
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 179
Query: 954 VSDKADVYSFGVVLLELISGKRSLDP 979
S ++D++S G+ L+E+ G+ + P
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPP 205
>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3DY7|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3E8N|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) Complexed With A Potent Inhibitor
Rdea119 And Mgatp
pdb|3V01|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions.
pdb|3V04|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions
Length = 341
Score = 77.4 bits (189), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
+F + +G G G +K P LV +KL + Q E+ L +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G + + E+ + + GG+L+ + KK+G+ I ++ K++I + + L YL
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREKH 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
+I+HRD+KPSNIL++ L DFG++ L S ++ GT Y++PE
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 179
Query: 954 VSDKADVYSFGVVLLELISGKRSLDP 979
S ++D++S G+ L+E+ G+ + P
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPP 205
>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3EQB|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
Length = 333
Score = 77.4 bits (189), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
+F + +G G G +K P LV +KL + Q E+ L +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G + + E+ + + GG+L+ + KK+G+ I ++ K++I + + L YL
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREKH 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
+I+HRD+KPSNIL++ L DFG++ L S ++ GT Y++PE
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 179
Query: 954 VSDKADVYSFGVVLLELISGKRSLDP 979
S ++D++S G+ L+E+ G+ + P
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPP 205
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 77.4 bits (189), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 15/210 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRIRHK 831
GN+ + IG G F A ++ G VA+K + + +Q+ E+ + + H
Sbjct: 12 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 71
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYL 889
N+V L E ++L+ + SGG + ++ H + +K S +I A+ Y
Sbjct: 72 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYC 127
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
H RIVHRD+K N+LLD ++N ++DFG + V T G+ Y APE
Sbjct: 128 HQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT--FCGSPPYAAPELF 182
Query: 950 TTCRVSD-KADVYSFGVVLLELISGKRSLD 978
+ + DV+S GV+L L+SG D
Sbjct: 183 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212
>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1
Catalytic Domain
pdb|1UVR|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-8
Length = 289
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 11 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 71 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 128
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 129 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F GN + I + K++ E E F P+
Sbjct: 186 EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 238
>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp
pdb|3PP1|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgatp
Length = 328
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
+F + +G G G +K P LV +KL + Q E+ L +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G + + E+ + + GG+L+ + KK+G+ I ++ K++I + + L YL
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREKH 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
+I+HRD+KPSNIL++ L DFG++ L S ++ GT Y++PE
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 179
Query: 954 VSDKADVYSFGVVLLELISGKRSLDP 979
S ++D++S G+ L+E+ G+ + P
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPP 205
>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound
Length = 322
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
+F + +G G G +K P LV +KL + Q E+ L +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G + + E+ + + GG+L+ + KK+G+ I ++ K++I + + L YL
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREKH 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
+I+HRD+KPSNIL++ L DFG++ L S ++ GT Y++PE
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 179
Query: 954 VSDKADVYSFGVVLLELISGKRSLDP 979
S ++D++S G+ L+E+ G+ + P
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPP 205
>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With
Compound 1, Atp-Gs And Mg2p
pdb|3EQD|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Atp-Gs
And Mg2p
pdb|3EQF|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With K252a
And Mg2p
pdb|3EQG|A Chain A, X-ray Structure Of The Human Mitogen-activated Protein
Kinase Kinase 1 (mek1) In A Ternary Complex With Pd, Adp
And Mg2p
pdb|3EQH|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With U0126,
Adp And Mg2p
pdb|3EQI|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Adp And
Mg2p
Length = 360
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
+F + +G G G +K P LV +KL + Q E+ L +
Sbjct: 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G + + E+ + + GG+L+ + KK+G+ I ++ K++I + + L YL
Sbjct: 94 VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREKH 151
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
+I+HRD+KPSNIL++ L DFG++ L S ++ GT Y++PE
Sbjct: 152 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 206
Query: 954 VSDKADVYSFGVVLLELISGKRSLDP 979
S ++D++S G+ L+E+ G+ + P
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPP 232
>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps171 Bound To The Pif-Pocket
pdb|4AW0|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Compound
Ps182 Bound To The Pif-Pocket
Length = 311
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 63/240 (26%), Positives = 108/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 93 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 150
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 151 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F G + +AK++ E E F P+
Sbjct: 208 EKSAXKSSDLWALGCIIYQLVAGL----PPFRAGNEG---LIFAKIIKLEYDFPEKFFPK 260
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPGY-------LVAVKKLSIGR-FQGIQQFDAEIGTLGRI 828
F + ++G GG+G ++ V G + +KK I R + AE L +
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH-KKSGKKIQWSVIHKIAIDIAQALA 887
+H +V LI + +++L+ +LSGG L F+ ++ G ++ + +A +I+ AL
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLA-EISMALG 135
Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
+LH I++RD+KP NI+L+ + + L+DFGL + + + T GT Y+APE
Sbjct: 136 HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHXFCGTIEYMAPE 191
Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
+ D +S G ++ ++++G
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTG 217
>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In
Complex With Atp
pdb|3HRF|A Chain A, Crystal Structure Of Human Pdk1 Kinase Domain In Complex
With An Allosteric Activator Bound To The Pif-Pocket
pdb|3RCJ|A Chain A, Rapid Preparation Of Triazolyl Substituted Nh-Heterocyclic
Kinase Inhibitors Via One-Pot Sonogashira Coupling
Tms-Deprotection Cuaac Sequence
pdb|4A06|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps114 Bound To The Pif-Pocket
pdb|4AW1|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Compound
Ps210 Bound To The Pif-Pocket
Length = 311
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 63/240 (26%), Positives = 108/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 93 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 150
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 151 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F G + +AK++ E E F P+
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGL----PPFRAGNEG---LIFAKIIKLEYDFPEKFFPK 260
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+IG G FG Y L+ AVK L+ I + QF E + H N+++
Sbjct: 54 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+G + E +V ++ G+L FI ++ +I + +A+ + YL
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 169
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
+ VHRD+ N +LDE+ ++DFGLAR + E H T ++A E T
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 952 CRVSDKADVYSFGVVLLELIS 972
+ + K+DV+SFGV+L EL++
Sbjct: 230 QKFTTKSDVWSFGVLLWELMT 250
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPGY-------LVAVKKLSIGR-FQGIQQFDAEIGTLGRI 828
F + ++G GG+G ++ V G + +KK I R + AE L +
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH-KKSGKKIQWSVIHKIAIDIAQALA 887
+H +V LI + +++L+ +LSGG L F+ ++ G ++ + +A +I+ AL
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLA-EISMALG 135
Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
+LH I++RD+KP NI+L+ + + L+DFGL + + + T GT Y+APE
Sbjct: 136 HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYMAPE 191
Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
+ D +S G ++ ++++G
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTG 217
>pdb|1Z5M|A Chain A, Crystal Structure Of
N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)
Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-
Dimethylpropanediamide Complexed With Human Pdk1
pdb|2PE0|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
5-Hydroxy-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-1,
3-Dihydro- Indol-2-One Complex
pdb|2PE1|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
{2-Oxo-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-2,
3-Dihydro-1h- Indol-5-Yl}-Urea {bx-517} Complex
pdb|2PE2|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
3-{5-[2-Oxo-5-Ureido-1,
2-Dihydro-Indol-(3z)-Ylidenemethyl]-1h-
Pyrrol-3-Yl}-N-(2-Piperidin-1-Yl-Ethyl)-Benzamide Complex
Length = 286
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 8 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 68 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 125
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 126 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F GN + I + K++ E E F P+
Sbjct: 183 EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 235
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+IG G FG Y L+ AVK L+ I + QF E + H N+++
Sbjct: 55 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+G + E +V ++ G+L FI ++ +I + +A+ + YL
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 170
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
+ VHRD+ N +LDE+ ++DFGLAR + E H T ++A E T
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 952 CRVSDKADVYSFGVVLLELIS 972
+ + K+DV+SFGV+L EL++
Sbjct: 231 QKFTTKSDVWSFGVLLWELMT 251
>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3
Length = 286
Score = 76.6 bits (187), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 10 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 70 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 127
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 128 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F GN + I + K++ E E F P+
Sbjct: 185 EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 237
>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain
Length = 310
Score = 76.6 bits (187), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 31 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 148
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-AGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 149 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F GN + I + K++ E E F P+
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 258
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 76.6 bits (187), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 775 GNFSIRNLIGTGGFGS------TYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI 828
GN+ I +G G FG T + V ++ K L+ QG + + EI L +
Sbjct: 14 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLL 71
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH +++ L + E+ +V + +G L +I ++ K+ + I A+ Y
Sbjct: 72 RHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRD--KMSEQEARRFFQQIISAVEY 128
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H +IVHRD+KP N+LLDE LN ++DFGL+ ++ T+ G+ Y APE
Sbjct: 129 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEV 183
Query: 949 AT-TCRVSDKADVYSFGVVLLELISGKRSLD 978
+ + DV+S GV+L ++ + D
Sbjct: 184 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 76.6 bits (187), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+IG G FG Y L+ AVK L+ I + QF E + H N+++
Sbjct: 28 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+G + E +V ++ G+L FI ++ +I + +A+ + YL
Sbjct: 88 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 143
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
+ VHRD+ N +LDE+ ++DFGLAR + E H T ++A E T
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 952 CRVSDKADVYSFGVVLLELIS 972
+ + K+DV+SFGV+L EL++
Sbjct: 204 QKFTTKSDVWSFGVLLWELMT 224
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 76.6 bits (187), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 24/220 (10%)
Query: 777 FSIRNLIGTGGFGSTYKAE---LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNL 833
F + + +G G Y+ + Y + V K ++ + + EIG L R+ H N+
Sbjct: 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK----KIVRTEIGVLLRLSHPNI 110
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
+ L + E+ LV ++GG L I +K G + + I +A+AYLH +
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVK-QILEAVAYLHENG 168
Query: 894 VPRIVHRDIKPSNILL-----DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
IVHRD+KP N+L D L ++DFGL++++E T V GT GY APE
Sbjct: 169 ---IVHRDLKPENLLYATPAPDAPLK--IADFGLSKIVEHQVLMKT--VCGTPGYCAPEI 221
Query: 949 ATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGF 988
C + D++S G++ L+ G +P + E G+ F
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCG---FEPFYDERGDQF 258
>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8
pdb|3NUU|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment11
pdb|3NUY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment17
Length = 286
Score = 76.6 bits (187), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 126
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 127 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F GN + I + K++ E E F P+
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 236
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 76.6 bits (187), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+IG G FG Y L+ AVK L+ I + QF E + H N+++
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+G + E +V ++ G+L FI ++ +I + +A+ + YL
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 151
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
+ VHRD+ N +LDE+ ++DFGLAR + E H T ++A E T
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 952 CRVSDKADVYSFGVVLLELIS 972
+ + K+DV+SFGV+L EL++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232
>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i
pdb|3QCQ|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-(3-
Amino-1h-Indazol-6-Yl)-N4-Ethyl-2,4-Pyrimidinediamine
pdb|3QCS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-[2-
Amino-6-(4-Morpholinyl)-4-Pyrimidinyl]-1h-Indazol-3-Amine
pdb|3QCX|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-{2-
Amino-6-[(3r)-3-Methyl-4-Morpholinyl]-4-Pyrimidinyl}-1h-
Indazol-3- Amine
pdb|3QCY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 4-[2-
Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-N-
Phenyl-2- Morpholinecarboxamide
pdb|3QD0|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With (2r,5s)-
1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-6-
Methyl-N- Phenyl-3-Piperidinecarboxamide
pdb|3QD3|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1- Dimethylethyl
{(3r,6s)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-6-Methyl-3-Piperidinyl}carbamate
pdb|3QD4|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1-
Dimethylethyl{(3r,
5r)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-5-Methyl-3-Piperidinyl}carbamate
Length = 312
Score = 76.6 bits (187), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 34 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 94 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 151
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 152 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F GN + I + K++ E E F P+
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 261
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 76.6 bits (187), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 67/232 (28%), Positives = 110/232 (47%), Gaps = 21/232 (9%)
Query: 752 GQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYK-AELVPGYLVAVKKLSIG 810
G +M TP + + + + ++G G FG + + G AVK +S
Sbjct: 3 GSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS-- 60
Query: 811 RFQGIQQFDAE-----IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHK 864
+ Q Q+ D E + L ++ H N++ L ++ + +LV +GG L + I +
Sbjct: 61 KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR 120
Query: 865 KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFG 921
K ++ + I I Q L+ + Y +IVHRD+KP N+LL+ ++ N + DFG
Sbjct: 121 KRFSEVDAARI------IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG 174
Query: 922 LARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
L+ E S+ D GT Y+APE +K DV+S GV+L L+SG
Sbjct: 175 LSTHFEASK--KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase-
1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine
Inhibitor
pdb|3ION|A Chain A, Pdk1 In Complex With Compound 8h
Length = 312
Score = 76.6 bits (187), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 34 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 94 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 151
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 152 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F GN + I + K++ E E F P+
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 261
>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In
Complex With Compound 9
Length = 311
Score = 76.6 bits (187), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 93 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 150
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 151 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F GN + I + K++ E E F P+
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 260
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 76.6 bits (187), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 775 GNFSIRNLIGTGGFGS------TYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI 828
GN+ I +G G FG T + V ++ K L+ QG + + EI L +
Sbjct: 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLL 70
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH +++ L + E+ +V + +G L +I ++ K+ + I A+ Y
Sbjct: 71 RHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRD--KMSEQEARRFFQQIISAVEY 127
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H +IVHRD+KP N+LLDE LN ++DFGL+ ++ T+ G+ Y APE
Sbjct: 128 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEV 182
Query: 949 AT-TCRVSDKADVYSFGVVLLELISGKRSLD 978
+ + DV+S GV+L ++ + D
Sbjct: 183 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213
>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ly333531
pdb|1UU7|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-2
pdb|1UU8|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-1
pdb|1OKY|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Staurosporine
pdb|1OKZ|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ucn-01
Length = 310
Score = 76.6 bits (187), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 31 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 148
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 149 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F GN + I + K++ E E F P+
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 258
>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 76.6 bits (187), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 93 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 150
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 151 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F GN + I + K++ E E F P+
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 260
>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 76.6 bits (187), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 31 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 148
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 149 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F GN + I + K++ E E F P+
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 258
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 76.6 bits (187), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 775 GNFSIRNLIGTGGFGS------TYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI 828
GN+ I +G G FG T + V ++ K L+ QG + + EI L +
Sbjct: 8 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLL 65
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH +++ L + E+ +V + +G L +I ++ K+ + I A+ Y
Sbjct: 66 RHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRD--KMSEQEARRFFQQIISAVEY 122
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H +IVHRD+KP N+LLDE LN ++DFGL+ ++ T+ G+ Y APE
Sbjct: 123 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEV 177
Query: 949 AT-TCRVSDKADVYSFGVVLLELISGKRSLD 978
+ + DV+S GV+L ++ + D
Sbjct: 178 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208
>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor
1f8
pdb|3ORX|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor
1f8
pdb|3ORX|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor
1f8
pdb|3ORX|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor
1f8
pdb|3ORX|E Chain E, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor
1f8
pdb|3ORX|F Chain F, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor
1f8
pdb|3ORX|G Chain G, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor
1f8
pdb|3ORX|H Chain H, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor
1f8
pdb|3ORZ|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Activator
2a2
pdb|3ORZ|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Activator
2a2
pdb|3ORZ|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Activator
2a2
pdb|3ORZ|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Activator
2a2
pdb|3OTU|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Activator
Js30
Length = 316
Score = 76.6 bits (187), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 38 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 98 FFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 155
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 156 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F GN + I + K++ E E F P+
Sbjct: 213 EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 265
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 76.6 bits (187), Expect = 7e-14, Method: Composition-based stats.
Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
+G G FG YKA+ G L A K + + ++ + EI L H +V L+G Y
Sbjct: 19 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
+ +++++ F GG ++ I + + + I + + +AL +LH RI+HRD
Sbjct: 79 HDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRD 134
Query: 902 IKPSNILLDEELNAYLSDFGL-ARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD---- 956
+K N+L+ E + L+DFG+ A+ L+ + + GT ++APE + D
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPYD 192
Query: 957 -KADVYSFGVVLLEL 970
KAD++S G+ L+E+
Sbjct: 193 YKADIWSLGITLIEM 207
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 76.6 bits (187), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 775 GNFSIRNLIGTGGFGS------TYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI 828
GN+ I +G G FG T + V ++ K L+ QG + + EI L +
Sbjct: 4 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLL 61
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
RH +++ L + E+ +V + +G L +I ++ K+ + I A+ Y
Sbjct: 62 RHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRD--KMSEQEARRFFQQIISAVEY 118
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
H +IVHRD+KP N+LLDE LN ++DFGL+ ++ T+ G+ Y APE
Sbjct: 119 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEV 173
Query: 949 AT-TCRVSDKADVYSFGVVLLELISGKRSLD 978
+ + DV+S GV+L ++ + D
Sbjct: 174 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 76.6 bits (187), Expect = 7e-14, Method: Composition-based stats.
Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
+G G FG YKA+ G L A K + + ++ + EI L H +V L+G Y
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
+ +++++ F GG ++ I + + + I + + +AL +LH RI+HRD
Sbjct: 87 HDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRD 142
Query: 902 IKPSNILLDEELNAYLSDFGL-ARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD---- 956
+K N+L+ E + L+DFG+ A+ L+ + + GT ++APE + D
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPYD 200
Query: 957 -KADVYSFGVVLLEL 970
KAD++S G+ L+E+
Sbjct: 201 YKADIWSLGITLIEM 215
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 76.6 bits (187), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+IG G FG Y L+ AVK L+ I + QF E + H N+++
Sbjct: 34 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+G + E +V ++ G+L FI ++ +I + +A+ + YL
Sbjct: 94 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 149
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
+ VHRD+ N +LDE+ ++DFGLAR + E H T ++A E T
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 952 CRVSDKADVYSFGVVLLELIS 972
+ + K+DV+SFGV+L EL++
Sbjct: 210 QKFTTKSDVWSFGVLLWELMT 230
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 76.6 bits (187), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+IG G FG Y L+ AVK L+ I + QF E + H N+++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+G + E +V ++ G+L FI ++ +I + +A+ + YL
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 148
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
+ VHRD+ N +LDE+ ++DFGLAR + E H T ++A E T
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 952 CRVSDKADVYSFGVVLLELIS 972
+ + K+DV+SFGV+L EL++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMT 229
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 76.6 bits (187), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 23/222 (10%)
Query: 763 AELTYDNVVRATGNFSIRNLIGTGGFG-------STYKAELVPGYLVAVKKLSIGRFQGI 815
+E + + + N+ ++ +G G F T E ++ KKLS FQ +
Sbjct: 17 SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKL 75
Query: 816 QQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSV 874
++ E +++H N+V L E+ +LV++ ++GG L E + ++ + S
Sbjct: 76 ER---EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS- 131
Query: 875 IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSET 931
H I I +++AY H + IVHR++KP N+LL + L+DFGLA +EV+++
Sbjct: 132 -HCIQ-QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDS 184
Query: 932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
A AGT GY++PE S D+++ GV+L L+ G
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through
Fragment-Based Lead Discovery
pdb|3RWQ|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 76.3 bits (186), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 93 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 150
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 151 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F GN + I + K++ E E F P+
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 260
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 76.3 bits (186), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+IG G FG Y L+ AVK L+ I + QF E + H N+++
Sbjct: 35 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+G + E +V ++ G+L FI ++ +I + +A+ + YL
Sbjct: 95 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 150
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
+ VHRD+ N +LDE+ ++DFGLAR + E H T ++A E T
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 952 CRVSDKADVYSFGVVLLELIS 972
+ + K+DV+SFGV+L EL++
Sbjct: 211 QKFTTKSDVWSFGVLLWELMT 231
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 76.3 bits (186), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+IG G FG Y L+ AVK L+ I + QF E + H N+++
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+G + E +V ++ G+L FI ++ +I + +A+ + YL
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 151
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
+ VHRD+ N +LDE+ ++DFGLAR + E H T ++A E T
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 952 CRVSDKADVYSFGVVLLELIS 972
+ + K+DV+SFGV+L EL++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 76.3 bits (186), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 9/206 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
+F + +G G G +K P LV +KL + Q E+ L +
Sbjct: 10 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 69
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G + + E+ + + GG+L+ + KK+G+ I ++ K++I + + L YL
Sbjct: 70 VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREKH 127
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
+I+HRD+KPSNIL++ L DFG++ L + E + GT Y++PE
Sbjct: 128 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDEM--ANEFVGTRSYMSPERLQGTH 182
Query: 954 VSDKADVYSFGVVLLELISGKRSLDP 979
S ++D++S G+ L+E+ G+ P
Sbjct: 183 YSVQSDIWSMGLSLVEMAVGRYPRPP 208
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 76.3 bits (186), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRIRHK 831
GN+ ++ IG G F A V G VAVK + + +Q+ E+ + + H
Sbjct: 15 GNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
N+V L E ++LV + SGG E F + + +++ I A+ Y H
Sbjct: 75 NIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
IVHRD+K N+LLD ++N ++DFG + V T G+ Y APE
Sbjct: 133 KY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT--FCGSPPYAAPELFQG 187
Query: 952 CRVS-DKADVYSFGVVLLELISGKRSLD 978
+ + DV+S GV+L L+SG D
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFD 215
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 76.3 bits (186), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+IG G FG Y L+ AVK L+ I + QF E + H N+++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+G + E +V ++ G+L FI ++ +I + +A+ + YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 146
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
+ VHRD+ N +LDE+ ++DFGLAR + E H T ++A E T
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 952 CRVSDKADVYSFGVVLLELIS 972
+ + K+DV+SFGV+L EL++
Sbjct: 207 QKFTTKSDVWSFGVLLWELMT 227
>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead
Compound
Length = 292
Score = 76.3 bits (186), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 15 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 75 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 132
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 133 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F GN + I + K++ E E F P+
Sbjct: 190 EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 242
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 75.9 bits (185), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 782 LIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
+IG G FG Y L+ AVK L+ I + QF E + H N+++L
Sbjct: 38 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 837 IGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
+G + E +V ++ G+L FI ++ +I + +A+ + +L
Sbjct: 98 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFL---ASK 153
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATTC 952
+ VHRD+ N +LDE+ ++DFGLAR + E H T ++A E T
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 953 RVSDKADVYSFGVVLLELIS 972
+ + K+DV+SFGV+L EL++
Sbjct: 214 KFTTKSDVWSFGVLLWELMT 233
>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
pdb|3QC4|B Chain B, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
Length = 314
Score = 75.9 bits (185), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 10/203 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 36 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 96 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 153
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 154 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 951 TCRVSDKADVYSFGVVLLELISG 973
+D+++ G ++ +L++G
Sbjct: 211 EKSACKSSDLWALGCIIYQLVAG 233
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 75.9 bits (185), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 782 LIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
+IG G FG Y L+ AVK L+ I + QF E + H N+++L
Sbjct: 42 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 837 IGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
+G + E +V ++ G+L FI ++ +I + +A+ + +L
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFL---ASK 157
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATTC 952
+ VHRD+ N +LDE+ ++DFGLAR + E H T ++A E T
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 217
Query: 953 RVSDKADVYSFGVVLLELIS 972
+ + K+DV+SFGV+L EL++
Sbjct: 218 KFTTKSDVWSFGVLLWELMT 237
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 75.9 bits (185), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRIRHK 831
GN+ + IG G F A ++ G VA+K + + +Q+ E+ + + H
Sbjct: 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYL 889
N+V L E ++L+ + SGG + ++ H + +K S +I A+ Y
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYC 130
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
H RIVHRD+K N+LLD ++N ++DFG + E + G Y APE
Sbjct: 131 HQK---RIVHRDLKAENLLLDADMNIKIADFGFSN--EFTVGGKLDAFCGAPPYAAPELF 185
Query: 950 TTCRVS-DKADVYSFGVVLLELISGKRSLD 978
+ + DV+S GV+L L+SG D
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 75.9 bits (185), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 771 VRATGNFSIRNLIGTGGFGSTY-KAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR 829
+R T F ++G+G F + + + G L A+K + + EI L +I+
Sbjct: 7 IRKT--FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS--GKKIQWSVIHKIAIDIAQALA 887
H+N+VTL Y +LV +SGG L I ++ +K VI + + A+
Sbjct: 65 HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ----VLSAVK 120
Query: 888 YLHYSCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
YLH + IVHRD+KP N+L +E ++DFGL+++ + + GT GYV
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYV 174
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSE 983
APE S D +S GV+ L+ G P F E
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGY----PPFYE 209
>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7
Length = 311
Score = 75.9 bits (185), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 30 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 90 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 147
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 148 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F GN + I + K++ E E F P+
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 257
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 75.9 bits (185), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 782 LIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
+IG G FG Y L+ AVK L+ I + QF E + H N+++L
Sbjct: 38 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 837 IGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
+G + E +V ++ G+L FI ++ +I + +A+ + +L
Sbjct: 98 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFL---ASK 153
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATTC 952
+ VHRD+ N +LDE+ ++DFGLAR + E H T ++A E T
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 953 RVSDKADVYSFGVVLLELIS 972
+ + K+DV+SFGV+L EL++
Sbjct: 214 KFTTKSDVWSFGVLLWELMT 233
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 75.9 bits (185), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+IG G FG Y L+ AVK L+ I + QF E + H N+++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+G + E +V ++ G+L FI ++ +I + +A+ + +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFL---AS 210
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
+ VHRD+ N +LDE+ ++DFGLAR + E H T ++A E T
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 952 CRVSDKADVYSFGVVLLELIS 972
+ + K+DV+SFGV+L EL++
Sbjct: 271 QKFTTKSDVWSFGVLLWELMT 291
>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6
pdb|3NAY|B Chain B, Pdk1 In Complex With Inhibitor Mp6
Length = 311
Score = 75.9 bits (185), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F ++G G F + A EL A+K K I + + E + R+ H
Sbjct: 30 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
V L + + +++ ++ G L +I K + +I AL YLH
Sbjct: 90 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 147
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
I+HRD+KP NILL+E+++ ++DFG A++L A + GT YV+PE T
Sbjct: 148 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+D+++ G ++ +L++G P F GN + I + K++ E E F P+
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 257
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 75.9 bits (185), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 782 LIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
+IG G FG Y L+ AVK L+ I + QF E + H N+++L
Sbjct: 35 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 837 IGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
+G + E +V ++ G+L FI ++ +I + +A+ + +L
Sbjct: 95 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFL---ASK 150
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATTC 952
+ VHRD+ N +LDE+ ++DFGLAR + E H T ++A E T
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 210
Query: 953 RVSDKADVYSFGVVLLELIS 972
+ + K+DV+SFGV+L EL++
Sbjct: 211 KFTTKSDVWSFGVLLWELMT 230
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 75.5 bits (184), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 782 LIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
+IG G FG Y L+ AVK L+ I + QF E + H N+++L
Sbjct: 37 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 837 IGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
+G + E +V ++ G+L FI ++ +I + +A+ + +L
Sbjct: 97 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFL---ASK 152
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATTC 952
+ VHRD+ N +LDE+ ++DFGLAR + E H T ++A E T
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 953 RVSDKADVYSFGVVLLELIS 972
+ + K+DV+SFGV+L EL++
Sbjct: 213 KFTTKSDVWSFGVLLWELMT 232
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 75.5 bits (184), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 782 LIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
+IG G FG Y L+ AVK L+ I + QF E + H N+++L
Sbjct: 37 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 837 IGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
+G + E +V ++ G+L FI ++ +I + +A+ + +L
Sbjct: 97 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFL---ASK 152
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATTC 952
+ VHRD+ N +LDE+ ++DFGLAR + E H T ++A E T
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 953 RVSDKADVYSFGVVLLELIS 972
+ + K+DV+SFGV+L EL++
Sbjct: 213 KFTTKSDVWSFGVLLWELMT 232
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 75.5 bits (184), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 11/208 (5%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHK 831
GN+ + IG G F A ++ G VAV+ + + +Q+ E+ + + H
Sbjct: 14 GNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
N+V L E ++LV + SGG E F + + +++ I A+ Y H
Sbjct: 74 NIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
IVHRD+K N+LLD ++N ++DFG + E + + + G+ Y APE
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDEFCGSPPYAAPELFQG 186
Query: 952 CRVS-DKADVYSFGVVLLELISGKRSLD 978
+ + DV+S GV+L L+SG D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 75.5 bits (184), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 50/192 (26%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+GTG FG + Y VA+K + G +F E + + H+ LV L G
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ +F++ +++ G L ++ ++ + Q + ++ D+ +A+ YL + +HRD+
Sbjct: 91 QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 146
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTCRVSDKADV 960
N L++++ +SDFGL+R V + T+ V F + PE + S K+D+
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRY--VLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 961 YSFGVVLLELIS 972
++FGV++ E+ S
Sbjct: 205 WAFGVLMWEIYS 216
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 75.5 bits (184), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 23/229 (10%)
Query: 753 QVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR 811
+VM + TP LT + +F I +G G FG+ Y A E ++VA+K L +
Sbjct: 4 KVMENSSGTPDILTRHFTI---DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQ 60
Query: 812 FQ--GIQ-QFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK 868
+ G++ Q EI + H N++ L Y+ ++L+ + G L + K
Sbjct: 61 IEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTF 120
Query: 869 KIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV 928
Q + I ++A AL Y H +++HRDIKP N+LL + ++DFG +
Sbjct: 121 DEQRTAT--IMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWS----- 170
Query: 929 SETHATT----DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
HA + + GT Y+ PE ++K D++ GV+ EL+ G
Sbjct: 171 --VHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 75.5 bits (184), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 25/218 (11%)
Query: 770 VVRATGNFSIR----NLIGTGGFGSTYK-AELVPGYLVAVKKLSIGRFQGIQQFDAE--- 821
V +T FS R ++G G FG + + G AVK +S + Q Q+ D E
Sbjct: 40 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTDKESLL 97
Query: 822 --IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKI 878
+ L ++ H N++ L ++ + +LV +GG L + I +K ++ + I
Sbjct: 98 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI--- 154
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATT 935
I Q L+ + Y +IVHRD+KP N+LL+ ++ N + DFGL+ E S+
Sbjct: 155 ---IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMK 209
Query: 936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
D GT Y+APE +K DV+S GV+L L+SG
Sbjct: 210 DKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 246
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 75.5 bits (184), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 767 YDNVVR---ATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEI 822
Y++V R + I +G G FG YKA+ L A K + + ++ + EI
Sbjct: 26 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 823 GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAI 880
L H N+V L+ + E ++++ F +GG ++ + + + + Q V+ K +
Sbjct: 86 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA----RLLEVSETHATTD 936
D AL YLH + +I+HRD+K NIL + + L+DFG++ R ++ ++
Sbjct: 146 D---ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS----- 194
Query: 937 VAGTFGYVAPEYATTCRVSD------KADVYSFGVVLLEL 970
GT ++APE C S KADV+S G+ L+E+
Sbjct: 195 FIGTPYWMAPE-VVMCETSKDRPYDYKADVWSLGITLIEM 233
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 75.5 bits (184), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 46/229 (20%)
Query: 770 VVRATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDA-------- 820
V + +F +++L+G G +G A P G +VA+KK I+ FD
Sbjct: 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTL 57
Query: 821 -EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN--FLSGGNLETFIHKK------SGKKIQ 871
EI L +H+N++T+ + + + F +N ++ ++T +H+ S IQ
Sbjct: 58 REIKILKHFKHENIITI--FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS-- 929
+ + + +A+ LH S V +HRD+KPSN+L++ + + DFGLAR+++ S
Sbjct: 116 YFIYQTL-----RAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 930 -------ETHATTDVAGTFGYVAPEYA-TTCRVSDKADVYSFGVVLLEL 970
+ T+ T Y APE T+ + S DV+S G +L EL
Sbjct: 168 DNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 75.1 bits (183), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/229 (27%), Positives = 109/229 (47%), Gaps = 46/229 (20%)
Query: 770 VVRATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDA-------- 820
V + +F +++L+G G +G A P G +VA+KK I+ FD
Sbjct: 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTL 57
Query: 821 -EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN--FLSGGNLETFIHKK------SGKKIQ 871
EI L +H+N++T+ + + F +N ++ ++T +H+ S IQ
Sbjct: 58 REIKILKHFKHENIITIFN--IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS-- 929
+ + + +A+ LH S V +HRD+KPSN+L++ + + DFGLAR+++ S
Sbjct: 116 YFIYQTL-----RAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 930 -------ETHATTDVAGTFGYVAPEYA-TTCRVSDKADVYSFGVVLLEL 970
+ T+ T Y APE T+ + S DV+S G +L EL
Sbjct: 168 DNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 75.1 bits (183), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 25/218 (11%)
Query: 770 VVRATGNFSIR----NLIGTGGFGSTYK-AELVPGYLVAVKKLSIGRFQGIQQFDAE--- 821
V +T FS R ++G G FG + + G AVK +S + Q Q+ D E
Sbjct: 41 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTDKESLL 98
Query: 822 --IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKI 878
+ L ++ H N++ L ++ + +LV +GG L + I +K ++ + I
Sbjct: 99 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI--- 155
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATT 935
I Q L+ + Y +IVHRD+KP N+LL+ ++ N + DFGL+ E S+
Sbjct: 156 ---IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMK 210
Query: 936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
D GT Y+APE +K DV+S GV+L L+SG
Sbjct: 211 DKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 247
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 75.1 bits (183), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 767 YDNVVR---ATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEI 822
Y++V R + I +G G FG YKA+ L A K + + ++ + EI
Sbjct: 26 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 823 GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAI 880
L H N+V L+ + E ++++ F +GG ++ + + + + Q V+ K +
Sbjct: 86 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA----RLLEVSETHATTD 936
D AL YLH + +I+HRD+K NIL + + L+DFG++ R ++ ++
Sbjct: 146 D---ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS----- 194
Query: 937 VAGTFGYVAPEYATTCRVSD------KADVYSFGVVLLEL 970
GT ++APE C S KADV+S G+ L+E+
Sbjct: 195 FIGTPYWMAPE-VVMCETSKDRPYDYKADVWSLGITLIEM 233
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 75.1 bits (183), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 21/223 (9%)
Query: 761 TPAELTYDNVVRATGNFSIRNLIGTGGFGSTYK-AELVPGYLVAVKKLSIGRFQGIQQFD 819
TP + + + + ++G G FG + + G AVK +S + Q Q+ D
Sbjct: 12 TPGXFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTD 69
Query: 820 AE-----IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWS 873
E + L ++ H N+ L ++ + +LV +GG L + I +K ++ +
Sbjct: 70 KESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 129
Query: 874 VIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSE 930
I I Q L+ + Y +IVHRD+KP N+LL+ ++ N + DFGL+ E S+
Sbjct: 130 RI------IRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183
Query: 931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
D GT Y+APE +K DV+S GV+L L+SG
Sbjct: 184 --KXKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 75.1 bits (183), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 11/208 (5%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHK 831
GN+ + IG G F A ++ G VAVK + + +Q+ E+ + + H
Sbjct: 14 GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
N+V L E ++LV + SGG E F + + +++ I A+ Y H
Sbjct: 74 NIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
IVHRD+K N+LLD ++N ++DFG + E + + G+ Y APE
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQG 186
Query: 952 CRVS-DKADVYSFGVVLLELISGKRSLD 978
+ + DV+S GV+L L+SG D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 75.1 bits (183), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 11/208 (5%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHK 831
GN+ + IG G F A ++ G VAVK + + +Q+ E+ + + H
Sbjct: 14 GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
N+V L E ++LV + SGG E F + + +++ I A+ Y H
Sbjct: 74 NIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
IVHRD+K N+LLD ++N ++DFG + E + + G+ Y APE
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQG 186
Query: 952 CRVS-DKADVYSFGVVLLELISGKRSLD 978
+ + DV+S GV+L L+SG D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 75.1 bits (183), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 50/192 (26%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+GTG FG + Y VA+K + G +F E + + H+ LV L G
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ +F++ +++ G L ++ ++ + Q + ++ D+ +A+ YL + +HRD+
Sbjct: 91 QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 146
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTCRVSDKADV 960
N L++++ +SDFGL+R V + T+ V F + PE + S K+D+
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 961 YSFGVVLLELIS 972
++FGV++ E+ S
Sbjct: 205 WAFGVLMWEIYS 216
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 767 YDNVVR---ATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEI 822
Y++V R + I +G G FG YKA+ L A K + + ++ + EI
Sbjct: 26 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 823 GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAI 880
L H N+V L+ + E ++++ F +GG ++ + + + + Q V+ K +
Sbjct: 86 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
D AL YLH + +I+HRD+K NIL + + L+DFG++ GT
Sbjct: 146 D---ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS-AKNTRXIQRRDXFIGT 198
Query: 941 FGYVAPEYATTCRVSD------KADVYSFGVVLLEL 970
++APE C S KADV+S G+ L+E+
Sbjct: 199 PYWMAPE-VVMCETSKDRPYDYKADVWSLGITLIEM 233
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 774 TGNFSIRNLIGTGGFGSTYKA-------ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLG 826
+ N+ ++ +G G F + E ++ KKLS FQ +++ E
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLER---EARICR 60
Query: 827 RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQA 885
+++H N+V L E+ +LV++ ++GG L E + ++ + S H I I ++
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS--HCIQ-QILES 117
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELN---AYLSDFGLARLLEVSETHATTDVAGTFG 942
+AY H + IVHR++KP N+LL + L+DFGLA +EV+++ A AGT G
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPG 172
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISG 973
Y++PE S D+++ GV+L L+ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 774 TGNFSIRNLIGTGGFGSTYKA-------ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLG 826
+ N+ ++ +G G F + E ++ KKLS FQ +++ E
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLER---EARICR 60
Query: 827 RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQA 885
+++H N+V L E+ +LV++ ++GG L E + ++ + S H I I ++
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS--HCIQ-QILES 117
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+AY H + IVHR++KP N+LL + L+DFGLA +EV+++ A AGT G
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPG 172
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISG 973
Y++PE S D+++ GV+L L+ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 50/192 (26%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+GTG FG + Y VA+K + G +F E + + H+ LV L G
Sbjct: 16 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ +F++ +++ G L ++ ++ + Q + ++ D+ +A+ YL + +HRD+
Sbjct: 75 QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 130
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTCRVSDKADV 960
N L++++ +SDFGL+R V + T+ V F + PE + S K+D+
Sbjct: 131 AARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 188
Query: 961 YSFGVVLLELIS 972
++FGV++ E+ S
Sbjct: 189 WAFGVLMWEIYS 200
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 74.7 bits (182), Expect = 2e-13, Method: Composition-based stats.
Identities = 57/174 (32%), Positives = 85/174 (48%), Gaps = 19/174 (10%)
Query: 817 QFDAEIGTLGRIRHKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFIHKKSGKKI 870
+F E + H +V + Y GEAE ++V ++ G L +H + G
Sbjct: 58 RFRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMT 114
Query: 871 QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS- 929
I IA D QAL + H + I+HRD+KP+NIL+ + DFG+AR + S
Sbjct: 115 PKRAIEVIA-DACQALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSG 170
Query: 930 -ETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
T V GT Y++PE A V ++DVYS G VL E+++G +P F+
Sbjct: 171 NSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG----EPPFT 220
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 74.7 bits (182), Expect = 2e-13, Method: Composition-based stats.
Identities = 56/174 (32%), Positives = 85/174 (48%), Gaps = 19/174 (10%)
Query: 817 QFDAEIGTLGRIRHKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFIHKKSGKKI 870
+F E + H +V + Y GEAE ++V ++ G L +H + G
Sbjct: 75 RFRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMT 131
Query: 871 QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE 930
I IA D QAL + H + I+HRD+KP+NI++ + DFG+AR + S
Sbjct: 132 PKRAIEVIA-DACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 187
Query: 931 THATTDVA--GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
T A GT Y++PE A V ++DVYS G VL E+++G +P F+
Sbjct: 188 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG----EPPFT 237
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 74.7 bits (182), Expect = 2e-13, Method: Composition-based stats.
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
IG G G A E G VAVK + + + Q + E+ + +H N+V + Y+
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
E++++ FL GG L + S ++ I + + QALAYLH V +HRD
Sbjct: 113 VGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQGV---IHRD 166
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
IK +ILL + LSDFG + + + GT ++APE + + + D++
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKXLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 962 SFGVVLLELISGKRSLDPSFSE 983
S G++++E++ G+ P FS+
Sbjct: 226 SLGIMVIEMVDGE---PPYFSD 244
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 774 TGNFSIRNLIGTGGFGSTYKA-------ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLG 826
+ N+ ++ +G G F + E ++ KKLS FQ +++ E
Sbjct: 4 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLER---EARICR 59
Query: 827 RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQA 885
+++H N+V L E+ +LV++ ++GG L E + ++ + S H I I ++
Sbjct: 60 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS--HCIQ-QILES 116
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELN---AYLSDFGLARLLEVSETHATTDVAGTFG 942
+AY H + IVHR++KP N+LL + L+DFGLA +EV+++ A AGT G
Sbjct: 117 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPG 171
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISG 973
Y++PE S D+++ GV+L L+ G
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 202
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 74.7 bits (182), Expect = 3e-13, Method: Composition-based stats.
Identities = 56/174 (32%), Positives = 85/174 (48%), Gaps = 19/174 (10%)
Query: 817 QFDAEIGTLGRIRHKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFIHKKSGKKI 870
+F E + H +V + Y GEAE ++V ++ G L +H + G
Sbjct: 58 RFRREAQNAAALNHPAIVAV--YATGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMT 114
Query: 871 QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE 930
I IA D QAL + H + I+HRD+KP+NI++ + DFG+AR + S
Sbjct: 115 PKRAIEVIA-DACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 931 THATTDVA--GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
T A GT Y++PE A V ++DVYS G VL E+++G +P F+
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG----EPPFT 220
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 74.7 bits (182), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 50/192 (26%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+GTG FG + Y VA+K + G +F E + + H+ LV L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ +F++ +++ G L ++ ++ + Q + ++ D+ +A+ YL + +HRD+
Sbjct: 71 QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 126
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTCRVSDKADV 960
N L++++ +SDFGL+R V + T+ V F + PE + S K+D+
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 961 YSFGVVLLELIS 972
++FGV++ E+ S
Sbjct: 185 WAFGVLMWEIYS 196
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 74.3 bits (181), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 50/192 (26%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+GTG FG + Y VA+K + G +F E + + H+ LV L G
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ +F++ +++ G L ++ ++ + Q + ++ D+ +A+ YL + +HRD+
Sbjct: 76 QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 131
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTCRVSDKADV 960
N L++++ +SDFGL+R V + T+ V F + PE + S K+D+
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 961 YSFGVVLLELIS 972
++FGV++ E+ S
Sbjct: 190 WAFGVLMWEIYS 201
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 74.3 bits (181), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 11/208 (5%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHK 831
GN+ + IG G F A ++ G VAVK + + +Q+ E+ + + H
Sbjct: 7 GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 66
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
N+V L E ++LV + SGG + ++ W + Q ++ + Y
Sbjct: 67 NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-----WMKEKEARAKFRQIVSAVQY 121
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
IVHRD+K N+LLD ++N ++DFG + E + + G+ Y APE
Sbjct: 122 CHQKFIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQG 179
Query: 952 CRVS-DKADVYSFGVVLLELISGKRSLD 978
+ + DV+S GV+L L+SG D
Sbjct: 180 KKYDGPEVDVWSLGVILYTLVSGSLPFD 207
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 74.3 bits (181), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLG 826
AT + IG G +G+ YKA + G+ VA+K + + G E+ L
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 827 RIR---HKNLVTLIGYYVG-----EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI 878
R+ H N+V L+ E ++ LV+ + +L T++ K + I +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA 938
+ L +LH +C IVHRD+KP NIL+ L+DFGLAR+ S A T V
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTPVV 180
Query: 939 GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
T Y APE + D++S G + E+ K
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 74.3 bits (181), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 50/192 (26%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+GTG FG + Y VA+K + G +F E + + H+ LV L G
Sbjct: 23 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ +F++ +++ G L ++ ++ + Q + ++ D+ +A+ YL + +HRD+
Sbjct: 82 QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 137
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTCRVSDKADV 960
N L++++ +SDFGL+R V + T+ V F + PE + S K+D+
Sbjct: 138 AARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 195
Query: 961 YSFGVVLLELIS 972
++FGV++ E+ S
Sbjct: 196 WAFGVLMWEIYS 207
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 74.3 bits (181), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 49/154 (31%), Positives = 77/154 (50%), Gaps = 5/154 (3%)
Query: 821 EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI 880
E L ++ + +V+L Y + + LV ++GG+L+ I+ + A
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
+I L LH RIV+RD+KP NILLD+ + +SD GLA + V E GT
Sbjct: 294 EICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGT 348
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
GY+APE R + D ++ G +L E+I+G+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 74.3 bits (181), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 49/154 (31%), Positives = 77/154 (50%), Gaps = 5/154 (3%)
Query: 821 EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI 880
E L ++ + +V+L Y + + LV ++GG+L+ I+ + A
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
+I L LH RIV+RD+KP NILLD+ + +SD GLA + V E GT
Sbjct: 294 EICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGT 348
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
GY+APE R + D ++ G +L E+I+G+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 74.3 bits (181), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIG-TLGRIR---- 829
+F + ++G G FG + AE A+K L + + D ++ T+ R
Sbjct: 19 DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALK----KDVVLMDDDVECTMVEKRVLSL 74
Query: 830 ---HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
H L + + + +F V +L+GG+L H +S K S A +I L
Sbjct: 75 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGL 132
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
+LH IV+RD+K NILLD++ + ++DFG+ + + + T + GT Y+AP
Sbjct: 133 QFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNEFCGTPDYIAP 188
Query: 947 EYATTCRVSDKADVYSFGVVLLELISGK 974
E + + D +SFGV+L E++ G+
Sbjct: 189 EILLGQKYNHSVDWWSFGVLLYEMLIGQ 216
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 74.3 bits (181), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHK 831
GN+ + IG G F A ++ G VAVK + + +Q+ E+ + + H
Sbjct: 14 GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
N+V L E ++LV + SGG E F + + +++ I A+ Y H
Sbjct: 74 NIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
IVHRD+K N+LLD ++N ++DFG + E + + G Y APE
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDAFCGAPPYAAPELFQG 186
Query: 952 CRVS-DKADVYSFGVVLLELISGKRSLD 978
+ + DV+S GV+L L+SG D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 74.3 bits (181), Expect = 3e-13, Method: Composition-based stats.
Identities = 56/174 (32%), Positives = 85/174 (48%), Gaps = 19/174 (10%)
Query: 817 QFDAEIGTLGRIRHKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFIHKKSGKKI 870
+F E + H +V + Y GEAE ++V ++ G L +H + G
Sbjct: 58 RFRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMT 114
Query: 871 QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE 930
I IA D QAL + H + I+HRD+KP+NI++ + DFG+AR + S
Sbjct: 115 PKRAIEVIA-DACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 931 THATTDVA--GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
T A GT Y++PE A V ++DVYS G VL E+++G +P F+
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG----EPPFT 220
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 74.3 bits (181), Expect = 3e-13, Method: Composition-based stats.
Identities = 56/174 (32%), Positives = 85/174 (48%), Gaps = 19/174 (10%)
Query: 817 QFDAEIGTLGRIRHKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFIHKKSGKKI 870
+F E + H +V + Y GEAE ++V ++ G L +H + G
Sbjct: 58 RFRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMT 114
Query: 871 QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE 930
I IA D QAL + H + I+HRD+KP+NI++ + DFG+AR + S
Sbjct: 115 PKRAIEVIA-DACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 931 THATTDVA--GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
T A GT Y++PE A V ++DVYS G VL E+++G +P F+
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG----EPPFT 220
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 73.9 bits (180), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 11/208 (5%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHK 831
GN+ + IG G F A ++ G VAV+ + + +Q+ E+ + + H
Sbjct: 14 GNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
N+V L E ++LV + SGG E F + + +++ I A+ Y H
Sbjct: 74 NIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
IVHRD+K N+LLD ++N ++DFG + E + + G+ Y APE
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQG 186
Query: 952 CRVS-DKADVYSFGVVLLELISGKRSLD 978
+ + DV+S GV+L L+SG D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 73.9 bits (180), Expect = 4e-13, Method: Composition-based stats.
Identities = 56/174 (32%), Positives = 85/174 (48%), Gaps = 19/174 (10%)
Query: 817 QFDAEIGTLGRIRHKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFIHKKSGKKI 870
+F E + H +V + Y GEAE ++V ++ G L +H + G
Sbjct: 58 RFRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMT 114
Query: 871 QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE 930
I IA D QAL + H + I+HRD+KP+NI++ + DFG+AR + S
Sbjct: 115 PKRAIEVIA-DACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 931 THATTDVA--GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
T A GT Y++PE A V ++DVYS G VL E+++G +P F+
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG----EPPFT 220
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 73.9 bits (180), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 9/201 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
+F + +G G G +K P LV +KL + Q E+ L +
Sbjct: 26 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 85
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G + + E+ + + GG+L+ + KK+G+ I ++ K++I + + L YL
Sbjct: 86 VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREK- 142
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
+I+HRD+KPSNIL++ L DFG++ L S ++ GT Y++PE
Sbjct: 143 -HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 198
Query: 954 VSDKADVYSFGVVLLELISGK 974
S ++D++S G+ L+E+ G+
Sbjct: 199 YSVQSDIWSMGLSLVEMAVGR 219
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 73.9 bits (180), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 47/190 (24%), Positives = 94/190 (49%), Gaps = 5/190 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
+GTG FG + Y VA+K + G +F E + + H+ LV L G
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
+ +F++ +++ G L ++ ++ + Q + ++ D+ +A+ YL + +HRD+
Sbjct: 76 QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 131
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
N L++++ +SDFGL+R + E ++ + PE + S K+D+++
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 963 FGVVLLELIS 972
FGV++ E+ S
Sbjct: 192 FGVLMWEIYS 201
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 73.6 bits (179), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 20/220 (9%)
Query: 768 DNVVRATGNFSIRNLIGTGGFGSTYKAELVP--GYLVAVKKLSIGR------FQGIQQFD 819
D + RA + IG G +G +KA + G VA+K++ + I++
Sbjct: 4 DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV- 62
Query: 820 AEIGTLGRIRHKNLVTL-----IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV 874
A + L H N+V L + E ++ LV+ + +L T++ K +
Sbjct: 63 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121
Query: 875 IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT 934
I + + + L +LH R+VHRD+KP NIL+ L+DFGLAR+ S A
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMAL 176
Query: 935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
T V T Y APE + D++S G + E+ K
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 73.6 bits (179), Expect = 5e-13, Method: Composition-based stats.
Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 770 VVRATGNFSIR----NLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAE--- 821
V +T FS R ++G G FG + + G AVK +S + Q Q+ D E
Sbjct: 23 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTDKESLL 80
Query: 822 --IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKI 878
+ L ++ H N++ L ++ + +LV +GG L + I +K ++ + +I
Sbjct: 81 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RI 137
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATT 935
+ + Y+H + +IVHRD+KP N+LL+ ++ N + DFGL+ E S+
Sbjct: 138 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MK 192
Query: 936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
D GT Y+APE +K DV+S GV+L L+SG
Sbjct: 193 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 73.6 bits (179), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 768 DNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQF-DAEIGTL 825
+N+ F+ IG G FG +K + +VA+K + + + + EI L
Sbjct: 16 NNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVL 75
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
+ + G Y+ ++++++ +L GG+ + + Q + + K +I +
Sbjct: 76 SQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKG 132
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
L YLH + +HRDIK +N+LL E+ + L+DFG+A L ++ T V F ++A
Sbjct: 133 LDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMA 188
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGK 974
PE KAD++S G+ +EL G+
Sbjct: 189 PEVIQQSAYDSKADIWSLGITAIELAKGE 217
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 73.6 bits (179), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIR 829
AT + IG G +G+ YKA + G+ VA+K + + + E+ L R+
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 830 ---HKNLVTLIGYYVG-----EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
H N+V L+ E ++ LV+ + +L T++ K + I +
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
+ L +LH +C IVHRD+KP NIL+ L+DFGLAR+ S A V T
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALAPVVVTL 175
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
Y APE + D++S G + E+ K
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 73.6 bits (179), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 46/229 (20%)
Query: 770 VVRATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDA-------- 820
V + +F +++L+G G +G A P G +VA+KK I+ FD
Sbjct: 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTL 57
Query: 821 -EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN--FLSGGNLETFIHKK------SGKKIQ 871
EI L +H+N++T+ + + F +N ++ ++T +H+ S IQ
Sbjct: 58 REIKILKHFKHENIITIFN--IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS-- 929
+ + + +A+ LH S V +HRD+KPSN+L++ + + DFGLAR+++ S
Sbjct: 116 YFIYQTL-----RAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 930 -------ETHATTDVAGTFGYVAPEYA-TTCRVSDKADVYSFGVVLLEL 970
+ + T Y APE T+ + S DV+S G +L EL
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 73.2 bits (178), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIR 829
AT + IG G +G+ YKA + G+ VA+K + + + E+ L R+
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 830 ---HKNLVTLIGYYVG-----EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
H N+V L+ E ++ LV+ + +L T++ K + I +
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
+ L +LH +C IVHRD+KP NIL+ L+DFGLAR+ S A V T
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALDPVVVTL 175
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
Y APE + D++S G + E+ K
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208
>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|B Chain B, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|C Chain C, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|D Chain D, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
Length = 543
Score = 73.2 bits (178), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 781 NLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ---GIQQFDAEIGTLGRIRHKNLVTL 836
++G GGFG + ++ G L A KKL+ R + G Q E L ++ + +V+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI--AIDIAQALAYLHYSCV 894
+ + ++ LV ++GG++ I+ + I I L +LH
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-- 308
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
I++RD+KP N+LLD++ N +SD GLA L+ +T T AGT G++APE
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEY 366
Query: 955 SDKADVYSFGVVLLELISGK 974
D ++ GV L E+I+ +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 73.2 bits (178), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQF-DAEIGTLGRIRHKNLV 834
F+ + IG G FG YK + +VA+K + + + + EI L + +
Sbjct: 21 FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
G Y+ +++++ +L GG+ + K G ++ + I I +I + L YLH
Sbjct: 81 RYFGSYLKSTKLWIIMEYLGGGSALDLL--KPGP-LEETYIATILREILKGLDYLHSE-- 135
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
R +HRDIK +N+LL E+ + L+DFG+A L ++ V F ++APE
Sbjct: 136 -RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPF-WMAPEVIKQSAY 193
Query: 955 SDKADVYSFGVVLLELISGK 974
KAD++S G+ +EL G+
Sbjct: 194 DFKADIWSLGITAIELAKGE 213
>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4X|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4Y|A Chain A, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Y|B Chain B, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Z|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 1.84a
pdb|3C50|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C50|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C51|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
pdb|3C51|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
Length = 543
Score = 73.2 bits (178), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 781 NLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ---GIQQFDAEIGTLGRIRHKNLVTL 836
++G GGFG + ++ G L A KKL+ R + G Q E L ++ + +V+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI--AIDIAQALAYLHYSCV 894
+ + ++ LV ++GG++ I+ + I I L +LH
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-- 308
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
I++RD+KP N+LLD++ N +SD GLA L+ +T T AGT G++APE
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEY 366
Query: 955 SDKADVYSFGVVLLELISGK 974
D ++ GV L E+I+ +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386
>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution
Length = 543
Score = 73.2 bits (178), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 781 NLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ---GIQQFDAEIGTLGRIRHKNLVTL 836
++G GGFG + ++ G L A KKL+ R + G Q E L ++ + +V+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI--AIDIAQALAYLHYSCV 894
+ + ++ LV ++GG++ I+ + I I L +LH
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-- 308
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
I++RD+KP N+LLD++ N +SD GLA L+ +T T AGT G++APE
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEY 366
Query: 955 SDKADVYSFGVVLLELISGK 974
D ++ GV L E+I+ +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386
>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
pdb|3C4W|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
Length = 543
Score = 73.2 bits (178), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 781 NLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ---GIQQFDAEIGTLGRIRHKNLVTL 836
++G GGFG + ++ G L A KKL+ R + G Q E L ++ + +V+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI--AIDIAQALAYLHYSCV 894
+ + ++ LV ++GG++ I+ + I I L +LH
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-- 308
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
I++RD+KP N+LLD++ N +SD GLA L+ +T T AGT G++APE
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEY 366
Query: 955 SDKADVYSFGVVLLELISGK 974
D ++ GV L E+I+ +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 72.8 bits (177), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 781 NLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRF----QGIQQFD-AEIGTLGRIRHKNLV 834
+ +G G F + YKA + +VA+KK+ +G GI + EI L + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+ + ++ + LV++F+ +LE I K + + S I + Q L YLH
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVII-KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 132
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
I+HRD+KP+N+LLDE L+DFGLA+ S A T Y APE R+
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYXHQVVTRWYRAPELLFGARM 189
Query: 955 SD-KADVYSFGVVLLELI 971
D+++ G +L EL+
Sbjct: 190 YGVGVDMWAVGCILAELL 207
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 72.8 bits (177), Expect = 1e-12, Method: Composition-based stats.
Identities = 73/251 (29%), Positives = 112/251 (44%), Gaps = 23/251 (9%)
Query: 782 LIGTGGFGSTYKAE-LVPGYLVAVKK-LSIGRFQGIQQFDA-EIGTLGRIRHKNLVTLIG 838
L+G G +G K G +VA+KK L + +++ EI L ++RH+NLV L+
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ +LV+ F+ L+ +G + + V+ K I + + H I+
Sbjct: 92 VCKKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSH---NII 146
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDK 957
HRDIKP NIL+ + L DFG AR L + D T Y APE +
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATRWYRAPELLVGDVKYGKA 205
Query: 958 ADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF---------- 1007
DV++ G ++ E+ G+ L P S+ ++I+ LI R ELF
Sbjct: 206 VDVWAIGCLVTEMFMGE-PLFPGDSDIDQLYHIMMCLGNLIP--RHQELFNKNPVFAGVR 262
Query: 1008 LPELWEAGPQE 1018
LPE+ E P E
Sbjct: 263 LPEIKEREPLE 273
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 72.8 bits (177), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 20/220 (9%)
Query: 768 DNVVRATGNFSIRNLIGTGGFGSTYKAELVP--GYLVAVKKLSIGR------FQGIQQFD 819
D + RA + IG G +G +KA + G VA+K++ + I++
Sbjct: 4 DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV- 62
Query: 820 AEIGTLGRIRHKNLVTL-----IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV 874
A + L H N+V L + E ++ LV+ + +L T++ K +
Sbjct: 63 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121
Query: 875 IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT 934
I + + + L +LH R+VHRD+KP NIL+ L+DFGLAR+ S A
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMAL 176
Query: 935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
T V T Y APE + D++S G + E+ K
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G+ VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++AG T Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain
In Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G+ VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++AG T Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 20/220 (9%)
Query: 768 DNVVRATGNFSIRNLIGTGGFGSTYKAELVP--GYLVAVKKLSIGR------FQGIQQFD 819
D + RA + IG G +G +KA + G VA+K++ + I++
Sbjct: 4 DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV- 62
Query: 820 AEIGTLGRIRHKNLVTL-----IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV 874
A + L H N+V L + E ++ LV+ + +L T++ K +
Sbjct: 63 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121
Query: 875 IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT 934
I + + + L +LH R+VHRD+KP NIL+ L+DFGLAR+ S A
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMAL 176
Query: 935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
T V T Y APE + D++S G + E+ K
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIR 829
AT + IG G +G+ YKA + G+ VA+K + + + E+ L R+
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 830 ---HKNLVTLIGYYVG-----EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
H N+V L+ E ++ LV+ + +L T++ K + I +
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
+ L +LH +C IVHRD+KP NIL+ L+DFGLAR+ S A V T
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALFPVVVTL 175
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
Y APE + D++S G + E+ K
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VA+KKLS FQ ++ E+ L ++H+N++ L+
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHMQHENVIGLLD 90
Query: 839 YYVGEAEMFLVYNF-LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
+ + + Y+F L ++T + K G K I + + + L Y+H + V
Sbjct: 91 VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGV--- 147
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYATT-CR 953
VHRD+KP N+ ++E+ + DFGLAR HA ++ G T Y APE +
Sbjct: 148 VHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEVILSWMH 200
Query: 954 VSDKADVYSFGVVLLELISGK 974
+ D++S G ++ E+++GK
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGK 221
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
IG G FG ++ + P VA+K + ++F E T+ + H ++V LI
Sbjct: 18 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
G + E ++++ + G L +F+ + S+I A ++ ALAYL R
Sbjct: 78 GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-LYAYQLSTALAYLESK---RF 132
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
VHRDI N+L+ L DFGL+R +E S + + ++APE R +
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 958 ADVYSFGVVLLELI 971
+DV+ FGV + E++
Sbjct: 193 SDVWMFGVCMWEIL 206
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 18/225 (8%)
Query: 755 MVTFADTPAELTYD-NVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ 813
M TF E YD +G F+I G Y A+ + + + R
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCR-- 59
Query: 814 GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS 873
++ + E+ L ++ H N++TL Y ++ L+ +SGG L F+ +K S
Sbjct: 60 --EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE------S 111
Query: 874 VIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLARLLEV 928
+ + A I Q L ++Y +I H D+KP NI LLD+ + + L DFGLA E+
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EI 169
Query: 929 SETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
+ ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 72.0 bits (175), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
IG G FG ++ + P VA+K + ++F E T+ + H ++V LI
Sbjct: 18 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
G + E ++++ + G L +F+ + S+I A ++ ALAYL R
Sbjct: 78 GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-YAYQLSTALAYLESK---RF 132
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
VHRDI N+L+ L DFGL+R +E S + + ++APE R +
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 958 ADVYSFGVVLLELI 971
+DV+ FGV + E++
Sbjct: 193 SDVWMFGVCMWEIL 206
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 72.0 bits (175), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQF-DAEIGTLGRIRHKNLV 834
F+ IG G FG +K + +VA+K + + + + EI L + +
Sbjct: 29 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
G Y+ + +++++ +L GG+ + + Q + I + +I + L YLH
Sbjct: 89 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLDYLHSE-- 143
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
+ +HRDIK +N+LL E L+DFG+A L ++ T V F ++APE
Sbjct: 144 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAY 201
Query: 955 SDKADVYSFGVVLLELISGKRSLDPSFSE 983
KAD++S G+ +EL G +P SE
Sbjct: 202 DSKADIWSLGITAIELARG----EPPHSE 226
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 72.0 bits (175), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G+ VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 85 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++AG T Y APE
Sbjct: 141 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPEIM 190
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 220
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 72.0 bits (175), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
IG G FG ++ + P VA+K + ++F E T+ + H ++V LI
Sbjct: 46 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
G + E ++++ + G L +F+ + S+I A ++ ALAYL R
Sbjct: 106 GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-LYAYQLSTALAYLESK---RF 160
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
VHRDI N+L+ L DFGL+R +E S + + ++APE R +
Sbjct: 161 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 220
Query: 958 ADVYSFGVVLLELI 971
+DV+ FGV + E++
Sbjct: 221 SDVWMFGVCMWEIL 234
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 72.0 bits (175), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
IG G FG ++ + P VA+K + ++F E T+ + H ++V LI
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
G + E ++++ + G L +F+ + S+I A ++ ALAYL R
Sbjct: 83 GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-YAYQLSTALAYLESK---RF 137
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
VHRDI N+L+ L DFGL+R +E S + + ++APE R +
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 197
Query: 958 ADVYSFGVVLLELI 971
+DV+ FGV + E++
Sbjct: 198 SDVWMFGVCMWEIL 211
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 72.0 bits (175), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
IG G FG ++ + P VA+K + ++F E T+ + H ++V LI
Sbjct: 15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
G + E ++++ + G L +F+ + S+I A ++ ALAYL R
Sbjct: 75 GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-LYAYQLSTALAYLESK---RF 129
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
VHRDI N+L+ L DFGL+R +E S + + ++APE R +
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189
Query: 958 ADVYSFGVVLLELI 971
+DV+ FGV + E++
Sbjct: 190 SDVWMFGVCMWEIL 203
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 72.0 bits (175), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
++ + +G G +G A V VAVK + + R + EI + H+N+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G+ +L + SGG L I G + + + + YLH
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTC 952
I HRDIKP N+LLDE N +SDFGLA + + + + GT YVAPE
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
++ DV+S G+VL +++G+ D PS S EY +
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 72.0 bits (175), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
++ + +G G +G A V VAVK + + R + EI + H+N+
Sbjct: 7 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G+ +L + SGG L I G + + + + YLH
Sbjct: 67 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTC 952
I HRDIKP N+LLDE N +SDFGLA + + + + GT YVAPE
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
++ DV+S G+VL +++G+ D PS S EY +
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
IG G FG ++ + P VA+K + ++F E T+ + H ++V LI
Sbjct: 18 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
G + E ++++ + G L +F+ + S+I A ++ ALAYL R
Sbjct: 78 GV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLIL-YAYQLSTALAYLESK---RF 132
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
VHRDI N+L+ L DFGL+R +E S + + ++APE R +
Sbjct: 133 VHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 958 ADVYSFGVVLLELI 971
+DV+ FGV + E++
Sbjct: 193 SDVWMFGVCMWEIL 206
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
IG G FG ++ + P VA+K + ++F E T+ + H ++V LI
Sbjct: 18 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
G + E ++++ + G L +F+ + S+I A ++ ALAYL R
Sbjct: 78 GV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLIL-YAYQLSTALAYLESK---RF 132
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
VHRDI N+L+ L DFGL+R +E S + ++APE R +
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSA 192
Query: 958 ADVYSFGVVLLELI 971
+DV+ FGV + E++
Sbjct: 193 SDVWMFGVCMWEIL 206
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
IG G FG ++ + P VA+K + ++F E T+ + H ++V LI
Sbjct: 21 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
G + E ++++ + G L +F+ + S+I A ++ ALAYL R
Sbjct: 81 GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-YAYQLSTALAYLESK---RF 135
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
VHRDI N+L+ L DFGL+R +E S + + ++APE R +
Sbjct: 136 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 195
Query: 958 ADVYSFGVVLLELI 971
+DV+ FGV + E++
Sbjct: 196 SDVWMFGVCMWEIL 209
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
IG G FG ++ + P VA+K + ++F E T+ + H ++V LI
Sbjct: 20 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
G + E ++++ + G L +F+ + S+I A ++ ALAYL R
Sbjct: 80 GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-YAYQLSTALAYLESK---RF 134
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
VHRDI N+L+ L DFGL+R +E S + + ++APE R +
Sbjct: 135 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 194
Query: 958 ADVYSFGVVLLELI 971
+DV+ FGV + E++
Sbjct: 195 SDVWMFGVCMWEIL 208
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQF-DAEIGTLGRIRHKNLV 834
F+ IG G FG +K + +VA+K + + + + EI L + +
Sbjct: 9 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
G Y+ + +++++ +L GG+ + + Q I I +I + L YLH
Sbjct: 69 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ---IATILREILKGLDYLHSE-- 123
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
+ +HRDIK +N+LL E L+DFG+A L ++ T V GT ++APE
Sbjct: 124 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 181
Query: 955 SDKADVYSFGVVLLELISGKRSLDPSFSE 983
KAD++S G+ +EL G +P SE
Sbjct: 182 DSKADIWSLGITAIELARG----EPPHSE 206
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRF-QGIQQFD-AEIGTLGRIRHKNLVTLIGYY 840
IG G +G YKA+ G A+KK+ + + +GI EI L ++H N+V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
+ + LV+ L +L+ + G ++ + + +AY H R++HR
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKAD 959
D+KP N+L++ E ++DFGLAR + T +V T Y AP+ + + S D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTID 183
Query: 960 VYSFGVVLLELISGKRSLDPSFSE 983
++S G + E+++G L P SE
Sbjct: 184 IWSVGCIFAEMVNGT-PLFPGVSE 206
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRF-QGIQQFD-AEIGTLGRIRHKNLVTLIGYY 840
IG G +G YKA+ G A+KK+ + + +GI EI L ++H N+V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
+ + LV+ L +L+ + G ++ + + +AY H R++HR
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKAD 959
D+KP N+L++ E ++DFGLAR + T +V T Y AP+ + + S D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTID 183
Query: 960 VYSFGVVLLELISGKRSLDPSFSE 983
++S G + E+++G L P SE
Sbjct: 184 IWSVGCIFAEMVNGA-PLFPGVSE 206
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
++ + +G G +G A V VAVK + + R + EI + H+N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G+ +L + SGG L I G + + + + YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTC 952
I HRDIKP N+LLDE N +SDFGLA + + + + GT YVAPE
Sbjct: 124 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
++ DV+S G+VL +++G+ D PS S EY +
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 218
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
++ + +G G +G A V VAVK + + R + EI + H+N+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G+ +L + SGG L I G + + + + YLH
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTC 952
I HRDIKP N+LLDE N +SDFGLA + + + + GT YVAPE
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
++ DV+S G+VL +++G+ D PS S EY +
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
++ + +G G +G A V VAVK + + R + EI + H+N+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G+ +L + SGG L I G + + + + YLH
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTC 952
I HRDIKP N+LLDE N +SDFGLA + + + + GT YVAPE
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
++ DV+S G+VL +++G+ D PS S EY +
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As Potent
Chk1 Inhibitors
Length = 295
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
++ + +G G +G A V VAVK + + R + EI + H+N+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G+ +L + SGG L I G + + + + YLH
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTC 952
I HRDIKP N+LLDE N +SDFGLA + + + + GT YVAPE
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
++ DV+S G+VL +++G+ D PS S EY +
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
++ + +G G +G A V VAVK + + R + EI + H+N+
Sbjct: 7 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G+ +L + SGG L I G + + + + YLH
Sbjct: 67 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYATTC 952
I HRDIKP N+LLDE N +SDFGLA + + + GT YVAPE
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
++ DV+S G+VL +++G+ D PS S EY +
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
++ + +G G +G A V VAVK + + R + EI + H+N+
Sbjct: 7 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G+ +L + SGG L I G + + + + YLH
Sbjct: 67 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYATTC 952
I HRDIKP N+LLDE N +SDFGLA + + + GT YVAPE
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
++ DV+S G+VL +++G+ D PS S EY +
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 71.2 bits (173), Expect = 2e-12, Method: Composition-based stats.
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRIRHK 831
+F I +G G FG+ Y A E +++A+K L + + G++ Q EI +RH
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
N++ + Y+ ++L+ F G L + K Q S ++A AL Y H
Sbjct: 75 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA--TFMEELADALHYCHE 132
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT----DVAGTFGYVAPE 947
+++HRDIKP N+L+ + ++DFG + HA + + GT Y+ PE
Sbjct: 133 R---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLPPE 182
Query: 948 YATTCRVSDKADVYSFGVVLLELISGKRSLD-PSFSE 983
+K D++ GV+ E + G D PS +E
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 71.2 bits (173), Expect = 2e-12, Method: Composition-based stats.
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRIRHK 831
+F I +G G FG+ Y A E +++A+K L + + G++ Q EI +RH
Sbjct: 16 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
N++ + Y+ ++L+ F G L + K Q S ++A AL Y H
Sbjct: 76 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA--TFMEELADALHYCHE 133
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT----DVAGTFGYVAPE 947
+++HRDIKP N+L+ + ++DFG + HA + + GT Y+ PE
Sbjct: 134 R---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLPPE 183
Query: 948 YATTCRVSDKADVYSFGVVLLELISGKRSLD-PSFSE 983
+K D++ GV+ E + G D PS +E
Sbjct: 184 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 220
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 71.2 bits (173), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VA+KKLS FQ ++ E+ L ++H+N++ L+
Sbjct: 50 VGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHMQHENVIGLLD 108
Query: 839 YYVGEAEMFLVYNF-LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
+ + + Y+F L ++T + K G + I + + + L Y+H + V
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGV--- 165
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYATT-CR 953
VHRD+KP N+ ++E+ + DFGLAR HA ++ G T Y APE +
Sbjct: 166 VHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEVILSWMH 218
Query: 954 VSDKADVYSFGVVLLELISGK 974
+ D++S G ++ E+++GK
Sbjct: 219 YNQTVDIWSVGCIMAEMLTGK 239
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 71.2 bits (173), Expect = 3e-12, Method: Composition-based stats.
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRIRHK 831
+F I +G G FG+ Y A E +++A+K L + + G++ Q EI +RH
Sbjct: 15 DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
N++ + Y+ ++L+ F G L + K Q S ++A AL Y H
Sbjct: 75 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA--TFMEELADALHYCHE 132
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT----DVAGTFGYVAPE 947
+++HRDIKP N+L+ + ++DFG + HA + + GT Y+ PE
Sbjct: 133 R---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLPPE 182
Query: 948 YATTCRVSDKADVYSFGVVLLELISGKRSLD-PSFSE 983
+K D++ GV+ E + G D PS +E
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 71.2 bits (173), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 79/316 (25%), Positives = 129/316 (40%), Gaps = 47/316 (14%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
+ Q + F D EL +G F+I G Y A+ + + +
Sbjct: 5 FKQQKVEDFYDIGEEL-------GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R ++ + E+ L ++ H N++TL Y ++ L+ +SGG L F+ +K
Sbjct: 58 SR----EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--- 110
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
S+ + A I Q L ++Y +I H D+KP NI LLD+ + + L DFGLA
Sbjct: 111 ---SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG----------- 973
E+ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 168 --EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225
Query: 974 --------KRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS---ELFLPELWEAGPQENLLG 1022
D F + + KLL+KE R + L W P +N
Sbjct: 226 TLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW-ITPVDNQQA 284
Query: 1023 MMRLASTCTVETLSTR 1038
M+R S +E +
Sbjct: 285 MVRRESVVNLENFRKQ 300
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 71.2 bits (173), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRF-QGIQQFD-AEIGTLGRIRHKNLVTLIGYY 840
IG G +G YKA+ G A+KK+ + + +GI EI L ++H N+V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
+ + LV+ L +L+ + G ++ + + +AY H R++HR
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKAD 959
D+KP N+L++ E ++DFGLAR + T ++ T Y AP+ + + S D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTID 183
Query: 960 VYSFGVVLLELISGKRSLDPSFSE 983
++S G + E+++G L P SE
Sbjct: 184 IWSVGCIFAEMVNGT-PLFPGVSE 206
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 71.2 bits (173), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 77/315 (24%), Positives = 127/315 (40%), Gaps = 45/315 (14%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
+ Q + F D EL +G F+I G Y A+ + + +
Sbjct: 5 FKQQKVEDFYDIGEEL-------GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R ++ + E+ L ++ H N++TL Y ++ L+ +SGG L F+ +K
Sbjct: 58 SR----EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS 113
Query: 870 IQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLARL 925
+ + I Q L ++Y +I H D+KP NI LLD+ + + L DFGLA
Sbjct: 114 EEEATSF-----IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH- 167
Query: 926 LEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKR---------- 975
E+ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 168 -EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 226
Query: 976 ---------SLDPSFSEYGNGFNIVSWAKLLIKEGRSS---ELFLPELWEAGPQENLLGM 1023
D F + + KLL+KE R + L W P +N M
Sbjct: 227 LANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW-ITPVDNQQAM 285
Query: 1024 MRLASTCTVETLSTR 1038
+R S +E +
Sbjct: 286 VRRESVVNLENFRKQ 300
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 71.2 bits (173), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAE-------IGTLGR 827
NF ++G G FG A + G L AVK L +Q D E I +L R
Sbjct: 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI--LQDDDVECTMTEKRILSLAR 81
Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
H L L + +F V F++GG+L H + ++ + A +I AL
Sbjct: 82 -NHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISALM 138
Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
+LH I++RD+K N+LLD E + L+DFG+ + + T GT Y+APE
Sbjct: 139 FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPE 194
Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
D ++ GV+L E++ G
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCG 220
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 71.2 bits (173), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
++ + +G G +G A V VAVK + + R + EI + H+N+
Sbjct: 7 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G+ +L + SGG L I G + + + + YLH
Sbjct: 67 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYATTC 952
I HRDIKP N+LLDE N +SDFGLA + + + GT YVAPE
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
++ DV+S G+VL +++G+ D PS S EY +
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 71.2 bits (173), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
++ + +G G +G A V VAVK + + R + EI + H+N+
Sbjct: 7 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G+ +L + SGG L I G + + + + YLH
Sbjct: 67 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYATTC 952
I HRDIKP N+LLDE N +SDFGLA + + + GT YVAPE
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
++ DV+S G+VL +++G+ D PS S EY +
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 71.2 bits (173), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 15/210 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHK 831
GN+ + IG G F A ++ G VAVK + + +Q+ E+ + H
Sbjct: 14 GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHP 73
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYL 889
N+V L E ++LV + SGG + ++ H + +K + +I A+ Y
Sbjct: 74 NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIV----SAVQYC 129
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
H IVHRD+K N+LLD + N ++DFG + E + + G Y APE
Sbjct: 130 HQKF---IVHRDLKAENLLLDADXNIKIADFGFSN--EFTFGNKLDAFCGAPPYAAPELF 184
Query: 950 TTCRVS-DKADVYSFGVVLLELISGKRSLD 978
+ + DV+S GV+L L+SG D
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 70.9 bits (172), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
+ Q + F D EL +G F+I G Y A+ + + +
Sbjct: 5 FKQQKVEDFYDIGEEL-------GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R ++ + E+ L ++ H N++TL Y ++ L+ +SGG L F+ +K
Sbjct: 58 SR----EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--- 110
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
S+ + A I Q L ++Y +I H D+KP NI LLD+ + + L DFGLA
Sbjct: 111 ---SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
E+ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 168 --EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 70.9 bits (172), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN-----LVTL 836
+G+G G +K G+++AVK++ R G ++ + I + K+ +V
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQM---RRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
G ++ ++F+ + G + K+ I ++ K+ + I +AL YL
Sbjct: 90 FGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HG 145
Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLA-RLLEVSETHATTDVAGTFGYVAPEY-----AT 950
++HRD+KPSNILLDE L DFG++ RL+ + A AG Y+APE T
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 951 TCRVSDKADVYSFGVVLLELISGK 974
+ADV+S G+ L+EL +G+
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQ 226
>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide
Substrate Complex: Kinase Substrate Recognition
Length = 277
Score = 70.9 bits (172), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 16/161 (9%)
Query: 821 EIGTLGRIR-HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
E+ L ++ H N++ L Y FLV++ + G L ++ +K + KI
Sbjct: 60 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIM 117
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
+ + + LH IVHRD+KP NILLD+++N L+DFG + L+ E +V G
Sbjct: 118 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCG 172
Query: 940 TFGYVAPEYATTCRVSD-------KADVYSFGVVLLELISG 973
T Y+APE C ++D + D++S GV++ L++G
Sbjct: 173 TPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 70.9 bits (172), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 66/231 (28%), Positives = 101/231 (43%), Gaps = 24/231 (10%)
Query: 765 LTYDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIG 823
L YD G+ R ++G G +G Y +L +A+K++ + Q EI
Sbjct: 15 LEYDYEYDENGD---RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIA 71
Query: 824 TLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK-KIQWSVIHKIAIDI 882
++HKN+V +G + + + + GG+L + K G K I I
Sbjct: 72 LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 131
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-----LSDFGLARLLEVSETHATTDV 937
+ L YLH + +IVHRDIK N+L +N Y +SDFG ++ L T
Sbjct: 132 LEGLKYLHDN---QIVHRDIKGDNVL----INTYSGVLKISDFGTSKRL-AGINPCTETF 183
Query: 938 AGTFGYVAPEYATTCR--VSDKADVYSFGVVLLELISGKRSLDPSFSEYGN 986
GT Y+APE AD++S G ++E+ +GK P F E G
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK----PPFYELGE 230
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 70.9 bits (172), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
IG G FG ++ + P VA+K + ++F E T+ + H ++V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
G + E ++++ + G L +F+ + S+I A ++ ALAYL R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLI-LYAYQLSTALAYLESK---RF 512
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
VHRDI N+L+ L DFGL+R +E S + + ++APE R +
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 958 ADVYSFGVVLLELI 971
+DV+ FGV + E++
Sbjct: 573 SDVWMFGVCMWEIL 586
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 70.9 bits (172), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 18/199 (9%)
Query: 783 IGTGGFGSTY----KAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +G K V + ++K S+ + + E+ L + H N++ L
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE-EVAVLKLLDHPNIMKLYD 103
Query: 839 YYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
++ + +LV GG L + IH+ ++ +VI I Q L+ + Y I
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI------IKQVLSGVTYLHKHNI 157
Query: 898 VHRDIKPSNILLD-EELNAYLS--DFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
VHRD+KP N+LL+ +E +A + DFGL+ + E + GT Y+APE +
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIAPEVLRK-KY 214
Query: 955 SDKADVYSFGVVLLELISG 973
+K DV+S GV+L L++G
Sbjct: 215 DEKCDVWSIGVILFILLAG 233
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 70.9 bits (172), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
++ + +G G +G A V VAVK + + R + EI + H+N+
Sbjct: 7 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V G+ +L + SGG L I G + + + + YLH
Sbjct: 67 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYATTC 952
I HRDIKP N+LLDE N +SDFGLA + + + GT YVAPE
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLDP---SFSEYGN 986
++ DV+S G+VL +++G+ D S EY +
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSD 219
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Activator Mkk3b
Length = 360
Score = 70.9 bits (172), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G+ VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 67/216 (31%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 782 LIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGR-IRHKNLVT 835
+IG G FG Y E + A+K LS I Q ++ F E G L R + H N++
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE-GLLMRGLNHPNVLA 86
Query: 836 LIGYYVG-EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
LIG + E ++ ++ G+L FI +I + +A+ + YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI-SFGLQVARGMEYLAEQ-- 143
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE-------THATTDVAGTFGYVAPE 947
+ VHRD+ N +LDE ++DFGLAR + E HA V + A E
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK----WTALE 198
Query: 948 YATTCRVSDKADVYSFGVVLLELISGK----RSLDP 979
T R + K+DV+SFGV+L EL++ R +DP
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 70.5 bits (171), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G+ VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 40 VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 98
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 99 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 152
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 153 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 202
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 203 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 234
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 70.5 bits (171), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 22/228 (9%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
+ Q + F D EL +G F+I G Y A+ + + +
Sbjct: 5 FKQQKVEDFYDIGEEL-------GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R ++ + E+ L ++ H N++TL Y ++ L+ +SGG L F+ +K
Sbjct: 58 SR----EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS 113
Query: 870 IQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLARL 925
+ + I Q L ++Y +I H D+KP NI LLD+ + + L DFGLA
Sbjct: 114 EEEATSF-----IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH- 167
Query: 926 LEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
E+ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 168 -EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 70.5 bits (171), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G+ VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 49 VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 107
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 108 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 163
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 164 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 213
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 243
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk
Docking Partner
Length = 380
Score = 70.5 bits (171), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G+ VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 50 VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 109 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 165 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 214
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 244
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 70.5 bits (171), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G+ VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 50 VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 109 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 165 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGXVATRWYRAPEIM 214
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 244
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 70.5 bits (171), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G+ VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 36 VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 95 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 151 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 200
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 230
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 70.5 bits (171), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
IG G FG ++ + P VA+K + ++F E T+ + H ++V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
G + E ++++ + G L +F+ + S+I A ++ ALAYL R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLI-LYAYQLSTALAYLESK---RF 512
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
VHRDI N+L+ L DFGL+R +E S + + ++APE R +
Sbjct: 513 VHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 958 ADVYSFGVVLLELI 971
+DV+ FGV + E++
Sbjct: 573 SDVWMFGVCMWEIL 586
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 70.5 bits (171), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 781 NLIGTGGFGSTYKAEL----VPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVT 835
+L+ T G G+ + +L V VAVK + + R + EI + H+N+V
Sbjct: 9 DLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
G+ +L + SGG L I G + + + + YLH
Sbjct: 69 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG-- 124
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYATTCRV 954
I HRDIKP N+LLDE N +SDFGLA + + + GT YVAPE
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 955 -SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
++ DV+S G+VL +++G+ D PS S EY +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219
>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase,
Kinase: An Active Protein Kinase Complexed With
Nucleotide, Substrate-Analogue And Product
Length = 298
Score = 70.5 bits (171), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 16/161 (9%)
Query: 821 EIGTLGRIR-HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
E+ L ++ H N++ L Y FLV++ + G L ++ +K + KI
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIM 130
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
+ + + LH IVHRD+KP NILLD+++N L+DFG + L+ E +V G
Sbjct: 131 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCG 185
Query: 940 TFGYVAPEYATTCRVSD-------KADVYSFGVVLLELISG 973
T Y+APE C ++D + D++S GV++ L++G
Sbjct: 186 TPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 70.5 bits (171), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G+ VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 85 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 141 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 190
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 220
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 70.1 bits (170), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQF-DAEIGTLGRIRHKNLV 834
F+ IG G FG +K + +VA+K + + + + EI L + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
G Y+ + +++++ +L GG+ + + Q + I + +I + L YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLDYLHSE-- 138
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
+ +HRDIK +N+LL E L+DFG+A L ++ V GT ++APE
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAY 196
Query: 955 SDKADVYSFGVVLLELISGKRSLDPSFSE 983
KAD++S G+ +EL G +P SE
Sbjct: 197 DSKADIWSLGITAIELARG----EPPHSE 221
>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|B Chain B, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|C Chain C, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|D Chain D, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|E Chain E, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|F Chain F, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|G Chain G, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|H Chain H, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
Length = 288
Score = 70.1 bits (170), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
+ Q + F D EL +G F+I G Y A+ + + +
Sbjct: 5 FKQQKVEDFYDIGEEL-------GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R ++ + E+ L ++ H N++TL Y ++ L+ +SGG L F+ +K
Sbjct: 58 SR----EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--- 110
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
S+ + A I Q L ++Y +I H D+KP NI LLD+ + + L DFGLA
Sbjct: 111 ---SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
E+ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 168 --EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 69.7 bits (169), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YA-TTCRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 IMLNAMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 69.7 bits (169), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
IG+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 35 IGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 94 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 147
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 148 SA---DIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 197
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 229
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 69.7 bits (169), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 96 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 149
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVATRWYRAPE 199
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 231
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 69.7 bits (169), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 66/231 (28%), Positives = 101/231 (43%), Gaps = 24/231 (10%)
Query: 765 LTYDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIG 823
L YD G+ R ++G G +G Y +L +A+K++ + Q EI
Sbjct: 1 LEYDYEYDENGD---RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIA 57
Query: 824 TLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK-KIQWSVIHKIAIDI 882
++HKN+V +G + + + + GG+L + K G K I I
Sbjct: 58 LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 117
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-----LSDFGLARLLEVSETHATTDV 937
+ L YLH + +IVHRDIK N+L +N Y +SDFG ++ L T
Sbjct: 118 LEGLKYLHDN---QIVHRDIKGDNVL----INTYSGVLKISDFGTSKRL-AGINPCTETF 169
Query: 938 AGTFGYVAPEYATTCR--VSDKADVYSFGVVLLELISGKRSLDPSFSEYGN 986
GT Y+APE AD++S G ++E+ +GK P F E G
Sbjct: 170 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK----PPFYELGE 216
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 69.7 bits (169), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 96 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 149
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVATRWYRAPE 199
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 231
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 69.7 bits (169), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 13/209 (6%)
Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQF-DAEIGTLGRIRHKNLV 834
F+ IG G FG +K + +VA+K + + + + EI L + +
Sbjct: 9 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
G Y+ + +++++ +L GG+ + + Q I I +I + L YLH
Sbjct: 69 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ---IATILREILKGLDYLHSE-- 123
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
+ +HRDIK +N+LL E L+DFG+A L ++ V GT ++APE
Sbjct: 124 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAY 181
Query: 955 SDKADVYSFGVVLLELISGKRSLDPSFSE 983
KAD++S G+ +EL G +P SE
Sbjct: 182 DSKADIWSLGITAIELARG----EPPHSE 206
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 69.7 bits (169), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KXQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 145 ---DIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 194
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 69.7 bits (169), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 69.7 bits (169), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGXVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 69.7 bits (169), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 783 IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE + P + VAVK L S + + +E+ + I +HKN
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
++ L+G + ++++ + S GNL ++ + +++S +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
A +A+ + YL + +HRD+ N+L+ E+ ++DFGLAR + + TT+
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + ++DV+SFGV+L E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a)
Activating Mutant
Length = 367
Score = 69.7 bits (169), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 96 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 149
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVATRWYRAPE 199
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 231
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 69.7 bits (169), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLS-KPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 101 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 157 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 206
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 236
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A
1-O-Tolyl-1,2, 3-Triazole-4-Carboxamide
Length = 348
Score = 69.7 bits (169), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G+ VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIH--KKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 85 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCAKLTDDHVQFLIYQ-----ILRGLKYIH 138
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 139 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 188
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 220
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 69.7 bits (169), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 69.7 bits (169), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 32/221 (14%)
Query: 769 NVVRATGNFSIRNLIGTGGFGSTY---KAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
N+ +FS+ +IG GGFG Y KA+ G + A+K L R + Q G
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADT--GKMYAMKCLDKKRIKMKQ------GET 234
Query: 826 GRIRHKNLVTLIG-----YYVGEAEMF-------LVYNFLSGGNLETFIHKKSGKKIQWS 873
+ + +++L+ + V + F + + ++GG+L H +
Sbjct: 235 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEA 292
Query: 874 VIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA 933
+ A +I L ++H V V+RD+KP+NILLDE + +SD GLA + HA
Sbjct: 293 DMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 349
Query: 934 TTDVAGTFGYVAPEYATTCRVSD-KADVYSFGVVLLELISG 973
+ GT GY+APE D AD +S G +L +L+ G
Sbjct: 350 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 69.7 bits (169), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 32/221 (14%)
Query: 769 NVVRATGNFSIRNLIGTGGFGSTY---KAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
N+ +FS+ +IG GGFG Y KA+ G + A+K L R + Q G
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADT--GKMYAMKCLDKKRIKMKQ------GET 234
Query: 826 GRIRHKNLVTLIG-----YYVGEAEMF-------LVYNFLSGGNLETFIHKKSGKKIQWS 873
+ + +++L+ + V + F + + ++GG+L H +
Sbjct: 235 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEA 292
Query: 874 VIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA 933
+ A +I L ++H V V+RD+KP+NILLDE + +SD GLA + HA
Sbjct: 293 DMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 349
Query: 934 TTDVAGTFGYVAPEYATTCRVSD-KADVYSFGVVLLELISG 973
+ GT GY+APE D AD +S G +L +L+ G
Sbjct: 350 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 69.7 bits (169), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 69.3 bits (168), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 783 IGTGGFGSTYKAEL---VPG---YLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNLV 834
+G FG YK L PG VA+K L + +G ++F E R++H N+V
Sbjct: 34 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFI-----HKKSGKKIQWSVIHKIAID-------I 882
L+G + + +++++ S G+L F+ H G + K A++ +
Sbjct: 93 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV-KSALEPPDFVHLV 151
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTF 941
AQ A + Y +VH+D+ N+L+ ++LN +SD GL R + ++ + +
Sbjct: 152 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 211
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + S +D++S+GVVL E+ S
Sbjct: 212 RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 69.3 bits (168), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 31/226 (13%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQF 818
D P E++Y + +IG G FG Y+A+L G LVA+KK+ QG
Sbjct: 15 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFK 60
Query: 819 DAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQW 872
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 61 NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLP 120
Query: 873 SVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSE 930
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L E
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 931 THATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
+ + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 178 PNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220
>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By
Mutational Studies
Length = 298
Score = 69.3 bits (168), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 50/161 (31%), Positives = 82/161 (50%), Gaps = 16/161 (9%)
Query: 821 EIGTLGRIR-HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
E+ L ++ H N++ L Y FLV++ + G L ++ +K + KI
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIM 130
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
+ + + LH IVHRD+KP NILLD+++N L+DFG + L+ E V G
Sbjct: 131 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLRSVCG 185
Query: 940 TFGYVAPEYATTCRVSD-------KADVYSFGVVLLELISG 973
T Y+APE C ++D + D++S GV++ L++G
Sbjct: 186 TPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 53 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 111
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 112 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 167
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 168 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 217
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 247
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydropyrido- Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A Selective
Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen Activated
Protein Kinase P38 (P38 Map Kinase) The Mammalian
Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With 2-Amino-Phenylamino-
Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 95 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 151 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 200
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 230
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map
Kinase
Length = 360
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
Length = 360
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KXQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 194
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 50 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 109 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 165 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 214
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 244
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 96 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 149
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 199
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 231
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A
Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE
COMPLEX IN Solution
Length = 359
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 94 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 147
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 148 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 197
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 229
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 32/221 (14%)
Query: 769 NVVRATGNFSIRNLIGTGGFGSTY---KAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
N+ +FS+ +IG GGFG Y KA+ G + A+K L R + Q G
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADT--GKMYAMKCLDKKRIKMKQ------GET 234
Query: 826 GRIRHKNLVTLIG-----YYVGEAEMF-------LVYNFLSGGNLETFIHKKSGKKIQWS 873
+ + +++L+ + V + F + + ++GG+L H +
Sbjct: 235 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEA 292
Query: 874 VIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA 933
+ A +I L ++H V V+RD+KP+NILLDE + +SD GLA + HA
Sbjct: 293 DMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 349
Query: 934 TTDVAGTFGYVAPEYATTCRVSD-KADVYSFGVVLLELISG 973
+ GT GY+APE D AD +S G +L +L+ G
Sbjct: 350 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 94 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 147
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 148 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 197
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 229
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 29 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 87
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 88 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 141
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 142 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 191
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 192 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 223
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino
Quinoline Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 94 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 147
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 148 SA---DIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 197
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 229
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 91 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 144
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 145 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 194
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 226
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 32/221 (14%)
Query: 769 NVVRATGNFSIRNLIGTGGFGSTY---KAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
N+ +FS+ +IG GGFG Y KA+ G + A+K L R + Q G
Sbjct: 182 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADT--GKMYAMKCLDKKRIKMKQ------GET 233
Query: 826 GRIRHKNLVTLIG-----YYVGEAEMF-------LVYNFLSGGNLETFIHKKSGKKIQWS 873
+ + +++L+ + V + F + + ++GG+L H +
Sbjct: 234 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEA 291
Query: 874 VIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA 933
+ A +I L ++H V V+RD+KP+NILLDE + +SD GLA + HA
Sbjct: 292 DMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 348
Query: 934 TTDVAGTFGYVAPEYATTCRVSD-KADVYSFGVVLLELISG 973
+ GT GY+APE D AD +S G +L +L+ G
Sbjct: 349 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 27 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 85
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 86 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 139
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 140 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 189
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 221
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 101 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 157 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 206
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 236
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-Pyrido[2,
3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl- Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 101 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 157 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 206
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 236
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 782 LIGTGGFGSTYKAELVP-----GYLVAVKKL--SIGRFQGIQQFDAEIGTLGRIRHKNLV 834
++G+G FG+ YK VP VA+K L + G ++ D E + + H +LV
Sbjct: 45 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD-EALIMASMDHPHLV 103
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+G + + LV + G L ++H+ I ++ + IA+ + YL
Sbjct: 104 RLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER-- 159
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-FGYVAPEYATTCR 953
R+VHRD+ N+L+ + ++DFGLARLLE E D ++A E +
Sbjct: 160 -RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 218
Query: 954 VSDKADVYSFGVVLLELIS 972
+ ++DV+S+GV + EL++
Sbjct: 219 FTHQSDVWSYGVTIWELMT 237
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 782 LIGTGGFGSTYKAELVP-----GYLVAVKKL--SIGRFQGIQQFDAEIGTLGRIRHKNLV 834
++G+G FG+ YK VP VA+K L + G ++ D E + + H +LV
Sbjct: 22 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD-EALIMASMDHPHLV 80
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+G + + LV + G L ++H+ I ++ + IA+ + YL
Sbjct: 81 RLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER-- 136
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-FGYVAPEYATTCR 953
R+VHRD+ N+L+ + ++DFGLARLLE E D ++A E +
Sbjct: 137 -RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 195
Query: 954 VSDKADVYSFGVVLLELIS 972
+ ++DV+S+GV + EL++
Sbjct: 196 FTHQSDVWSYGVTIWELMT 214
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole Based
Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine
Based Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine Based
Inhibitor
Length = 366
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 95 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 151 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 200
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 230
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 41 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 99
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 100 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 153
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 154 SA---DIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 203
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 235
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Pyrrole-2- Carboxamide Inhibitor
Length = 371
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 41 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 99
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 100 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 155
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 156 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 205
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 235
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 91 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 144
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 145 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 194
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 226
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three Clinical
P38alpha Inhibitors
Length = 362
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 91 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 147 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 196
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 226
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide
Substituted Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 53 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 111
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 112 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 165
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 166 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGYVATRWYRAPE 215
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 247
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 779 IRNLIGTGGFGSTYKAELVP-----GYLVAVKKL---SIGRFQGIQQFDAEIGTLGRIRH 830
IR+L G G FG P G VAVK L S G I EI L + H
Sbjct: 14 IRDL-GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYH 70
Query: 831 KNLVTLIGYYV--GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
+N+V G G + L+ FL G+L+ ++ K+ KI K A+ I + + Y
Sbjct: 71 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDY 129
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT--DVAGTFGYVAP 946
L + VHRD+ N+L++ E + DFGL + +E + T D + AP
Sbjct: 130 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 186
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS 972
E + +DV+SFGV L EL++
Sbjct: 187 ECLMQSKFYIASDVWSFGVTLHELLT 212
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 49 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 107
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 108 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 163
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 164 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 213
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 243
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 15/217 (6%)
Query: 768 DNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG-----IQQFDAE 821
D+ V + + +IG G F + G AVK + + +F + E
Sbjct: 17 DDDVLFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKRE 76
Query: 822 IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS--VIHKIA 879
++H ++V L+ Y + +++V+ F+ G +L I K++ +S V
Sbjct: 77 ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 136
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTD 936
I +AL Y H + I+HRD+KP N+LL + N+ L DFG+A L S A
Sbjct: 137 RQILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR 193
Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
V GT ++APE DV+ GV+L L+SG
Sbjct: 194 V-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 85 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 138
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 139 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 188
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 220
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 28 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 86
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 87 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 142
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 143 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 192
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 222
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 783 IGTGGFGSTYKAEL---VPG---YLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNLV 834
+G FG YK L PG VA+K L + +G ++F E R++H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFI-----HKKSGKKIQWSVIHKIAID-------I 882
L+G + + +++++ S G+L F+ H G + K A++ +
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV-KSALEPPDFVHLV 134
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTF 941
AQ A + Y +VH+D+ N+L+ ++LN +SD GL R + ++ + +
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 194
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + S +D++S+GVVL E+ S
Sbjct: 195 RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQ---FDAEIGTLGRIRHKNLVTLIG 838
+G G +G K VP G ++AVK++ Q+ D +I ++ + VT G
Sbjct: 59 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI-SMRTVDCPFTVTFYG 117
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
E ++++ + +L+ F + G+ I ++ KIA+ I +AL +LH
Sbjct: 118 ALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--S 174
Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA----TTC 952
++HRD+KPSN+L++ + DFG++ L V T D AG Y+APE
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYL-VDSVAKTID-AGCKPYMAPERINPELNQK 232
Query: 953 RVSDKADVYSFGVVLLEL 970
S K+D++S G+ ++EL
Sbjct: 233 GYSVKSDIWSLGITMIEL 250
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
Length = 349
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 27 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 85
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 86 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 139
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 140 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 189
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 221
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 779 IRNLIGTGGFGSTYKAELVP-----GYLVAVKKL---SIGRFQGIQQFDAEIGTLGRIRH 830
IR+L G G FG P G VAVK L S G I EI L + H
Sbjct: 26 IRDL-GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYH 82
Query: 831 KNLVTLIGYYV--GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
+N+V G G + L+ FL G+L+ ++ K+ KI K A+ I + + Y
Sbjct: 83 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDY 141
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT--DVAGTFGYVAP 946
L + VHRD+ N+L++ E + DFGL + +E + T D + AP
Sbjct: 142 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 198
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS 972
E + +DV+SFGV L EL++
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And Potentiation
Of Cytotoxic Drugs By Novel Chk2 Inhibitor Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 27/221 (12%)
Query: 801 LVAVKKLSIGRFQGIQ---QFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGN 857
+++ +K +IG + + EI L ++ H ++ + ++ E + ++V + GG
Sbjct: 42 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGE 100
Query: 858 LETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELN 914
L F K+++ + + A+ YLH + I+HRD+KP N+LL +E+
Sbjct: 101 L--FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL 155
Query: 915 AYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELI 971
++DFG +++L ET + GT Y+APE T + D +S GV+L +
Sbjct: 156 IKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213
Query: 972 SGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012
SG P FSE+ ++ K I G+ + F+PE+W
Sbjct: 214 SGY----PPFSEHRTQVSL----KDQITSGKYN--FIPEVW 244
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 68.9 bits (167), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
D P E++Y + +IG G FG Y+A+L G LVA+KK L RF+
Sbjct: 49 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 94
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 95 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 153
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
E + + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 211 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 254
>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1531
Length = 322
Score = 68.9 bits (167), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 27/221 (12%)
Query: 801 LVAVKKLSIGRFQGIQ---QFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGN 857
+++ +K +IG + + EI L ++ H ++ + ++ E + ++V + GG
Sbjct: 42 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGE 100
Query: 858 LETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELN 914
L F K+++ + + A+ YLH + I+HRD+KP N+LL +E+
Sbjct: 101 L--FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL 155
Query: 915 AYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELI 971
++DFG +++L ET + GT Y+APE T + D +S GV+L +
Sbjct: 156 IKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213
Query: 972 SGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012
SG P FSE+ ++ K I G+ + F+PE+W
Sbjct: 214 SGY----PPFSEHRTQVSL----KDQITSGKYN--FIPEVW 244
>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp
pdb|2CN8|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Debromohymenialdisine
pdb|2WTC|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTD|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTI|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XBJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XM8|A Chain A, Co-Crystal Structure Of A Small Molecule Inhibitor Bound To
The Kinase Domain Of Chk2
pdb|2XM9|A Chain A, Structure Of A Small Molecule Inhibitor With The Kinase
Domain Of Chk2
pdb|4A9R|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9S|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9T|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9U|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
Length = 329
Score = 68.9 bits (167), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 27/221 (12%)
Query: 801 LVAVKKLSIGRFQGIQ---QFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGN 857
+++ +K +IG + + EI L ++ H ++ + ++ E + ++V + GG
Sbjct: 48 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGE 106
Query: 858 LETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELN 914
L F K+++ + + A+ YLH + I+HRD+KP N+LL +E+
Sbjct: 107 L--FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL 161
Query: 915 AYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELI 971
++DFG +++L ET + GT Y+APE T + D +S GV+L +
Sbjct: 162 IKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 219
Query: 972 SGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012
SG P FSE+ ++ K I G+ + F+PE+W
Sbjct: 220 SGY----PPFSEHRTQVSL----KDQITSGKYN--FIPEVW 250
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 68.9 bits (167), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPGYLV--AVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
+++ N IG G +G K + G + A KK+ + + +F EI + + H N++
Sbjct: 11 YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
L + +++LV +GG L E +HK+ ++ S +I D+ A+AY H
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE---SDAARIMKDVLSAVAYCHKLN 126
Query: 894 VPRIVHRDIKPSNILL-----DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE- 947
V HRD+KP N L D L L DFGLA + + T GT YV+P+
Sbjct: 127 V---AHRDLKPENFLFLTDSPDSPLK--LIDFGLAARFKPGKMMRTK--VGTPYYVSPQV 179
Query: 948 ----YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
Y C D +S GV++ L+ G P FS
Sbjct: 180 LEGLYGPEC------DEWSAGVMMYVLLCGY----PPFS 208
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 95 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 148
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 149 SA---DIIHRDLKPSNLAVNEDSELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 198
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 230
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPGYLV--AVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
+++ N IG G +G K + G + A KK+ + + +F EI + + H N++
Sbjct: 28 YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
L + +++LV +GG L E +HK+ ++ S +I D+ A+AY H
Sbjct: 87 RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE---SDAARIMKDVLSAVAYCHKLN 143
Query: 894 VPRIVHRDIKPSNILL-----DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE- 947
V HRD+KP N L D L L DFGLA + + T GT YV+P+
Sbjct: 144 V---AHRDLKPENFLFLTDSPDSPLK--LIDFGLAARFKPGKMMRTK--VGTPYYVSPQV 196
Query: 948 ----YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
Y C D +S GV++ L+ G P FS
Sbjct: 197 LEGLYGPEC------DEWSAGVMMYVLLCGY----PPFS 225
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIG-TLGRIR---- 829
+F + ++G G FG + AE A+K L + + D ++ T+ R
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK----KDVVLMDDDVECTMVEKRVLSL 73
Query: 830 ---HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
H L + + + +F V +L+GG+L H +S K S A +I L
Sbjct: 74 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGL 131
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
+LH IV+RD+K NILLD++ + ++DFG+ + + + T GT Y+AP
Sbjct: 132 QFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNXFCGTPDYIAP 187
Query: 947 EYATTCRVSDKADVYSFGVVLLELISGK 974
E + + D +SFGV+L E++ G+
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv976
Length = 323
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 27/221 (12%)
Query: 801 LVAVKKLSIGRFQGIQ---QFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGN 857
+++ +K +IG + + EI L ++ H ++ + ++ E + ++V + GG
Sbjct: 42 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGE 100
Query: 858 LETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELN 914
L F K+++ + + A+ YLH + I+HRD+KP N+LL +E+
Sbjct: 101 L--FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL 155
Query: 915 AYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELI 971
++DFG +++L ET + GT Y+APE T + D +S GV+L +
Sbjct: 156 IKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213
Query: 972 SGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012
SG P FSE+ ++ K I G+ + F+PE+W
Sbjct: 214 SGY----PPFSEHRTQVSL----KDQITSGKYN--FIPEVW 244
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex
With Inhibitor Pv1533
Length = 322
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 27/221 (12%)
Query: 801 LVAVKKLSIGRFQGIQ---QFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGN 857
+++ +K +IG + + EI L ++ H ++ + ++ E + ++V + GG
Sbjct: 41 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGE 99
Query: 858 LETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELN 914
L F K+++ + + A+ YLH + I+HRD+KP N+LL +E+
Sbjct: 100 L--FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL 154
Query: 915 AYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELI 971
++DFG +++L ET + GT Y+APE T + D +S GV+L +
Sbjct: 155 IKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 212
Query: 972 SGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012
SG P FSE+ ++ K I G+ + F+PE+W
Sbjct: 213 SGY----PPFSEHRTQVSL----KDQITSGKYN--FIPEVW 243
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 783 IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE + P + VAVK L S + + +E+ + I +HKN
Sbjct: 25 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
++ L+G + ++++ + S GNL ++ + +++S +
Sbjct: 85 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
A +A+ + YL + +HRD+ N+L+ E+ ++DFGLAR + + TT+
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + ++DV+SFGV+L E+ +
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 783 IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE + P + VAVK L S + + +E+ + I +HKN
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
++ L+G + ++++ + S GNL ++ + +++S +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
A +A+ + YL + +HRD+ N+L+ E+ ++DFGLAR + + TT+
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + ++DV+SFGV+L E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|B Chain B, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|C Chain C, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALO|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Ternary Complex With Amp-Pnp And P38 Peptide
pdb|3VUT|A Chain A, Crystal Structures Of Non-Phosphorylated Map2k4
pdb|3VUT|B Chain B, Crystal Structures Of Non-Phosphorylated Map2k4
Length = 327
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKL-SIGRFQGIQQFDAEIGTLGRIRH-KNLVTLIGY 839
IG G +GS K P G ++AVK++ S + +Q ++ + R +V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 840 YVGEAEMFLVYNFLSGG--NLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
E + ++ +S +++ I ++ KI + +AL +L + +I
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KI 147
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY----ATTCR 953
+HRDIKPSNILLD N L DFG++ ++ ++ A T AG Y+APE A+
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 954 VSDKADVYSFGVVLLELISGK 974
++DV+S G+ L EL +G+
Sbjct: 206 YDVRSDVWSLGITLYELATGR 226
>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6U|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 419
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 74/291 (25%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 751 RGQVMVTFADTPAELT-YDNVVRATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVA 803
R +V V F T + + Y +R + + +G+G G A + V +++
Sbjct: 112 RNKVFVFFDLTVDDQSVYPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS 169
Query: 804 VKKLSIGRFQGIQ---QFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLET 860
+K +IG + + EI L ++ H ++ + ++ E + ++V + GG L
Sbjct: 170 KRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGEL-- 226
Query: 861 FIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELNAYL 917
F K+++ + + A+ YLH + I+HRD+KP N+LL +E+ +
Sbjct: 227 FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283
Query: 918 SDFGLARLLEVSETHATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELISGK 974
+DFG +++L ET + GT Y+APE T + D +S GV+L +SG
Sbjct: 284 TDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 341
Query: 975 RSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMR 1025
P FSE+ ++ K I G+ + F+PE+W A E L +++
Sbjct: 342 ----PPFSEHRTQVSL----KDQITSGKYN--FIPEVW-AEVSEKALDLVK 381
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 33/229 (14%)
Query: 771 VRATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR 829
+R +F ++G G FG KA + A+KK+ + + +E+ L +
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLN 60
Query: 830 HKNLVTLIGYYV-------------GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH 876
H+ +V ++ ++ +F+ + G L IH ++ + Q
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ-QRDEYW 119
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS------- 929
++ I +AL+Y+H I+HRD+KP NI +DE N + DFGLA+ + S
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 930 ------ETHATTDVAGTFGYVAPEYAT-TCRVSDKADVYSFGVVLLELI 971
+ T GT YVA E T ++K D+YS G++ E+I
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTLIGY 839
IG G +G +K G +VA+KK + + A EI L +++H NLV L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDIAQALAYLH-YSCVPR 896
+ + + LV+ + T +H+ + + + ++ I QA+ + H ++C+
Sbjct: 71 FRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCI-- 124
Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVS 955
HRD+KP NIL+ + L DFG ARLL + +VA T Y +PE +
Sbjct: 125 --HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQYG 181
Query: 956 DKADVYSFGVVLLELISG 973
DV++ G V EL+SG
Sbjct: 182 PPVDVWAIGCVFAELLSG 199
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 783 IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE + P + VAVK L S + + +E+ + I +HKN
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
++ L+G + ++++ + S GNL ++ + +++S +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
A +A+ + YL + +HRD+ N+L+ E+ ++DFGLAR + + TT+
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + ++DV+SFGV+L E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma
pdb|1CM8|B Chain B, Phosphorylated Map Kinase P38-Gamma
Length = 367
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 29/206 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +G+ A + G VA+KKL FQ ++ E+ L +RH+N++ L+
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 91
Query: 839 YYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ + + +LV F+ + H+K G+ +I + Q L L Y
Sbjct: 92 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED-------RIQFLVYQMLKGLRYI 144
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KP N+ ++E+ + DFGLAR A +++ G T Y APE
Sbjct: 145 HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QADSEMXGXVVTRWYRAPEVI 197
Query: 950 TT-CRVSDKADVYSFGVVLLELISGK 974
R + D++S G ++ E+I+GK
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK 223
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 783 IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE + P + VAVK L S + + +E+ + I +HKN
Sbjct: 29 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
++ L+G + ++++ + S GNL ++ + +++S +
Sbjct: 89 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
A +A+ + YL + +HRD+ N+L+ E+ ++DFGLAR + + TT+
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + ++DV+SFGV+L E+ +
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk
Docking Peptide
Length = 362
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 91 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 144
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 145 SA---DIIHRDLKPSNLAVNEDSELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 194
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 226
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
Length = 382
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + V VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 51 IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K +++ I I + L Y+H + V +H
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANV---LH 167
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+L++ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 168 RDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTK 227
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 228 SIDIWSVGCILAEMLSNRPIFPGKHYLD 255
>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|C Chain C, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|D Chain D, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|E Chain E, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|F Chain F, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|G Chain G, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|H Chain H, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 443
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 74/291 (25%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 751 RGQVMVTFADTPAELT-YDNVVRATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVA 803
R +V V F T + + Y +R + + +G+G G A + V +++
Sbjct: 126 RNKVFVFFDLTVDDQSVYPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS 183
Query: 804 VKKLSIGRFQGIQ---QFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLET 860
+K +IG + + EI L ++ H ++ + ++ E + ++V + GG L
Sbjct: 184 KRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGEL-- 240
Query: 861 FIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELNAYL 917
F K+++ + + A+ YLH + I+HRD+KP N+LL +E+ +
Sbjct: 241 FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 297
Query: 918 SDFGLARLLEVSETHATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELISGK 974
+DFG +++L ET + GT Y+APE T + D +S GV+L +SG
Sbjct: 298 TDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 355
Query: 975 RSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMR 1025
P FSE+ ++ K I G+ + F+PE+W A E L +++
Sbjct: 356 ----PPFSEHRTQVSL----KDQITSGKYN--FIPEVW-AEVSEKALDLVK 395
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 783 IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE + P + VAVK L S + + +E+ + I +HKN
Sbjct: 28 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
++ L+G + ++++ + S GNL ++ + +++S +
Sbjct: 88 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
A +A+ + YL + +HRD+ N+L+ E+ ++DFGLAR + + TT+
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + ++DV+SFGV+L E+ +
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 783 IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE + P + VAVK L S + + +E+ + I +HKN
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
++ L+G + ++++ + S GNL ++ + +++S +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
A +A+ + YL + +HRD+ N+L+ E+ ++DFGLAR + + TT+
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + ++DV+SFGV+L E+ +
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
D P E++Y + +IG G FG Y+A+L G LVA+KK L RF+
Sbjct: 27 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 72
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 73 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 131
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L
Sbjct: 132 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 188
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
E + + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 189 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 232
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
D P E++Y + +IG G FG Y+A+L G LVA+KK L RF+
Sbjct: 16 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 61
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 62 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 120
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L
Sbjct: 121 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 177
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
E + + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 178 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 221
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
D P E++Y + +IG G FG Y+A+L G LVA+KK L RF+
Sbjct: 51 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 96
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 97 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 155
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L
Sbjct: 156 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 212
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
E + + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 213 EPNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 256
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
D P E++Y + +IG G FG Y+A+L G LVA+KK L RF+
Sbjct: 27 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 72
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 73 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 131
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L
Sbjct: 132 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 188
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
E + + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 189 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 232
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
D P E++Y + +IG G FG Y+A+L G LVA+KK L RF+
Sbjct: 34 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 79
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 80 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 138
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L
Sbjct: 139 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 195
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
E + + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 196 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 239
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
D P E++Y + +IG G FG Y+A+L G LVA+KK L RF+
Sbjct: 53 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 98
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 99 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 157
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L
Sbjct: 158 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 214
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
E + + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 215 EPNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 258
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
D P E++Y + +IG G FG Y+A+L G LVA+KK L RF+
Sbjct: 94 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 139
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 140 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 198
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L
Sbjct: 199 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 255
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
E + + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 256 EPNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 299
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
D P E++Y + +IG G FG Y+A+L G LVA+KK L RF+
Sbjct: 15 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 60
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 61 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
E + + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 177 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
D P E++Y + +IG G FG Y+A+L G LVA+KK L RF+
Sbjct: 23 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 68
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 69 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 127
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L
Sbjct: 128 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 184
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
E + + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 185 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 228
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + D+GLAR H ++ G T Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDYGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
D P E++Y + +IG G FG Y+A+L G LVA+KK L RF+
Sbjct: 49 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 94
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 95 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 153
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
E + + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 211 EPNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 254
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 783 IGTGGFGST---YKAELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTL 836
+G+G +GS Y A L VAVKKLS FQ + ++ E+ L ++H+N++ L
Sbjct: 36 VGSGAYGSVCSAYDARLRQK--VAVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAY 888
+ + +E++LV + G +L + + S + +Q+ V + + L Y
Sbjct: 93 LDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKSQALSDEHVQFLVYQ-----LLRGLKY 146
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
+H + I+HRD+KPSN+ ++E+ + DFGLAR T T Y APE
Sbjct: 147 IHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGYVATRWYRAPEI 199
Query: 949 ATT-CRVSDKADVYSFGVVLLELISGK 974
+ D++S G ++ EL+ GK
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 68.2 bits (165), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
D P E++Y + +IG G FG Y+A+L G LVA+KK L RF+
Sbjct: 15 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 60
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 61 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
E + + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 177 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 68.2 bits (165), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
D P E++Y + +IG G FG Y+A+L G LVA+KK L RF+
Sbjct: 15 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 60
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 61 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
E + + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 177 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 68.2 bits (165), Expect = 3e-11, Method: Composition-based stats.
Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
+G G +G A V VAVK + + R + EI + H+N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
+L + SGG L I G + + + + YLH I HR
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHR 129
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRV-SDKA 958
DIKP N+LLDE N +SDFGLA + + + + GT YVAPE ++
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 959 DVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
DV+S G+VL +++G+ D PS S EY +
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 68.2 bits (165), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
D P E++Y + +IG G FG Y+A+L G LVA+KK L RF+
Sbjct: 43 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 88
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 89 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 147
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L
Sbjct: 148 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 204
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
E + + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 205 EPNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 248
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 68.2 bits (165), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 776 NFSIRNLIGTGGFGSTYKAE---LVP---GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR 829
N ++ +G G FG + AE L P LVAVK L + F E L ++
Sbjct: 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 73
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKI------------QWSVIHK 877
H+++V G V + +V+ ++ G+L F+ + Q ++H
Sbjct: 74 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH- 132
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV 937
IA IA + YL VHRD+ N L+ E L + DFG++R + ++ + V
Sbjct: 133 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR---V 186
Query: 938 AG----TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
G ++ PE + + ++DV+S GVVL E+ + GK+
Sbjct: 187 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 229
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
D P E++Y + +IG G FG Y+A+L G LVA+KK L RF+
Sbjct: 19 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 64
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 65 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 123
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L
Sbjct: 124 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 180
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
E + + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 181 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 224
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 31/226 (13%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQF 818
D P E++Y + +IG G FG Y+A+L G LVA+KK+ QG
Sbjct: 15 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFK 60
Query: 819 DAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQW 872
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 61 NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP 120
Query: 873 SVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSE 930
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L E
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 931 THATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
+ + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 178 PNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 31/226 (13%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQF 818
D P E++Y + +IG G FG Y+A+L G LVA+KK+ QG
Sbjct: 15 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFK 60
Query: 819 DAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQW 872
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 61 NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP 120
Query: 873 SVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSE 930
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L E
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 931 THATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
+ + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 178 PNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLV----TL 836
IG G +G A + V VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 51 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
+ + + + L G +L + K Q I + Q L L Y
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLL------KTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRV 954
++HRD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE +
Sbjct: 165 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 955 SDKA-DVYSFGVVLLELIS------GKRSLD 978
K+ D++S G +L E++S GK LD
Sbjct: 225 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 255
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 45/150 (30%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
H LV L + E+ +F V +++GG+L H + +K+ + +I+ AL YL
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL-LEVSETHATTDVAGTFGYVAPEY 948
H I++RD+K N+LLD E + L+D+G+ + L +T T+ GT Y+APE
Sbjct: 170 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEI 224
Query: 949 ATTCRVSDKADVYSFGVVLLELISGKRSLD 978
D ++ GV++ E+++G+ D
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
D P E++Y + +IG G FG Y+A+L G LVA+KK L RF+
Sbjct: 20 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 65
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 66 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 124
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L
Sbjct: 125 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 181
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
E + + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 182 EPNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 225
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 23/223 (10%)
Query: 777 FSIRNLIGTGGFGSTYKAE---LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNL 833
++I ++G G FG K + Y V V + + + E+ L ++ H N+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ L + ++V +GG L + I +K + H A I Q + + Y
Sbjct: 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE------HDAARIIKQVFSGITYM 137
Query: 893 CVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
IVHRD+KP NILL +++ + + DFGL+ + + D GT Y+APE
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAPEVL 195
Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYG-NGFNIV 991
+K DV+S GV+L L+SG P F YG N ++I+
Sbjct: 196 RGT-YDEKCDVWSAGVILYILLSGT----PPF--YGKNEYDIL 231
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 783 IGTGGFGST---YKAELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTL 836
+G+G +GS Y A L VAVKKLS FQ + ++ E+ L ++H+N++ L
Sbjct: 28 VGSGAYGSVCSAYDARLRQK--VAVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAY 888
+ + +E++LV + G +L + + S + +Q+ V + + L Y
Sbjct: 85 LDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHVQFLVYQ-----LLRGLKY 138
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
+H + I+HRD+KPSN+ ++E+ + DFGLAR T T Y APE
Sbjct: 139 IHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR----QADEEMTGYVATRWYRAPEI 191
Query: 949 ATT-CRVSDKADVYSFGVVLLELISGK 974
+ D++S G ++ EL+ GK
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLQGK 218
>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In
With Amp-Pnp
pdb|3KN5|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In
With Amp-Pnp
pdb|3KN6|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
pdb|3KN6|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
Length = 325
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 55/192 (28%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
H N+V L + + FLV L+GG L I KK K + I + A++++
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHM 122
Query: 890 HYSCVPRIVHRDIKPSNILLDEE---LNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
H V VHRD+KP N+L +E L + DFG ARL + + T Y AP
Sbjct: 123 HDVGV---VHRDLKPENLLFTDENDNLEIKIIDFGFARL-KPPDNQPLKTPCFTLHYAAP 178
Query: 947 EYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006
E + D++S GV+L ++SG+ F + S +++ K +
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQ----VPFQSHDRSLTCTSAVEIMKKIKKGDFS 234
Query: 1007 FLPELWEAGPQE 1018
F E W+ QE
Sbjct: 235 FEGEAWKNVSQE 246
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
D P E++Y + +IG G FG Y+A+L G LVA+KK L RF+
Sbjct: 28 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 73
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 74 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 132
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L
Sbjct: 133 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 189
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
E + + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 190 EPNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 233
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 45/150 (30%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
H LV L + E+ +F V +++GG+L H + +K+ + +I+ AL YL
Sbjct: 80 HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 137
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL-LEVSETHATTDVAGTFGYVAPEY 948
H I++RD+K N+LLD E + L+D+G+ + L +T T+ GT Y+APE
Sbjct: 138 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEI 192
Query: 949 ATTCRVSDKADVYSFGVVLLELISGKRSLD 978
D ++ GV++ E+++G+ D
Sbjct: 193 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 45/150 (30%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
H LV L + E+ +F V +++GG+L H + +K+ + +I+ AL YL
Sbjct: 69 HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL-LEVSETHATTDVAGTFGYVAPEY 948
H I++RD+K N+LLD E + L+D+G+ + L +T T+ GT Y+APE
Sbjct: 127 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEI 181
Query: 949 ATTCRVSDKADVYSFGVVLLELISGKRSLD 978
D ++ GV++ E+++G+ D
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211
>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent
Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In
Complex With Sto-609
Length = 298
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 12/165 (7%)
Query: 815 IQQFDAEIGTLGRIRHKNLVTLIGYY--VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQW 872
I+Q EI L ++ H N+V L+ E +++V+ ++ G + K + Q
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 873 SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
+ D+ + + YLHY +I+HRDIKPSN+L+ E+ + ++DFG++ + S+
Sbjct: 140 RFYFQ---DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA- 192
Query: 933 ATTDVAGTFGYVAPEYATTCR--VSDKA-DVYSFGVVLLELISGK 974
++ GT ++APE + R S KA DV++ GV L + G+
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
R + + + DT EL +G F++ G Y A+ + + +
Sbjct: 4 FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R + + E+ L I+H N++TL Y + ++ L+ ++GG L F+ +K
Sbjct: 57 SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
S+ + A + + Q L ++Y +I H D+KP NI LLD + + DFGLA
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
++ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
D P E++Y + +IG G FG Y+A+L G LVA+KK L RF+
Sbjct: 15 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 60
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
+ E+ + ++ H N+V L ++ E + LV +++ H K+
Sbjct: 61 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
+ K+ + + ++LAY+H I HRDIKP N+LLD + L DFG A+ L
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
E + + + + Y APE + T S DV+S G VL EL+ G+
Sbjct: 177 EPNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 67.4 bits (163), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 45/150 (30%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
H LV L + E+ +F V +++GG+L H + +K+ + +I+ AL YL
Sbjct: 65 HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 122
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL-LEVSETHATTDVAGTFGYVAPEY 948
H I++RD+K N+LLD E + L+D+G+ + L +T T+ GT Y+APE
Sbjct: 123 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEI 177
Query: 949 ATTCRVSDKADVYSFGVVLLELISGKRSLD 978
D ++ GV++ E+++G+ D
Sbjct: 178 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex With
A Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 67.4 bits (163), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KSQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGL R H ++ G T Y APE
Sbjct: 145 ---DIIHRDLKPSNLAVNEDSELKILDFGLCR-------HTDDEMTGYVATRWYRAPEIM 194
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 67.4 bits (163), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + V VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 93 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 149
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGKHYLD 237
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
+G G +G A V VAVK + + R + EI + H+N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
+L + SGG L I G + + + + YLH I HR
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHR 129
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRV-SDKA 958
DIKP N+LLDE N +SDFGLA + + + + GT YVAPE ++
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 189
Query: 959 DVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
DV+S G+VL +++G+ D PS S EY +
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In
Complex With P38 Map Kinase
Length = 360
Score = 67.4 bits (163), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G+ VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + DF LAR H ++ G T Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFYLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 67.4 bits (163), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS + ++ G +AVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 59 VGSGAYGSVCSSYDVKSGLKIAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 117
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ +++LV L G +L + +K+ + + I + L Y+H +
Sbjct: 118 VFTPATSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 173
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
I+HRD+KPSN+ ++E+ + DFGLAR H ++ G T Y APE
Sbjct: 174 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 223
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTG-RTLFP 253
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 67.4 bits (163), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + V VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 91 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 147
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLD 235
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 67.4 bits (163), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + V VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 39 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 99 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 155
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 215
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 216 SIDIWSVGCILAEMLSNRPIFPGKHYLD 243
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 67.4 bits (163), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + V VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 91 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 147
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLD 235
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 67.4 bits (163), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/234 (23%), Positives = 104/234 (44%), Gaps = 22/234 (9%)
Query: 757 TFADTPAELTYDNVVR-ATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG 814
TF D P +L Y+ N +G G FG +A G AV K+++ +
Sbjct: 20 TFID-PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS 78
Query: 815 IQQFDAEIGTLGRIR-------HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS- 866
D + + ++ H+N+V L+G + ++ + G+L F+ +K+
Sbjct: 79 TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAE 138
Query: 867 -------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSD 919
G+ ++ + + +AQ +A+L +HRD+ N+LL A + D
Sbjct: 139 ADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGD 195
Query: 920 FGLAR-LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
FGLAR ++ S + ++APE C + ++DV+S+G++L E+ S
Sbjct: 196 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
+G G +G A V VAVK + + R + EI + H+N+V G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
+L + SGG L I G + + + + YLH I HR
Sbjct: 74 REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHR 128
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRV-SDKA 958
DIKP N+LLDE N +SDFGLA + + + + GT YVAPE ++
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 959 DVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
DV+S G+VL +++G+ D PS S EY +
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
+G G +G A V VAVK + + R + EI + H+N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
+L + SGG L I G + + + + YLH I HR
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHR 129
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRV-SDKA 958
DIKP N+LLDE N +SDFGLA + + + + GT YVAPE ++
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 959 DVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
DV+S G+VL +++G+ D PS S EY +
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
+G G +G A V VAVK + + R + EI + H+N+V G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
+L + SGG L I G + + + + YLH I HR
Sbjct: 74 REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHR 128
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRV-SDKA 958
DIKP N+LLDE N +SDFGLA + + + + GT YVAPE ++
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 959 DVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
DV+S G+VL +++G+ D PS S EY +
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
+G G +G A V VAVK + + R + EI + H+N+V G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
+L + SGG L I G + + + + YLH I HR
Sbjct: 74 REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHR 128
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRV-SDKA 958
DIKP N+LLDE N +SDFGLA + + + + GT YVAPE ++
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 959 DVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
DV+S G+VL +++G+ D PS S EY +
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
+G G +G A V VAVK + + R + EI + H+N+V G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
+L + SGG L I G + + + + YLH I HR
Sbjct: 74 REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHR 128
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRV-SDKA 958
DIKP N+LLDE N +SDFGLA + + + + GT YVAPE ++
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 959 DVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
DV+S G+VL +++G+ D PS S EY +
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
+G G +G A V VAVK + + R + EI + H+N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
+L + SGG L I G + + + + YLH I HR
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHR 129
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRV-SDKA 958
DIKP N+LLDE N +SDFGLA + + + + GT YVAPE ++
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 959 DVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
DV+S G+VL +++G+ D PS S EY +
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 67.4 bits (163), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 64/226 (28%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 758 FADTPAELTYDNVVRATGNFSIRNL-IGTGGFGSTYKAELVPGYLVAVKKLSIG---RFQ 813
F+D P EL + N I ++ +G G FGS + Y + K++ + Q
Sbjct: 319 FSD-PEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQ 373
Query: 814 GIQQFDAE-IGTLGRIRHK----NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK 868
G ++ D E + +I H+ +V LIG EA + LV GG L F+ K +
Sbjct: 374 GTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKR-E 431
Query: 869 KIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV 928
+I S + ++ ++ + YL VHR++ N+LL A +SDFGL++ L
Sbjct: 432 EIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488
Query: 929 SETHATTDVAGTF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
+++ T AG + + APE + S ++DV+S+GV + E +S
Sbjct: 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 67.4 bits (163), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + V VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 51 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 167
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 228 SIDIWSVGCILAEMLSNRPIFPGKHYLD 255
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 67.4 bits (163), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + V VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 91 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 147
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLD 235
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 67.0 bits (162), Expect = 5e-11, Method: Composition-based stats.
Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
+G G +G A V VAVK + + R + EI + H+N+V G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
+L + SGG L I G + + + + YLH I HR
Sbjct: 74 REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHR 128
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRV-SDKA 958
DIKP N+LLDE N +SDFGLA + + + + GT YVAPE ++
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 188
Query: 959 DVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
DV+S G+VL +++G+ D PS S EY +
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + V VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + V +H
Sbjct: 91 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 147
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLD 235
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + V VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + V +H
Sbjct: 91 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 147
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 148 RDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLD 235
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 53/215 (24%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 783 IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE + P + VAVK L S + + +E+ + I +HKN
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
++ L+G + ++++ + S GNL ++ + +++ +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
A +A+ + YL + +HRD+ N+L+ E+ ++DFGLAR + + TT+
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + ++DV+SFGV+L E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 53/215 (24%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 783 IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE + P + VAVK L S + + +E+ + I +HKN
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
++ L+G + ++++ + S GNL ++ + +++ +
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
A +A+ + YL + +HRD+ N+L+ E+ ++DFGLAR + + TT+
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + ++DV+SFGV+L E+ +
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
N ++ +G G FG Y+ ++ P L VAVK L + Q F E + ++
Sbjct: 32 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 91
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
H+N+V IG + F++ ++GG+L++F+ + + Q S ++H +A DI
Sbjct: 92 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 150
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
A YL + +HRDI N LL A + DFG+AR + + + A
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++ PE + K D +SFGV+L E+ S
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
pdb|2V5Q|B Chain B, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
Length = 315
Score = 67.0 bits (162), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 782 LIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G GGF ++ E+ G +V K L + Q ++ EI + H+++V
Sbjct: 28 FLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVG 85
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
G++ +F+V +L +HK+ + + + I YLH +
Sbjct: 86 FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN--- 140
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
R++HRD+K N+ L+E+L + DFGLA +E T + GT Y+APE + S
Sbjct: 141 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 199
Query: 956 DKADVYSFGVVLLELISGKRSLDPS 980
+ DV+S G ++ L+ GK + S
Sbjct: 200 FEVDVWSIGCIMYTLLVGKPPFETS 224
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 67.0 bits (162), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
R + + + DT EL +G F++ G Y A+ + + +
Sbjct: 4 FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R + + E+ L I+H N++TL Y + ++ L+ ++GG L F+ +K
Sbjct: 57 SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
S+ + A + + Q L ++Y +I H D+KP NI LLD + + DFGLA
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
++ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 311
Score = 67.0 bits (162), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 782 LIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G GGF ++ E+ G +V K L + Q ++ EI + H+++V
Sbjct: 24 FLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVG 81
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
G++ +F+V +L +HK+ + + + I YLH +
Sbjct: 82 FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN--- 136
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
R++HRD+K N+ L+E+L + DFGLA +E T + GT Y+APE + S
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 195
Query: 956 DKADVYSFGVVLLELISGKRSLDPS 980
+ DV+S G ++ L+ GK + S
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETS 220
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 67.0 bits (162), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 783 IGTGGFGSTYKAEL-VPG---YLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G G FG + E P VAVK L + + + + F E+ + + H+NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
L G V M +V G+L + K G + + + A+ +A+ + YL
Sbjct: 86 LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESK--- 140
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAPEYATTCR 953
R +HRD+ N+LL + DFGL R L ++ H F + APE T
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRT 200
Query: 954 VSDKADVYSFGVVLLELIS 972
S +D + FGV L E+ +
Sbjct: 201 FSHASDTWMFGVTLWEMFT 219
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 67.0 bits (162), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
N ++ +G G FG Y+ ++ P L VAVK L + Q F E + ++
Sbjct: 46 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 105
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
H+N+V IG + F++ ++GG+L++F+ + + Q S ++H +A DI
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 164
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
A YL + +HRDI N LL A + DFG+AR + + + A
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++ PE + K D +SFGV+L E+ S
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With
Nms-P937
pdb|4A4L|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
5-(2-Amino-Pyrimidin-4-Yl)-1h-Pyrrole Inhibitor
pdb|4A4O|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
2-
(2-Amino-Pyrimidin-4-Yl)-1,5,6,
7-Tetrahydro-Pyrrolopyridin- 4-One Inhibitor
Length = 311
Score = 66.6 bits (161), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 782 LIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G GGF ++ E+ G +V K L + Q ++ EI + H+++V
Sbjct: 24 FLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVG 81
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
G++ +F+V +L +HK+ + + + I YLH +
Sbjct: 82 FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN--- 136
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
R++HRD+K N+ L+E+L + DFGLA +E T + GT Y+APE + S
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 195
Query: 956 DKADVYSFGVVLLELISGKRSLDPS 980
+ DV+S G ++ L+ GK + S
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETS 220
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 66.6 bits (161), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 783 IGTGGFGST---YKAELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTL 836
+G+G +GS Y A L VAVKKLS FQ + ++ E+ L ++H+N++ L
Sbjct: 36 VGSGAYGSVCSAYDARLRQK--VAVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAY 888
+ + +E++LV + G +L + + S + +Q+ V + + L Y
Sbjct: 93 LDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHVQFLVYQ-----LLRGLKY 146
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
+H + I+HRD+KPSN+ ++E+ + DFGLAR T T Y APE
Sbjct: 147 IHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGYVATRWYRAPEI 199
Query: 949 ATT-CRVSDKADVYSFGVVLLELISGK 974
+ D++S G ++ EL+ GK
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 66.6 bits (161), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 776 NFSIRNLIGTGGFGSTYKAE---LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN 832
++I ++G G FG K + Y V V + + + E+ L ++ H N
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
++ L + ++V +GG L + I +K + H A I Q + + Y
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE------HDAARIIKQVFSGITY 136
Query: 892 SCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
IVHRD+KP NILL +++ + + DFGL+ + + D GT Y+APE
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAPE- 193
Query: 949 ATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYG-NGFNIVS 992
+K DV+S GV+L L+SG P F YG N ++I+
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSGT----PPF--YGKNEYDILK 232
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 66.6 bits (161), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
N ++ +G G FG Y+ ++ P L VAVK L + Q F E + +
Sbjct: 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
H+N+V IG + F++ ++GG+L++F+ + + Q S ++H +A DI
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 149
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
A YL + +HRDI N LL A + DFG+AR + + + A
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++ PE + K D +SFGV+L E+ S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 66.6 bits (161), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 776 NFSIRNLIGTGGFGSTYKAE---LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN 832
++I ++G G FG K + Y V V + + + E+ L ++ H N
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
++ L + ++V +GG L + I +K + H A I Q + + Y
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE------HDAARIIKQVFSGITY 136
Query: 892 SCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
IVHRD+KP NILL +++ + + DFGL+ + + D GT Y+APE
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAPE- 193
Query: 949 ATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYG-NGFNIVS 992
+K DV+S GV+L L+SG P F YG N ++I+
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSGT----PPF--YGKNEYDILK 232
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 66.6 bits (161), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 772 RATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
R T ++ + +G G F + + ++ KKLS Q +++ +A I L
Sbjct: 28 RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER-EARICRL 86
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWS-VIHKIAIDIA 883
++H N+V L E +LV++ ++GG L E + ++ + S IH+I
Sbjct: 87 --LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQIL---- 140
Query: 884 QALAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVS-ETHATTDVAG 939
+++ ++H IVHRD+KP N+LL + L+DFGLA +EV E A AG
Sbjct: 141 ESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAG 195
Query: 940 TFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
T GY++PE D+++ GV+L L+ G
Sbjct: 196 TPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 66.6 bits (161), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
N ++ +G G FG Y+ ++ P L VAVK L + Q F E + +
Sbjct: 23 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 82
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
H+N+V IG + F++ ++GG+L++F+ + + Q S ++H +A DI
Sbjct: 83 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 141
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
A YL + +HRDI N LL A + DFG+AR + + + A
Sbjct: 142 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 198
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++ PE + K D +SFGV+L E+ S
Sbjct: 199 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 66.6 bits (161), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQ---FDAEIGTLGRIRHKNLVTLIG 838
+G G +G K VP G ++AVK++ Q+ D +I ++ + VT G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI-SMRTVDCPFTVTFYG 73
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
E ++++ + +L+ F + G+ I ++ KIA+ I +AL +LH
Sbjct: 74 ALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--S 130
Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA----TTC 952
++HRD+KPSN+L++ + DFG++ L V + D AG Y+APE
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID-AGCKPYMAPERINPELNQK 188
Query: 953 RVSDKADVYSFGVVLLEL 970
S K+D++S G+ ++EL
Sbjct: 189 GYSVKSDIWSLGITMIEL 206
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 66.6 bits (161), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 56/234 (23%), Positives = 104/234 (44%), Gaps = 22/234 (9%)
Query: 757 TFADTPAELTYDNVVR-ATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG 814
TF D P +L Y+ N +G G FG +A G AV K+++ +
Sbjct: 28 TFID-PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS 86
Query: 815 IQQFDAEIGTLGRIR-------HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS- 866
D + + ++ H+N+V L+G + ++ + G+L F+ +K+
Sbjct: 87 TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAE 146
Query: 867 -------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSD 919
G+ ++ + + +AQ +A+L +HRD+ N+LL A + D
Sbjct: 147 ADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGD 203
Query: 920 FGLAR-LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
FGLAR ++ S + ++APE C + ++DV+S+G++L E+ S
Sbjct: 204 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 66.6 bits (161), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
R + + + DT EL +G F++ G Y A+ + + +
Sbjct: 4 FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R + + E+ L I+H N++TL Y + ++ L+ ++GG L F+ +K
Sbjct: 57 SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
S+ + A + + Q L ++Y +I H D+KP NI LLD + + DFGLA
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
++ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 66.6 bits (161), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 783 IGTGGFGSTYKAEL-VPG---YLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G G FG + E P VAVK L + + + + F E+ + + H+NL+
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
L G V M +V G+L + K G + + + A+ +A+ + YL
Sbjct: 80 LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESK--- 134
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAPEYATTCR 953
R +HRD+ N+LL + DFGL R L ++ H F + APE T
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 194
Query: 954 VSDKADVYSFGVVLLELIS 972
S +D + FGV L E+ +
Sbjct: 195 FSHASDTWMFGVTLWEMFT 213
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 66.2 bits (160), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
N ++ +G G FG Y+ ++ P L VAVK L + Q F E + +
Sbjct: 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
H+N+V IG + F++ ++GG+L++F+ + + Q S ++H +A DI
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 149
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
A YL + +HRDI N LL A + DFG+AR + + + A
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++ PE + K D +SFGV+L E+ S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 66.2 bits (160), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
R + + + DT EL +G F++ G Y A+ + + +
Sbjct: 4 FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R + + E+ L I+H N++TL Y + ++ L+ ++GG L F+ +K
Sbjct: 57 SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
S+ + A + + Q L ++Y +I H D+KP NI LLD + + DFGLA
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
++ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 66.2 bits (160), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
N ++ +G G FG Y+ ++ P L VAVK L + Q F E + +
Sbjct: 32 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
H+N+V IG + F++ ++GG+L++F+ + + Q S ++H +A DI
Sbjct: 92 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 150
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
A YL + +HRDI N LL A + DFG+AR + + + A
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++ PE + K D +SFGV+L E+ S
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 66.2 bits (160), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
N ++ +G G FG Y+ ++ P L VAVK L + Q F E + +
Sbjct: 48 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 107
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
H+N+V IG + F++ ++GG+L++F+ + + Q S ++H +A DI
Sbjct: 108 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 166
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
A YL + +HRDI N LL A + DFG+AR + + + A
Sbjct: 167 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 223
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++ PE + K D +SFGV+L E+ S
Sbjct: 224 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 66.2 bits (160), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
R + + + DT EL +G F++ G Y A+ + + +
Sbjct: 4 FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R + + E+ L I+H N++TL Y + ++ L+ ++GG L F+ +K
Sbjct: 57 SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
S+ + A + + Q L ++Y +I H D+KP NI LLD + + DFGLA
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
++ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 66.2 bits (160), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 783 IGTGGFGSTYKAEL-VPG---YLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G G FG + E P VAVK L + + + + F E+ + + H+NL+
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
L G V M +V G+L + K G + + + A+ +A+ + YL
Sbjct: 80 LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESK--- 134
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAPEYATTCR 953
R +HRD+ N+LL + DFGL R L ++ H F + APE T
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 194
Query: 954 VSDKADVYSFGVVLLELIS 972
S +D + FGV L E+ +
Sbjct: 195 FSHASDTWMFGVTLWEMFT 213
>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain.
pdb|3DB8|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With Compound
041
pdb|3DBC|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With Compound
257
pdb|3DBD|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With Compound
094
Length = 317
Score = 66.2 bits (160), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 67/284 (23%), Positives = 120/284 (42%), Gaps = 38/284 (13%)
Query: 772 RATGNFSIRNLIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
R + +G GGF Y+ E+ G +V K + + Q ++ EI
Sbjct: 39 RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVP-KSMLLKPHQK-EKMSTEIAIH 96
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
+ + ++V G++ + +++V +L +HK+ K + Q
Sbjct: 97 KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRR-KAVTEPEARYFMRQTIQG 154
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YLH + R++HRD+K N+ L+++++ + DFGLA +E + D+ GT Y+A
Sbjct: 155 VQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKDLCGTPNYIA 210
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSF----------SEYGNGFNIVSWAK 995
PE S + D++S G +L L+ GK + S +EY +I A
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVAS 270
Query: 996 LLIK---------EGRSSELFLPELWEAGPQENLLGMMRLASTC 1030
LI+ +EL E + +G MRL ++C
Sbjct: 271 ALIRRMLHADPTLRPSVAELLTDEFFTSG-----YAPMRLPTSC 309
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 66.2 bits (160), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 783 IGTGGFGSTYKAEL-VPG---YLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G G FG + E P VAVK L + + + + F E+ + + H+NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
L G V M +V G+L + K G + + + A+ +A+ + YL
Sbjct: 86 LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESK--- 140
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAPEYATTCR 953
R +HRD+ N+LL + DFGL R L ++ H F + APE T
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 954 VSDKADVYSFGVVLLELIS 972
S +D + FGV L E+ +
Sbjct: 201 FSHASDTWMFGVTLWEMFT 219
>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 902
pdb|3D5X|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Wortmannin.
pdb|3DBE|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 557
pdb|3DBF|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 562
Length = 301
Score = 66.2 bits (160), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 772 RATGNFSIRNLIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
R + +G GGF Y+ E+ G +V K + + Q ++ EI
Sbjct: 23 RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVP-KSMLLKPHQK-EKMSTEIAIH 80
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
+ + ++V G++ + +++V +L +HK+ K + Q
Sbjct: 81 KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRR-KAVTEPEARYFMRQTIQG 138
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YLH + R++HRD+K N+ L+++++ + DFGLA +E + D+ GT Y+A
Sbjct: 139 VQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKDLCGTPNYIA 194
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPS 980
PE S + D++S G +L L+ GK + S
Sbjct: 195 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 229
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 66.2 bits (160), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
N ++ +G G FG Y+ ++ P L VAVK L + Q F E + +
Sbjct: 46 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 105
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
H+N+V IG + F++ ++GG+L++F+ + + Q S ++H +A DI
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 164
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
A YL + +HRDI N LL A + DFG+AR + + + A
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++ PE + K D +SFGV+L E+ S
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 66.2 bits (160), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
R + + + DT EL +G F++ G Y A+ + + +
Sbjct: 4 FRQENVDDYYDTGEEL-------GSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R + + E+ L I+H N++TL Y + ++ L+ ++GG L F+ +K
Sbjct: 57 SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
S+ + A + + Q L ++Y +I H D+KP NI LLD + + DFGLA
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
++ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 66.2 bits (160), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
R + + + DT EL +G F++ G Y A+ + + +
Sbjct: 3 FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 55
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R + + E+ L I+H N++TL Y + ++ L+ ++GG L F+ +K
Sbjct: 56 SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 108
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
S+ + A + + Q L ++Y +I H D+KP NI LLD + + DFGLA
Sbjct: 109 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
++ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 166 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 66.2 bits (160), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
R + + + DT EL +G F++ G Y A+ + + +
Sbjct: 3 FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 55
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R + + E+ L I+H N++TL Y + ++ L+ ++GG L F+ +K
Sbjct: 56 SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 108
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
S+ + A + + Q L ++Y +I H D+KP NI LLD + + DFGLA
Sbjct: 109 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
++ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 166 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 66.2 bits (160), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
N ++ +G G FG Y+ ++ P L VAVK L + Q F E + +
Sbjct: 38 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 97
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
H+N+V IG + F++ ++GG+L++F+ + + Q S ++H +A DI
Sbjct: 98 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 156
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
A YL + +HRDI N LL A + DFG+AR + + + A
Sbjct: 157 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 213
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++ PE + K D +SFGV+L E+ S
Sbjct: 214 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 66.2 bits (160), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 783 IGTGGFGSTYKAEL-VPG---YLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G G FG + E P VAVK L + + + + F E+ + + H+NL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
L G V M +V G+L + K G + + + A+ +A+ + YL
Sbjct: 76 LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESK--- 130
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAPEYATTCR 953
R +HRD+ N+LL + DFGL R L ++ H F + APE T
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 954 VSDKADVYSFGVVLLELIS 972
S +D + FGV L E+ +
Sbjct: 191 FSHASDTWMFGVTLWEMFT 209
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 66.2 bits (160), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + + VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 36 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 96 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 152
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 213 SIDIWSVGCILAEMLSNRPIFPGKHYLD 240
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 66.2 bits (160), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + + VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 37 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 97 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 153
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 214 SIDIWSVGCILAEMLSNRPIFPGKHYLD 241
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 66.2 bits (160), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + + VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 28 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 88 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 144
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 205 SIDIWSVGCILAEMLSNRPIFPGKHYLD 232
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 66.2 bits (160), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + + VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLD 239
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 66.2 bits (160), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + + VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 29 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 89 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 145
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 206 SIDIWSVGCILAEMLSNRPIFPGKHYLD 233
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 781 NLIGTGGFGSTYKAELVPGYLVAVKK-LSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGY 839
+IG G FG ++A+LV VA+KK L RF+ + E+ + ++H N+V L +
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK-----NRELQIMRIVKHPNVVDLKAF 100
Query: 840 YVG----EAEMFL--VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI-DIAQALAYLHYS 892
+ + E+FL V ++ H K+ ++ K+ + + ++LAY+H
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 893 CVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSETHATTDVAGTFGYVAPE--YA 949
I HRDIKP N+LLD L DFG A++L E + + + + Y APE +
Sbjct: 161 G---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX-ICSRY-YRAPELIFG 215
Query: 950 TTCRVSDKADVYSFGVVLLELISGK 974
T ++ D++S G V+ EL+ G+
Sbjct: 216 ATNYTTN-IDIWSTGCVMAELMQGQ 239
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + + VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLD 239
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + D GLAR H ++ G T Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDAGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
R + + + DT EL +G F++ G Y A+ + + +
Sbjct: 4 FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R + + E+ L I+H N++TL Y + ++ L+ ++GG L F+ +K
Sbjct: 57 SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
S+ + A + + Q L ++Y +I H D+KP NI LLD + + DFGLA
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
++ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + FGLAR H ++ G T Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILGFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + + VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 29 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 89 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 145
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 206 SIDIWSVGCILAEMLSNRPIFPGKHYLD 233
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
R + + + DT EL +G F++ G Y A+ + + +
Sbjct: 4 FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R + + E+ L I+H N++TL Y + ++ L+ ++GG L F+ +K
Sbjct: 57 SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
S+ + A + + Q L ++Y +I H D+KP NI LLD + + DFGLA
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
++ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
N ++ +G G FG Y+ ++ P L VAVK L + Q F E + +
Sbjct: 58 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 117
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
H+N+V IG + F++ ++GG+L++F+ + + Q S ++H +A DI
Sbjct: 118 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 176
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
A YL + +HRDI N LL A + DFG+AR + + + A
Sbjct: 177 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 233
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++ PE + K D +SFGV+L E+ S
Sbjct: 234 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic
Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic
Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution
Length = 336
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 79/290 (27%), Positives = 116/290 (40%), Gaps = 48/290 (16%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQF--DAEIGTLGRIRHKNL 833
N + LIG G +G+ YK L VAVK S F Q F + I + + H N+
Sbjct: 14 NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNIYRVPLMEHDNI 69
Query: 834 VTLIG-----YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
I G E LV + G+L ++ + W ++A + + LAY
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS---DWVSSCRLAHSVTRGLAY 126
Query: 889 LHYSC------VPRIVHRDIKPSNILLDEELNAYLSDFGLA------RLLEV-SETHATT 935
LH P I HRD+ N+L+ + +SDFGL+ RL+ E +A
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 936 DVAGTFGYVAPEY---ATTCRVSDKA----DVYSFGVVLLELISGKRSLDP--SFSEYGN 986
GT Y+APE A R + A D+Y+ G++ E+ L P S EY
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246
Query: 987 GFN-------IVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLAST 1029
F ++L+ + F PE W +EN L + L T
Sbjct: 247 AFQTEVGNHPTFEDMQVLVSREKQRPKF-PEAW----KENSLAVRSLKET 291
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
Length = 360
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + D GLAR H ++ G T Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDRGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 37/222 (16%)
Query: 783 IGTGGFGSTYKAELVPGYL-------VAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLV 834
IG G FG ++A PG L VAVK L +Q F E + + N+V
Sbjct: 55 IGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK----------------- 877
L+G M L++ +++ G+L F+ S + S+ H
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTV-CSLSHSDLSTRARVSSPGPPPLS 172
Query: 878 ------IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
IA +A +AYL + VHRD+ N L+ E + ++DFGL+R + ++
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 932 H-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
+ A + A ++ PE R + ++DV+++GVVL E+ S
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
R + + + DT EL +G F++ G Y A+ + + +
Sbjct: 4 FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R + + E+ L I+H N++TL Y + ++ L+ ++GG L F+ +K
Sbjct: 57 SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
S+ + A + + Q L ++Y +I H D+KP NI LLD + + DFGLA
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
++ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFD-AEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + + VA+KK+S Q Q EI L R RH+N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + V +H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 151
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLD 239
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
R + + + DT EL +G F++ G Y A+ + + +
Sbjct: 4 FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R + + E+ L I+H N++TL Y + ++ L+ ++GG L F+ +K
Sbjct: 57 SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
S+ + A + + Q L ++Y +I H D+KP NI LLD + + DFGLA
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
++ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + + VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLD 239
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
N ++ +G G FG Y+ ++ P L VAVK L + Q F E + +
Sbjct: 49 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 108
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
H+N+V IG + F++ ++GG+L++F+ + + Q S ++H +A DI
Sbjct: 109 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 167
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
A YL + +HRDI N LL A + DFG+AR + + + A
Sbjct: 168 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 224
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++ PE + K D +SFGV+L E+ S
Sbjct: 225 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 65.5 bits (158), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 33/229 (14%)
Query: 771 VRATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR 829
+R +F ++G G FG KA + A+KK+ + + +E+ L +
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLN 60
Query: 830 HKNLVTLIGYYV-------------GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH 876
H+ +V ++ ++ +F+ + L IH ++ + Q
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQ-QRDEYW 119
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS------- 929
++ I +AL+Y+H I+HRD+KP NI +DE N + DFGLA+ + S
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 930 ------ETHATTDVAGTFGYVAPEYAT-TCRVSDKADVYSFGVVLLELI 971
+ T GT YVA E T ++K D+YS G++ E+I
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 65.5 bits (158), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 52/195 (26%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLVTLIGYY 840
+G G + + YK + + LVA+K++ + +G E+ L ++H N+VTL
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
E + LV+ +L +L+ ++ G I +H + + + Q L L Y +++HR
Sbjct: 70 HTEKSLTLVFEYLDK-DLKQYL-DDCGNIIN---MHNVKLFLFQLLRGLAYCHRQKVLHR 124
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKAD 959
D+KP N+L++E L+DFGLAR + +V T Y P+ + S + D
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYSTQID 183
Query: 960 VYSFGVVLLELISGK 974
++ G + E+ +G+
Sbjct: 184 MWGVGCIFYEMATGR 198
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 65.5 bits (158), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
N ++ +G G FG Y+ ++ P L VAVK L + Q F E + +
Sbjct: 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 131
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
H+N+V IG + F++ ++GG+L++F+ + + Q S ++H +A DI
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 190
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
A YL + +HRDI N LL A + DFG+AR + + + A
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++ PE + K D +SFGV+L E+ S
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 65.5 bits (158), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
N ++ +G G FG Y+ ++ P L VAVK L + Q F E + +
Sbjct: 46 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKF 105
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
H+N+V IG + F++ ++GG+L++F+ + + Q S ++H +A DI
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 164
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
A YL + +HRDI N LL A + DFG+AR + + + A
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++ PE + K D +SFGV+L E+ S
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 65.5 bits (158), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
R + + + DT EL +G F++ G Y A+ + + +
Sbjct: 4 FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R + + E+ L I+H N++TL Y + ++ L+ ++GG L F+ +K
Sbjct: 57 SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
S+ + A + + Q L ++Y +I H D+KP NI LLD + + DFGLA
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
++ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 65.5 bits (158), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
+G+G +GS A + G VAVKKLS FQ I ++ E+ L ++H+N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ +++LV L G +L + K + +Q+ + I + L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
+ I+HRD+KPSN+ ++E+ + D GLAR H ++ G T Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDGGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
+ D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 65.5 bits (158), Expect = 2e-10, Method: Composition-based stats.
Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 19/200 (9%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIG---RFQGIQQFDAE-IGTLGRIRHK----NLV 834
+G G FGS + Y + K++ + QG ++ D E + +I H+ +V
Sbjct: 18 LGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
LIG EA M LV GG L F+ K ++I S + ++ ++ + YL
Sbjct: 74 RLIGVCQAEALM-LVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK-- 129
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTC 952
VHRD+ N+LL A +SDFGL++ L +++ T AG + + APE
Sbjct: 130 -NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 953 RVSDKADVYSFGVVLLELIS 972
+ S ++DV+S+GV + E +S
Sbjct: 189 KFSSRSDVWSYGVTMWEALS 208
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine
Mutation At Position 52
Length = 364
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + + VA++K+S Q Q+ EI L R RH+N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLD 239
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 67/268 (25%), Positives = 119/268 (44%), Gaps = 40/268 (14%)
Query: 783 IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE V VAVK L + + +E+ + I +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
++TL+G + ++++ + S GNL ++ + +++S + K +
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883 AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
LA + Y + +HRD+ N+L+ E ++DFGLAR + + TT+
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
++APE + ++DV+SFGV++ E+ + S P G + KLL KE
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 274
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
G ++EL+ + + W A P +
Sbjct: 275 GHRMDKPANCTNELYMMMRDCWHAVPSQ 302
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 54/195 (27%), Positives = 90/195 (46%), Gaps = 9/195 (4%)
Query: 782 LIGTGGFGSTYK-AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
++G G FG +K E G +A K + + ++ EI + ++ H NL+ L +
Sbjct: 96 ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
+ ++ LV ++ GG L I +S + I + I + + ++H I+H
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK-QICEGIRHMHQMY---ILHL 211
Query: 901 DIKPSNILL--DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
D+KP NIL + + DFGLAR + E GT ++APE VS
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN--FGTPEFLAPEVVNYDFVSFPT 269
Query: 959 DVYSFGVVLLELISG 973
D++S GV+ L+SG
Sbjct: 270 DMWSVGVIAYMLLSG 284
>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A
Benzolactam-Derived Inhibitor
Length = 333
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 782 LIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G GGF ++ E+ G +V K L + Q ++ EI + H+++V
Sbjct: 46 FLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVG 103
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
G++ +F+V +L +HK+ + + + I YLH +
Sbjct: 104 FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN--- 158
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
R++HRD+K N+ L+E+L + DFGLA +E + GT Y+APE + S
Sbjct: 159 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 217
Query: 956 DKADVYSFGVVLLELISGKRSLDPS 980
+ DV+S G ++ L+ GK + S
Sbjct: 218 FEVDVWSIGCIMYTLLVGKPPFETS 242
>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|2OWB|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|3FC2|A Chain A, Plk1 In Complex With Bi6727
Length = 335
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 782 LIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G GGF ++ E+ G +V K L + Q ++ EI + H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVG 105
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
G++ +F+V +L +HK+ + + + I YLH +
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN--- 160
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
R++HRD+K N+ L+E+L + DFGLA +E + GT Y+APE + S
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 219
Query: 956 DKADVYSFGVVLLELISGKRSLDPS 980
+ DV+S G ++ L+ GK + S
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETS 244
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 774 TGNFSIRNLIGTGGFGSTYKAELVP------GYLVAVKKLSIGRFQGIQQFDAEIGTLGR 827
T + + +G G F + +P ++ KKLS Q +++ +A I L
Sbjct: 3 TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER-EARICRL-- 59
Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
++H N+V L E +LV++ ++GG L E + ++ + S I Q L
Sbjct: 60 LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHC------IQQIL 113
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVS-ETHATTDVAGTFG 942
+++ + IVHRD+KP N+LL + L+DFGLA +EV + A AGT G
Sbjct: 114 ESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPG 171
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISG 973
Y++PE D+++ GV+L L+ G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
R + + + DT EL +G F++ G Y A+ + + +
Sbjct: 4 FRQENVDDYYDTGEEL-------GSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
R + + E+ L I+H N++TL Y + ++ L+ ++GG L F+ +K
Sbjct: 57 SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
S+ + A + + Q L ++Y +I H D+KP NI LLD + + DFGLA
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
++ + ++ GT +VAPE + +AD++S GV+ L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1)
Catalytic Domain
Length = 317
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 67/284 (23%), Positives = 119/284 (41%), Gaps = 38/284 (13%)
Query: 772 RATGNFSIRNLIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
R + +G GGF Y+ E+ G +V K + + Q ++ EI
Sbjct: 39 RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVP-KSMLLKPHQK-EKMSTEIAIH 96
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
+ + ++V G++ + +++V +L +HK+ K + Q
Sbjct: 97 KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRR-KAVTEPEARYFMRQTIQG 154
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YLH + R++HRD+K N+ L+++++ + DFGLA +E T + GT Y+A
Sbjct: 155 VQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIA 210
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSF----------SEYGNGFNIVSWAK 995
PE S + D++S G +L L+ GK + S +EY +I A
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVAS 270
Query: 996 LLIK---------EGRSSELFLPELWEAGPQENLLGMMRLASTC 1030
LI+ +EL E + +G MRL ++C
Sbjct: 271 ALIRRMLHADPTLRPSVAELLTDEFFTSG-----YAPMRLPTSC 309
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 64.7 bits (156), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 774 TGNFSIRNLIGTGGFGSTYKAELVP------GYLVAVKKLSIGRFQGIQQFDAEIGTLGR 827
T + + +G G F + +P ++ KKLS Q +++ +A I L
Sbjct: 3 TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER-EARICRL-- 59
Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
++H N+V L E +LV++ ++GG L E + ++ + S I Q L
Sbjct: 60 LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHC------IQQIL 113
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVS-ETHATTDVAGTFG 942
+++ + IVHRD+KP N+LL + L+DFGLA +EV + A AGT G
Sbjct: 114 ESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPG 171
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISG 973
Y++PE D+++ GV+L L+ G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 64.7 bits (156), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 40/222 (18%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIR-HKNLVTLI 837
+G G +G +K+ + G +VAVKK+ FQ Q+ EI L + H+N+V L+
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKI-FDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 838 GYYVGE--AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK--IAIDIAQALAYLHYSC 893
+ +++LV++++ ET +H I +HK + + + + YLH
Sbjct: 76 NVLRADNDRDVYLVFDYM-----ETDLHAVIRANI-LEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARL------------LEVSETHAT------- 934
++HRD+KPSNILL+ E + ++DFGL+R L ++E
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 935 -TDVAGTFGYVAPEYAT-TCRVSDKADVYSFGVVLLELISGK 974
TD T Y APE + + + D++S G +L E++ GK
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 64.7 bits (156), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + V VA+KK+S Q Q+ EI L RH+N++ +
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 93 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 149
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGKHYLD 237
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 64.7 bits (156), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 783 IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE V VAVK L + + +E+ + I +HKN
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
++ L+G + ++++ + S GNL ++ + +++S + K +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 883 AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGT 940
LA + Y + +HRD+ N+L+ E ++DFGLAR + + TT+
Sbjct: 209 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 268
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + ++DV+SFGV++ E+ +
Sbjct: 269 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 64.3 bits (155), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
N ++ +G G FG Y+ ++ P L VAVK L + Q F E + +
Sbjct: 32 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
H+N+V IG + F++ ++GG+L++F+ + + Q S ++H +A DI
Sbjct: 92 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 150
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
A YL + +HRDI N LL A + DFG+A+ + + + A
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAM 207
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++ PE + K D +SFGV+L E+ S
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 82/282 (29%), Positives = 121/282 (42%), Gaps = 40/282 (14%)
Query: 779 IRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQ---FDAEIGTLGRIRH 830
IR+L G G FG P G +VAVK L G Q + EI L + H
Sbjct: 36 IRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYH 92
Query: 831 KNLVTLIGYY--VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
++++ G G A + LV ++ G+L ++ + S I + + A I + +AY
Sbjct: 93 EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAY 149
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-----AGTFGY 943
LH +HRD+ N+LLD + + DFGLA+ V E H V + F Y
Sbjct: 150 LH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEXYRVREDGDSPVFWY 204
Query: 944 VAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003
APE + +DV+SFGV L EL++ D S S ++ I +G+
Sbjct: 205 -APECLKEYKFYYASDVWSFGVTLYELLT---HCDSSQSPPTKFLELIG-----IAQGQM 255
Query: 1004 SELFLPELWEAG-----PQENLLGMMRLASTCTVETLSTRPS 1040
+ L L EL E G P + + L C S RP+
Sbjct: 256 TVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPT 297
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 64.3 bits (155), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 783 IGTGGFGSTYKAELVPGY-LVAVKKLSIGRF-QGIQQFD-AEIGTLGRIRHKNLVTLIGY 839
IG G +G+ +KA+ + +VA+K++ + +G+ EI L ++HKN+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ LV+ F +L+ + +G + ++ + + L + H ++H
Sbjct: 70 LHSDKKLTLVFEF-CDQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSR---NVLH 124
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV-SDKA 958
RD+KP N+L++ L+DFGLAR + + +V T Y P+ ++ S
Sbjct: 125 RDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSI 183
Query: 959 DVYSFGVVLLELISGKRSLDP 979
D++S G + EL + R L P
Sbjct: 184 DMWSAGCIFAELANAARPLFP 204
>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536
Length = 294
Score = 64.3 bits (155), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 782 LIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G GGF ++ E+ G +V K L + Q ++ EI + H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVG 79
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
G++ +F+V +L +HK+ + + + I YLH +
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN--- 134
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
R++HRD+K N+ L+E+L + DFGLA +E + GT Y+APE + S
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 193
Query: 956 DKADVYSFGVVLLELISGKRSLDPS 980
+ DV+S G ++ L+ GK + S
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETS 218
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 64.3 bits (155), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
G FS+ G Y A+++ KKLS Q +++ +A I L ++H N+V
Sbjct: 33 GAFSVVRRCVKVLAGQEYAAKII-----NTKKLSARDHQKLER-EARICRL--LKHPNIV 84
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
L E +L+++ ++GG L E + ++ + S H I I +A+ + H
Sbjct: 85 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS--HCIQ-QILEAVLHCHQMG 141
Query: 894 VPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
V VHRD+KP N+LL +L L+DFGLA +E E A AGT GY++PE
Sbjct: 142 V---VHRDLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYLSPEVLR 197
Query: 951 TCRVSDKADVYSFGVVLLELISG 973
D+++ GV+L L+ G
Sbjct: 198 KDPYGKPVDLWACGVILYILLVG 220
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 64.3 bits (155), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 772 RATGNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
R T + + +G G F + V ++ KKLS Q +++ +A I L
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER-EARICRL 66
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQ 884
++H N+V L E +L+++ ++GG L E + ++ + S H I I +
Sbjct: 67 --LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS--HCIQ-QILE 121
Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTF 941
A+ + H V VHR++KP N+LL +L L+DFGLA +E E A AGT
Sbjct: 122 AVLHCHQMGV---VHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTP 177
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
GY++PE D+++ GV+L L+ G
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 64.3 bits (155), Expect = 4e-10, Method: Composition-based stats.
Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783 IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE V VAVK L + + +E+ + I +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
++ L+G + ++++ + S GNL ++ + +++S + K +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883 AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
LA + Y + +HRD+ N+L+ E ++DFGLAR + + TT+
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
++APE + ++DV+SFGV++ E+ + S P G + KLL KE
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 274
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
G ++EL+ + + W A P +
Sbjct: 275 GHRMDKPANCTNELYMMMRDCWHAVPSQ 302
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 64.3 bits (155), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 57/241 (23%), Positives = 105/241 (43%), Gaps = 30/241 (12%)
Query: 757 TFADTPAELTYDNVVR-ATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG 814
TF D P +L Y+ N +G G FG +A G AV K+++ +
Sbjct: 28 TFID-PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS 86
Query: 815 IQQFDAEIGTLGRIR-------HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSG 867
D + + ++ H+N+V L+G + ++ + G+L F+ +K
Sbjct: 87 TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRP 146
Query: 868 KKIQWS---------------VIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE 912
+++S ++H + +AQ +A+L +HRD+ N+LL
Sbjct: 147 PGLEYSYNPSHNPEEQLSSRDLLH-FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNG 202
Query: 913 LNAYLSDFGLAR-LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELI 971
A + DFGLAR ++ S + ++APE C + ++DV+S+G++L E+
Sbjct: 203 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 262
Query: 972 S 972
S
Sbjct: 263 S 263
>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha
(Mrck Alpha)
Length = 437
Score = 63.9 bits (154), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQ-----FDAEIGTLGRIRH 830
+F I +IG G FG +L V K+ + +++ +++ F E L
Sbjct: 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKI-LNKWEMLKRAETACFREERDVLVNGDS 133
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ-----WSVIHKIAIDIAQA 885
K + TL + + ++LV ++ GG+L T + K + + + IAID
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
L Y VHRDIKP NIL+D + L+DFG L T ++ GT Y++
Sbjct: 194 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 946 PEYATTC-----RVSDKADVYSFGVVLLELISGK 974
PE R + D +S GV + E++ G+
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 63.9 bits (154), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 54/226 (23%), Positives = 101/226 (44%), Gaps = 29/226 (12%)
Query: 772 RATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRIR 829
R +F +G GGFG ++A+ V A+K++ + R ++ E+ L ++
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 830 HKNLVTLIGYYVGE------------AEMFLVYNFLSGGNLETFIHKKSG-KKIQWSVIH 876
H +V ++ + +++ NL+ +++ + ++ + SV
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT-- 934
I + IA+A+ +LH ++HRD+KPSNI + + DFGL ++ E T
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 935 ---------TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELI 971
T GT Y++PE S K D++S G++L EL+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 63.9 bits (154), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + + VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H + T Y APE + K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLD 239
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 63.9 bits (154), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + + VA+KK+S Q Q+ EI L R RH+N++ +
Sbjct: 36 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 96 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 152
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H + T Y APE + K
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 213 SIDIWSVGCILAEMLSNRPIFPGKHYLD 240
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 63.9 bits (154), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 49/157 (31%), Positives = 77/157 (49%), Gaps = 13/157 (8%)
Query: 821 EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIA 879
E+ L ++ H N++ L ++ + +LV GG L + I ++ ++ +VI K
Sbjct: 71 EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK-- 128
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYL---SDFGLARLLEVSETHATTD 936
+ YLH IVHRD+KP N+LL+ + L DFGL+ EV +
Sbjct: 129 -QVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG--GKMKE 182
Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
GT Y+APE + +K DV+S GV+L L+ G
Sbjct: 183 RLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCG 218
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 63.9 bits (154), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 49/157 (31%), Positives = 77/157 (49%), Gaps = 13/157 (8%)
Query: 821 EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIA 879
E+ L ++ H N++ L ++ + +LV GG L + I ++ ++ +VI K
Sbjct: 54 EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK-- 111
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYL---SDFGLARLLEVSETHATTD 936
+ YLH IVHRD+KP N+LL+ + L DFGL+ EV +
Sbjct: 112 -QVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG--GKMKE 165
Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
GT Y+APE + +K DV+S GV+L L+ G
Sbjct: 166 RLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCG 201
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 63.9 bits (154), Expect = 5e-10, Method: Composition-based stats.
Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 783 IGTGGFGSTYKAEL-VPG---YLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G G FG + E P VAVK L + + + + F E+ + + H+NL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
L G V M +V G+L + K G + + + A+ +A+ + YL
Sbjct: 76 LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESK--- 130
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAPEYATTCR 953
R +HRD+ N+LL + DFGL R L ++ H F + APE T
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRT 190
Query: 954 VSDKADVYSFGVVLLELIS 972
S +D + FGV L E+ +
Sbjct: 191 FSHASDTWMFGVTLWEMFT 209
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
IG G +G A + V VA+KK+S Q Q+ EI L RH+N++ +
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ +ET ++K + + I I + L Y+H + ++H
Sbjct: 93 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 149
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
RD+KPSN+LL+ + + DFGLAR+ + H T+ T Y APE + K
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
+ D++S G +L E++S GK LD
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGKHYLD 237
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 34/221 (15%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL---VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RH 830
+ +++IG G FG KA + L A+K++ + F E+ L ++ H
Sbjct: 16 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 75
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK--------------SGKKIQWSVIH 876
N++ L+G ++L + GNL F+ K + + +
Sbjct: 76 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 135
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
A D+A+ + YL + +HRD+ NIL+ E A ++DFGL+R EV
Sbjct: 136 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY------- 185
Query: 937 VAGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
V T G ++A E + +DV+S+GV+L E++S
Sbjct: 186 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 34/221 (15%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL---VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RH 830
+ +++IG G FG KA + L A+K++ + F E+ L ++ H
Sbjct: 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 85
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK--------------SGKKIQWSVIH 876
N++ L+G ++L + GNL F+ K + + +
Sbjct: 86 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
A D+A+ + YL + +HRD+ NIL+ E A ++DFGL+R EV
Sbjct: 146 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY------- 195
Query: 937 VAGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
V T G ++A E + +DV+S+GV+L E++S
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain
pdb|2HW6|B Chain B, Crystal Structure Of Mnk1 Catalytic Domain
Length = 307
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 781 NLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR-HKNLVTLIG 838
L+G G + A L G AVK + + E+ TL + + +KN++ LI
Sbjct: 19 ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
++ + +LV+ L GG++ I K+ K ++ D+A AL +LH I
Sbjct: 79 FFEDDTRFYLVFEKLQGGSILAHIQKQ--KHFNEREASRVVRDVAAALDFLH---TKGIA 133
Query: 899 HRDIKPSNILLD--EELN-AYLSDFGLARLLEVSE------THATTDVAGTFGYVAPE-- 947
HRD+KP NIL + E+++ + DF L ++++ T T G+ Y+APE
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 948 --YATTCRVSDK-ADVYSFGVVLLELISG 973
+ DK D++S GVVL ++SG
Sbjct: 194 EVFTDQATFYDKRCDLWSLGVVLYIMLSG 222
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 63.5 bits (153), Expect = 6e-10, Method: Composition-based stats.
Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783 IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE V VAVK L + + +E+ + I +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
++ L+G + ++++ + S GNL ++ + +++S + K +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883 AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
LA + Y + +HRD+ N+L+ E ++DFGLAR + + TT+
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
++APE + ++DV+SFGV++ E+ + S P G + KLL KE
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 274
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
G ++EL+ + + W A P +
Sbjct: 275 GHRMDKPANCTNELYMMMRDCWHAVPSQ 302
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 63.5 bits (153), Expect = 6e-10, Method: Composition-based stats.
Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 783 IGTGGFGSTYKAEL-VPG---YLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G G FG + E P VAVK L + + + + F E+ + + H+NL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
L G V M +V G+L + K G + + + A+ +A+ + YL
Sbjct: 76 LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESK--- 130
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAPEYATTCR 953
R +HRD+ N+LL + DFGL R L ++ H F + APE T
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 954 VSDKADVYSFGVVLLELIS 972
S +D + FGV L E+ +
Sbjct: 191 FSHASDTWMFGVTLWEMFT 209
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 63.2 bits (152), Expect = 7e-10, Method: Composition-based stats.
Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783 IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE V VAVK L + + +E+ + I +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
++ L+G + ++++ + S GNL ++ + +++S + K +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883 AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
LA + Y + +HRD+ N+L+ E ++DFGLAR + + TT+
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLP 222
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
++APE + ++DV+SFGV++ E+ + S P G + KLL KE
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 274
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
G ++EL+ + + W A P +
Sbjct: 275 GHRMDKPANCTNELYMMMRDCWHAVPSQ 302
>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1
(Plk1) Catalytic Domain In Complex With Adp
Length = 317
Score = 63.2 bits (152), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 66/284 (23%), Positives = 119/284 (41%), Gaps = 38/284 (13%)
Query: 772 RATGNFSIRNLIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
R + +G GGF Y+ E+ G +V K + + Q ++ EI
Sbjct: 39 RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVP-KSMLLKPHQK-EKMSTEIAIH 96
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
+ + ++V G++ + +++V +L +HK+ K + Q
Sbjct: 97 KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRR-KAVTEPEARYFMRQTIQG 154
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ YLH + R++HRD+K N+ L+++++ + DFGLA +E + + GT Y+A
Sbjct: 155 VQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKXLCGTPNYIA 210
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSF----------SEYGNGFNIVSWAK 995
PE S + D++S G +L L+ GK + S +EY +I A
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVAS 270
Query: 996 LLIK---------EGRSSELFLPELWEAGPQENLLGMMRLASTC 1030
LI+ +EL E + +G MRL ++C
Sbjct: 271 ALIRRMLHADPTLRPSVAELLTDEFFTSG-----YAPMRLPTSC 309
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 63.2 bits (152), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
IG G FG ++ + G VAVK S R + +AEI +RH+N++ I
Sbjct: 50 IGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 843 E----AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
+ +++LV ++ G+L ++++ + + + K+A+ A LA+LH V
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQG 164
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA-----GTFGYVAPEY 948
P I HRD+K NIL+ + ++D GLA + T D+A GT Y+APE
Sbjct: 165 KPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 949 ATTC------RVSDKADVYSFGVVLLEL 970
+AD+Y+ G+V E+
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEI 250
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 63.2 bits (152), Expect = 8e-10, Method: Composition-based stats.
Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783 IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE V VAVK L + + +E+ + I +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
++ L+G + ++++ + S GNL ++ + +++S + K +
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883 AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
LA + Y + +HRD+ N+L+ E ++DFGLAR + + TT+
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
++APE + ++DV+SFGV++ E+ + S P G + KLL KE
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 274
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
G ++EL+ + + W A P +
Sbjct: 275 GHRMDKPANCTNELYMMMRDCWHAVPSQ 302
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 63.2 bits (152), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 58/228 (25%), Positives = 103/228 (45%), Gaps = 22/228 (9%)
Query: 766 TYDNVVRATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKL--SIGRFQGIQQFDAEI 822
++D + I IG G +G A + G VA+KK+ + ++ E+
Sbjct: 46 SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 105
Query: 823 GTLGRIRHKNLVTL-------IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVI 875
L +H N++ + + Y GE + V L +L IH S + + +
Sbjct: 106 KILKHFKHDNIIAIKDILRPTVPY--GEFKSVYVVLDLMESDLHQIIH--SSQPLTLEHV 161
Query: 876 HKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS---ETH 932
+ + L Y+H + +++HRD+KPSN+L++E + DFG+AR L S +
Sbjct: 162 RYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 218
Query: 933 ATTDVAGTFGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGKRSLDP 979
T+ T Y APE + +A D++S G + E+++ +R L P
Sbjct: 219 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA-RRQLFP 265
>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|B Chain B, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|C Chain C, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|D Chain D, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|E Chain E, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|F Chain F, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|G Chain G, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|H Chain H, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|I Chain I, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|J Chain J, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|K Chain K, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|L Chain L, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|M Chain M, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|N Chain N, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|O Chain O, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|P Chain P, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|Q Chain Q, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|R Chain R, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|S Chain S, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|T Chain T, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|U Chain U, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|V Chain V, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|W Chain W, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|X Chain X, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
Length = 305
Score = 63.2 bits (152), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV- 841
+G G +G ++ L G VAVK S R + + EI +RH N++ I +
Sbjct: 16 VGKGRYGEVWRG-LWHGESVAVKIFS-SRDEQSWFRETEIYNTVLLRHDNILGFIASDMT 73
Query: 842 ---GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
+++L+ ++ G+L F+ +++ ++ + ++A+ A LA+LH
Sbjct: 74 SRNSSTQLWLITHYHEHGSLYDFLQRQT---LEPHLALRLAVSAACGLAHLHVEIFGTQG 130
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH---ATTDVAGTFGYVAPEY-- 948
P I HRD K N+L+ L ++D GLA + + GT Y+APE
Sbjct: 131 KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLD 190
Query: 949 ---ATTCRVSDK-ADVYSFGVVLLEL 970
T C S K D+++FG+VL E+
Sbjct: 191 EQIRTDCFESYKWTDIWAFGLVLWEI 216
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 63.2 bits (152), Expect = 8e-10, Method: Composition-based stats.
Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 774 TGNFSIRNLIGTGGFGSTYK-AELVPGY-----LVAVKKLSIGRFQGIQQFDAEIGTLGR 827
T + + IG G F + +L G+ ++ KKLS Q +++ +A I L
Sbjct: 3 TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLER-EARICRL-- 59
Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
++H N+V L E +LV++ ++GG L E + ++ + S H I I +A+
Sbjct: 60 LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS--HCIQ-QILEAV 116
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAY---LSDFGLARLLEVS-ETHATTDVAGTFG 942
+ H V VHRD+KP N+LL + L+DFGLA +EV + A AGT G
Sbjct: 117 LHCHQMGV---VHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPG 171
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISG 973
Y++PE D+++ GV+L L+ G
Sbjct: 172 YLSPEVLRKEAYGKPVDIWACGVILYILLVG 202
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 63.2 bits (152), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 781 NLIGTGGFGSTY----KAELVPGYLVAVK--KLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
++G G FGS K E VAVK KL + I++F +E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 835 TLIGYYV-----GEAEMFLVYNFLSGGNLETFI---HKKSG-KKIQWSVIHKIAIDIAQA 885
L+G + G + ++ F+ G+L T++ ++G K I + K +DIA
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-FGYV 944
+ YL +HRD+ N +L +++ ++DFGL++ + + + +A ++
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGKRSLDP 979
A E + K+DV++FGV + E+ + R + P
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIAT--RGMTP 249
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 63.2 bits (152), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 58/236 (24%), Positives = 101/236 (42%), Gaps = 22/236 (9%)
Query: 757 TFADTPAELTYDNVVR-ATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG 814
TF D P +L Y+ N +G G FG +A G AV K+++ +
Sbjct: 28 TFID-PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS 86
Query: 815 IQQFDAEIGTLGRIR-------HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSG 867
D + + ++ H+N+V L+G + ++ + G+L F+ +KS
Sbjct: 87 TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKS- 145
Query: 868 KKIQWSVIHKIAIDIAQALAYLHYS----------CVPRIVHRDIKPSNILLDEELNAYL 917
+ ++ IA A LH+S +HRD+ N+LL A +
Sbjct: 146 RVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKI 205
Query: 918 SDFGLAR-LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
DFGLAR ++ S + ++APE C + ++DV+S+G++L E+ S
Sbjct: 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 62.8 bits (151), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 9/200 (4%)
Query: 777 FSIRNLIGTGGFGSTYK-AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+ I +G+G FG ++ E G + K ++ EI + ++ H L+
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
L + + EM L+ FLSGG L I + K + VI+ + + L ++H
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR-QACEGLKHMHEHS-- 169
Query: 896 RIVHRDIKPSNILLDEELNAYLS--DFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
IVH DIKP NI+ + + + + DFGLA L E T F APE
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFA--APEIVDREP 226
Query: 954 VSDKADVYSFGVVLLELISG 973
V D+++ GV+ L+SG
Sbjct: 227 VGFYTDMWAIGVLGYVLLSG 246
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 62.8 bits (151), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 56/247 (22%), Positives = 104/247 (42%), Gaps = 35/247 (14%)
Query: 757 TFADTPAELTYDNVVR-ATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG 814
TF D P +L Y+ N +G G FG +A G AV K+++ +
Sbjct: 13 TFID-PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS 71
Query: 815 IQQFDAEIGTLGRIR-------HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS- 866
D + + ++ H+N+V L+G + ++ + G+L F+ +K+
Sbjct: 72 TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAE 131
Query: 867 --------------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSN 906
G+ ++ + + +AQ +A+L +HRD+ N
Sbjct: 132 AMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARN 188
Query: 907 ILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGV 965
+LL A + DFGLAR ++ S + ++APE C + ++DV+S+G+
Sbjct: 189 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 248
Query: 966 VLLELIS 972
+L E+ S
Sbjct: 249 LLWEIFS 255
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 62.8 bits (151), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
IG G FG ++ + G VAVK S R + +AEI +RH+N++ I
Sbjct: 37 IGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 94
Query: 843 E----AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
+ +++LV ++ G+L ++++ + + + K+A+ A LA+LH V
Sbjct: 95 DNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQG 151
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA-----GTFGYVAPEY 948
P I HRD+K NIL+ + ++D GLA + T D+A GT Y+APE
Sbjct: 152 KPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEV 209
Query: 949 ATTC------RVSDKADVYSFGVVLLEL 970
+AD+Y+ G+V E+
Sbjct: 210 LDDSINMKHFESFKRADIYAMGLVFWEI 237
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 62.8 bits (151), Expect = 9e-10, Method: Composition-based stats.
Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783 IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE V VAVK L + + +E+ + I +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
++ L+G + ++++ + S GNL ++ + +++S + K +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883 AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
LA + Y + +HRD+ N+L+ E ++DFGLAR + + TT+
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLP 222
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
++APE + ++DV+SFGV++ E+ + S P G + KLL KE
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 274
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
G ++EL+ + + W A P +
Sbjct: 275 GHRMDKPANCTNELYMMMRDCWHAVPSQ 302
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 62.8 bits (151), Expect = 1e-09, Method: Composition-based stats.
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 36/220 (16%)
Query: 783 IGTGGFGSTYKAE---LVP---GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
+G G FG + AE L+P LVAVK L Q F E L ++H+++V
Sbjct: 26 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFI--HKKSGK-----------KIQWSVIHKIAIDIA 883
G + +V+ ++ G+L F+ H K + + +A +A
Sbjct: 86 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 884 QALAY---LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG- 939
+ Y LH+ VHRD+ N L+ + L + DFG++R + ++ + V G
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGGR 196
Query: 940 ---TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
++ PE + + ++DV+SFGVVL E+ + GK+
Sbjct: 197 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 236
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 62.8 bits (151), Expect = 1e-09, Method: Composition-based stats.
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 36/220 (16%)
Query: 783 IGTGGFGSTYKAE---LVP---GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
+G G FG + AE L+P LVAVK L Q F E L ++H+++V
Sbjct: 20 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFI--HKKSGK-----------KIQWSVIHKIAIDIA 883
G + +V+ ++ G+L F+ H K + + +A +A
Sbjct: 80 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 884 QALAY---LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG- 939
+ Y LH+ VHRD+ N L+ + L + DFG++R + ++ + V G
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGGR 190
Query: 940 ---TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
++ PE + + ++DV+SFGVVL E+ + GK+
Sbjct: 191 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 230
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 62.8 bits (151), Expect = 1e-09, Method: Composition-based stats.
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 36/220 (16%)
Query: 783 IGTGGFGSTYKAE---LVP---GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
+G G FG + AE L+P LVAVK L Q F E L ++H+++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFI--HKKSGK-----------KIQWSVIHKIAIDIA 883
G + +V+ ++ G+L F+ H K + + +A +A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 884 QALAY---LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG- 939
+ Y LH+ VHRD+ N L+ + L + DFG++R + ++ + V G
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGGR 219
Query: 940 ---TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
++ PE + + ++DV+SFGVVL E+ + GK+
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 62.8 bits (151), Expect = 1e-09, Method: Composition-based stats.
Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783 IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE V VAVK L + + +E+ + I +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
++ L+G + ++++ + S GNL ++ + +++S + K +
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883 AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
LA + Y + +HRD+ N+L+ E ++DFGLAR + + TT+
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
++APE + ++DV+SFGV++ E+ + S P G + KLL KE
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 274
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
G ++EL+ + + W A P +
Sbjct: 275 GHRMDKPANCTNELYMMMRDCWHAVPSQ 302
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
IG G FG ++ + G VAVK S R + +AEI +RH+N++ I
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 843 E----AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
+ +++LV ++ G+L ++++ + + + K+A+ A LA+LH V
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA-----GTFGYVAPEY 948
P I HRD+K NIL+ + ++D GLA + T D+A GT Y+APE
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 949 ATTC------RVSDKADVYSFGVVLLEL 970
+AD+Y+ G+V E+
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEI 211
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
IG G FG ++ + G VAVK S R + +AEI +RH+N++ I
Sbjct: 17 IGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 74
Query: 843 E----AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
+ +++LV ++ G+L ++++ + + + K+A+ A LA+LH V
Sbjct: 75 DNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQG 131
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA-----GTFGYVAPEY 948
P I HRD+K NIL+ + ++D GLA + T D+A GT Y+APE
Sbjct: 132 KPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEV 189
Query: 949 ATTC------RVSDKADVYSFGVVLLEL 970
+AD+Y+ G+V E+
Sbjct: 190 LDDSINMKHFESFKRADIYAMGLVFWEI 217
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
IG G FG ++ + G VAVK S R + +AEI +RH+N++ I
Sbjct: 12 IGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 69
Query: 843 E----AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
+ +++LV ++ G+L ++++ + + + K+A+ A LA+LH V
Sbjct: 70 DNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQG 126
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA-----GTFGYVAPEY 948
P I HRD+K NIL+ + ++D GLA + T D+A GT Y+APE
Sbjct: 127 KPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEV 184
Query: 949 ATTC------RVSDKADVYSFGVVLLEL 970
+AD+Y+ G+V E+
Sbjct: 185 LDDSINMKHFESFKRADIYAMGLVFWEI 212
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 62.4 bits (150), Expect = 1e-09, Method: Composition-based stats.
Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783 IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE V VAVK L + + +E+ + I +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
++ L+G + ++++ + S GNL ++ + +++S + K +
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883 AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
LA + Y + +HRD+ N+L+ E ++DFGLAR + + TT+
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
++APE + ++DV+SFGV++ E+ + S P G + KLL KE
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 274
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
G ++EL+ + + W A P +
Sbjct: 275 GHRMDKPANCTNELYMMMRDCWHAVPSQ 302
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 773 ATGNFSIRNLIGTGGFGSTY-------KAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
A + + ++G G FG Y K E + + KK ++F +E +
Sbjct: 22 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIM 79
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK-KSGKKIQWSVIHKIAIDIAQ 884
+ H ++V LIG + E +++ G L ++ + K+ K+ V++ ++ I +
Sbjct: 80 KNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQICK 136
Query: 885 ALAYLH-YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGY 943
A+AYL +CV HRDI NIL+ L DFGL+R +E + + + +
Sbjct: 137 AMAYLESINCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 192
Query: 944 VAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
++PE R + +DV+ F V + E++S GK+
Sbjct: 193 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 225
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
IG G FG ++ + G VAVK S R + +AEI +RH+N++ I
Sbjct: 14 IGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 71
Query: 843 E----AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
+ +++LV ++ G+L ++++ + + + K+A+ A LA+LH V
Sbjct: 72 DNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQG 128
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA-----GTFGYVAPEY 948
P I HRD+K NIL+ + ++D GLA + T D+A GT Y+APE
Sbjct: 129 KPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEV 186
Query: 949 ATTC------RVSDKADVYSFGVVLLEL 970
+AD+Y+ G+V E+
Sbjct: 187 LDDSINMKHFESFKRADIYAMGLVFWEI 214
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 62.4 bits (150), Expect = 1e-09, Method: Composition-based stats.
Identities = 66/268 (24%), Positives = 117/268 (43%), Gaps = 40/268 (14%)
Query: 783 IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE V VAVK L + + +E+ + I +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
++ L+G + ++++ + S GNL ++ + ++ S + K +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 883 AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
LA + Y + +HRD+ N+L+ E ++DFGLAR + + TT+
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
++APE + ++DV+SFGV++ E+ + S P G + KLL KE
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 274
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
G ++EL+ + + W A P +
Sbjct: 275 GHRMDKPANCTNELYMMMRDCWHAVPSQ 302
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 10/156 (6%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMF-LVYNFLSGGNLETFIHKKSGKKIQWSVIHKI 878
AE + ++ + +V +IG + EAE + LV G L ++ + + ++ I ++
Sbjct: 420 AEANVMQQLDNPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIEL 475
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA 938
++ + YL S VHRD+ N+LL + A +SDFGL++ L E +
Sbjct: 476 VHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 532
Query: 939 GTF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
G + + APE + S K+DV+SFGV++ E S
Sbjct: 533 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 10/156 (6%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMF-LVYNFLSGGNLETFIHKKSGKKIQWSVIHKI 878
AE + ++ + +V +IG + EAE + LV G L ++ + + ++ I ++
Sbjct: 419 AEANVMQQLDNPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIEL 474
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA 938
++ + YL S VHRD+ N+LL + A +SDFGL++ L E +
Sbjct: 475 VHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531
Query: 939 GTF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
G + + APE + S K+DV+SFGV++ E S
Sbjct: 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 33/229 (14%)
Query: 771 VRATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR 829
+R +F ++G G FG KA + A+KK+ + + +E+ L +
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVXLLASLN 60
Query: 830 HKNLVTLIGYYV-------------GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH 876
H+ +V ++ ++ +F+ + L IH ++ + Q
Sbjct: 61 HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQ-QRDEYW 119
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS------- 929
++ I +AL+Y+H I+HR++KP NI +DE N + DFGLA+ + S
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 930 ------ETHATTDVAGTFGYVAPEYAT-TCRVSDKADVYSFGVVLLELI 971
+ T GT YVA E T ++K D YS G++ E I
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225
>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX
Length = 361
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 15/217 (6%)
Query: 768 DNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG-----IQQFDAE 821
D+ V + + +IG G F + G AVK + + +F + E
Sbjct: 19 DDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKRE 78
Query: 822 IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS--VIHKIA 879
++H ++V L+ Y + +++V+ F+ G +L I K++ +S V
Sbjct: 79 ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 138
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTD 936
I +AL Y H + I+HRD+KP +LL + N+ L FG+A L S A
Sbjct: 139 RQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 195
Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
V GT ++APE DV+ GV+L L+SG
Sbjct: 196 V-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/228 (25%), Positives = 103/228 (45%), Gaps = 22/228 (9%)
Query: 766 TYDNVVRATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKL--SIGRFQGIQQFDAEI 822
++D + I IG G +G A + G VA+KK+ + ++ E+
Sbjct: 45 SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 104
Query: 823 GTLGRIRHKNLVTL-------IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVI 875
L +H N++ + + Y GE + V L +L IH S + + +
Sbjct: 105 KILKHFKHDNIIAIKDILRPTVPY--GEFKSVYVVLDLMESDLHQIIH--SSQPLTLEHV 160
Query: 876 HKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS---ETH 932
+ + L Y+H + +++HRD+KPSN+L++E + DFG+AR L S +
Sbjct: 161 RYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 217
Query: 933 ATTDVAGTFGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGKRSLDP 979
T+ T Y APE + +A D++S G + E+++ +R L P
Sbjct: 218 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA-RRQLFP 264
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 776 NFSIRNLIGTGGFGSTYKAE---LVP---GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR 829
+ ++ +G G FG + AE L P LVAVK L + F E L ++
Sbjct: 16 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ 75
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH--------------KKSGKKIQWSVI 875
H+++V G + +V+ ++ G+L F+ +++ ++ S +
Sbjct: 76 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 876 HKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT 935
IA IA + YL VHRD+ N L+ L + DFG++R + ++ +
Sbjct: 136 LHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-- 190
Query: 936 DVAG----TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
V G ++ PE + + ++DV+SFGV+L E+ +
Sbjct: 191 -VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 51/201 (25%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 783 IGTGGFGSTYKAELVPGY-LVAVKKLSIGRF-QGIQQFD-AEIGTLGRIRHKNLVTLIGY 839
IG G +G+ +KA+ + +VA+K++ + +G+ EI L ++HKN+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
+ ++ LV+ F +L+ + +G + ++ + + L + H ++H
Sbjct: 70 LHSDKKLTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSR---NVLH 124
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV-SDKA 958
RD+KP N+L++ L++FGLAR + + +V T Y P+ ++ S
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSI 183
Query: 959 DVYSFGVVLLELISGKRSLDP 979
D++S G + EL + R L P
Sbjct: 184 DMWSAGCIFAELANAGRPLFP 204
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 62.0 bits (149), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTY-------KAELVPGYLVAVKKLSIG-RFQGIQQFDAEIGT 824
A + + ++G G FG Y K E + VAVK ++F +E
Sbjct: 6 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKIN---VAVKTCKKDCTLDNKEKFMSEAVI 62
Query: 825 LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK-KSGKKIQWSVIHKIAIDIA 883
+ + H ++V LIG + E +++ G L ++ + K+ K+ V++ ++ I
Sbjct: 63 MKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQIC 119
Query: 884 QALAYLH-YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG 942
+A+AYL +CV HRDI NIL+ L DFGL+R +E + + +
Sbjct: 120 KAMAYLESINCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 175
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSL 977
+++PE R + +DV+ F V + E++S GK+
Sbjct: 176 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 211
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 62.0 bits (149), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTY-------KAELVPGYLVAVKKLSIG-RFQGIQQFDAEIGT 824
A + + ++G G FG Y K E + VAVK ++F +E
Sbjct: 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKIN---VAVKTCKKDCTLDNKEKFMSEAVI 66
Query: 825 LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK-KSGKKIQWSVIHKIAIDIA 883
+ + H ++V LIG + E +++ G L ++ + K+ K+ V++ ++ I
Sbjct: 67 MKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQIC 123
Query: 884 QALAYLH-YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG 942
+A+AYL +CV HRDI NIL+ L DFGL+R +E + + +
Sbjct: 124 KAMAYLESINCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 179
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
+++PE R + +DV+ F V + E++S GK+
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 62.0 bits (149), Expect = 2e-09, Method: Composition-based stats.
Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783 IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE V VAVK L + + +E+ + I +HKN
Sbjct: 30 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
++ L+G + ++++ + S GNL ++ + +++S + K +
Sbjct: 90 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 883 AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
LA + Y + +HRD+ N+L+ E ++DFGLAR + + TT+
Sbjct: 150 TYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 209
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
++APE + ++DV+SFGV++ E+ + S P G + KLL KE
Sbjct: 210 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 261
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
G ++EL+ + + W A P +
Sbjct: 262 GHRMDKPANCTNELYMMMRDCWHAVPSQ 289
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 62.0 bits (149), Expect = 2e-09, Method: Composition-based stats.
Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783 IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE V VAVK L + + +E+ + I +HKN
Sbjct: 35 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
++ L+G + ++++ + S GNL ++ + +++S + K +
Sbjct: 95 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 883 AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
LA + Y + +HRD+ N+L+ E ++DFGLAR + + TT+
Sbjct: 155 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 214
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
++APE + ++DV+SFGV++ E+ + S P G + KLL KE
Sbjct: 215 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 266
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
G ++EL+ + + W A P +
Sbjct: 267 GHRMDKPANCTNELYMMMRDCWHAVPSQ 294
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In
Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In
Complex With Arq 069
Length = 313
Score = 62.0 bits (149), Expect = 2e-09, Method: Composition-based stats.
Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783 IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
+G G FG AE V VAVK L + + +E+ + I +HKN
Sbjct: 32 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
++ L+G + ++++ + S GNL ++ + +++S + K +
Sbjct: 92 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 883 AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
LA + Y + +HRD+ N+L+ E ++DFGLAR + + TT+
Sbjct: 152 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 211
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
++APE + ++DV+SFGV++ E+ + S P G + KLL KE
Sbjct: 212 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 263
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
G ++EL+ + + W A P +
Sbjct: 264 GHRMDKPANCTNELYMMMRDCWHAVPSQ 291
>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0G|B Chain B, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0H|A Chain A, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0H|B Chain B, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0I|A Chain A, Cask Cam-Kinase Domain- 3'-Amp Complex, P212121 Form
Length = 351
Score = 62.0 bits (149), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 15/217 (6%)
Query: 768 DNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG-----IQQFDAE 821
D+ V + + +IG G F + G AVK + + +F + E
Sbjct: 17 DDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKRE 76
Query: 822 IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS--VIHKIA 879
++H ++V L+ Y + +++V+ F+ G +L I K++ +S V
Sbjct: 77 ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 136
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTD 936
I +AL Y H + I+HRD+KP +LL + N+ L FG+A L S A
Sbjct: 137 RQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
V GT ++APE DV+ GV+L L+SG
Sbjct: 194 V-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 61.6 bits (148), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 64/251 (25%), Positives = 108/251 (43%), Gaps = 27/251 (10%)
Query: 783 IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
+G G FG +A+ VAVK L G + +E+ L I H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 835 TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY----- 888
L+G + ++ F GNL T++ K + + + ++K + + + Y
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 889 --LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTFGYVA 945
+ + + +HRD+ NILL E+ + DFGLAR + + D ++A
Sbjct: 155 KGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMA 214
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG---R 1002
PE + ++DV+SFGV+L E+ S S P G I +KEG R
Sbjct: 215 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFXRRLKEGTRMR 267
Query: 1003 SSELFLPELWE 1013
+ + PE+++
Sbjct: 268 APDYTTPEMYQ 278
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 61.6 bits (148), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 783 IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
+G G FG +A+ VAVK L G + +E+ L I H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 835 TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY----- 888
L+G + ++ F GNL T++ K + + + ++K + + + Y
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 889 --LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTFGYVA 945
+ + + +HRD+ NILL E+ + DFGLAR + + D ++A
Sbjct: 155 KGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 214
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS 972
PE + ++DV+SFGV+L E+ S
Sbjct: 215 PETIFDRVYTIQSDVWSFGVLLWEIFS 241
>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor
6-(5-(2-Aminopyrimidin-4-Ylamino)-2-
Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide
Length = 320
Score = 61.6 bits (148), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
Y G + +V L GG L + I + + +I I +A+ YLH I H
Sbjct: 82 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 138
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
RD+KP N+L + NA L +DFG A+ E + ++ T+ T YVAPE +
Sbjct: 139 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTEPCYTPYYVAPEVLGPEKYDK 196
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
D++S GV++ L+ G P +S +G
Sbjct: 197 SCDMWSLGVIMYILLCG---YPPFYSNHG 222
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 71/133 (53%), Gaps = 6/133 (4%)
Query: 846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPS 905
++ V +++GG+L I + K +V + A +I+ L +LH I++RD+K
Sbjct: 95 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY--AAEISIGLFFLHKRG---IIYRDLKLD 149
Query: 906 NILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGV 965
N++LD E + ++DFG+ + + + T + GT Y+APE D +++GV
Sbjct: 150 NVMLDSEGHIKIADFGMCK-EHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGV 208
Query: 966 VLLELISGKRSLD 978
+L E+++G+ D
Sbjct: 209 LLYEMLAGQPPFD 221
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 34/221 (15%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL---VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RH 830
+ +++IG G FG KA + L A+K++ + F E+ L ++ H
Sbjct: 23 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 82
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK--------------SGKKIQWSVIH 876
N++ L+G ++L + GNL F+ K + + +
Sbjct: 83 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 142
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
A D+A+ + YL + +HR++ NIL+ E A ++DFGL+R EV
Sbjct: 143 HFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSRGQEVY------- 192
Query: 937 VAGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
V T G ++A E + +DV+S+GV+L E++S
Sbjct: 193 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 61.2 bits (147), Expect = 3e-09, Method: Composition-based stats.
Identities = 80/280 (28%), Positives = 120/280 (42%), Gaps = 36/280 (12%)
Query: 779 IRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRHKN 832
IR+L G G FG P G +VAVK L Q + EI L + H++
Sbjct: 19 IRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEH 77
Query: 833 LVTLIGYY--VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
++ G GE + LV ++ G+L ++ + S I + + A I + +AYLH
Sbjct: 78 IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH 134
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-----AGTFGYVA 945
+HR++ N+LLD + + DFGLA+ V E H V + F Y A
Sbjct: 135 ---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWY-A 188
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
PE + +DV+SFGV L EL++ D S S ++ I +G+ +
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELLT---HCDSSQSPPTKFLELIG-----IAQGQMTV 240
Query: 1006 LFLPELWEAG-----PQENLLGMMRLASTCTVETLSTRPS 1040
L L EL E G P + + L C S RP+
Sbjct: 241 LRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPT 280
>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain
Length = 335
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI------------- 822
+F L+G G FG ++ V++ + GR+ ++ E+
Sbjct: 6 DFDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 823 -GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
L RH L L + + V + +GG L F H + +
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE 113
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
I AL YLH V V+RDIK N++LD++ + ++DFGL + +S+ GT
Sbjct: 114 IVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTP 169
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
Y+APE D + GVV+ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
pdb|1MRY|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
Length = 339
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI------------- 822
+F L+G G FG ++ V++ + GR+ ++ E+
Sbjct: 9 DFDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 58
Query: 823 -GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
L RH L L + + V + +GG L F H + +
Sbjct: 59 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE 116
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
I AL YLH V V+RDIK N++LD++ + ++DFGL + +S+ GT
Sbjct: 117 IVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTP 172
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
Y+APE D + GVV+ E++ G+
Sbjct: 173 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 56/238 (23%), Positives = 101/238 (42%), Gaps = 26/238 (10%)
Query: 757 TFADTPAELTYDNVVR-ATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG 814
TF D P +L Y+ N +G G FG +A G AV K+++ +
Sbjct: 28 TFID-PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS 86
Query: 815 IQQFDAEIGTLGRIR-------HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS- 866
D + + ++ H+N+V L+G + ++ + G+L F+ +KS
Sbjct: 87 TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR 146
Query: 867 -----------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNA 915
+ + + +AQ +A+L +HRD+ N+LL A
Sbjct: 147 VLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVA 203
Query: 916 YLSDFGLAR-LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
+ DFGLAR ++ S + ++APE C + ++DV+S+G++L E+ S
Sbjct: 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 61.2 bits (147), Expect = 3e-09, Method: Composition-based stats.
Identities = 80/280 (28%), Positives = 120/280 (42%), Gaps = 36/280 (12%)
Query: 779 IRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRHKN 832
IR+L G G FG P G +VAVK L Q + EI L + H++
Sbjct: 19 IRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEH 77
Query: 833 LVTLIGYY--VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
++ G GE + LV ++ G+L ++ + S I + + A I + +AYLH
Sbjct: 78 IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH 134
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-----AGTFGYVA 945
+HR++ N+LLD + + DFGLA+ V E H V + F Y A
Sbjct: 135 SQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWY-A 188
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
PE + +DV+SFGV L EL++ D S S ++ I +G+ +
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELLT---HCDSSQSPPTKFLELIG-----IAQGQMTV 240
Query: 1006 LFLPELWEAG-----PQENLLGMMRLASTCTVETLSTRPS 1040
L L EL E G P + + L C S RP+
Sbjct: 241 LRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPT 280
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 60.8 bits (146), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 66/239 (27%), Positives = 109/239 (45%), Gaps = 28/239 (11%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTLIG 838
IG+G G A + V G VAVKKLS FQ ++ E+ L + HKN+++L+
Sbjct: 30 IGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQTHAKRAYRELVLLKCVNHKNIISLLN 88
Query: 839 YYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ + +++LV + NL IH + + +++++ I +LH +
Sbjct: 89 VFTPQKTLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIK----HLHSA 143
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 144 G---IIHRDLKPSNIVVKSDCTLKILDFGLART--ASTNFMMTPYVVTRYYRAPEVILGM 198
Query: 953 RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011
+ D++S G ++ EL+ G + +I W K++ + G S F+ L
Sbjct: 199 GYKENVDIWSVGCIMGELVKGSVI-------FQGTDHIDQWNKVIEQLGTPSAEFMAAL 250
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 60.8 bits (146), Expect = 4e-09, Method: Composition-based stats.
Identities = 81/285 (28%), Positives = 121/285 (42%), Gaps = 46/285 (16%)
Query: 779 IRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKN 832
IR+L G G FG P G +VAVK L G ++ + EI L + H++
Sbjct: 13 IRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEH 71
Query: 833 LVTLIGYY--VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+V G GE + LV ++ G+L ++ + + + + A I + +AYLH
Sbjct: 72 IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC---VGLAQLLLFAQQICEGMAYLH 128
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-----AGTFGYVA 945
+HR + N+LLD + + DFGLA+ V E H V + F Y A
Sbjct: 129 ---AQHYIHRALAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWY-A 182
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS---GKRSLDPSFSEYGNGFNIVSWAKLLI--KE 1000
PE C+ +DV+SFGV L EL++ +S F+E LI +
Sbjct: 183 PECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTE-------------LIGHTQ 229
Query: 1001 GRSSELFLPELWEAG-----PQENLLGMMRLASTCTVETLSTRPS 1040
G+ + L L EL E G P + L C S RP+
Sbjct: 230 GQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPT 274
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 60.8 bits (146), Expect = 4e-09, Method: Composition-based stats.
Identities = 81/285 (28%), Positives = 121/285 (42%), Gaps = 46/285 (16%)
Query: 779 IRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKN 832
IR+L G G FG P G +VAVK L G ++ + EI L + H++
Sbjct: 14 IRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEH 72
Query: 833 LVTLIGYY--VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+V G GE + LV ++ G+L ++ + + + + A I + +AYLH
Sbjct: 73 IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC---VGLAQLLLFAQQICEGMAYLH 129
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-----AGTFGYVA 945
+HR + N+LLD + + DFGLA+ V E H V + F Y A
Sbjct: 130 ---AQHYIHRALAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWY-A 183
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS---GKRSLDPSFSEYGNGFNIVSWAKLLI--KE 1000
PE C+ +DV+SFGV L EL++ +S F+E LI +
Sbjct: 184 PECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTE-------------LIGHTQ 230
Query: 1001 GRSSELFLPELWEAG-----PQENLLGMMRLASTCTVETLSTRPS 1040
G+ + L L EL E G P + L C S RP+
Sbjct: 231 GQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPT 275
>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands
pdb|3GOK|B Chain B, Binding Site Mapping Of Protein Ligands
pdb|3GOK|C Chain C, Binding Site Mapping Of Protein Ligands
pdb|3GOK|D Chain D, Binding Site Mapping Of Protein Ligands
pdb|3GOK|E Chain E, Binding Site Mapping Of Protein Ligands
pdb|3GOK|F Chain F, Binding Site Mapping Of Protein Ligands
pdb|3GOK|G Chain G, Binding Site Mapping Of Protein Ligands
pdb|3GOK|H Chain H, Binding Site Mapping Of Protein Ligands
pdb|3GOK|I Chain I, Binding Site Mapping Of Protein Ligands
pdb|3GOK|J Chain J, Binding Site Mapping Of Protein Ligands
pdb|3GOK|K Chain K, Binding Site Mapping Of Protein Ligands
pdb|3GOK|L Chain L, Binding Site Mapping Of Protein Ligands
Length = 334
Score = 60.8 bits (146), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
Y G + +V L GG L + I + + +I I +A+ YLH I H
Sbjct: 98 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 154
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
RD+KP N+L + NA L +DFG A+ E + ++ T T YVAPE +
Sbjct: 155 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 212
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
D++S GV++ L+ G P +S +G
Sbjct: 213 SCDMWSLGVIMYILLCG---YPPFYSNHG 238
>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
pdb|3RNY|B Chain B, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
Length = 346
Score = 60.8 bits (146), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 21/165 (12%)
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWS-VIHKIAIDIAQAL 886
+H N++TL Y ++LV + GG L + + +K + + S V+H I + +
Sbjct: 79 QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG----KTV 134
Query: 887 AYLHYSCVPRIVHRDIKPSNIL-LDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
YLH V VHRD+KPSNIL +DE N + DFG A+ L +E T
Sbjct: 135 EYLHSQGV---VHRDLKPSNILYVDESGNPECLRICDFGFAKQLR-AENGLLMTPCYTAN 190
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
+VAPE + D++S G++L +++G ++ + NG
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAG-------YTPFANG 228
>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal
Form-1, Soaking)
pdb|2JBP|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|B Chain B, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|C Chain C, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|D Chain D, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|E Chain E, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|F Chain F, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|G Chain G, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|H Chain H, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|I Chain I, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|J Chain J, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|K Chain K, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|L Chain L, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
Length = 326
Score = 60.5 bits (145), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
Y G + +V L GG L + I + + +I I +A+ YLH I H
Sbjct: 90 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 146
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
RD+KP N+L + NA L +DFG A+ E + ++ T T YVAPE +
Sbjct: 147 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 204
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
D++S GV++ L+ G P +S +G
Sbjct: 205 SCDMWSLGVIMYILLCG---YPPFYSNHG 230
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 60.5 bits (145), Expect = 4e-09, Method: Composition-based stats.
Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 8/155 (5%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
AE + ++ + +V +IG E+ M LV G L ++ + + ++ I ++
Sbjct: 55 AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNIIELV 111
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
++ + YL S VHRD+ N+LL + A +SDFGL++ L E + G
Sbjct: 112 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 168
Query: 940 TF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
+ + APE + S K+DV+SFGV++ E S
Sbjct: 169 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 60.5 bits (145), Expect = 4e-09, Method: Composition-based stats.
Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 8/155 (5%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
AE + ++ + +V +IG E+ M LV G L ++ + + ++ I ++
Sbjct: 67 AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNIIELV 123
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
++ + YL S VHRD+ N+LL + A +SDFGL++ L E + G
Sbjct: 124 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 180
Query: 940 TF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
+ + APE + S K+DV+SFGV++ E S
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 60.5 bits (145), Expect = 4e-09, Method: Composition-based stats.
Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 8/155 (5%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
AE + ++ + +V +IG E+ M LV G L ++ + + ++ I ++
Sbjct: 77 AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNIIELV 133
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
++ + YL S VHRD+ N+LL + A +SDFGL++ L E + G
Sbjct: 134 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 190
Query: 940 TF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
+ + APE + S K+DV+SFGV++ E S
Sbjct: 191 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 60.5 bits (145), Expect = 4e-09, Method: Composition-based stats.
Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 8/155 (5%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
AE + ++ + +V +IG E+ M LV G L ++ + + ++ I ++
Sbjct: 77 AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNIIELV 133
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
++ + YL S VHRD+ N+LL + A +SDFGL++ L E + G
Sbjct: 134 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 190
Query: 940 TF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
+ + APE + S K+DV+SFGV++ E S
Sbjct: 191 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 60.5 bits (145), Expect = 4e-09, Method: Composition-based stats.
Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 8/155 (5%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
AE + ++ + +V +IG E+ M LV G L ++ + + ++ I ++
Sbjct: 57 AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNIIELV 113
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
++ + YL S VHRD+ N+LL + A +SDFGL++ L E + G
Sbjct: 114 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 940 TF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
+ + APE + S K+DV+SFGV++ E S
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 60.5 bits (145), Expect = 4e-09, Method: Composition-based stats.
Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 8/155 (5%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
AE + ++ + +V +IG E+ M LV G L ++ + + ++ I ++
Sbjct: 61 AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNIIELV 117
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
++ + YL S VHRD+ N+LL + A +SDFGL++ L E + G
Sbjct: 118 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 174
Query: 940 TF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
+ + APE + S K+DV+SFGV++ E S
Sbjct: 175 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 60.5 bits (145), Expect = 4e-09, Method: Composition-based stats.
Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 8/155 (5%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
AE + ++ + +V +IG E+ M LV G L ++ + + ++ I ++
Sbjct: 75 AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNIIELV 131
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
++ + YL S VHRD+ N+LL + A +SDFGL++ L E + G
Sbjct: 132 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 188
Query: 940 TF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
+ + APE + S K+DV+SFGV++ E S
Sbjct: 189 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223
>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2
pdb|1KWP|B Chain B, Crystal Structure Of Mapkap2
pdb|1NY3|A Chain A, Crystal Structure Of Adp Bound To Map Kap Kinase 2
Length = 400
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
Y G + +V L GG L + I + + +I I +A+ YLH I H
Sbjct: 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 184
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
RD+KP N+L + NA L +DFG A+ E + ++ T T YVAPE +
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 242
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
D++S GV++ L+ G P +S +G
Sbjct: 243 SCDMWSLGVIMYILLCG---YPPFYSNHG 268
>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap
Kinase-2
Length = 325
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
Y G + +V L GG L + I + + +I I +A+ YLH I H
Sbjct: 89 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 145
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
RD+KP N+L + NA L +DFG A+ E + ++ T T YVAPE +
Sbjct: 146 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 203
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
D++S GV++ L+ G P +S +G
Sbjct: 204 SCDMWSLGVIMYILLCG---YPPFYSNHG 229
>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
Length = 406
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
Y G + +V L GG L + I + + +I I +A+ YLH I H
Sbjct: 134 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 190
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
RD+KP N+L + NA L +DFG A+ E + ++ T T YVAPE +
Sbjct: 191 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 248
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
D++S GV++ L+ G P +S +G
Sbjct: 249 SCDMWSLGVIMYILLCG---YPPFYSNHG 274
>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|B Chain B, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|C Chain C, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|D Chain D, Structure Of Mk2 Complexed With Compound 76
pdb|3KC3|A Chain A, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|B Chain B, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|C Chain C, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|D Chain D, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|E Chain E, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|F Chain F, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|G Chain G, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|H Chain H, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|I Chain I, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|J Chain J, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|K Chain K, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|L Chain L, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3A2C|A Chain A, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|B Chain B, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|C Chain C, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|D Chain D, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|E Chain E, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|F Chain F, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|G Chain G, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|H Chain H, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|I Chain I, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|J Chain J, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|K Chain K, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|L Chain L, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
Length = 324
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
Y G + +V L GG L + I + + +I I +A+ YLH I H
Sbjct: 88 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 144
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
RD+KP N+L + NA L +DFG A+ E + ++ T T YVAPE +
Sbjct: 145 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 202
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
D++S GV++ L+ G P +S +G
Sbjct: 203 SCDMWSLGVIMYILLCG---YPPFYSNHG 228
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 51/199 (25%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG-----YLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLV 834
++G+G FG+ YK +P VA+K L + ++ E + + +
Sbjct: 23 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
L+G + + + LV + G L + + G+ +++ + IA+ ++YL
Sbjct: 83 RLLGICL-TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLN-WCMQIAKGMSYLEDV-- 138
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-FGYVAPEYATTCR 953
R+VHRD+ N+L+ + ++DFGLARLL++ ET D ++A E R
Sbjct: 139 -RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRR 197
Query: 954 VSDKADVYSFGVVLLELIS 972
+ ++DV+S+GV + EL++
Sbjct: 198 FTHQSDVWSYGVTVWELMT 216
>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|B Chain B, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|C Chain C, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|D Chain D, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|E Chain E, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|F Chain F, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|G Chain G, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|H Chain H, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|I Chain I, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|J Chain J, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|K Chain K, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|L Chain L, Mk2 Kinase Bound To Compound 5b
Length = 318
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
Y G + +V L GG L + I + + +I I +A+ YLH I H
Sbjct: 82 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 138
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
RD+KP N+L + NA L +DFG A+ E + ++ T T YVAPE +
Sbjct: 139 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 196
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
D++S GV++ L+ G P +S +G
Sbjct: 197 SCDMWSLGVIMYILLCG---YPPFYSNHG 222
>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|B Chain B, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|C Chain C, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|D Chain D, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
Length = 316
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 16/198 (8%)
Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQ---FDAEIGTLGRIRHKNLVTLIG 838
+G G +G K VP G + AVK++ Q+ D +I + + VT G
Sbjct: 42 LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDI-SXRTVDCPFTVTFYG 100
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
E ++++ L +L+ F + G+ I ++ KIA+ I +AL +LH
Sbjct: 101 ALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--S 157
Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA----TTC 952
++HRD+KPSN+L++ DFG++ L V + D AG Y APE
Sbjct: 158 VIHRDVKPSNVLINALGQVKXCDFGISGYL-VDDVAKDID-AGCKPYXAPERINPELNQK 215
Query: 953 RVSDKADVYSFGVVLLEL 970
S K+D++S G+ +EL
Sbjct: 216 GYSVKSDIWSLGITXIEL 233
>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1
pdb|3R30|A Chain A, Mk2 Kinase Bound To Compound 2
Length = 319
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
Y G + +V L GG L + I + + +I I +A+ YLH I H
Sbjct: 83 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 139
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
RD+KP N+L + NA L +DFG A+ E + ++ T T YVAPE +
Sbjct: 140 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 197
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
D++S GV++ L+ G P +S +G
Sbjct: 198 SCDMWSLGVIMYILLCG---YPPFYSNHG 223
>pdb|2OZA|A Chain A, Structure Of P38alpha Complex
Length = 356
Score = 60.1 bits (144), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
Y G + +V L GG L + I + + +I I +A+ YLH I H
Sbjct: 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 140
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
RD+KP N+L + NA L +DFG A+ E + ++ T T YVAPE +
Sbjct: 141 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 198
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
D++S GV++ L+ G P +S +G
Sbjct: 199 SCDMWSLGVIMYILLCG---YPPFYSNHG 224
>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2F2U|B Chain B, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2H9V|A Chain A, Structural Basis For Induced-Fit Binding Of Rho-Kinase To
The Inhibitor Y27632
Length = 402
Score = 60.1 bits (144), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIRH 830
++ + +IG G FG V KL + +F+ I++ D+ E +
Sbjct: 76 DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKL-LSKFEMIKRSDSAFFWEERDIMAFANS 134
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+V L + + +++V ++ GG+L + + +W+ + ++ AL +H
Sbjct: 135 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAKFY--TAEVVLALDAIH 191
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA-RLLEVSETHATTDVAGTFGYVAPE-- 947
++HRD+KP N+LLD+ + L+DFG ++ E H T V GT Y++PE
Sbjct: 192 SMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYISPEVL 247
Query: 948 --------YATTCRVSDKADVYSFGVVLLELISG 973
Y C D +S GV L E++ G
Sbjct: 248 KSQGGDGYYGREC------DWWSVGVFLFEMLVG 275
>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
pdb|2WNT|B Chain B, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
Length = 330
Score = 60.1 bits (144), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 54/174 (31%), Positives = 85/174 (48%), Gaps = 22/174 (12%)
Query: 821 EIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWS-VIHK 877
EI L R +H N++TL Y ++LV + GG L + + +K + + S V+H
Sbjct: 70 EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHT 129
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNIL-LDEELNA---YLSDFGLARLLEVSETHA 933
I + + YLH V VHRD+KPSNIL +DE N + DFG A+ L +E
Sbjct: 130 IG----KTVEYLHSQGV---VHRDLKPSNILYVDESGNPECLRICDFGFAKQLR-AENGL 181
Query: 934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
T +VAPE + D++S G++L +++G ++ + NG
Sbjct: 182 LMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG-------YTPFANG 228
>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To
Mapkap Kinase-2
pdb|3FYJ|X Chain X, Crystal Structure Of An Optimzied Benzothiophene Inhibitor
Bound To Mapkap Kinase-2 (Mk-2)
pdb|3FYK|X Chain X, Crystal Structure Of A Benzthiophene Lead Bound To Mapkap
Kinase-2 (Mk-2)
Length = 327
Score = 60.1 bits (144), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
Y G + +V L GG L + I + + +I I +A+ YLH I H
Sbjct: 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 140
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
RD+KP N+L + NA L +DFG A+ E + ++ T T YVAPE +
Sbjct: 141 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 198
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
D++S GV++ L+ G P +S +G
Sbjct: 199 SCDMWSLGVIMYILLCG---YPPFYSNHG 224
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 59.7 bits (143), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 762 PAELTYDNVVRATGNFSIRNL--IGTGGFGSTYKAELVP-------GYLVAVKKLSIGRF 812
P+E + R +R L +G+G FG+ +K +P + V + GR
Sbjct: 16 PSEKANKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR- 74
Query: 813 QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQW 872
Q Q + +G + H ++V L+G G + + LV +L G+L + + G +
Sbjct: 75 QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA-LGP 132
Query: 873 SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
++ + IA+ + YL +VHR++ N+LL ++DFG+A LL +
Sbjct: 133 QLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 189
Query: 933 ATTDVAGT-FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
A T ++A E + + ++DV+S+GV + EL++
Sbjct: 190 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230
>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B
Akt By Hydrophobic Motif Phosphorylation
pdb|1GZO|A Chain A, Structure Of Protein Kinase B Unphosphorylated
Length = 315
Score = 59.7 bits (143), Expect = 9e-09, Method: Composition-based stats.
Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI------------- 822
+F L+G G FG ++ V++ + GR+ ++ E+
Sbjct: 6 DFDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 823 -GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
L RH L L + + V + +GG E F H + +
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAE 113
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
I AL YLH +V+RDIK N++LD++ + ++DFGL + +S+ GT
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTP 169
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
Y+APE D + GVV+ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDR|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With The Inhibitor
A- 443654
pdb|2UW9|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|2X39|A Chain A, Structure Of
4-Amino-N-(4-Chlorobenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidine-4-Carboxamide Bound To Pkb
pdb|2XH5|A Chain A, Structure Of 4-(4-Tert-Butylbenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidin-4-Amine Bound To Pkb
Length = 342
Score = 59.7 bits (143), Expect = 9e-09, Method: Composition-based stats.
Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI------------- 822
+F L+G G FG ++ V++ + GR+ ++ E+
Sbjct: 11 DFDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 60
Query: 823 -GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
L RH L L + + V + +GG E F H + +
Sbjct: 61 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAE 118
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
I AL YLH +V+RDIK N++LD++ + ++DFGL + +S+ GT
Sbjct: 119 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTP 174
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
Y+APE D + GVV+ E++ G+
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207
>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B
(pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3
Peptide
Length = 337
Score = 59.7 bits (143), Expect = 9e-09, Method: Composition-based stats.
Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI------------- 822
+F L+G G FG ++ V++ + GR+ ++ E+
Sbjct: 6 DFDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 823 -GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
L RH L L + + V + +GG E F H + +
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAE 113
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
I AL YLH +V+RDIK N++LD++ + ++DFGL + +S+ GT
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTP 169
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
Y+APE D + GVV+ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d
With Gsk3 Peptide And Amp-Pnp
Length = 336
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI------------- 822
+F L+G G FG ++ V++ + GR+ ++ E+
Sbjct: 6 DFDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 823 -GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
L RH L L + + V + +GG E F H + +
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAE 113
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
I AL YLH +V+RDIK N++LD++ + ++DFGL + +S+ GT
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTP 169
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
Y+APE D + GVV+ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E87|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3D0E|A Chain A, Crystal Structure Of Human Akt2 In Complex With Gsk690693
pdb|3D0E|B Chain B, Crystal Structure Of Human Akt2 In Complex With Gsk690693
Length = 335
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI------------- 822
+F L+G G FG ++ V++ + GR+ ++ E+
Sbjct: 6 DFDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 823 -GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
L RH L L + + V + +GG E F H + +
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAE 113
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
I AL YLH +V+RDIK N++LD++ + ++DFGL + +S+ GT
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTP 169
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
Y+APE D + GVV+ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 8/155 (5%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
AE + ++ + +V +IG E+ M LV G L ++ + + ++ I ++
Sbjct: 61 AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNIIELV 117
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
++ + YL S VHRD+ N+LL + A +SDFGL++ L E G
Sbjct: 118 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHG 174
Query: 940 TF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
+ + APE + S K+DV+SFGV++ E S
Sbjct: 175 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209
>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363
Length = 340
Score = 59.3 bits (142), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 30/218 (13%)
Query: 772 RATGN-FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI-------- 822
R T N F L+G G FG ++ VK+ + GR+ ++ E+
Sbjct: 4 RVTMNEFEYLKLLGKGTFGK----------VILVKEKATGRYYAMKILKKEVIVAKDEVA 53
Query: 823 ------GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH 876
L RH L L + + V + +GG L F H +
Sbjct: 54 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRAR 111
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
+I AL YLH +V+RD+K N++LD++ + ++DFGL + + +
Sbjct: 112 FYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKX 168
Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
GT Y+APE D + GVV+ E++ G+
Sbjct: 169 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206
>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex
With N-(4-
(5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h-
Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide
Length = 446
Score = 59.3 bits (142), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 30/218 (13%)
Query: 772 RATGN-FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI-------- 822
R T N F L+G G FG ++ VK+ + GR+ ++ E+
Sbjct: 144 RVTMNEFEYLKLLGKGTFGK----------VILVKEKATGRYYAMKILKKEVIVAKDEVA 193
Query: 823 ------GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH 876
L RH L L + + V + +GG L F H +
Sbjct: 194 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRAR 251
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
+I AL YLH +V+RD+K N++LD++ + ++DFGL + + +
Sbjct: 252 FYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKT 308
Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
GT Y+APE D + GVV+ E++ G+
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric
Inhibitor
Length = 446
Score = 59.3 bits (142), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 30/218 (13%)
Query: 772 RATGN-FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI-------- 822
R T N F L+G G FG ++ VK+ + GR+ ++ E+
Sbjct: 147 RVTMNEFEYLKLLGKGTFGK----------VILVKEKATGRYYAMKILKKEVIVAKDEVA 196
Query: 823 ------GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH 876
L RH L L + + V + +GG L F H +
Sbjct: 197 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRAR 254
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
+I AL YLH +V+RD+K N++LD++ + ++DFGL + + +
Sbjct: 255 FYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKT 311
Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
GT Y+APE D + GVV+ E++ G+
Sbjct: 312 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 816 QQFDAEIGTLGRIRHKNLVTLIGYY----VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
Q+F E L ++H N+V + G+ + LV + G L+T++ + KI+
Sbjct: 70 QRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIK 129
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSE 930
V+ I + L +LH + P I+HRD+K NI + + + D GLA L S
Sbjct: 130 --VLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186
Query: 931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
A V GT + APE + + DVY+FG LE + + +SE N I
Sbjct: 187 AKA---VIGTPEFXAPEXYEE-KYDESVDVYAFGXCXLEXATSEY----PYSECQNAAQI 238
Query: 991 VSWAKLLIKEGRSSELFLPELWE 1013
+K ++ +PE+ E
Sbjct: 239 YRRVTSGVKPASFDKVAIPEVKE 261
>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From
Cryptosporidium Parvum, Cgd7_40
Length = 345
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 68/250 (27%), Positives = 96/250 (38%), Gaps = 58/250 (23%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFD--------AEIGTLGRI 828
+ ++ IG G +G A + A++ + I I+Q + E+ + ++
Sbjct: 28 YHLKGAIGQGSYGVVRVA--IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNL----ETFIHKKSGK------KIQW------ 872
H N+ L Y E + LV GG+L FI +GK K Q
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 873 ----------------------SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL- 909
+I I I AL YLH I HRDIKP N L
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFS 202
Query: 910 -DEELNAYLSDFGLAR---LLEVSETHATTDVAGTFGYVAPEYATTCRVS--DKADVYSF 963
++ L DFGL++ L E + T AGT +VAPE T S K D +S
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262
Query: 964 GVVLLELISG 973
GV+L L+ G
Sbjct: 263 GVLLHLLLMG 272
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 65/255 (25%), Positives = 110/255 (43%), Gaps = 31/255 (12%)
Query: 783 IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
+G G FG +A+ VAVK L G + +E+ L I H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 835 TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV----IHKIAIDIAQALAY- 888
L+G + ++ F GNL T++ K + + + V ++K + + + Y
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 889 ------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTF 941
+ + + +HRD+ NILL E+ + DFGLAR + + + D
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001
++APE + ++DV+SFGV+L E+ S S P G I +KEG
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFCRRLKEG 267
Query: 1002 ---RSSELFLPELWE 1013
R+ + PE+++
Sbjct: 268 TRMRAPDYTTPEMYQ 282
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 65/255 (25%), Positives = 109/255 (42%), Gaps = 31/255 (12%)
Query: 783 IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
+G G FG +A+ VAVK L G + +E+ L I H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 835 TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV----IHKIAIDIAQALAY- 888
L+G + ++ F GNL T++ K + + + V ++K + + + Y
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 889 ------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTF 941
+ + + +HRD+ NILL E+ + DFGLAR + + D
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 214
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001
++APE + ++DV+SFGV+L E+ S S P G I +KEG
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFCRRLKEG 267
Query: 1002 ---RSSELFLPELWE 1013
R+ + PE+++
Sbjct: 268 TRMRAPDYTTPEMYQ 282
>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin
Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin
Length = 330
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV- 841
+G G +G ++ G VAVK S R + + E+ +RH+N++ I +
Sbjct: 45 VGKGRYGEVWRGSW-QGENVAVKIFS-SRDEKSWFRETELYNTVMLRHENILGFIASDMT 102
Query: 842 ---GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
+++L+ ++ G+L ++ + + +I + IA LA+LH
Sbjct: 103 SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSIASGLAHLHIEIFGTQG 159
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-----AGTFGYVAPEY 948
P I HRD+K NIL+ + ++D GLA + S++ DV GT Y+APE
Sbjct: 160 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH--SQSTNQLDVGNNPRVGTKRYMAPEV 217
Query: 949 -ATTCRVS-----DKADVYSFGVVLLEL 970
T +V + D+++FG+VL E+
Sbjct: 218 LDETIQVDCFDSYKRVDIWAFGLVLWEV 245
>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3MTF|B Chain B, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3OOM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00507
pdb|3Q4U|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|B Chain B, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|C Chain C, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|D Chain D, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
Length = 301
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+ ++ +G G +G ++ G VAVK S R + + E+ +RH+N++
Sbjct: 9 DITLLECVGKGRYGEVWRGSW-QGENVAVKIFS-SRDEKSWFRETELYNTVMLRHENILG 66
Query: 836 LIGYYV----GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
I + +++L+ ++ G+L ++ + + +I + IA LA+LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSIASGLAHLHI 123
Query: 892 SCV-----PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-----AGTF 941
P I HRD+K NIL+ + ++D GLA + S++ DV GT
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH--SQSTNQLDVGNNPRVGTK 181
Query: 942 GYVAPEY-ATTCRVS-----DKADVYSFGVVLLEL 970
Y+APE T +V + D+++FG+VL E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216
>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine
Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex
With An Indirubin Ligand
Length = 429
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 71/281 (25%), Positives = 114/281 (40%), Gaps = 29/281 (10%)
Query: 764 ELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIG 823
++ +D+V + + +IG G FG KA + K+ + +Q EI
Sbjct: 89 QVPHDHVAY---RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR 145
Query: 824 TLGRIRHK------NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK 877
L +R + N++ ++ + + + + LS NL I K + ++ K
Sbjct: 146 ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRK 204
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS--DFGLARLLEVSETHATT 935
A I Q L LH + RI+H D+KP NILL ++ + + DFG + T
Sbjct: 205 FAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYT 258
Query: 936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAK 995
+ F Y APE R D++S G +L EL++G P G + +
Sbjct: 259 XIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY----PLLPGEDEGDQLACMIE 313
Query: 996 LLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLS 1036
LL G S+ L A +N + CTV TLS
Sbjct: 314 LL---GMPSQKLLDASKRA---KNFVSXKGYPRYCTVTTLS 348
>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1
pdb|3QFV|B Chain B, Mrck Beta In Complex With Tpca-1
Length = 415
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHK---- 831
+F I +IG G FG ++ + K+ + +++ +++ AE R
Sbjct: 75 DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKI-LNKWEMLKR--AETACFREERDVLVNG 131
Query: 832 --NLVTLIGY-YVGEAEMFLVYNFLSGGNLETFIHKKSGK---KIQWSVIHKIAIDIAQA 885
+T + Y + E ++LV ++ GG+L T + K K + I ++ + I +
Sbjct: 132 DCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI-DS 190
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ LHY VHRDIKP N+LLD + L+DFG + T ++ GT Y++
Sbjct: 191 IHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYIS 244
Query: 946 PEYATTC-----RVSDKADVYSFGVVLLELISGK 974
PE + + D +S GV + E++ G+
Sbjct: 245 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278
>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OCB|B Chain B, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OW4|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3OW4|B Chain B, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3QKK|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKL|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKM|A Chain A, Spirocyclic Sulfonamides As Akt Inhibitors
pdb|4EKK|A Chain A, Akt1 With Amp-Pnp
pdb|4EKK|B Chain B, Akt1 With Amp-Pnp
pdb|4EKL|A Chain A, Akt1 With Gdc0068
Length = 341
Score = 58.5 bits (140), Expect = 2e-08, Method: Composition-based stats.
Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 30/220 (13%)
Query: 770 VVRATGN-FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI------ 822
+ R T N F L+G G FG ++ VK+ + GR+ ++ E+
Sbjct: 3 MARVTMNEFEYLKLLGKGTFGK----------VILVKEKATGRYYAMKILKKEVIVAKDE 52
Query: 823 --------GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV 874
L RH L L + + V + +GG E F H +
Sbjct: 53 VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG--ELFFHLSRERVFSEDR 110
Query: 875 IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT 934
+I AL YLH +V+RD+K N++LD++ + ++DFGL + + +
Sbjct: 111 ARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATM 167
Query: 935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
GT Y+APE D + GVV+ E++ G+
Sbjct: 168 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 65/255 (25%), Positives = 110/255 (43%), Gaps = 31/255 (12%)
Query: 783 IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
+G G FG +A+ VAVK L G + +E+ L I H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 835 TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV----IHKIAIDIAQALAY- 888
L+G + ++ F GNL T++ K + + + V ++K + + + Y
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 889 ------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTF 941
+ + + +HRD+ NILL E+ + DFGLAR + + + D
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPL 214
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001
++APE + ++DV+SFGV+L E+ S S P G I +KEG
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFCRRLKEG 267
Query: 1002 ---RSSELFLPELWE 1013
R+ + PE+++
Sbjct: 268 TRMRAPDYTTPEMYQ 282
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 65/255 (25%), Positives = 109/255 (42%), Gaps = 31/255 (12%)
Query: 783 IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
+G G FG +A+ VAVK L G + +E+ L I H N+V
Sbjct: 72 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 835 TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV----IHKIAIDIAQALAY- 888
L+G + ++ F GNL T++ K + + + V ++K + + + Y
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 889 ------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTF 941
+ + + +HRD+ NILL E+ + DFGLAR + + D
Sbjct: 192 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001
++APE + ++DV+SFGV+L E+ S S P G I +KEG
Sbjct: 252 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFCRRLKEG 304
Query: 1002 ---RSSELFLPELWE 1013
R+ + PE+++
Sbjct: 305 TRMRAPDYTTPEMYQ 319
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 21/201 (10%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTLIG 838
IG+G G A + V G VAVKKLS FQ ++ E+ L + HKN+++L+
Sbjct: 32 IGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQTHAKRAYRELVLLKCVNHKNIISLLN 90
Query: 839 YYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
+ + +++LV + NL IH + + +++++ I +LH +
Sbjct: 91 VFTPQKTLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIK----HLHSA 145
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
I+HRD+KPSNI++ + + DFGLAR T T Y APE
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRYYRAPEVILGM 200
Query: 953 RVSDKADVYSFGVVLLELISG 973
+ D++S G ++ EL+ G
Sbjct: 201 GYAANVDIWSVGCIMGELVKG 221
>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
pdb|1NXK|B Chain B, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
pdb|1NXK|C Chain C, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
pdb|1NXK|D Chain D, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
Length = 400
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
Y G + +V L GG L + I + + +I I +A+ YLH I H
Sbjct: 128 YAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSI---NIAH 184
Query: 900 RDIKPSNILL-DEELNAY--LSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
RD+KP N+L + NA L+DFG A+ E + ++ T T YVAPE +
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 242
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
D +S GV+ L+ G P +S +G
Sbjct: 243 SCDXWSLGVIXYILLCG---YPPFYSNHG 268
>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3CQW|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3MV5|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
pdb|3MVH|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
Length = 342
Score = 58.2 bits (139), Expect = 2e-08, Method: Composition-based stats.
Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 30/218 (13%)
Query: 772 RATGN-FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI-------- 822
R T N F L+G G FG ++ VK+ + GR+ ++ E+
Sbjct: 6 RVTMNEFEYLKLLGKGTFGK----------VILVKEKATGRYYAMKILKKEVIVAKDEVA 55
Query: 823 ------GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH 876
L RH L L + + V + +GG E F H +
Sbjct: 56 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG--ELFFHLSRERVFSEDRAR 113
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
+I AL YLH +V+RD+K N++LD++ + ++DFGL + + +
Sbjct: 114 FYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKX 170
Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
GT Y+APE D + GVV+ E++ G+
Sbjct: 171 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208
>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil
pdb|3TKU|B Chain B, Mrck Beta In Complex With Fasudil
Length = 433
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHK---- 831
+F I +IG G FG ++ + K+ + +++ +++ AE R
Sbjct: 91 DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKI-LNKWEMLKR--AETACFREERDVLVNG 147
Query: 832 --NLVTLIGY-YVGEAEMFLVYNFLSGGNLETFIHKKSGK---KIQWSVIHKIAIDIAQA 885
+T + Y + E ++LV ++ GG+L T + K K + I ++ + I +
Sbjct: 148 DCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI-DS 206
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
+ LHY VHRDIKP N+LLD + L+DFG + T ++ GT Y++
Sbjct: 207 IHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYIS 260
Query: 946 PEYATTC-----RVSDKADVYSFGVVLLELISGK 974
PE + + D +S GV + E++ G+
Sbjct: 261 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294
>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41
Length = 417
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 19/219 (8%)
Query: 763 AELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI 822
++ +D+V + + +IG G FG KA + K+ + +Q EI
Sbjct: 88 VQVPHDHVAY---RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEI 144
Query: 823 GTLGRIRHK------NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH 876
L +R + N++ ++ + + + + LS NL I K + ++
Sbjct: 145 RILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVR 203
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS--DFGLARLLEVSETHAT 934
K A I Q L LH + RI+H D+KP NILL ++ + + DFG +
Sbjct: 204 KFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVY 257
Query: 935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
T + F Y APE R D++S G +L EL++G
Sbjct: 258 TXIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTG 295
>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00135
Length = 301
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV- 841
+G G +G ++ G VAVK S R + + E+ +RH+N++ I +
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVKIFS-SRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 842 ---GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
+++L+ ++ G+L ++ + + +I + IA LA+LH
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSIASGLAHLHIEIFGTQG 130
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-----AGTFGYVAPEY 948
P I HRD+K NIL+ + ++D GLA + S++ DV GT Y+APE
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH--SQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 949 -ATTCRVS-----DKADVYSFGVVLLEL 970
T +V + D+++FG+VL E+
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEV 216
>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein
Kinase C Beta Ii
Length = 674
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 69/133 (51%), Gaps = 6/133 (4%)
Query: 846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPS 905
++ V +++GG+L I + K +V + A +IA L +L I++RD+K
Sbjct: 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAIGLFFLQSKG---IIYRDLKLD 471
Query: 906 NILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGV 965
N++LD E + ++DFG+ + + + T GT Y+APE D ++FGV
Sbjct: 472 NVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 530
Query: 966 VLLELISGKRSLD 978
+L E+++G+ +
Sbjct: 531 LLYEMLAGQAPFE 543
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 58.2 bits (139), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 783 IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
+G G FG +A+ VAVK L G + +E+ L I H N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 835 TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV----IHKIAIDIAQALAY- 888
L+G + ++ F GNL T++ K + + + V ++K + + + Y
Sbjct: 86 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 889 ------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTF 941
+ + + +HRD+ NILL E+ + DFGLAR + + + D
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + ++DV+SFGV+L E+ S
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236
>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2 (rsk2)
pdb|4D9U|A Chain A, Rsk2 C-Terminal Kinase Domain, (E)-Tert-Butyl
3-(4-Amino-7-(3-
Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
pdb|4D9T|A Chain A, Rsk2 C-Terminal Kinase Domain With Inhibitor (E)-Methyl
3-(4-Amino-7-
(3-Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
Length = 342
Score = 58.2 bits (139), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 25/228 (10%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
+ N ++ T + ++ IG G + + AVK + + + EI L
Sbjct: 14 HRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEIL 69
Query: 826 GRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIA 883
R +H N++TL Y +++V + GG L + + +K + + S + I
Sbjct: 70 LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV---LFTIT 126
Query: 884 QALAYLHYSCVPRIVHRDIKPSNIL-LDEELNA---YLSDFGLARLLEVSETHATTDVAG 939
+ + YLH V VHRD+KPSNIL +DE N + DFG A+ L +E
Sbjct: 127 KTVEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTPCY 182
Query: 940 TFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
T +VAPE D++S GV+L +++G ++ + NG
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG-------YTPFANG 223
>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
pdb|2I0E|B Chain B, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
Length = 353
Score = 58.2 bits (139), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 69/133 (51%), Gaps = 6/133 (4%)
Query: 846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPS 905
++ V +++GG+L I + K +V + A +IA L +L I++RD+K
Sbjct: 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAIGLFFLQSKG---IIYRDLKLD 150
Query: 906 NILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGV 965
N++LD E + ++DFG+ + + + T GT Y+APE D ++FGV
Sbjct: 151 NVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 209
Query: 966 VLLELISGKRSLD 978
+L E+++G+ +
Sbjct: 210 LLYEMLAGQAPFE 222
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 58.2 bits (139), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 50/200 (25%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 781 NLIGTGGFGSTYKAELVP-------GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNL 833
++G+G FG+ +K +P + V + GR Q Q + +G + H ++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGSLDHAHI 77
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V L+G G + + LV +L G+L + + G + ++ + IA+ + YL
Sbjct: 78 VRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-FGYVAPEYATTC 952
+VHR++ N+LL ++DFG+A LL + A T ++A E
Sbjct: 136 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 953 RVSDKADVYSFGVVLLELIS 972
+ + ++DV+S+GV + EL++
Sbjct: 193 KYTHQSDVWSYGVTVWELMT 212
>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide
pdb|4F9A|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide
pdb|4F9A|C Chain C, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide
pdb|4F9B|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Pha767491
pdb|4F9B|C Chain C, Human Cdc7 Kinase In Complex With Dbf4 And Pha767491
pdb|4F9C|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Xl413
Length = 361
Score = 57.8 bits (138), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 68/245 (27%), Positives = 110/245 (44%), Gaps = 44/245 (17%)
Query: 764 ELTYDNVVRATGNFSIRNLIGTGGFGSTYKA----ELVPGYLVAVKKLSIGRFQGIQQFD 819
E Y+ V + + F I + IG G F S Y A ++ P +A+K L I I+
Sbjct: 10 EKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHL-IPTSHPIR-IA 67
Query: 820 AEIGTLGRIRHKNLVTLIGY-YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI 878
AE+ L ++ V + Y + + + +L E+F+ + + + + +
Sbjct: 68 AELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEH---ESFLDILNS--LSFQEVREY 122
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLAR--------LLEVS 929
+++ +AL +H IVHRD+KPSN L + L Y L DFGLA+ LL+
Sbjct: 123 MLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFV 179
Query: 930 ETHATTD-------------------VAGTFGYVAPEYATTCRVSDKA-DVYSFGVVLLE 969
++ A + AGT G+ APE T C A D++S GV+ L
Sbjct: 180 QSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS 239
Query: 970 LISGK 974
L+SG+
Sbjct: 240 LLSGR 244
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 57.8 bits (138), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 65/255 (25%), Positives = 109/255 (42%), Gaps = 31/255 (12%)
Query: 783 IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
+G G FG +A+ VAVK L G + +E+ L I H N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 835 TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV----IHKIAIDIAQALAY- 888
L+G + ++ F GNL T++ K + + + V ++K + + + Y
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 889 ------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTF 941
+ + + +HRD+ NILL E+ + DFGLAR + + D
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001
++APE + ++DV+SFGV+L E+ S S P G I +KEG
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFCRRLKEG 258
Query: 1002 ---RSSELFLPELWE 1013
R+ + PE+++
Sbjct: 259 TRMRAPDYTTPEMYQ 273
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 57.8 bits (138), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 783 IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
+G G FG +A+ VAVK L G + +E+ L I H N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 835 TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV----IHKIAIDIAQALAY- 888
L+G + ++ F GNL T++ K + + + V ++K + + + Y
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 889 ------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTF 941
+ + + +HRD+ NILL E+ + DFGLAR + + + D
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + ++DV+SFGV+L E+ S
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 57.8 bits (138), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 783 IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
+G G FG +A+ VAVK L G + +E+ L I H N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 835 TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV----IHKIAIDIAQALAY- 888
L+G + ++ F GNL T++ K + + + V ++K + + + Y
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 889 ------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTF 941
+ + + +HRD+ NILL E+ + DFGLAR + + D
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + ++DV+SFGV+L E+ S
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236
>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
pdb|2H34|B Chain B, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
Length = 309
Score = 57.4 bits (137), Expect = 4e-08, Method: Composition-based stats.
Identities = 28/75 (37%), Positives = 41/75 (54%)
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
HRD+KP NIL+ + AYL DFG+A + + GT Y APE + + +A
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 959 DVYSFGVVLLELISG 973
D+Y+ VL E ++G
Sbjct: 217 DIYALTCVLYECLTG 231
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 57.4 bits (137), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 64/254 (25%), Positives = 109/254 (42%), Gaps = 30/254 (11%)
Query: 783 IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
+G G FG +A+ VAVK L G + +E+ L I H N+V
Sbjct: 36 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 835 TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV---IHKIAIDIAQALAY-- 888
L+G + ++ F GNL T++ K + + + ++K + + + Y
Sbjct: 96 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 889 -----LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTFG 942
+ + + +HRD+ NILL E+ + DFGLAR + + + D
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK 215
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG- 1001
++APE + ++DV+SFGV+L E+ S S P G I +KEG
Sbjct: 216 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFCRRLKEGT 268
Query: 1002 --RSSELFLPELWE 1013
R+ + PE+++
Sbjct: 269 RMRAPDYTTPEMYQ 282
>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase
pdb|2GNH|A Chain A, Pka Five Fold Mutant Model Of Rho-Kinase With H1152p
pdb|2GNI|A Chain A, Pka Fivefold Mutant Model Of Rho-Kinase With Inhibitor
Fasudil (Ha1077)
Length = 350
Score = 57.4 bits (137), Expect = 4e-08, Method: Composition-based stats.
Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
IGTG FG + + G A+K K + + + I+ E L + LV L
Sbjct: 49 IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V ++ GG++ F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYMPGGDM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 57.4 bits (137), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 32/284 (11%)
Query: 762 PAELTYDNVVRATGN-FSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSI-GRFQ 813
P +L YD+ N S +G G FG +A VAVK L
Sbjct: 9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 68
Query: 814 GIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKI-- 870
+ +E+ L + H N+V L+G ++ + G+L F+ +K I
Sbjct: 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 871 --------------QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY 916
+ + +A+ +A+L +HRD+ NILL
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITK 185
Query: 917 LSDFGLARLLEVSETHATTDVAG-TFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKR 975
+ DFGLAR ++ + A ++APE C + ++DV+S+G+ L EL S
Sbjct: 186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
Query: 976 SLDPSFSEYGNGFNIVSWA-KLLIKEGRSSELF--LPELWEAGP 1016
S P + ++ ++L E +E++ + W+A P
Sbjct: 246 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 57.4 bits (137), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 32/284 (11%)
Query: 762 PAELTYDNVVRATGN-FSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSI-GRFQ 813
P +L YD+ N S +G G FG +A VAVK L
Sbjct: 25 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 84
Query: 814 GIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKI-- 870
+ +E+ L + H N+V L+G ++ + G+L F+ +K I
Sbjct: 85 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 144
Query: 871 --------------QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY 916
+ + +A+ +A+L +HRD+ NILL
Sbjct: 145 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITK 201
Query: 917 LSDFGLARLLEVSETHATTDVAG-TFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKR 975
+ DFGLAR ++ + A ++APE C + ++DV+S+G+ L EL S
Sbjct: 202 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 261
Query: 976 SLDPSFSEYGNGFNIVSWA-KLLIKEGRSSELF--LPELWEAGP 1016
S P + ++ ++L E +E++ + W+A P
Sbjct: 262 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 305
>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
pdb|4DFY|E Chain E, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
Length = 371
Score = 57.4 bits (137), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/195 (24%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 70 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 130 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 184
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ AT + GT Y+APE + +
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GATWTLCGTPEYLAPEIILSKGYNKAV 240
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 241 DWWALGVLIYEMAAG 255
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 57.4 bits (137), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 61/252 (24%), Positives = 106/252 (42%), Gaps = 24/252 (9%)
Query: 748 ASLRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKK 806
A +G ++ + P+ + D R T +G G +G YKA + V VA+K+
Sbjct: 14 AQTQGPGSMSVSAAPSATSIDRYRRITK-------LGEGTYGEVYKAIDTVTNETVAIKR 66
Query: 807 LSIGRFQGIQQFDA--EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK 864
+ + + A E+ L ++H+N++ L + L++ + + +L+ ++ K
Sbjct: 67 IRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDK 125
Query: 865 KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL-----DEELNAYLSD 919
+ VI + + + H R +HRD+KP N+LL E + D
Sbjct: 126 NPD--VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGD 180
Query: 920 FGLARLLEVSETHATTDVAGTFGYVAPEYATTCR-VSDKADVYSFGVVLLELISGKRSLD 978
FGLAR + T ++ T Y PE R S D++S + E++ K L
Sbjct: 181 FGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTPLF 238
Query: 979 PSFSEYGNGFNI 990
P SE F I
Sbjct: 239 PGDSEIDQLFKI 250
>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With
Y- 27632
Length = 350
Score = 57.0 bits (136), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
IGTG FG + + G A+K K + + + I+ E L + LV L
Sbjct: 49 IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V ++ GG++ F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYMPGGDM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g
pdb|2HW7|A Chain A, Crystal Structure Of Mnk2-D228g In Complex With
Staurosporine
Length = 316
Score = 57.0 bits (136), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 49/159 (30%), Positives = 84/159 (52%), Gaps = 21/159 (13%)
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSG-KKIQWSVIHKIAIDIAQALAY 888
H+N++ LI ++ E +LV+ + GG++ + IHK+ +++ SV+ + D+A AL +
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ---DVASALDF 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELN---AYLSDFGLARLLEVS------ETHATTDVAG 939
LH I HRD+KP NIL + + DFGL ++++ T G
Sbjct: 127 LHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCG 183
Query: 940 TFGYVAPE----YATTCRVSDK-ADVYSFGVVLLELISG 973
+ Y+APE ++ + DK D++S GV+L L+SG
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine
Phosphorylation Regulated Kinase 2 (Dyrk2)
Length = 429
Score = 57.0 bits (136), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 19/218 (8%)
Query: 764 ELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIG 823
++ +D+V + + +IG G FG KA + K+ + +Q EI
Sbjct: 89 QVPHDHVAY---RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR 145
Query: 824 TLGRIRHK------NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK 877
L +R + N++ ++ + + + + LS NL I K + ++ K
Sbjct: 146 ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRK 204
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS--DFGLARLLEVSETHATT 935
A I Q L LH + RI+H D+KP NILL ++ + + DFG + E
Sbjct: 205 FAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVY 257
Query: 936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
+ Y APE R D++S G +L EL++G
Sbjct: 258 XXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 57.0 bits (136), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 32/284 (11%)
Query: 762 PAELTYDNVVRATGN-FSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSI-GRFQ 813
P +L YD+ N S +G G FG +A VAVK L
Sbjct: 32 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 91
Query: 814 GIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKI-- 870
+ +E+ L + H N+V L+G ++ + G+L F+ +K I
Sbjct: 92 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 151
Query: 871 --------------QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY 916
+ + +A+ +A+L +HRD+ NILL
Sbjct: 152 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITK 208
Query: 917 LSDFGLARLLEVSETHATTDVAG-TFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKR 975
+ DFGLAR ++ + A ++APE C + ++DV+S+G+ L EL S
Sbjct: 209 ICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 268
Query: 976 SLDPSFSEYGNGFNIVSWA-KLLIKEGRSSELF--LPELWEAGP 1016
S P + ++ ++L E +E++ + W+A P
Sbjct: 269 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 312
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 57.0 bits (136), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 32/284 (11%)
Query: 762 PAELTYDNVVRATGN-FSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSI-GRFQ 813
P +L YD+ N S +G G FG +A VAVK L
Sbjct: 27 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 86
Query: 814 GIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKI-- 870
+ +E+ L + H N+V L+G ++ + G+L F+ +K I
Sbjct: 87 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 146
Query: 871 --------------QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY 916
+ + +A+ +A+L +HRD+ NILL
Sbjct: 147 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITK 203
Query: 917 LSDFGLARLLEVSETHATTDVAG-TFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKR 975
+ DFGLAR ++ + A ++APE C + ++DV+S+G+ L EL S
Sbjct: 204 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 263
Query: 976 SLDPSFSEYGNGFNIVSWA-KLLIKEGRSSELF--LPELWEAGP 1016
S P + ++ ++L E +E++ + W+A P
Sbjct: 264 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 307
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 56.6 bits (135), Expect = 6e-08, Method: Composition-based stats.
Identities = 60/226 (26%), Positives = 90/226 (39%), Gaps = 35/226 (15%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
+G GGF E L G+ A+K++ Q ++ E H N++ L+ Y +
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 842 GEA----EMFLVYNFLSGGNLETFIH--KKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
E E +L+ F G L I K G + I + + I + L +H
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AK 153
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---------------T 940
HRD+KP+NILL +E L D G S A V G T
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLG-------SMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 941 FGYVAPEYATT---CRVSDKADVYSFGVVLLELISGKRSLDPSFSE 983
Y APE + C + ++ DV+S G VL ++ G+ D F +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252
>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And
Regulatory (Ri{alpha}) Subunits Of Pka
Length = 350
Score = 56.6 bits (135), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 48/195 (24%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T +AGT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLAGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue
pdb|2PMN|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp-Site
Inhibitor
pdb|2PMO|X Chain X, Crystal Structure Of Pfpk7 In Complex With Hymenialdisine
Length = 348
Score = 56.6 bits (135), Expect = 7e-08, Method: Composition-based stats.
Identities = 40/158 (25%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETF------IHKKSGKKIQ 871
F E+ + I+++ +T G E++++Y ++ ++ F + K I
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
VI I + + +Y+H I HRD+KPSNIL+D+ LSDFG + + +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 932 HATTDVAGTFGYVAPEYAT--TCRVSDKADVYSFGVVL 967
+ GT+ ++ PE+ + + K D++S G+ L
Sbjct: 208 KGSR---GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242
>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632
pdb|2GNL|A Chain A, Pka Threefold Mutant Model Of Rho-Kinase With Inhibitor H-
1152p
Length = 350
Score = 56.6 bits (135), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
IGTG FG + + G A+K K + + + I+ E L + LV L
Sbjct: 49 IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V ++ GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 56.6 bits (135), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 32/284 (11%)
Query: 762 PAELTYDNVVRATGN-FSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSI-GRFQ 813
P +L YD+ N S +G G FG +A VAVK L
Sbjct: 32 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 91
Query: 814 GIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKI-- 870
+ +E+ L + H N+V L+G ++ + G+L F+ +K I
Sbjct: 92 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 151
Query: 871 --------------QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY 916
+ + +A+ +A+L +HRD+ NILL
Sbjct: 152 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITK 208
Query: 917 LSDFGLARLLEVSETHATTDVAG-TFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKR 975
+ DFGLAR ++ + A ++APE C + ++DV+S+G+ L EL S
Sbjct: 209 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 268
Query: 976 SLDPSFSEYGNGFNIVSWA-KLLIKEGRSSELF--LPELWEAGP 1016
S P + ++ ++L E +E++ + W+A P
Sbjct: 269 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 312
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 56.6 bits (135), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 783 IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
+G G FG +A+ VAVK L G + +E+ L I H N+V
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 835 TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV--IHKIAIDIAQALAY--- 888
L+G + ++ F GNL T++ K + + + ++K + + + Y
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 889 ----LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTFGY 943
+ + + +HRD+ NILL E+ + DFGLAR + + + D +
Sbjct: 157 VAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKW 216
Query: 944 VAPEYATTCRVSDKADVYSFGVVLLELIS 972
+APE + ++DV+SFGV+L E+ S
Sbjct: 217 MAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 56.2 bits (134), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 65/241 (26%), Positives = 111/241 (46%), Gaps = 32/241 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ + + ++++V + NL I + + +++++ + I +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMSYLLYQMLVGIK----HLH 143
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+ D++S GV++ E+I G L P +I W K++ + G S F+ +
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKGG-VLFPGTD------HIDQWNKVIEQLGTPSPEFMKK 251
Query: 1011 L 1011
L
Sbjct: 252 L 252
>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H89 Protein
Kinase Inhibitor N-[2-
(4-Bromocinnamylamino)ethyl]-5-Isoquinoline
pdb|1YDR|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H7 Protein
Kinase Inhibitor 1-(5-
Isoquinolinesulfonyl)-2-Methylpiperazine
pdb|1YDS|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H8 Protein
Kinase Inhibitor [n-(2-Methylamino)ethyl]-5-
Isoquinolinesulfonamide
Length = 350
Score = 56.2 bits (134), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG + + G A+K K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And
Potent Inhibitors For Akt: Synthesis And Sar Studies
Length = 337
Score = 56.2 bits (134), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 48/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 36 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 95
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 96 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 150
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+DE+ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 151 YRDLKPENLLIDEQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAV 206
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 207 DWWALGVLIYEMAAG 221
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map
Kinase Jnk1
Length = 370
Score = 56.2 bits (134), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 65/241 (26%), Positives = 111/241 (46%), Gaps = 32/241 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN++ L
Sbjct: 32 IGSGAQGIVVAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ + + ++++V + NL I + + +++++ + I +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMSYLLYQMLVGIK----HLH 143
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+ D++S GV++ E+I G L P +I W K++ + G S F+ +
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKGG-VLFPGTD------HIDQWNKVIEQLGTPSPEFMKK 251
Query: 1011 L 1011
L
Sbjct: 252 L 252
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 64/255 (25%), Positives = 108/255 (42%), Gaps = 31/255 (12%)
Query: 783 IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
+G G FG +A+ VAVK L G + +E+ L I H N+V
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 835 TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV----IHKIAIDIAQALAY- 888
L+G + ++ F GNL T++ K + + + ++K + + + Y
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 889 ------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTF 941
+ + + +HRD+ NILL E+ + DFGLAR + + D
Sbjct: 157 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 216
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001
++APE + ++DV+SFGV+L E+ S S P G I +KEG
Sbjct: 217 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFCRRLKEG 269
Query: 1002 ---RSSELFLPELWE 1013
R+ + PE+++
Sbjct: 270 TRMRAPDYTTPEMYQ 284
>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl)amide
pdb|2C1B|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
(4r,2s)-5'-(4-(4-Chlorobenzyloxy)pyrrolidin-2-
Ylmethanesulfonyl)isoquinoline
pdb|2VO7|A Chain A, Structure Of Pka Complexed With 4-(4-Chlorobenzyl)-1-(7h-
Pyrrolo(2,3-D)pyrimidin-4-Yl)piperidin-4-Ylamine
pdb|3AG9|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
pdb|3AG9|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
Length = 351
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG + + G A+K K + + + I+ E L + LV L
Sbjct: 50 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V ++ GG E F H + + A I YLH ++
Sbjct: 110 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 221 DWWALGVLIYEMAAG 235
>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
A- 443654
Length = 351
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG + + G A+K K + + + I+ E L + LV L
Sbjct: 50 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V ++ GG E F H + + A I YLH ++
Sbjct: 110 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 221 DWWALGVLIYEMAAG 235
>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077)
pdb|1XH4|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|3BWJ|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Lead Compound Arc-1034
pdb|3KKV|A Chain A, Structure Of Pka With A Protein Kinase B-Selective
Inhibitor
Length = 350
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG + + G A+K K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V ++ GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|2F7E|E Chain E, Pka Complexed With
(S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6-
Yl-Pyridin-3-Yloxymethyl-Etylamine
pdb|2F7X|E Chain E, Protein Kinase A Bound To
(s)-2-(1h-indol-3-yl)-1-[5-((e)-2-
Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
pdb|2F7Z|E Chain E, Protein Kinase A Bound To
(R)-1-(1h-Indol-3-Ylmethyl)-2-(2-
Pyridin-4-Yl-[1,7]naphtyridin-5-Yloxy)-Ehylamine
pdb|2OH0|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
pdb|2OJF|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
Length = 351
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG + + G A+K K + + + I+ E L + LV L
Sbjct: 50 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V ++ GG E F H + + A I YLH ++
Sbjct: 110 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPEIILSKGYNKAV 220
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 221 DWWALGVLIYEMAAG 235
>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In
Complex With Staurosporine
pdb|1Q8T|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase
(Pka) In Complex With Rho-Kinase Inhibitor Y-27632
pdb|1Q8U|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor H-1152p
pdb|1SVE|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 1
pdb|1SVG|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 4
pdb|1VEB|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 5
pdb|3E8C|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|C Chain C, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|D Chain D, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|F Chain F, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8E|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|I Chain I, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|L Chain L, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|P Chain P, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
Length = 350
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG + + G A+K K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V ++ GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 8
pdb|1XH5|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH6|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH8|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|2GFC|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG + + G A+K K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V ++ GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors
pdb|2UZU|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
pdb|2UZV|A Chain A, Pka Structures Of Indazole-pyridine Series Of Akt
Inhibitors
pdb|2UZW|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
Length = 336
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG + + G A+K K + + + I+ E L + LV L
Sbjct: 35 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V ++ GG E F H + + A I YLH ++
Sbjct: 95 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 149
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 150 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPEIILSKGYNKAV 205
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 206 DWWALGVLIYEMAAG 220
>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG + + G A+K K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V ++ GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|B Chain B, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|C Chain C, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|D Chain D, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|E Chain E, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|F Chain F, Crystal Structure Of Human Pas Kinase Bound To Adp
Length = 335
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 16/206 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-------ELVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLG 826
+S + +G+G FG + A E+V ++ K L + + + EI L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 827 RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
R+ H N++ ++ + + LV G L+ F ++ + I + A+
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVME-KHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
YL + I+HRDIK NI++ E+ L DFG A LE + T GT Y AP
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT--FCGTIEYCAP 198
Query: 947 EYAT-TCRVSDKADVYSFGVVLLELI 971
E + +++S GV L L+
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLV 224
>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of
Camp-Dependent Protein Kinase
Length = 345
Score = 55.5 bits (132), Expect = 1e-07, Method: Composition-based stats.
Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 19/198 (9%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+GTG FG + LV G A+K K + + + I+ E L + LV
Sbjct: 44 LGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 100
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
L + + +++V +++GG E F H + + A I YLH
Sbjct: 101 LEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL--- 155
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
+++RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 156 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYN 211
Query: 956 DKADVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 212 KAVDWWALGVLIYEMAAG 229
>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
pdb|3DNE|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG + + G A+K K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V ++ GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
pdb|2WTK|F Chain F, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
Length = 305
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 9/158 (5%)
Query: 821 EIGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI 878
EI L R+RHKN++ L+ Y + +M++V + G ++ + K+ H
Sbjct: 56 EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGY 114
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA 938
+ L YLH IVH+DIKP N+LL +S G+A L T +
Sbjct: 115 FCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 939 -GTFGYVAPEYATTCRVSD--KADVYSFGVVLLELISG 973
G+ + PE A K D++S GV L + +G
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered
N- Terminal Helix
pdb|1XHA|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 55.5 bits (132), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG + + G A+K K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V + GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+++D++ ++DFGLA+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLMIDQQGYIQVTDFGLAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2: Se-Met Derivative
Length = 342
Score = 55.5 bits (132), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 25/228 (10%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
+ N ++ T + ++ IG G + + AVK + + + EI L
Sbjct: 14 HRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTE----EIEIL 69
Query: 826 GRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIA 883
R +H N++TL Y +++V GG L + + +K + + S + I
Sbjct: 70 LRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAV---LFTIT 126
Query: 884 QALAYLHYSCVPRIVHRDIKPSNIL-LDEELNA---YLSDFGLARLLEVSETHATTDVAG 939
+ + YLH V VHRD+KPSNIL +DE N + DFG A+ L +E
Sbjct: 127 KTVEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLXTPCY 182
Query: 940 TFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
T +VAPE D++S GV+L ++G ++ + NG
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG-------YTPFANG 223
>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated
Protein Kinase-Activated Protein Kinase 3
(Mk3)-Inhibitor Complex
pdb|3FXW|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated
Protein Kinase- Activated Protein Kinase 3INHIBITOR 2
COMPLEX
Length = 336
Score = 55.5 bits (132), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
G+ + ++ + GG L + I ++ + +I DI A+ +LH I HRD
Sbjct: 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRD 153
Query: 902 IKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+KP N+L +E +A L +DFG A+ E ++ T + YVAPE +
Sbjct: 154 VKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPY-YVAPEVLGPEKYDKSC 210
Query: 959 DVYSFGVVLLELISGKRSLDPSFSEYGNGFN 989
D++S GV++ L+ G P +S G +
Sbjct: 211 DMWSLGVIMYILLCG---FPPFYSNTGQAIS 238
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4-
Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 67/259 (25%), Positives = 108/259 (41%), Gaps = 59/259 (22%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTLIG- 838
IG G FG +KA G VA+KK+ + + A EI L ++H+N+V LI
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 839 -------YYVGEAEMFLVYNFLS---GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
Y +A ++LV++F G L + K S I ++ + L Y
Sbjct: 86 CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYY 140
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR---LLEVSETHATTDVAGTFGYVA 945
+H + +I+HRD+K +N+L+ + L+DFGLAR L + S+ + + T Y
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVS-WAKLLIKEGRSS 1004
P EL+ G+R P +G G + W + I +G +
Sbjct: 198 P----------------------ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235
Query: 1005 ELFL-----------PELW 1012
+ L PE+W
Sbjct: 236 QHQLALISQLCGSITPEVW 254
>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent
Protein Kinase
Length = 350
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG + + G A+K K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V + GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+++D++ ++DFGLA+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGLAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
pdb|4AE6|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
Length = 343
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTY---KAELVPGYLVAV-KKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG E Y + + K + + + I+ E L + LV L
Sbjct: 42 LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V ++ GG E F H + + A I YLH ++
Sbjct: 102 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 156
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 157 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 212
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 213 DWWALGVLIYEMAAG 227
>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
pdb|4AE9|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
Length = 343
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTY---KAELVPGYLVAV-KKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG E Y + + K + + + I+ E L + LV L
Sbjct: 42 LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V ++ GG E F H + + A I YLH ++
Sbjct: 102 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 156
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 157 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 212
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 213 DWWALGVLIYEMAAG 227
>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To
Hydroxyfasudil
Length = 351
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 50 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 110 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 221 DWWALGVLIYEMAAG 235
>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
And Amp-Pnp
pdb|4DFZ|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
Length = 350
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent
Protein Kinase With Unphosphorylated Turn Motif
Length = 371
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 70 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 130 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 184
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 240
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 241 DWWALGVLIYEMAAG 255
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 50/222 (22%), Positives = 100/222 (45%), Gaps = 20/222 (9%)
Query: 768 DNVVRATGNFSIRNLIGTGGFGSTYKAELVPG----YLVAVK--KLSIGRFQGIQQFDAE 821
++V+ F++ ++G G FGS +A+L VAVK K I I++F E
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 822 IGTLGRIRHKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFI-HKKSGKK---IQ 871
+ H ++ L+G + ++ F+ G+L F+ + G+ +
Sbjct: 76 AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
+ + +DIA + YL +HRD+ N +L E++ ++DFGL+R + +
Sbjct: 136 LQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 932 HATTDVAG-TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
+ + ++A E + +DV++FGV + E+++
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|B Chain B, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|E Chain E, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
Length = 371
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTY---KAELVPGYLVAV-KKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG E Y + + K + + + I+ E L + LV L
Sbjct: 70 LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V ++ GG E F H + + A I YLH ++
Sbjct: 130 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 184
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 240
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 241 DWWALGVLIYEMAAG 255
>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant
Catalytic Subunit Of Camp-Dependent Protein Kinase
Complexed With The Peptide Inhibitor Pki(5-24) And
Adenosine
pdb|1JLU|E Chain E, Crystal Structure Of The Catalytic Subunit Of
Camp-dependent Protein Kinase Complexed With A
Phosphorylated Substrate Peptide And Detergent
pdb|1RE8|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 2
pdb|1REJ|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 1
pdb|1REK|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 8
pdb|2QVS|E Chain E, Crystal Structure Of Type Iia Holoenzyme Of Camp-Dependent
Protein Kinase
pdb|3FJQ|E Chain E, Crystal Structure Of Camp-Dependent Protein Kinase
Catalytic Subunit Alpha In Complex With Peptide
Inhibitor Pki Alpha (6-25)
pdb|3IDB|A Chain A, Crystal Structure Of (108-268)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3IDC|A Chain A, Crystal Structure Of (102-265)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3O7L|D Chain D, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
pdb|3OW3|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|1ATP|E Chain E, 2.2 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
Mnatp And A Peptide Inhibitor
pdb|4DIN|A Chain A, Novel Localization And Quaternary Structure Of The Pka Ri
Beta Holoenzyme
Length = 350
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii,
25.M01780 Or Tgme49_007820
Length = 458
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 41/163 (25%), Positives = 86/163 (52%), Gaps = 16/163 (9%)
Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKN 832
+ IR+LIGTG +G +A + + +VA+KK+ + F+ + ++ EI L R+ H +
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-LRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 833 LVTLIGYYVGEA-----EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
+V ++ + + E+++V + F ++ + I + ++ +
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF---RTPVYLTELHIKTLLYNLLVGVK 170
Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE 930
Y+H + I+HRD+KP+N L++++ + + DFGLAR ++ E
Sbjct: 171 YVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210
>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
pdb|1J3H|B Chain B, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
Length = 350
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLXGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory
Subunit Of Protein Kinase A That Represents The
Inhibited State
pdb|2CPK|E Chain E, Crystal Structure Of The Catalytic Subunit Of Cyclic
Adenosine Monophosphate-Dependent Protein Kinase
pdb|4DG0|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20 And
Amp-Pnp
pdb|4DG2|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20
pdb|4DH1|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With Low Mg2+, Atp And Ip20
pdb|4DH3|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Atp And Ip20
pdb|4DH5|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Adp,
Phosphate, And Ip20
pdb|4DH7|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20'
pdb|4DH8|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20
Length = 350
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of
Camp-Dependent Protein Kinase And Adenosine Further
Defines Conformational Flexibility
pdb|1BX6|A Chain A, Crystal Structure Of The Potent Natural Product Inhibitor
Balanol In Complex With The Catalytic Subunit Of Camp-
Dependent Protein Kinase
Length = 350
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of
Camp-Dependent Protein Kinase And An Inhibitor Peptide
Displays An Open Conformation
Length = 350
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 16/214 (7%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVP----GYLVAVK---KLSIGRFQGIQQFD 819
++N + T + I T G GS + LV G A+K K + + + I+
Sbjct: 30 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL 89
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
E L + LV L + + +++V ++ GG E F H + + A
Sbjct: 90 NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYA 147
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
I YLH +++RD+KP N+L+D++ ++DFG A+ ++ T + G
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCG 200
Query: 940 TFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
T Y+APE + + D ++ GV++ E+ +G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol
Length = 351
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTY---KAELVPGYLVAV-KKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG E Y + + K + + + I+ E L + LV L
Sbjct: 50 LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V ++ GG E F H + + A I YLH ++
Sbjct: 110 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 221 DWWALGVLIYEMAAG 235
>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp-
Dependent Protein Kinase Complexed With A Substrate
Peptide, Adp And Detergent
Length = 350
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b
pdb|3SHE|A Chain A, Novel Atp-Competitive Mk2 Inhibitors With Potent
Biochemical And Cell- Based Activity Throughout The
Series
Length = 317
Score = 54.7 bits (130), Expect = 2e-07, Method: Composition-based stats.
Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
G+ + ++ + GG L + I ++ + +I DI A+ +LH I HRD
Sbjct: 78 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRD 134
Query: 902 IKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+KP N+L +E +A L +DFG A+ E ++ T + YVAPE +
Sbjct: 135 VKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPY-YVAPEVLGPEKYDKSC 191
Query: 959 DVYSFGVVLLELISGKRSLDPSFSEYGNGFN 989
D++S GV++ L+ G P +S G +
Sbjct: 192 DMWSLGVIMYILLCG---FPPFYSNTGQAIS 219
>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The
Catalytic Subunit Of Camp-Dependent Protein Kinase
pdb|3TNP|C Chain C, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNP|F Chain F, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNQ|B Chain B, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
Length = 350
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
pdb|1TKI|B Chain B, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
Length = 321
Score = 54.7 bits (130), Expect = 3e-07, Method: Composition-based stats.
Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFD-----AEIGTLGRIRHK 831
+ I +G G FG ++ + KK + +F ++ D EI L RH+
Sbjct: 7 YMIAEDLGRGEFGIVHRC-----VETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHR 61
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
N++ L + E+ +++ F+SG ++ I+ + + + ++ + + +AL +LH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-QVCEALQFLHS 120
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLS--DFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
I H DI+P NI+ ++ + +FG AR L+ + A Y APE
Sbjct: 121 H---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE--YYAPEVH 175
Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSE 983
VS D++S G ++ L+SG ++P +E
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG---INPFLAE 206
>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
pdb|1CDK|B Chain B, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
Length = 350
Score = 54.7 bits (130), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 16/214 (7%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVP----GYLVAVK---KLSIGRFQGIQQFD 819
++N + T + I T G GS + LV G A+K K + + + I+
Sbjct: 30 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL 89
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
E L + LV L + + +++V ++ GG E F H + + A
Sbjct: 90 NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYA 147
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
I YLH +++RD+KP N+L+D++ ++DFG A+ ++ T + G
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCG 200
Query: 940 TFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
T Y+APE + + D ++ GV++ E+ +G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-670
pdb|3L9L|A Chain A, Crystal Structure Of Pka With Compound 36
pdb|3L9L|B Chain B, Crystal Structure Of Pka With Compound 36
pdb|3OOG|A Chain A, Human Camp-Dependent Protein Kinase In Complex With A
Small Fragment
pdb|3OVV|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OWP|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OXT|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3P0M|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3POO|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
Length = 351
Score = 54.7 bits (130), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTY---KAELVPGYLVAV-KKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG E Y + + K + + + I+ E L + LV L
Sbjct: 50 LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V ++ GG E F H + + A I YLH ++
Sbjct: 110 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 221 DWWALGVLIYEMAAG 235
>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In
Complex With The Bisindoylmaleide Inhibitor Bim Viii
pdb|2VD5|B Chain B, Structure Of Human Myotonic Dystrophy Protein Kinase In
Complex With The Bisindoylmaleide Inhibitor Bim Viii
Length = 412
Score = 54.7 bits (130), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 72/274 (26%), Positives = 112/274 (40%), Gaps = 35/274 (12%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
+F I +IG G F ++ G + A+K K + + + F E L +
Sbjct: 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR 121
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
+ L + E ++LV + GG+L T + K G++I + +I A+ +H
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLL-SKFGERIPAEMARFYLAEIVMAIDSVH- 179
Query: 892 SCVPRI--VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
R+ VHRDIKP NILLD + L+DFG L T + GT Y++PE
Sbjct: 180 ----RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235
Query: 950 TTCRVSD-------KADVYSFGVVLLELISGKRSL--DPSFSEYGNGFNIVSWAKLLIKE 1000
+ D ++ GV E+ G+ D + YG IV + +
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG---KIVHYKE----- 287
Query: 1001 GRSSELFLPELWEAGPQENLLGMMRLASTCTVET 1034
L LP + E P+E + RL C ET
Sbjct: 288 ----HLSLPLVDEGVPEEARDFIQRL--LCPPET 315
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 54.7 bits (130), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 38/138 (27%), Positives = 66/138 (47%), Gaps = 15/138 (10%)
Query: 846 MFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKP 904
+++ NL+ +++++ S + + V I I IA+A+ +LH ++HRD+KP
Sbjct: 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKP 192
Query: 905 SNILLDEELNAYLSDFGLARLLEVSETHATT-----------DVAGTFGYVAPEYATTCR 953
SNI + + DFGL ++ E T GT Y++PE
Sbjct: 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNN 252
Query: 954 VSDKADVYSFGVVLLELI 971
S K D++S G++L EL+
Sbjct: 253 YSHKVDIFSLGLILFELL 270
>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3AGL|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3VQH|A Chain A, Bromine Sad Partially Resolves Multiple Binding Modes For
Pka Inhibitor H-89
Length = 351
Score = 54.7 bits (130), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTY---KAELVPGYLVAV-KKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG E Y + + K + + + I+ E L + LV L
Sbjct: 50 LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V ++ GG E F H + + A I YLH ++
Sbjct: 110 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 221 DWWALGVLIYEMAAG 235
>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|B Chain B, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|D Chain D, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|E Chain E, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
Length = 371
Score = 54.7 bits (130), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 21/227 (9%)
Query: 754 VMVTFADTPAELTYDNVVRATGNFSIRNL-IGTGGFGSTYKAE-LVPGYLVAVKKLSIGR 811
V++T P + Y V +++ L +G G FG ++ E G+ AVKK+ +
Sbjct: 75 VLLTEKLKPVDYEYREEV----HWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEV 130
Query: 812 FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
F+ E+ + +V L G + + L GG+L + ++
Sbjct: 131 FRA-----EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPED 185
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE-LNAYLSDFGLARLLE--- 927
++ + + QAL L Y RI+H D+K N+LL + +A L DFG A L+
Sbjct: 186 RALYY-----LGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG 240
Query: 928 VSETHATTD-VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
+ ++ T D + GT ++APE K DV+S ++L +++G
Sbjct: 241 LGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287
>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
A Peptide Inhibitor And Detergent
Length = 350
Score = 54.7 bits (130), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFAEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit
Of Camp- Dependent Protein Kinase Reveal Open And Closed
Conformations
Length = 350
Score = 54.7 bits (130), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 16/214 (7%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVP----GYLVAVK---KLSIGRFQGIQQFD 819
++N + T + I T G GS + LV G A+K K + + + I+
Sbjct: 30 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL 89
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
E L + LV L + + +++V ++ GG E F H + + A
Sbjct: 90 NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYA 147
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
I YLH +++RD+KP N+L+D++ ++DFG A+ ++ T + G
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCG 200
Query: 940 TFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
T Y+APE + + D ++ GV++ E+ +G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map
Kinase Jnk1
Length = 370
Score = 54.7 bits (130), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 64/241 (26%), Positives = 110/241 (45%), Gaps = 32/241 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ + + ++++V + NL I + + +++++ + I +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMSYLLYQMLVGIK----HLH 143
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+ D++S G ++ E+I G L P +I W K++ + G S F+ +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG-VLFPGTD------HIDQWNKVIEQLGTPSPEFMKK 251
Query: 1011 L 1011
L
Sbjct: 252 L 252
>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|B Chain B, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|C Chain C, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|D Chain D, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3TV7|A Chain A, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|B Chain B, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|C Chain C, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|D Chain D, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TWJ|A Chain A, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|B Chain B, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|C Chain C, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|D Chain D, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
Length = 410
Score = 54.3 bits (129), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIRH 830
++ + +IG G FG V KL + +F+ I++ D+ E +
Sbjct: 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL-LSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+V L + + +++V ++ GG+L + + +W+ + ++ AL +H
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFY--TAEVVLALDAIH 185
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE--- 947
+HRD+KP N+LLD+ + L+DFG + GT Y++PE
Sbjct: 186 SMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 948 -------YATTCRVSDKADVYSFGVVLLELISG 973
Y C D +S GV L E++ G
Sbjct: 243 SQGGDGYYGREC------DWWSVGVFLYEMLVG 269
>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
pdb|3LL6|B Chain B, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
Length = 337
Score = 54.3 bits (129), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 64/254 (25%), Positives = 107/254 (42%), Gaps = 52/254 (20%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR-HKNL 833
+R ++ GGF Y+A+ V G A+K+L + + E+ + ++ H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 834 VTL-----IGYY---VGEAEMFLVYNFLSGGNLETFIHK-KSGKKIQWSVIHKIAIDIAQ 884
V IG G+AE FL+ L G L F+ K +S + + KI +
Sbjct: 89 VQFCSAASIGKEESDTGQAE-FLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR----------------LLEV 928
A+ ++H P I+HRD+K N+LL + L DFG A L+E
Sbjct: 148 AVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 929 SETHATTDVAGTFGYVAPEYA---TTCRVSDKADVYSFGVVL---------------LEL 970
T TT + Y PE + + +K D+++ G +L L +
Sbjct: 207 EITRNTTPM-----YRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261
Query: 971 ISGKRSLDPSFSEY 984
++GK S+ P ++Y
Sbjct: 262 VNGKYSIPPHDTQY 275
>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ESM|B Chain B, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ETK|A Chain A, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETK|B Chain B, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETR|A Chain A, Crystal Structure Of Rock I Bound To Y-27632
pdb|2ETR|B Chain B, Crystal Structure Of Rock I Bound To Y-27632
pdb|3D9V|A Chain A, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3D9V|B Chain B, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3NCZ|A Chain A, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|B Chain B, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|C Chain C, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|D Chain D, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NDM|A Chain A, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|B Chain B, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|C Chain C, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|D Chain D, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
Length = 415
Score = 54.3 bits (129), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIRH 830
++ + +IG G FG V KL + +F+ I++ D+ E +
Sbjct: 75 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL-LSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+V L + + +++V ++ GG+L + + +W+ + ++ AL +H
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFY--TAEVVLALDAIH 190
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE--- 947
+HRD+KP N+LLD+ + L+DFG + GT Y++PE
Sbjct: 191 SMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 247
Query: 948 -------YATTCRVSDKADVYSFGVVLLELISG 973
Y C D +S GV L E++ G
Sbjct: 248 SQGGDGYYGREC------DWWSVGVFLYEMLVG 274
>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
Length = 350
Score = 54.3 bits (129), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 46/195 (23%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+++D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLIIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIIISKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain
Length = 316
Score = 54.3 bits (129), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 48/159 (30%), Positives = 83/159 (52%), Gaps = 21/159 (13%)
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSG-KKIQWSVIHKIAIDIAQALAY 888
H+N++ LI ++ E +LV+ + GG++ + IHK+ +++ SV+ + D+A AL +
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ---DVASALDF 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELN---AYLSDFGLARLLEVS------ETHATTDVAG 939
LH I HRD+KP NIL + + DF L ++++ T G
Sbjct: 127 LHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 940 TFGYVAPE----YATTCRVSDK-ADVYSFGVVLLELISG 973
+ Y+APE ++ + DK D++S GV+L L+SG
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp
pdb|1Q62|A Chain A, Pka Double Mutant Model Of Pkb
Length = 350
Score = 54.3 bits (129), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 48/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG + + G A+K K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V + GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+++D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLMIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 54.3 bits (129), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 20 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 80 NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 138 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 193
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 53.9 bits (128), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 79 NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 192
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 53.9 bits (128), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 17 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 77 NPHVCRLLGICLT-STVQLIMQLMPFGXLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 135 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 190
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222
>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb
Length = 350
Score = 53.9 bits (128), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 48/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG + + G A+K K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V + GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+++D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
pdb|1SZM|B Chain B, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
Length = 350
Score = 53.9 bits (128), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 48/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG + + G A+K K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V + GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+++D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 17 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 77 NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 135 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 190
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222
>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
pdb|2V55|C Chain C, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
Length = 406
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIRH 830
++ + +IG G FG V KL + +F+ I++ D+ E +
Sbjct: 75 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL-LSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+V L + + +++V ++ GG+L + + +W+ + ++ AL +H
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFY--TAEVVLALDAIH 190
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE--- 947
+HRD+KP N+LLD+ + L+DFG + GT Y++PE
Sbjct: 191 SMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 247
Query: 948 -------YATTCRVSDKADVYSFGVVLLELISG 973
Y C D +S GV L E++ G
Sbjct: 248 SQGGDGYYGREC------DWWSVGVFLYEMLVG 274
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 78 NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 191
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With Cyclin
T
Length = 373
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 66/259 (25%), Positives = 107/259 (41%), Gaps = 59/259 (22%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTLIG- 838
IG G FG +KA G VA+KK+ + + A EI L ++H+N+V LI
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 839 -------YYVGEAEMFLVYNFLS---GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
Y + ++LV++F G L + K S I ++ + L Y
Sbjct: 86 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYY 140
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR---LLEVSETHATTDVAGTFGYVA 945
+H + +I+HRD+K +N+L+ + L+DFGLAR L + S+ + + T Y
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVS-WAKLLIKEGRSS 1004
P EL+ G+R P +G G + W + I +G +
Sbjct: 198 P----------------------ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235
Query: 1005 ELFL-----------PELW 1012
+ L PE+W
Sbjct: 236 QHQLALISQLCGSITPEVW 254
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN+++L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + +++LV + + IQ + H +++ + Q L +
Sbjct: 89 LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 139
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR + T T Y APE
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 950 TTCRVSDKADVYSFGVVLLELISGK 974
+ D++S G ++ E++ K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN+++L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + +++LV + + IQ + H +++ + Q L +
Sbjct: 89 LNVFTPQKTLEEFQDVYLVMELMDANLXQV---------IQMELDHERMSYLLYQMLCGI 139
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 197
Query: 950 TTCRVSDKADVYSFGVVLLELISGK 974
+ D++S G ++ E++ K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN+++L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ + + +++LV + NL I + + +++++ I +LH
Sbjct: 89 LNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHERMSYLLYQMLXGIK----HLH 143
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 951 TCRVSDKADVYSFGVVLLELISGK 974
+ D++S G ++ E++ K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 76 NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 189
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221
>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
pdb|1SYK|B Chain B, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
Length = 350
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 46/195 (23%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ ++ +G
Sbjct: 220 DWWALGVLIYQMAAG 234
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 53.5 bits (127), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 76 NPHVCRLLGICLT-STVQLITQLMPFGXLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 189
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 79 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 192
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 79 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 192
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 76 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 189
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 13 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 73 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAEGMNYL 130
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 131 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 186
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 187 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 22 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 82 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 139
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 140 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 195
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 196 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 66/259 (25%), Positives = 107/259 (41%), Gaps = 59/259 (22%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTLIG- 838
IG G FG +KA G VA+KK+ + + A EI L ++H+N+V LI
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 839 -------YYVGEAEMFLVYNFLS---GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
Y + ++LV++F G L + K S I ++ + L Y
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYY 139
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR---LLEVSETHATTDVAGTFGYVA 945
+H + +I+HRD+K +N+L+ + L+DFGLAR L + S+ + + T Y
Sbjct: 140 IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVS-WAKLLIKEGRSS 1004
P EL+ G+R P +G G + W + I +G +
Sbjct: 197 P----------------------ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234
Query: 1005 ELFL-----------PELW 1012
+ L PE+W
Sbjct: 235 QHQLALISQLCGSITPEVW 253
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 53.5 bits (127), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 26 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 86 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 143
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 144 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 199
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 200 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 53.5 bits (127), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 78 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 191
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 53.5 bits (127), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 23 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 83 NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 196
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 53.5 bits (127), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 79 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 192
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 53.5 bits (127), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 34/242 (14%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN+++L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + +++LV + + IQ + H +++ + Q L +
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 177
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 235
Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
+ D++S G ++ E++ K L P G + I W K++ + G F+
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHK-ILFP-----GRDY-IDQWNKVIEQLGTPCPEFMK 288
Query: 1010 EL 1011
+L
Sbjct: 289 KL 290
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4-
Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4-
Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4-
Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 66/259 (25%), Positives = 107/259 (41%), Gaps = 59/259 (22%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTLIG- 838
IG G FG +KA G VA+KK+ + + A EI L ++H+N+V LI
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 839 -------YYVGEAEMFLVYNFLS---GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
Y + ++LV++F G L + K S I ++ + L Y
Sbjct: 86 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYY 140
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR---LLEVSETHATTDVAGTFGYVA 945
+H + +I+HRD+K +N+L+ + L+DFGLAR L + S+ + + T Y
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVS-WAKLLIKEGRSS 1004
P EL+ G+R P +G G + W + I +G +
Sbjct: 198 P----------------------ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235
Query: 1005 ELFL-----------PELW 1012
+ L PE+W
Sbjct: 236 QHQLALISQLCGSITPEVW 254
>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDV|A Chain A, Structure Of Pka-Pkb Chimera Complexed With A-443654
pdb|2UVX|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 7-Azaindole
pdb|2UW4|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
2-(4-(5-Methyl- 1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW7|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|4AXA|A Chain A, Structure Of Pka-pkb Chimera Complexed With
(1s)-2-amino-1-(
4-chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol
Length = 351
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 46/205 (22%), Positives = 91/205 (44%), Gaps = 33/205 (16%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAE-IGTLGRIRH----KNLVTLI 837
+GTG FG ++ VK + G ++ D + + L +I H K ++ +
Sbjct: 50 LGTGSFGR----------VMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 838 GY---------YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
+ + + +++V + GG E F H + + A I Y
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
LH +++RD+KP N+++D++ ++DFG A+ ++ T + GT Y+APE
Sbjct: 158 LH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEI 210
Query: 949 ATTCRVSDKADVYSFGVVLLELISG 973
+ + D ++ GV++ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 76 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 189
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221
>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h-
Purin-6-yl)-benzyl)-amine
pdb|2UVZ|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
C-Phenyl-C-(4-( 9h-Purin-6-Yl)-Phenyl)-Methylamine
pdb|2UW0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 6-(4-(4-(4-
Chloro-Phenyl)-Piperidin-4-Yl)-Phenyl)-9h-Purine
pdb|2UW3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 5-Methyl-4-
Phenyl-1h-Pyrazole
pdb|2UW5|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (R)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (S)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW8|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 2-(4-Chloro-
Phenyl)-2-Phenyl-Ethylamine
pdb|2VNW|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)methanamine
pdb|2VNY|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)amine
pdb|2VO3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
pdb|2VO6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-
Chlorobenzyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Ylamine
Length = 351
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 46/205 (22%), Positives = 91/205 (44%), Gaps = 33/205 (16%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAE-IGTLGRIRH----KNLVTLI 837
+GTG FG ++ VK + G ++ D + + L +I H K ++ +
Sbjct: 50 LGTGSFGR----------VMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 838 GY---------YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
+ + + +++V + GG E F H + + A I Y
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEY 157
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
LH +++RD+KP N+++D++ ++DFG A+ ++ T + GT Y+APE
Sbjct: 158 LH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEI 210
Query: 949 ATTCRVSDKADVYSFGVVLLELISG 973
+ + D ++ GV++ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
Length = 351
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 46/205 (22%), Positives = 91/205 (44%), Gaps = 33/205 (16%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAE-IGTLGRIRH----KNLVTLI 837
+GTG FG ++ VK + G ++ D + + L +I H K ++ +
Sbjct: 50 LGTGSFGR----------VMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 838 GY---------YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
+ + + +++V + GG E F H + + A I Y
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
LH +++RD+KP N+++D++ ++DFG A+ ++ T + GT Y+APE
Sbjct: 158 LH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEI 210
Query: 949 ATTCRVSDKADVYSFGVVLLELISG 973
+ + D ++ GV++ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3C|B Chain B, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3E|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
pdb|4G3E|B Chain B, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
Length = 352
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 19/226 (8%)
Query: 754 VMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYK-AELVPGYLVAVKKLSIGRF 812
V++T P + Y V + + +G G FG ++ + G+ AVKK+ + F
Sbjct: 56 VLLTEKLKPVDYEYREEVHW---MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF 112
Query: 813 QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQW 872
+ +++ A G + +V L G + + L GG+L I K++
Sbjct: 113 R-VEELVACAG----LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-----KQMGC 162
Query: 873 SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE-LNAYLSDFGLARLLE---V 928
+ + QAL L Y RI+H D+K N+LL + A L DFG A L+ +
Sbjct: 163 LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 222
Query: 929 SETHATTD-VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
++ T D + GT ++APE K D++S ++L +++G
Sbjct: 223 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268
>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik)
pdb|4DN5|B Chain B, Crystal Structure Of Nf-kb-inducing Kinase (nik)
Length = 356
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 21/227 (9%)
Query: 754 VMVTFADTPAELTYDNVVRATGNFSIRNL-IGTGGFGSTYKAE-LVPGYLVAVKKLSIGR 811
V++T P + Y V +++ L +G G FG ++ E G+ AVKK+ +
Sbjct: 56 VLLTEKLKPVDYEYREEV----HWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEV 111
Query: 812 FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
F+ E+ + +V L G + + L GG+L + ++
Sbjct: 112 FRA-----EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPED 166
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE-LNAYLSDFGLARLLE--- 927
++ + + QAL L Y RI+H D+K N+LL + +A L DFG A L+
Sbjct: 167 RALYY-----LGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG 221
Query: 928 VSETHATTD-VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
+ + T D + GT ++APE K DV+S ++L +++G
Sbjct: 222 LGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268
>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
pdb|2RIO|B Chain B, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
Length = 434
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 66/237 (27%), Positives = 105/237 (44%), Gaps = 41/237 (17%)
Query: 782 LIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
++G G G+ G VAVK++ I F I + ++ T H N+ I YY
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLID-FCDIALMEIKLLTESD-DHPNV---IRYYC 76
Query: 842 GEAEMFLVYNFLS--GGNLETFIHKKS----GKKIQWSVIHKIAI--DIAQALAYLHYSC 893
E +Y L NL+ + K+ K+Q + I++ IA +A+LH
Sbjct: 77 SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY-NPISLLRQIASGVAHLH--- 132
Query: 894 VPRIVHRDIKPSNILLD-------------EELNAYLSDFGLARLLEVSETHATTDV--- 937
+I+HRD+KP NIL+ E L +SDFGL + L+ ++ T++
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 938 AGTFGYVAPE-------YATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGN 986
+GT G+ APE T R++ D++S G V ++S GK +S N
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 41 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 101 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 158
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 159 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 214
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 215 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole
Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 53.1 bits (126), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 34/242 (14%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN+++L
Sbjct: 31 IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 87
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + +++LV + + IQ + H +++ + Q L +
Sbjct: 88 LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 138
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 139 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 196
Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
+ D++S G ++ E++ K L P G + I W K++ + G F+
Sbjct: 197 LGMGYKENVDIWSVGCIMGEMVRHK-ILFP-----GRDY-IDQWNKVIEQLGTPCPEFMK 249
Query: 1010 EL 1011
+L
Sbjct: 250 KL 251
>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9M|B Chain B, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9N|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 27
Length = 351
Score = 53.1 bits (126), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 47/195 (24%), Positives = 87/195 (44%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTY---KAELVPGYLVAV-KKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG E Y + + K + + + I+ E L + LV L
Sbjct: 50 LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V + GG E F H + + A I YLH ++
Sbjct: 110 SFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+++D++ ++DFG A+ ++ T + GT Y+APE + +
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 221 DWWALGVLIYEMAAG 235
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 53.1 bits (126), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 70 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 128 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 183
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 53.1 bits (126), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN+++L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + +++LV + + IQ + H +++ + Q L +
Sbjct: 89 LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 139
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 197
Query: 950 TTCRVSDKADVYSFGVVLLELISGK 974
+ D++S G ++ E++ K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 53.1 bits (126), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 32/241 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ + + ++++V + NL I + + +++++ I +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMSYLLYQMLCGIK----HLH 143
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+ D++S G ++ E+I G L P +I W K++ + G S F+ +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG-VLFPGTD------HIDQWNKVIEQLGTPSPEFMKK 251
Query: 1011 L 1011
L
Sbjct: 252 L 252
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 53.1 bits (126), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 32/241 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ + + ++++V + NL I + + +++++ I +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMSYLLYQMLCGIK----HLH 143
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+ D++S G ++ E+I G L P +I W K++ + G S F+ +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG-VLFPGTD------HIDQWNKVIEQLGTPSPEFMKK 251
Query: 1011 L 1011
L
Sbjct: 252 L 252
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 53.1 bits (126), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 63/242 (26%), Positives = 107/242 (44%), Gaps = 34/242 (14%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + ++++V + + IQ + H +++ + Q L +
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 139
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 197
Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
+ D++S G ++ E+I G L P +I W K++ + G S F+
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGG-VLFPGTD------HIDQWNKVIEQLGTPSPEFMK 250
Query: 1010 EL 1011
+L
Sbjct: 251 KL 252
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 53.1 bits (126), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN+++L
Sbjct: 33 IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + +++LV + + IQ + H +++ + Q L +
Sbjct: 90 LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 140
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 198
Query: 950 TTCRVSDKADVYSFGVVLLELISGK 974
+ D++S G ++ E++ K
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMVRHK 223
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 53.1 bits (126), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 34/242 (14%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN+++L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + +++LV + + IQ + H +++ + Q L +
Sbjct: 89 LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 139
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 197
Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
+ D++S G ++ E++ K L P G + I W K++ + G F+
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK-ILFP-----GRDY-IDQWNKVIEQLGTPCPEFMK 250
Query: 1010 EL 1011
+L
Sbjct: 251 KL 252
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 53.1 bits (126), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 34/242 (14%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN+++L
Sbjct: 33 IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + +++LV + + IQ + H +++ + Q L +
Sbjct: 90 LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 140
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 198
Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
+ D++S G ++ E++ K L P G + I W K++ + G F+
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMVRHK-ILFP-----GRDY-IDQWNKVIEQLGTPCPEFMK 251
Query: 1010 EL 1011
+L
Sbjct: 252 KL 253
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With
Sb203580
Length = 362
Score = 52.8 bits (125), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKL----SIGRFQGI-------QQFDAEIGTL 825
++++ I +G +G+ G VA+K++ S GR I ++ EI L
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 826 GRIRHKNLVTLIGYYVGEAE-----MFLVYNFLSGGNLETFIHKK----SGKKIQWSVIH 876
H N++ L +V E ++LV + +L IH + S + IQ+ + H
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYH 142
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR--LLEVSETHAT 934
I L LH + V VHRD+ P NILL + + + DF LAR + ++TH
Sbjct: 143 -----ILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV 194
Query: 935 TDVAGTFGYVAPEYATTCRVSDK-ADVYSFGVVLLELISGK 974
T Y APE + K D++S G V+ E+ + K
Sbjct: 195 THR----WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC
Length = 405
Score = 52.8 bits (125), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 44/170 (25%), Positives = 80/170 (47%), Gaps = 20/170 (11%)
Query: 821 EIGTLGRIRHKNLVTLIGYYVGEAE--MFLVYNFLSGGNLETFIHKKSGK------KIQW 872
EI L ++H N+++L ++ A+ ++L++++ ++ K ++
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 873 SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL----DEELNAYLSDFGLARLLEV 928
++ + I + YLH + V +HRD+KP+NIL+ E ++D G ARL
Sbjct: 128 GMVKSLLYQILDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFN- 183
Query: 929 SETHATTD---VAGTFGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGK 974
S D V TF Y APE R KA D+++ G + EL++ +
Sbjct: 184 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 52.8 bits (125), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 34/242 (14%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN+++L
Sbjct: 26 IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 82
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + +++LV + + IQ + H +++ + Q L +
Sbjct: 83 LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 133
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 134 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 191
Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
+ D++S G ++ E++ K L P G + I W K++ + G F+
Sbjct: 192 LGMGYKENVDIWSVGCIMGEMVRHK-ILFP-----GRDY-IDQWNKVIEQLGTPCPEFMK 244
Query: 1010 EL 1011
+L
Sbjct: 245 KL 246
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 52.8 bits (125), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN+++L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ + + +++LV + NL I + + +++++ I +LH
Sbjct: 89 LNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHERMSYLLYQMLXGIK----HLH 143
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 951 TCRVSDKADVYSFGVVLLELISGK 974
+ D++S G ++ E++ K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map
Kinase Jnk1
Length = 370
Score = 52.8 bits (125), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 32/241 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ + + ++++V + NL I + + +++++ I +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMSYLLYQMLCGIK----HLH 143
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
+ D++S G ++ E+I G L P +I W K++ + G S F+ +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG-VLFPGTD------HIDQWNKVIEQLGTPSPEFMKK 251
Query: 1011 L 1011
L
Sbjct: 252 L 252
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp
Length = 423
Score = 52.8 bits (125), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 34/242 (14%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN+++L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + +++LV + + IQ + H +++ + Q L +
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 177
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 235
Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
+ D++S G ++ E++ K L P G + I W K++ + G F+
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHK-ILFP-----GRDY-IDQWNKVIEQLGTPCPEFMK 288
Query: 1010 EL 1011
+L
Sbjct: 289 KL 290
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 52.8 bits (125), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 62/242 (25%), Positives = 108/242 (44%), Gaps = 34/242 (14%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN+++L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + +++LV + + IQ + H +++ + Q L +
Sbjct: 82 LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 132
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR + T T Y APE
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVI 190
Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
+ D++S G ++ E++ K L P G + I W K++ + G F+
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK-ILFP-----GRDY-IDQWNKVIEQLGTPCPEFMK 243
Query: 1010 EL 1011
+L
Sbjct: 244 KL 245
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
Length = 356
Score = 52.8 bits (125), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN+++L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
+ + + +++LV + NL I + + +++++ I +LH
Sbjct: 82 LNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHERMSYLLYQMLXGIK----HLH 136
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 191
Query: 951 TCRVSDKADVYSFGVVLLELISGK 974
+ D++S G ++ E++ K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 52.8 bits (125), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 34/242 (14%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN+++L
Sbjct: 26 IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 82
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + +++LV + + IQ + H +++ + Q L +
Sbjct: 83 LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 133
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 134 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 191
Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
+ D++S G ++ E++ K L P G + I W K++ + G F+
Sbjct: 192 LGMGYKENVDIWSVGCIMGEMVRHK-ILFP-----GRDY-IDQWNKVIEQLGTPCPEFMK 244
Query: 1010 EL 1011
+L
Sbjct: 245 KL 246
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 52.8 bits (125), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKL----SIGRFQGI-------QQFDAEIGTL 825
++++ I +G +G+ G VA+K++ S GR I ++ EI L
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 826 GRIRHKNLVTLIGYYVGEAE-----MFLVYNFLSGGNLETFIHKK----SGKKIQWSVIH 876
H N++ L +V E ++LV + +L IH + S + IQ+ + H
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYH 142
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR--LLEVSETHAT 934
I L LH + V VHRD+ P NILL + + + DF LAR + ++TH
Sbjct: 143 -----ILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV 194
Query: 935 TDVAGTFGYVAPEYATTCRVSDK-ADVYSFGVVLLELISGK 974
T Y APE + K D++S G V+ E+ + K
Sbjct: 195 THR----WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 27/204 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + ++++V + + IQ + H +++ + Q L +
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 139
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 197
Query: 950 TTCRVSDKADVYSFGVVLLELISG 973
+ D++S G ++ E+I G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 27/204 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + ++++V + + IQ + H +++ + Q L +
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 139
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR S T +V + Y APE
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPEVVTRY-YRAPEVI 197
Query: 950 TTCRVSDKADVYSFGVVLLELISG 973
+ D++S G ++ E+I G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 46/195 (23%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+AP + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPAIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 22/210 (10%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNL 833
I LIG G FG Y VA++ + I R ++ F E+ + RH+N+
Sbjct: 34 QLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
V +G + + ++ + G L + + + + + + +IA +I + + YLH
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA----GTFGYVAPEYA 949
I+H+D+K N+ D ++DFGL + V + D G ++APE
Sbjct: 151 ---ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 950 TTCR---------VSDKADVYSFGVVLLEL 970
S +DV++ G + EL
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 27/204 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN++ L
Sbjct: 33 IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + ++++V + + IQ + H +++ + Q L +
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 140
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 198
Query: 950 TTCRVSDKADVYSFGVVLLELISG 973
+ D++S G ++ E+I G
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMIKG 222
>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|B Chain B, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|C Chain C, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|D Chain D, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|E Chain E, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|F Chain F, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|G Chain G, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|H Chain H, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|I Chain I, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|J Chain J, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|K Chain K, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|L Chain L, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|M Chain M, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|N Chain N, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
Length = 448
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 65/234 (27%), Positives = 104/234 (44%), Gaps = 37/234 (15%)
Query: 781 NLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
++G G G+ G VAVK++ I F I + ++ T H N+ I YY
Sbjct: 39 KILGYGSSGTVVFQGSFQGRPVAVKRMLID-FCDIALMEIKLLTESD-DHPNV---IRYY 93
Query: 841 VGEAEMFLVYNFLS--GGNLETFIHKKS----GKKIQWSVIHKIAI--DIAQALAYLHYS 892
E +Y L NL+ + K+ K+Q + I++ IA +A+LH
Sbjct: 94 CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY-NPISLLRQIASGVAHLHSL 152
Query: 893 CVPRIVHRDIKPSNILLD-------------EELNAYLSDFGLARLLEVSETHATTDV-- 937
+I+HRD+KP NIL+ E L +SDFGL + L+ + ++
Sbjct: 153 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 938 -AGTFGYVAPEY---ATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGN 986
+GT G+ APE +T R++ D++S G V ++S GK +S N
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147
pdb|3NIE|B Chain B, Crystal Structure Of Pf11_0147
Length = 429
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 56/240 (23%), Positives = 104/240 (43%), Gaps = 41/240 (17%)
Query: 771 VRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLG 826
V+ N+ I++LIG G +G Y A + VA+KK++ F+ + ++ EI L
Sbjct: 24 VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVN-RMFEDLIDCKRILREITILN 82
Query: 827 RIRHKNLVTLIGYYVGEA-----EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
R++ ++ L + E E+++V + F K+ + + I +
Sbjct: 83 RLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLF---KTPIFLTEQHVKTILYN 139
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAG- 939
+ ++H S I+HRD+KP+N LL+++ + + DFGLAR + + H D+
Sbjct: 140 LLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEK 196
Query: 940 ----------------------TFGYVAPEYATTCR-VSDKADVYSFGVVLLELISGKRS 976
T Y APE ++ D++S G + EL++ +S
Sbjct: 197 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKS 256
>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|B Chain B, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|C Chain C, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|D Chain D, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|E Chain E, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|F Chain F, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|G Chain G, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|H Chain H, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|I Chain I, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|J Chain J, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|K Chain K, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|L Chain L, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|M Chain M, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|N Chain N, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3SDM|A Chain A, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|B Chain B, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|C Chain C, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|D Chain D, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|E Chain E, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|F Chain F, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|G Chain G, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
Length = 448
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 65/234 (27%), Positives = 104/234 (44%), Gaps = 37/234 (15%)
Query: 781 NLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
++G G G+ G VAVK++ I F I + ++ T H N+ I YY
Sbjct: 39 KILGYGSSGTVVFQGSFQGRPVAVKRMLID-FCDIALMEIKLLTESD-DHPNV---IRYY 93
Query: 841 VGEAEMFLVYNFLS--GGNLETFIHKKS----GKKIQWSVIHKIAI--DIAQALAYLHYS 892
E +Y L NL+ + K+ K+Q + I++ IA +A+LH
Sbjct: 94 CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY-NPISLLRQIASGVAHLHSL 152
Query: 893 CVPRIVHRDIKPSNILLD-------------EELNAYLSDFGLARLLEVSETHATTDV-- 937
+I+HRD+KP NIL+ E L +SDFGL + L+ + ++
Sbjct: 153 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 938 -AGTFGYVAPEY---ATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGN 986
+GT G+ APE +T R++ D++S G V ++S GK +S N
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Jnj- 7706621
pdb|3AMB|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Vx- 680
Length = 351
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 34/209 (16%)
Query: 779 IRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAE-IGTLGRIRHK------ 831
IR L GTG FG ++ VK G ++ D + + L +I H
Sbjct: 47 IRTL-GTGSFGR----------VMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 832 -------NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
LV L + + +++V + GG E F H + + A I
Sbjct: 96 QQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGG--EMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
YLH +++RD+KP N+L+D++ ++DFG A+ ++ T + GT Y+
Sbjct: 154 TFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYL 206
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISG 973
APE + + D ++ GV++ E+ +G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 33/227 (14%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKLSI-GRFQGIQQFDAEIGTLGRI 828
N + +G G FG KA GY VAVK L ++ +E L ++
Sbjct: 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH--KKSG------------------- 867
H +++ L G + + L+ + G+L F+ +K G
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 868 -KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL 926
+ + + A I+Q + YL ++VHRD+ NIL+ E +SDFGL+R +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 927 EVSETHATTDVAGT-FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
+++ ++A E + ++DV+SFGV+L E+++
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|B Chain B, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|C Chain C, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|D Chain D, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
Length = 432
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 770 VVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI- 828
V+ +F ++++G G G+ + VAVK++ F D E+ L
Sbjct: 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESD 75
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNF--LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
H N+ I Y+ E + Y L L+ ++ +K + I + L
Sbjct: 76 EHPNV---IRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPI-TLLQQTTSGL 131
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDE-----ELNAYLSDFGLARLLEVSETHAT--TDVAG 939
A+LH IVHRD+KP NIL+ ++ A +SDFGL + L V + + V G
Sbjct: 132 AHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188
Query: 940 TFGYVAPEY-ATTCRVSD--KADVYSFGVVLLELIS 972
T G++APE + C+ + D++S G V +IS
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 78 NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFG A+LL E E HA ++A E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKWMALE 191
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 78 NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFG A+LL E E HA ++A E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKWMALE 191
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 51.6 bits (122), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 49/220 (22%), Positives = 97/220 (44%), Gaps = 27/220 (12%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVAVKKLS-IGRFQGIQQFDAEIGTL 825
A ++ +G G FG Y+ + P VA+K ++ + +F E +
Sbjct: 8 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH--------K 877
++V L+G ++ ++ G+L++++ + V+ +
Sbjct: 68 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV 937
+A +IA +AYL+ + + VHRD+ N ++ E+ + DFG+ R ++ ET
Sbjct: 128 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXXR-- 180
Query: 938 AGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
G G +++PE + +DV+SFGVVL E+ +
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 51.6 bits (122), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 41/231 (17%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKLSI-GRFQGIQQFDAEIGTLGRI 828
N + +G G FG KA GY VAVK L ++ +E L ++
Sbjct: 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH--KKSG------------------- 867
H +++ L G + + L+ + G+L F+ +K G
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 868 -KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL 926
+ + + A I+Q + YL ++VHRD+ NIL+ E +SDFGL+R
Sbjct: 144 ERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-- 198
Query: 927 EVSETHATTDVAGTFGYVAPEYATTCRVSD-----KADVYSFGVVLLELIS 972
+V E + V + G + ++ + D ++DV+SFGV+L E+++
Sbjct: 199 DVYEEDSX--VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 20 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 80 NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFG A+LL E E HA ++A E
Sbjct: 138 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKWMALE 193
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225
>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of
Camp-Dependent Protein Kinase
Length = 350
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 46/195 (23%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
+GTG FG +K + + K + + + I+ E L + LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
+ + +++V +++GG E F H + + A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
+RD+KP N+L+D++ ++DFG A+ ++ T + GT +APE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEALAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++ +G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 23 EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 83 NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 196
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 78 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFG A+LL E E HA ++A E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKWMALE 191
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 76 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFG A+LL E E HA ++A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKWMALE 189
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+ +L + ++ E + +
Sbjct: 50 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 110 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 167
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 168 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 223
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 224 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++G+G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 23 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 83 NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFG A+LL E E HA ++A E
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKWMALE 196
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 49/220 (22%), Positives = 97/220 (44%), Gaps = 27/220 (12%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVAVKKLS-IGRFQGIQQFDAEIGTL 825
A ++ +G G FG Y+ + P VA+K ++ + +F E +
Sbjct: 17 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH--------K 877
++V L+G ++ ++ G+L++++ + V+ +
Sbjct: 77 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV 937
+A +IA +AYL+ + + VHRD+ N ++ E+ + DFG+ R ++ ET
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXXR-- 189
Query: 938 AGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
G G +++PE + +DV+SFGVVL E+ +
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++ +G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 16 EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 76 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 189
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
F ++ +G FG+ YK +P VA+K+L + ++ E + +
Sbjct: 23 EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
+ ++ L+G + + + L+ + G L ++ ++ I + + IA+ + YL
Sbjct: 83 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
R+VHRD+ N+L+ + ++DFGLA+LL E E HA ++A E
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 196
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
+ ++DV+S+GV + EL++ G + D
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 50/212 (23%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 783 IGTGGFGSTYKA---ELVPGYL---VAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G G FG Y+ +++ G VAVK ++ + +F E + ++V
Sbjct: 22 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHK----------KSGKKIQWSVIHKIAIDIAQA 885
L+G +V ++ G+L++++ + +Q + ++A +IA
Sbjct: 82 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIADG 139
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG--- 942
+AYL+ + VHRD+ N ++ + + DFG+ R ++ ET G G
Sbjct: 140 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXR--KGGKGLLP 192
Query: 943 --YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + +D++SFGVVL E+ S
Sbjct: 193 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN++ L
Sbjct: 34 IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 90
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + ++++V + + IQ + H +++ + Q L +
Sbjct: 91 LNVFTPQKSLEEFQDVYIVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 141
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR S T Y APE
Sbjct: 142 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMVPFVVTRYYRAPEVI 199
Query: 950 TTCRVSDKADVYSFGVVLLELISG 973
+ D++S G ++ E+I G
Sbjct: 200 LGMGYKENVDIWSVGCIMGEMIKG 223
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 50/212 (23%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 783 IGTGGFGSTYKA---ELVPGYL---VAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G G FG Y+ +++ G VAVK ++ + +F E + ++V
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHK----------KSGKKIQWSVIHKIAIDIAQA 885
L+G +V ++ G+L++++ + +Q + ++A +IA
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIADG 142
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG--- 942
+AYL+ + VHRD+ N ++ + + DFG+ R ++ ET G G
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXR--KGGKGLLP 195
Query: 943 --YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + +D++SFGVVL E+ S
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum
In Complex With Indirubin E804
pdb|3EB0|C Chain C, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum
In Complex With Indirubin E804
Length = 383
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 63/246 (25%), Positives = 105/246 (42%), Gaps = 55/246 (22%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHK 831
++ +S+ +GTG FG + ++ G A+KK+ Q + + E+ + + H
Sbjct: 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHV 60
Query: 832 NLVTLIGYY--VGEAEMFLV-----YNFLSGGN--------------------------- 857
N++ L+ Y+ G+ E +N L G N
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 858 -------LETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD 910
L++FI +SG+ I ++I + +A+ ++H I HRDIKP N+L++
Sbjct: 121 PDTLHKVLKSFI--RSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVN 175
Query: 911 EELNAY-LSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKADVYSFGVVLL 968
+ N L DFG A+ L SE + + F Y APE + D++S G V
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEP-SVAXICSRF-YRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 969 ELISGK 974
ELI GK
Sbjct: 234 ELILGK 239
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 50/212 (23%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 783 IGTGGFGSTYKA---ELVPGYL---VAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G G FG Y+ +++ G VAVK ++ + +F E + ++V
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHK----------KSGKKIQWSVIHKIAIDIAQA 885
L+G +V ++ G+L++++ + +Q + ++A +IA
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIADG 142
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG--- 942
+AYL+ + VHRD+ N ++ + + DFG+ R ++ ET G G
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXR--KGGKGLLP 195
Query: 943 --YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + +D++SFGVVL E+ S
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin
pdb|3LJ0|B Chain B, Ire1 Complexed With Adp And Quercetin
pdb|3LJ1|A Chain A, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ1|B Chain B, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ2|A Chain A, Ire1 Complexed With Jak Inhibitor I
pdb|3LJ2|B Chain B, Ire1 Complexed With Jak Inhibitor I
Length = 434
Score = 50.4 bits (119), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 41/237 (17%)
Query: 782 LIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
++G G G+ G VAVK++ I F I + ++ T H N+ I YY
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLID-FCDIALMEIKLLTESD-DHPNV---IRYYC 76
Query: 842 GEAEMFLVYNFLS--GGNLETFIHKKS----GKKIQWSVIHKIAI--DIAQALAYLHYSC 893
E +Y L NL+ + K+ K+Q + I++ IA +A+LH
Sbjct: 77 SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY-NPISLLRQIASGVAHLHSL- 134
Query: 894 VPRIVHRDIKPSNILLD-------------EELNAYLSDFGLARLLEVSETHATTDV--- 937
+I+HRD+KP NIL+ E L +SDFGL + L+ + ++
Sbjct: 135 --KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 192
Query: 938 AGTFGYVAPE-------YATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGN 986
+GT G+ APE T R++ D++S G V ++S GK +S N
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major
pdb|3E3P|B Chain B, Glycogen Synthase Kinase From Leishmania Major
Length = 360
Score = 50.4 bits (119), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 19/216 (8%)
Query: 772 RATGNFSIRNLIGTGGFGSTY-KAELVPGYLVAVKK-LSIGRFQGIQ-QFDAEIGTLGRI 828
+ F + + G G FG+ E G VA+KK + RF+ + Q ++ L
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL--- 76
Query: 829 RHKNLVTLIGYY--VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV------IHKIAI 880
H N+V L Y+ +GE + +Y + + +H+ + V I
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDE-ELNAYLSDFGLARLLEVSETHATTDVAG 939
+ +++ LH V + HRDIKP N+L++E + L DFG A+ L SE + +
Sbjct: 137 QLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY-ICS 194
Query: 940 TFGYVAPEYA-TTCRVSDKADVYSFGVVLLELISGK 974
+ Y APE + D++S G + E++ G+
Sbjct: 195 RY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte
Receptors Of Jawless Vertebrates By Module Engineering
pdb|3RFS|B Chain B, Design Of A Binding Scaffold Based On Variable Lymphocyte
Receptors Of Jawless Vertebrates By Module Engineering
Length = 272
Score = 50.4 bits (119), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 56/186 (30%), Positives = 80/186 (43%), Gaps = 8/186 (4%)
Query: 509 SFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRV 568
+F+ + ANL +A + + ++ ANN S+ G+ L ++ L L GN++
Sbjct: 17 AFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNKL 75
Query: 569 SGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKAT 628
L +L L +++L GN L F L +L L L N L K T
Sbjct: 76 HDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLT 133
Query: 629 KLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS----GHIPHLQHLDCIAFKGNKY 684
L L LAHN+L F L NL+ LDLS+N L G L L + N+
Sbjct: 134 NLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ- 192
Query: 685 LASCPD 690
L S PD
Sbjct: 193 LKSVPD 198
Score = 44.3 bits (103), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 45/145 (31%), Positives = 62/145 (42%), Gaps = 6/145 (4%)
Query: 550 AGVGKLMKLQRLDLRGNRVSGSLPDEL-GKLKFLKWILLGGNNLTGEIPSQFGHLISLVV 608
+ + +L L L L GN++ SLP+ + KL LK ++L N L F L +L
Sbjct: 79 SALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTY 137
Query: 609 LDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNL---- 664
L+L+HN L K T L L L++N+L F L L L L N L
Sbjct: 138 LNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVP 197
Query: 665 SGHIPHLQHLDCIAFKGNKYLASCP 689
G L L I N + +CP
Sbjct: 198 DGVFDRLTSLQYIWLHDNPWDCTCP 222
Score = 39.3 bits (90), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 44/135 (32%), Positives = 62/135 (45%), Gaps = 4/135 (2%)
Query: 542 NQISGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDEL-GKLKFLKWILLGGNNLTGEIPSQ 599
NQ+ S+ GV KL L+ L L N++ SLPD + KL L ++ L N L
Sbjct: 95 NQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGV 152
Query: 600 FGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDL 659
F L +L LDLS+N L K T+L+ L L N+L F L +L + L
Sbjct: 153 FDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWL 212
Query: 660 SFNNLSGHIPHLQHL 674
N P +++L
Sbjct: 213 HDNPWDCTCPGIRYL 227
>pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By
Binding Of A Tri-Acylated Lipopeptide
Length = 520
Score = 50.4 bits (119), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 129/537 (24%), Positives = 212/537 (39%), Gaps = 86/537 (16%)
Query: 163 IPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFL 222
+P +S ++ +LN+S N S ++ +L ++ +S NR+ L I + L
Sbjct: 15 VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQEL 71
Query: 223 TYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEG-SIPKEIGTISELKVLDVSRNSL- 280
YL LS N L + NLK+L L N + I KE G +S+LK L +S L
Sbjct: 72 EYLDLSHNKL---VKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 281 -TDRIPVELADCSKLSVLVLTNIDASLDLD-----NSRGEFSAFDGGVPYELLLSRSLE- 333
+ +P+ + SK+ +++ D + N+ F + +L S++
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKT 188
Query: 334 VLWAPRANLGGRLPDNWSESCS--LKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLE 391
V +N+ L DN CS L +L Q + K + +L+LNN+E
Sbjct: 189 VANLELSNIKCVLEDN---KCSYFLSILAKLQTNPKLS--------------NLTLNNIE 231
Query: 392 GYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFV 451
+ + +V+ H +NV + G + +F
Sbjct: 232 TTWNSFIRILQLVW----------------------HTTVWYFSISNVKLQGQLDFRDF- 268
Query: 452 IIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERI------SKCN 505
D+SG L +L + + Y + N N+ N +V G R+ SK +
Sbjct: 269 ---DYSGTS-LKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324
Query: 506 DLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEA---ANNQIS--GSIAAGVGKLMKLQR 560
++ S NLL+ +E +C L E E NQ+ IA ++ LQ+
Sbjct: 325 PF--LHLDFSNNLLTDTVFE----NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQ 378
Query: 561 LDLRGNRVSGSLPDELGKLKFLKWIL---LGGNNLTGEIPSQFGHLISLVVLDLSHNALT 617
LD+ N VS ++ G + K +L + N LT I I VLDL N +
Sbjct: 379 LDISQNSVSYD--EKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIK--VLDLHSNKI- 433
Query: 618 GSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHL 674
SIP + K L+ L +A N+L F L +L + L N P + +L
Sbjct: 434 KSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 490
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 50.4 bits (119), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 57/231 (24%), Positives = 98/231 (42%), Gaps = 41/231 (17%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKLSI-GRFQGIQQFDAEIGTLGRI 828
N + +G G FG KA GY VAVK L ++ +E L ++
Sbjct: 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH--KKSG------------------- 867
H +++ L G + + L+ + G+L F+ +K G
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 868 -KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL 926
+ + + A I+Q + YL +VHRD+ NIL+ E +SDFGL+R
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSR-- 198
Query: 927 EVSETHATTDVAGTFGYVAPEYATTCRVSD-----KADVYSFGVVLLELIS 972
+V E + V + G + ++ + D ++DV+SFGV+L E+++
Sbjct: 199 DVYEEDSX--VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B)
pdb|3LM5|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B) IN Complex With Quercetin
Length = 327
Score = 50.1 bits (118), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 33/143 (23%), Positives = 71/143 (49%), Gaps = 8/143 (5%)
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
++ L Y +E+ L+ + +GG + + + + + + + ++ I + + YLH +
Sbjct: 91 VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN 150
Query: 893 CVPRIVHRDIKPSNILLDEEL---NAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
IVH D+KP NILL + + DFG++R ++ ++ GT Y+APE
Sbjct: 151 ---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR--KIGHACELREIMGTPEYLAPEIL 205
Query: 950 TTCRVSDKADVYSFGVVLLELIS 972
++ D+++ G++ L++
Sbjct: 206 NYDPITTATDMWNIGIIAYMLLT 228
>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 2-(aminothiazoly)phenol (cmp2)
Length = 336
Score = 50.1 bits (118), Expect = 7e-06, Method: Composition-based stats.
Identities = 54/197 (27%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 783 IGTGGFGSTYK-AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
+G G FG ++ + G+ AVKK+ + F+ +++ A G + +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-VEELVACAG----LSSPRIVPLYGAVR 120
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
+ + L GG+L I K+ G + ++ + QAL L Y RI+H D
Sbjct: 121 EGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLG----QALEGLEYLHTRRILHGD 175
Query: 902 IKPSNILLDEE-LNAYLSDFGLARLLE---VSETHATTD-VAGTFGYVAPEYATTCRVSD 956
+K N+LL + A L DFG A L+ + ++ T D + GT ++APE
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235
Query: 957 KADVYSFGVVLLELISG 973
K D++S ++L +++G
Sbjct: 236 KVDIWSSCCMMLHMLNG 252
>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex
pdb|4B8C|J Chain J, Nuclease Module Of The Yeast Ccr4-Not Complex
pdb|4B8C|K Chain K, Nuclease Module Of The Yeast Ccr4-Not Complex
pdb|4B8C|L Chain L, Nuclease Module Of The Yeast Ccr4-Not Complex
Length = 727
Score = 50.1 bits (118), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 35/87 (40%), Positives = 50/87 (57%), Gaps = 3/87 (3%)
Query: 578 KLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAH 637
K FL + L GN+LT E+P++ +L +L VLDLSHN LT S+PA L +L+ +
Sbjct: 245 KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFD 302
Query: 638 NRLSGEIPVSFSTLVNLSALDLSFNNL 664
N ++ +P F L NL L + N L
Sbjct: 303 NMVTT-LPWEFGNLCNLQFLGVEGNPL 328
Score = 40.8 bits (94), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 32/86 (37%), Positives = 42/86 (48%), Gaps = 3/86 (3%)
Query: 214 DSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVL 273
DS + + L LS N +I I K L L L+GN L +P EI +S L+VL
Sbjct: 218 DSKYDDQLWHALDLS-NLQIFNISANIFKYDFLTRLYLNGNSL-TELPAEIKNLSNLRVL 275
Query: 274 DVSRNSLTDRIPVELADCSKLSVLVL 299
D+S N LT +P EL C +L
Sbjct: 276 DLSHNRLTS-LPAELGSCFQLKYFYF 300
Score = 38.1 bits (87), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 17/108 (15%)
Query: 169 NLERLRVLNLSFNSFS--------------GEVPRGLIGNGELSVIDMSSNRLSGGLAID 214
+L L++ N+S N F E+P + L V+D+S NRL+ A
Sbjct: 230 DLSNLQIFNISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLTSLPAEL 289
Query: 215 SSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPK 262
S C L Y DN +T ++P E G NL+ L ++GN LE K
Sbjct: 290 GS--CFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLK 334
Score = 30.8 bits (68), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 24/59 (40%), Positives = 31/59 (52%), Gaps = 2/59 (3%)
Query: 608 VLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSG 666
LDLS N +I A++ K L L+L N L+ E+P L NL LDLS N L+
Sbjct: 228 ALDLS-NLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTS 284
>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine
Inhibitor
Length = 369
Score = 50.1 bits (118), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 27/205 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN++ L
Sbjct: 37 IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 93
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + ++++V + + IQ + H +++ + Q L +
Sbjct: 94 LNVFTPQKSLEEFQDVYIVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 144
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 145 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 202
Query: 950 TTCRVSDKADVYSFGVVLLELISGK 974
+ D++S G ++ E++ K
Sbjct: 203 LGMGYKENVDLWSVGCIMGEMVCHK 227
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 49.7 bits (117), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 37 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 97 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 154
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 155 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 206
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 49.7 bits (117), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 38 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 98 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 155
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 156 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 207
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 49.7 bits (117), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 37 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 97 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 154
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 155 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 206
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 49.7 bits (117), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 37 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 97 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 154
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 155 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 206
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor
Length = 358
Score = 49.7 bits (117), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 27/205 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN++ L
Sbjct: 26 IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 82
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + ++++V + + IQ + H +++ + Q L +
Sbjct: 83 LNVFTPQKSLEEFQDVYIVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 133
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR S T T Y APE
Sbjct: 134 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 191
Query: 950 TTCRVSDKADVYSFGVVLLELISGK 974
+ D++S G ++ E++ K
Sbjct: 192 LGMGYKENVDLWSVGCIMGEMVCHK 216
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 49.7 bits (117), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 38 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 98 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 155
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 156 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 207
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3)
Length = 350
Score = 49.7 bits (117), Expect = 9e-06, Method: Composition-based stats.
Identities = 54/197 (27%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 783 IGTGGFGSTYK-AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
+G G FG ++ + G+ AVKK+ + F+ +++ A G + +V L G
Sbjct: 80 LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-VEELVACAG----LSSPRIVPLYGAVR 134
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
+ + L GG+L I K+ G + ++ + QAL L Y RI+H D
Sbjct: 135 EGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLG----QALEGLEYLHTRRILHGD 189
Query: 902 IKPSNILLDEE-LNAYLSDFGLARLLE---VSETHATTD-VAGTFGYVAPEYATTCRVSD 956
+K N+LL + A L DFG A L+ + ++ T D + GT ++APE
Sbjct: 190 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 249
Query: 957 KADVYSFGVVLLELISG 973
K D++S ++L +++G
Sbjct: 250 KVDIWSSCCMMLHMLNG 266
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 49.7 bits (117), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 37 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 97 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 154
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 155 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 206
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 49.7 bits (117), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 24 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 84 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 141
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 142 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 193
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 194 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 49.7 bits (117), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 161
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 162 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 213
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 49.7 bits (117), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 38 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 98 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 155
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 156 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 207
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 49.7 bits (117), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 38 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 98 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 155
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 156 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 207
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 49.7 bits (117), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 52 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 169
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 170 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 221
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 24 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 84 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 141
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 142 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 193
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 194 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 52 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 169
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 170 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 221
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 25 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 85 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 142
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 143 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 194
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226
>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O17|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O2M|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
pdb|3O2M|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
Length = 370
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 62/242 (25%), Positives = 107/242 (44%), Gaps = 34/242 (14%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
IG+G G + Y A L VA+KKLS FQ ++ E+ + + HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
+ + + ++++V + + IQ + H +++ + Q L +
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 139
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
+ I+HRD+KPSNI++ + + DFGLAR S V T Y APE
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV--TRYYRAPEVI 197
Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
+ D++S G ++ E++ K L P G + I W K++ + G F+
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVCHK-ILFP-----GRDY-IDQWNKVIEQLGTPCPAFMK 250
Query: 1010 EL 1011
+L
Sbjct: 251 KL 252
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/220 (22%), Positives = 97/220 (44%), Gaps = 27/220 (12%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVAVKKLS-IGRFQGIQQFDAEIGTL 825
A ++ +G G FG Y+ + P VA+K ++ + +F E +
Sbjct: 10 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH--------K 877
++V L+G ++ ++ G+L++++ + V+ +
Sbjct: 70 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV 937
+A +IA +AYL+ + + VHRD+ N ++ E+ + DFG+ R ++ ET
Sbjct: 130 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR-- 182
Query: 938 AGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
G G +++PE + +DV+SFGVVL E+ +
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222
>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp
Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12
An 193189
pdb|3MDY|C Chain C, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp
Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12
An 193189
Length = 337
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 72/289 (24%), Positives = 119/289 (41%), Gaps = 50/289 (17%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV- 841
IG G +G + + G VAVK + + EI +RH+N++ I +
Sbjct: 45 IGKGRYGEVWMGKW-RGEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 842 ---GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
+++L+ ++ G+L ++ + + + K+A L +LH
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQG 159
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-----AGTFGYVAPEY 948
P I HRD+K NIL+ + ++D GLA +S+T+ D+ GT Y+ PE
Sbjct: 160 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF-ISDTNE-VDIPPNTRVGTKRYMPPEV 217
Query: 949 ATTCRVSDK------ADVYSFGVVLLEL----ISG---------KRSLDPSFSEYGNGFN 989
+ AD+YSFG++L E+ +SG L PS Y +
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277
Query: 990 IVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTR 1038
IV IK+ R S P W + E L M +L + C ++R
Sbjct: 278 IVC-----IKKLRPS---FPNRWSS--DECLRQMGKLMTECWAHNPASR 316
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 10 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 70 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 127
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 128 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 179
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 25 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 85 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 142
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 143 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 194
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 57 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 174
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 175 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 226
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 227 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 25 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 85 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 142
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 143 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 194
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 42/178 (23%), Positives = 85/178 (47%), Gaps = 14/178 (7%)
Query: 801 LVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMF--LVYNFLSGGNL 858
+V V K+ + + F+ E L H N++ ++G L+ +++ G+L
Sbjct: 37 VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSL 96
Query: 859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS 918
+H+ + + S K A+D+A+ +A+LH + P I + ++++DE++ A +S
Sbjct: 97 YNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARIS 155
Query: 919 DFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD----KADVYSFGVVLLELIS 972
+ +V + + +VAPE A + D AD++SF V+L EL++
Sbjct: 156 ------MADVKFSFQSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVT 206
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 47/208 (22%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 783 IGTGGFGSTYKA---ELVPGYL---VAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G G FG Y+ +++ G VAVK ++ + +F E + ++V
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHK----------KSGKKIQWSVIHKIAIDIAQA 885
L+G +V ++ G+L++++ + +Q + ++A +IA
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIADG 142
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTFGYV 944
+AYL+ + VHRD+ N ++ + + DFG+ R + E + ++
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM 199
Query: 945 APEYATTCRVSDKADVYSFGVVLLELIS 972
APE + +D++SFGVVL E+ S
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
+ + L+G+GGFGS Y V L VA+K + R + E+ L ++
Sbjct: 10 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
++ L+ ++ L+ +L FI ++ +Q + + +A
Sbjct: 70 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 127
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
+ + H +C ++HRDIK NIL+D LN L DFG LL+ + TD GT
Sbjct: 128 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 179
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
Y PE+ R + A V+S G++L +++ G
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211
>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And
Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1)
Length = 311
Score = 49.3 bits (116), Expect = 1e-05, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 22/197 (11%)
Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFD---AEIGTLGRIRHKNLVTLIG 838
+G G +G +K G L AVK+ S+ F+G + AE+G+ ++ +
Sbjct: 65 LGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
E + + L G +L+ + G + + + D ALA+LH +V
Sbjct: 124 QAWEEGGILYLQTELCGPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLV 179
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE-----YATTCR 953
H D+KP+NI L L DFGL L+E+ A G Y+APE Y T
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMAPELLQGSYGTA-- 235
Query: 954 VSDKADVYSFGVVLLEL 970
ADV+S G+ +LE+
Sbjct: 236 ----ADVFSLGLTILEV 248
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/220 (22%), Positives = 97/220 (44%), Gaps = 27/220 (12%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVAVKKLS-IGRFQGIQQFDAEIGTL 825
A ++ +G G FG Y+ + P VA+K ++ + +F E +
Sbjct: 17 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH--------K 877
++V L+G ++ ++ G+L++++ + V+ +
Sbjct: 77 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV 937
+A +IA +AYL+ + + VHRD+ N ++ E+ + DFG+ R ++ ET
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR-- 189
Query: 938 AGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
G G +++PE + +DV+SFGVVL E+ +
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229
>pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr)
Rbc36 In Complex With H-Trisaccharide
Length = 229
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 50/151 (33%), Positives = 66/151 (43%), Gaps = 11/151 (7%)
Query: 546 GSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIP-SQFGHLI 604
S+ AG+ Q L L N+++ P L LK + LG N L G +P F L
Sbjct: 32 ASVPAGIPT--NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLT 88
Query: 605 SLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNL 664
L VLDL N LT A + L+ LF+ N+L+ E+P L +L+ L L N L
Sbjct: 89 QLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
Query: 665 SGHIPH-----LQHLDCIAFKGNKYLASCPD 690
IPH L L GN + C D
Sbjct: 148 KS-IPHGAFDRLSSLTHAYLFGNPWDCECRD 177
>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
pdb|3N9X|B Chain B, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
Length = 432
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 56/233 (24%), Positives = 102/233 (43%), Gaps = 38/233 (16%)
Query: 771 VRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLG 826
V N+ I++LIG G +G Y A + VA+KK++ F+ + ++ EI L
Sbjct: 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILREITILN 80
Query: 827 RIRHKNLVTLIGYYVGEA-----EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
R++ ++ L + + E+++V + F K+ + I I +
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF---KTPIFLTEEHIKTILYN 137
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS-ETHATTDVAG- 939
+ ++H S I+HRD+KP+N LL+++ + + DFGLAR + +T+ D+
Sbjct: 138 LLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 940 -------------------TFGYVAPEYATTCRVSDKA-DVYSFGVVLLELIS 972
T Y APE K+ D++S G + EL++
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 48.9 bits (115), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 47/208 (22%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 783 IGTGGFGSTYKA---ELVPGYL---VAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G G FG Y+ +++ G VAVK ++ + +F E + ++V
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHK----------KSGKKIQWSVIHKIAIDIAQA 885
L+G +V ++ G+L++++ + +Q + ++A +IA
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIADG 142
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTFGYV 944
+AYL+ + VHRD+ N ++ + + DFG+ R + E ++
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 945 APEYATTCRVSDKADVYSFGVVLLELIS 972
APE + +D++SFGVVL E+ S
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 48.9 bits (115), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 40/166 (24%), Positives = 77/166 (46%), Gaps = 27/166 (16%)
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK----KIQWSVIHKI------- 878
H+N+V L+G ++L++ + G+L ++ K K +I++ ++
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 879 ----------AIDIAQALAYLHY-SCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LL 926
A +A+ + +L + SCV HRD+ N+L+ + DFGLAR ++
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCV----HRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 927 EVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
S + ++APE + K+DV+S+G++L E+ S
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 48.9 bits (115), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/220 (22%), Positives = 96/220 (43%), Gaps = 27/220 (12%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVAVKKLS-IGRFQGIQQFDAEIGTL 825
A ++ +G G FG Y+ + P VA+K ++ + +F E +
Sbjct: 13 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH--------K 877
++V L+G ++ ++ G+L++++ V+ +
Sbjct: 73 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV 937
+A +IA +AYL+ + + VHRD+ N ++ E+ + DFG+ R ++ ET
Sbjct: 133 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR-- 185
Query: 938 AGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
G G +++PE + +DV+SFGVVL E+ +
Sbjct: 186 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225
>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1
Catalytic Domain Apo Form
Length = 390
Score = 48.9 bits (115), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 37/221 (16%)
Query: 777 FSIRNLIGTGGFGSTYKA--ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN-- 832
+SI IG+GG ++ E Y + L Q + + EI L +++ +
Sbjct: 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLE--TFIHKKSG-----KKIQWSVIHKIAIDIAQA 885
++ L Y + + +++V + GN++ +++ KK +K W ++ +A
Sbjct: 118 IIRLYDYEITDQYIYMV---MECGNIDLNSWLKKKKSIDPWERKSYWK-------NMLEA 167
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYV 944
+ +H IVH D+KP+N L+ + + L DFG+A ++ T D GT Y+
Sbjct: 168 VHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 945 APEYATTCRVSDK-----------ADVYSFGVVLLELISGK 974
PE S + +DV+S G +L + GK
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 50/212 (23%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 783 IGTGGFGSTYKA---ELVPGYL---VAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
+G G FG Y+ +++ G VAVK ++ + +F E + ++V
Sbjct: 24 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHK----------KSGKKIQWSVIHKIAIDIAQA 885
L+G +V ++ G+L++++ + +Q + ++A +IA
Sbjct: 84 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIADG 141
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG--- 942
+AYL+ + VHRD+ N ++ + + DFG+ R ++ ET G G
Sbjct: 142 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR--KGGKGLLP 194
Query: 943 --YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
++APE + +D++SFGVVL E+ S
Sbjct: 195 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/220 (22%), Positives = 97/220 (44%), Gaps = 27/220 (12%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVAVKKLS-IGRFQGIQQFDAEIGTL 825
A ++ +G G FG Y+ + P VA+K ++ + +F E +
Sbjct: 45 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH--------K 877
++V L+G ++ ++ G+L++++ + V+ +
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 164
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV 937
+A +IA +AYL+ + + VHRD+ N ++ E+ + DFG+ R ++ ET
Sbjct: 165 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR-- 217
Query: 938 AGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
G G +++PE + +DV+SFGVVL E+ +
Sbjct: 218 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257
>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVJ|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVK|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVL|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVM|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVN|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|3BE9|A Chain A, Structure-Based Design And Synthesis Of Novel Macrocyclic
Pyrazolo[1,5-A] [1,3,5]triazine Compounds As Potent
Inhibitors Of Protein Kinase Ck2 And Their Anticancer
Activities
Length = 352
Score = 48.1 bits (113), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 47/182 (25%), Positives = 83/182 (45%), Gaps = 27/182 (14%)
Query: 827 RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
R +H +LI YV + ++Y L+ ++ +I+ ++ +AL
Sbjct: 117 RDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIY-----------------ELLKAL 159
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNA-YLSDFGLARLLEVSETHATTDVAGTFGYVA 945
Y H I+HRD+KP N+++D EL L D+GLA + + VA + +
Sbjct: 160 DYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRY-FKG 214
Query: 946 PEYATTCRVSDKA-DVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004
PE + D + D++S G + +I K +P F + N +V AK+L +G ++
Sbjct: 215 PELLVDLQDYDYSLDMWSLGCMFAGMIFRK---EPFFYGHDNHDQLVKIAKVLGTDGLNA 271
Query: 1005 EL 1006
L
Sbjct: 272 YL 273
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.319 0.135 0.395
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 29,244,870
Number of Sequences: 62578
Number of extensions: 1225124
Number of successful extensions: 6102
Number of sequences better than 100.0: 1000
Number of HSP's better than 100.0 without gapping: 931
Number of HSP's successfully gapped in prelim test: 269
Number of HSP's that attempted gapping in prelim test: 3010
Number of HSP's gapped (non-prelim): 1584
length of query: 1052
length of database: 14,973,337
effective HSP length: 109
effective length of query: 943
effective length of database: 8,152,335
effective search space: 7687651905
effective search space used: 7687651905
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 57 (26.6 bits)